<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:admin="http://webns.net/mvcb/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel rdf:about="https://www.mdpi.com/rss/journal/tropicalmed">
		<title>Tropical Medicine and Infectious Disease</title>
		<description>Latest open access articles published in Trop. Med. Infect. Dis. at https://www.mdpi.com/journal/tropicalmed</description>
		<link>https://www.mdpi.com/journal/tropicalmed</link>
		<admin:generatorAgent rdf:resource="https://www.mdpi.com/journal/tropicalmed"/>
		<admin:errorReportsTo rdf:resource="mailto:support@mdpi.com"/>
		<dc:publisher>MDPI</dc:publisher>
		<dc:language>en</dc:language>
		<dc:rights>Creative Commons Attribution (CC-BY)</dc:rights>
						<prism:copyright>MDPI</prism:copyright>
		<prism:rightsAgent>support@mdpi.com</prism:rightsAgent>
		<image rdf:resource="https://pub.mdpi-res.com/img/design/mdpi-pub-logo.png?13cf3b5bd783e021?1789717955"/>
				<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/259" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/258" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/257" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/256" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/255" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/254" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/253" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/252" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/251" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/250" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/249" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/248" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/247" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/246" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/245" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/244" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/243" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/242" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/241" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/240" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/239" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/238" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/9/237" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/236" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/235" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/234" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/233" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/232" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/231" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/230" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/229" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/228" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/227" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/226" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/225" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/224" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/223" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/222" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/221" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/220" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/219" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/218" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/217" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/216" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/215" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/214" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/213" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/212" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/211" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/210" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/209" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/8/208" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/207" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/206" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/205" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/203" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/204" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/202" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/201" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/200" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/199" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/198" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/197" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/196" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/195" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/194" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/193" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/192" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/191" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/190" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/189" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/188" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/187" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/186" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/185" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/184" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/183" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/182" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/181" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/180" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/179" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/177" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/178" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/176" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/175" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/174" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/173" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/172" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/7/171" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/170" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/169" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/168" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/167" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/166" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/165" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/164" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/163" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/162" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/161" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2414-6366/11/6/160" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="https://creativecommons.org/licenses/by/4.0/" />
	</channel>

        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/259">

	<title>TropicalMed, Vol. 11, Pages 259: Risk Factors for Poor Neurological Outcomes at Discharge in Tuberculous Meningitis: Disease Severity, Host Factors, and Drug Therapy</title>
	<link>https://www.mdpi.com/2414-6366/11/9/259</link>
	<description>Introduction: This study investigated independent factors associated with neurological prognosis at discharge in patients with tuberculous meningitis (TBM) and evaluated the impact of intensified treatment regimens. Methods: A retrospective analysis was conducted in 518 TBM patients from two Chinese medical centers. LASSO and multivariable logistic regression were used to identify independent risk factors for poor neurological outcomes. A 1:1 PSM based on intensified treatment exposure was performed to assess its association with neurological outcomes, with an exploratory outcome-based matched comparison conducted for other prognostic factors. Results: Among 518 patients, 123 (23.75%) had poor neurological outcomes. The poor-prognosis group had higher proportions of MRC stage III (30.08% vs. 8.35%, p &amp;amp;lt; 0.001), linezolid use (58.54% vs. 40.76%, |SMD| = 0.361), and fluoroquinolone use (87.8% vs. 75.19%, |SMD| = 0.386). Multivariable analysis identified decreased muscle strength, MRC stage II/III, albumin &amp;amp;lt; 30 g/L, and hydrocephalus as independent risk factors for poor neurological outcomes. After treatment-exposure-based PSM, intensified treatment was not significantly associated with neurological outcomes, while an exploratory matched analysis suggested a potential association between diabetes mellitus and unfavorable neurological outcomes. Conclusion: Neurological prognosis in TBM is influenced by both disease severity and host baseline status. Intensified therapy was not significantly associated with neurological outcome at discharge after adjustment, highlighting the importance of individualized risk management.</description>
	<pubDate>2026-09-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 259: Risk Factors for Poor Neurological Outcomes at Discharge in Tuberculous Meningitis: Disease Severity, Host Factors, and Drug Therapy</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/259">doi: 10.3390/tropicalmed11090259</a></p>
	<p>Authors:
		Yuxia Yu
		Huarui Liu
		Huan Yang
		Dan Ye
		Lu Xia
		Xiaoqing Ma
		Jiayi Wang
		Yuchong Sun
		Feng Li
		Yuanyuan Chen
		</p>
	<p>Introduction: This study investigated independent factors associated with neurological prognosis at discharge in patients with tuberculous meningitis (TBM) and evaluated the impact of intensified treatment regimens. Methods: A retrospective analysis was conducted in 518 TBM patients from two Chinese medical centers. LASSO and multivariable logistic regression were used to identify independent risk factors for poor neurological outcomes. A 1:1 PSM based on intensified treatment exposure was performed to assess its association with neurological outcomes, with an exploratory outcome-based matched comparison conducted for other prognostic factors. Results: Among 518 patients, 123 (23.75%) had poor neurological outcomes. The poor-prognosis group had higher proportions of MRC stage III (30.08% vs. 8.35%, p &amp;amp;lt; 0.001), linezolid use (58.54% vs. 40.76%, |SMD| = 0.361), and fluoroquinolone use (87.8% vs. 75.19%, |SMD| = 0.386). Multivariable analysis identified decreased muscle strength, MRC stage II/III, albumin &amp;amp;lt; 30 g/L, and hydrocephalus as independent risk factors for poor neurological outcomes. After treatment-exposure-based PSM, intensified treatment was not significantly associated with neurological outcomes, while an exploratory matched analysis suggested a potential association between diabetes mellitus and unfavorable neurological outcomes. Conclusion: Neurological prognosis in TBM is influenced by both disease severity and host baseline status. Intensified therapy was not significantly associated with neurological outcome at discharge after adjustment, highlighting the importance of individualized risk management.</p>
	]]></content:encoded>

	<dc:title>Risk Factors for Poor Neurological Outcomes at Discharge in Tuberculous Meningitis: Disease Severity, Host Factors, and Drug Therapy</dc:title>
			<dc:creator>Yuxia Yu</dc:creator>
			<dc:creator>Huarui Liu</dc:creator>
			<dc:creator>Huan Yang</dc:creator>
			<dc:creator>Dan Ye</dc:creator>
			<dc:creator>Lu Xia</dc:creator>
			<dc:creator>Xiaoqing Ma</dc:creator>
			<dc:creator>Jiayi Wang</dc:creator>
			<dc:creator>Yuchong Sun</dc:creator>
			<dc:creator>Feng Li</dc:creator>
			<dc:creator>Yuanyuan Chen</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090259</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-14</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-14</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>259</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090259</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/259</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/258">

	<title>TropicalMed, Vol. 11, Pages 258: Exploring the Effects of Climate Variability on Diarrheal Diseases, Malaria, and Malnutrition in Children Under Five Years in Revu&amp;egrave; Sub-Basin, Manica Province, Mozambique</title>
	<link>https://www.mdpi.com/2414-6366/11/9/258</link>
	<description>Transmission of water, vector, and foodborne diseases tends to increase with climate variability, disproportionately affecting vulnerable communities. Globally, this dynamic contributes to adverse health outcomes in low- and middle-income countries such as Mozambique. Nevertheless, the influence of climate variability on disease patterns remains unclear. We assessed the potential relationship between climate variables and diseases, including diarrheal diseases, malaria, and malnutrition, in four districts around the Revu&amp;amp;egrave; sub-basin. An ecological, longitudinal, retrospective study conducted from 2016 to 2024 used secondary weekly disease data and annual malnutrition records. We applied a Generalized Additive Model framework to evaluate non-linear associations between climate factors and disease case counts. Our main findings showed that while higher maximum temperature was associated with increased cumulative malaria case counts, cumulative and heavy rainfall (~100 mm/week) was associated with decreased diarrheal disease case counts. Higher prevalence of moderate acute malnutrition is associated with a decrease in annual mean total precipitation (p = 0.0062). In contrast, higher prevalence of severe acute malnutrition is associated with a decrease in annual mean temperature (p = 0.0312). This study contributes to understanding climate variables associated with water, vector, and foodborne diseases, enhancing our understanding of factors contributing to overall food insecurity and affecting public health.</description>
	<pubDate>2026-09-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 258: Exploring the Effects of Climate Variability on Diarrheal Diseases, Malaria, and Malnutrition in Children Under Five Years in Revu&amp;egrave; Sub-Basin, Manica Province, Mozambique</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/258">doi: 10.3390/tropicalmed11090258</a></p>
	<p>Authors:
		Tatiana J. Marrufo
		Genito A. Maúre
		Américo F. José
		Osvaldo F. Inlamea
		Bettencourt P. S. Capece
		Maria-Raquel G. Silva
		</p>
	<p>Transmission of water, vector, and foodborne diseases tends to increase with climate variability, disproportionately affecting vulnerable communities. Globally, this dynamic contributes to adverse health outcomes in low- and middle-income countries such as Mozambique. Nevertheless, the influence of climate variability on disease patterns remains unclear. We assessed the potential relationship between climate variables and diseases, including diarrheal diseases, malaria, and malnutrition, in four districts around the Revu&amp;amp;egrave; sub-basin. An ecological, longitudinal, retrospective study conducted from 2016 to 2024 used secondary weekly disease data and annual malnutrition records. We applied a Generalized Additive Model framework to evaluate non-linear associations between climate factors and disease case counts. Our main findings showed that while higher maximum temperature was associated with increased cumulative malaria case counts, cumulative and heavy rainfall (~100 mm/week) was associated with decreased diarrheal disease case counts. Higher prevalence of moderate acute malnutrition is associated with a decrease in annual mean total precipitation (p = 0.0062). In contrast, higher prevalence of severe acute malnutrition is associated with a decrease in annual mean temperature (p = 0.0312). This study contributes to understanding climate variables associated with water, vector, and foodborne diseases, enhancing our understanding of factors contributing to overall food insecurity and affecting public health.</p>
	]]></content:encoded>

	<dc:title>Exploring the Effects of Climate Variability on Diarrheal Diseases, Malaria, and Malnutrition in Children Under Five Years in Revu&amp;amp;egrave; Sub-Basin, Manica Province, Mozambique</dc:title>
			<dc:creator>Tatiana J. Marrufo</dc:creator>
			<dc:creator>Genito A. Maúre</dc:creator>
			<dc:creator>Américo F. José</dc:creator>
			<dc:creator>Osvaldo F. Inlamea</dc:creator>
			<dc:creator>Bettencourt P. S. Capece</dc:creator>
			<dc:creator>Maria-Raquel G. Silva</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090258</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-12</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-12</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>258</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090258</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/258</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/257">

	<title>TropicalMed, Vol. 11, Pages 257: Effects of Three Anthelmintics on the Transcriptome of FHs 74 Int Enterocytes</title>
	<link>https://www.mdpi.com/2414-6366/11/9/257</link>
	<description>Helminth infections continue to present a substantial public health challenge worldwide, particularly in tropical and developing areas. Despite the widespread use of anthelmintic drugs for treatment and control, their effects on host cells remain poorly understood. In this study, the three commonly used anthelmintics albendazole, ivermectin, and praziquantel were investigated by transcriptome analysis for their effects on gene activity in the human intestinal cell line FHs 74 Int after 24-h exposure. The drug concentrations used were substantially higher than in the treatment of helminthiases but did not affect cell viability after 24 h and less than 50% after 72 h. Praziquantel had negligible toxic effects on the intestinal cells at the highest achievable concentration of 1 mM whereas albendazole and ivermectin were already effective at low micromolar concentrations and were tested at 1 &amp;amp;micro;M and 15 &amp;amp;micro;M concentrations. Consistent with the observed cytotoxicity, transcriptome analysis showed no transcriptional changes for 1 mM praziquantel at low cutoff criteria of adjusted p-value (padj) &amp;amp;le; 0.05, log2 fold change &amp;amp;ge; 0. At the same padj but with log2 fold change &amp;amp;ge; 2, 17 upregulated and 2 downregulated genes were found after treatment with 1 &amp;amp;micro;M albendazole and 106 upregulated and 65 downregulated genes with 15 &amp;amp;micro;M ivermectin. Analysis of these genes showed that albendazole caused a modest upregulation of cell cycle related processes, especially mitotic spindle formation, and chromosome segregation. The cells showed a stronger response to ivermectin and the data suggested inhibition of cell proliferation through downregulated transcription factors and nuclear receptors and stimulation of cell growth and cell survival mechanisms through upregulated metabolic enzymes.</description>
	<pubDate>2026-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 257: Effects of Three Anthelmintics on the Transcriptome of FHs 74 Int Enterocytes</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/257">doi: 10.3390/tropicalmed11090257</a></p>
	<p>Authors:
		Kornkanok Nakudom
		Amornrat Geadkaew-Krenc
		Wansika Phadungsil
		Rudi Grams
		</p>
	<p>Helminth infections continue to present a substantial public health challenge worldwide, particularly in tropical and developing areas. Despite the widespread use of anthelmintic drugs for treatment and control, their effects on host cells remain poorly understood. In this study, the three commonly used anthelmintics albendazole, ivermectin, and praziquantel were investigated by transcriptome analysis for their effects on gene activity in the human intestinal cell line FHs 74 Int after 24-h exposure. The drug concentrations used were substantially higher than in the treatment of helminthiases but did not affect cell viability after 24 h and less than 50% after 72 h. Praziquantel had negligible toxic effects on the intestinal cells at the highest achievable concentration of 1 mM whereas albendazole and ivermectin were already effective at low micromolar concentrations and were tested at 1 &amp;amp;micro;M and 15 &amp;amp;micro;M concentrations. Consistent with the observed cytotoxicity, transcriptome analysis showed no transcriptional changes for 1 mM praziquantel at low cutoff criteria of adjusted p-value (padj) &amp;amp;le; 0.05, log2 fold change &amp;amp;ge; 0. At the same padj but with log2 fold change &amp;amp;ge; 2, 17 upregulated and 2 downregulated genes were found after treatment with 1 &amp;amp;micro;M albendazole and 106 upregulated and 65 downregulated genes with 15 &amp;amp;micro;M ivermectin. Analysis of these genes showed that albendazole caused a modest upregulation of cell cycle related processes, especially mitotic spindle formation, and chromosome segregation. The cells showed a stronger response to ivermectin and the data suggested inhibition of cell proliferation through downregulated transcription factors and nuclear receptors and stimulation of cell growth and cell survival mechanisms through upregulated metabolic enzymes.</p>
	]]></content:encoded>

	<dc:title>Effects of Three Anthelmintics on the Transcriptome of FHs 74 Int Enterocytes</dc:title>
			<dc:creator>Kornkanok Nakudom</dc:creator>
			<dc:creator>Amornrat Geadkaew-Krenc</dc:creator>
			<dc:creator>Wansika Phadungsil</dc:creator>
			<dc:creator>Rudi Grams</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090257</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-10</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-10</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>257</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090257</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/257</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/256">

	<title>TropicalMed, Vol. 11, Pages 256: Enterococcus mundtii CRL35 as a Dual-Route Treatment for Cutaneous Leishmaniasis: Preclinical Safety and Efficacy Assessment</title>
	<link>https://www.mdpi.com/2414-6366/11/9/256</link>
	<description>American tegumentary leishmaniasis (ATL) remains a therapeutic challenge due to the toxicity and limited effectiveness of conventional agents. This study evaluated Enterococcus mundtii CRL35, a food-grade lactic acid bacterium, as a dual-mechanism therapeutic platform against Leishmania (L.) amazonensis. Initial screening identified E. mundtii CRL35 as the most active strain among four enterococci tested, demonstrating high selectivity against promastigotes (SI = 95) and intracellular amastigotes (SI = 25). In a BALB/c murine model of cutaneous leishmaniasis, three treatment modalities were evaluated: topical application of cell-free supernatant (CFS-T), oral viable bacteria (LB-O), and their combination (CFS-T+LB-O). All three treatments achieved significant reductions in lesion parasite burden (approximately 2&amp;amp;ndash;3 orders of magnitude versus untreated controls), substantially exceeding the parasitological efficacy of amphotericin B under identical experimental conditions. CFS-T and CFS-T+LB-O additionally produced significant macroscopic lesion improvement. Importantly, no treatment was associated with adverse changes in organ indices or serum biochemical parameters. E. mundtii CRL35-based treatments promoted higher IgG2a/IgG1 antibody ratios compared to untreated controls and amphotericin B, generating an immune profile more favorable for intracellular parasite control. Taken together, these findings support the therapeutic potential of these modalities as safe, effective, and affordable alternatives for ATL, particularly in resource-limited endemic regions where toxicity and logistical barriers limit access to conventional therapy.</description>
	<pubDate>2026-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 256: Enterococcus mundtii CRL35 as a Dual-Route Treatment for Cutaneous Leishmaniasis: Preclinical Safety and Efficacy Assessment</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/256">doi: 10.3390/tropicalmed11090256</a></p>
	<p>Authors:
		María A. Occhionero
		Daniela A. Gaspar
		Daniela E. Barraza
		María Elisa Vázquez
		Brenda A. Zabala
		Rita A. Sandoval
		Lucila Saavedra
		Cecilia Pérez Brandán
		Natalia S. Corbalán
		Leonardo Acuña
		</p>
	<p>American tegumentary leishmaniasis (ATL) remains a therapeutic challenge due to the toxicity and limited effectiveness of conventional agents. This study evaluated Enterococcus mundtii CRL35, a food-grade lactic acid bacterium, as a dual-mechanism therapeutic platform against Leishmania (L.) amazonensis. Initial screening identified E. mundtii CRL35 as the most active strain among four enterococci tested, demonstrating high selectivity against promastigotes (SI = 95) and intracellular amastigotes (SI = 25). In a BALB/c murine model of cutaneous leishmaniasis, three treatment modalities were evaluated: topical application of cell-free supernatant (CFS-T), oral viable bacteria (LB-O), and their combination (CFS-T+LB-O). All three treatments achieved significant reductions in lesion parasite burden (approximately 2&amp;amp;ndash;3 orders of magnitude versus untreated controls), substantially exceeding the parasitological efficacy of amphotericin B under identical experimental conditions. CFS-T and CFS-T+LB-O additionally produced significant macroscopic lesion improvement. Importantly, no treatment was associated with adverse changes in organ indices or serum biochemical parameters. E. mundtii CRL35-based treatments promoted higher IgG2a/IgG1 antibody ratios compared to untreated controls and amphotericin B, generating an immune profile more favorable for intracellular parasite control. Taken together, these findings support the therapeutic potential of these modalities as safe, effective, and affordable alternatives for ATL, particularly in resource-limited endemic regions where toxicity and logistical barriers limit access to conventional therapy.</p>
	]]></content:encoded>

	<dc:title>Enterococcus mundtii CRL35 as a Dual-Route Treatment for Cutaneous Leishmaniasis: Preclinical Safety and Efficacy Assessment</dc:title>
			<dc:creator>María A. Occhionero</dc:creator>
			<dc:creator>Daniela A. Gaspar</dc:creator>
			<dc:creator>Daniela E. Barraza</dc:creator>
			<dc:creator>María Elisa Vázquez</dc:creator>
			<dc:creator>Brenda A. Zabala</dc:creator>
			<dc:creator>Rita A. Sandoval</dc:creator>
			<dc:creator>Lucila Saavedra</dc:creator>
			<dc:creator>Cecilia Pérez Brandán</dc:creator>
			<dc:creator>Natalia S. Corbalán</dc:creator>
			<dc:creator>Leonardo Acuña</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090256</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-10</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-10</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>256</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090256</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/256</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/255">

	<title>TropicalMed, Vol. 11, Pages 255: Co-Endemic Zoonoses, Divergent Dynamics: A Comparative Spatiotemporal Analysis of Crimean&amp;ndash;Congo Hemorrhagic Fever and Brucellosis with Implications for Integrated Surveillance</title>
	<link>https://www.mdpi.com/2414-6366/11/9/255</link>
	<description>Co-endemic zoonoses may occur in the same broad geographic settings but not necessarily the same communities or time periods. This study investigated whether Crimean&amp;amp;ndash;Congo hemorrhagic fever (CCHF) and brucellosis exhibit convergent or divergent spatiotemporal patterns across geographic scales in a livestock-dependent, CCHF-endemic province of T&amp;amp;uuml;rkiye. This retrospective study analyzed confirmed human CCHF and brucellosis cases reported to the national infectious disease surveillance system between 2011 and 2024. Temporal analyses, kernel density estimation, settlement-level random labeling, and within- and cross-disease Knox tests were performed. Among the 611 eligible cases, CCHF (n = 442; 72.3%) and brucellosis (n = 116; 19.0%) accounted for 91.3%. CCHF was strongly seasonal, with 99.3% of cases occurring between April and September, whereas brucellosis occurred throughout the year. Although broad density surfaces partially overlapped, same-settlement co-occurrence was substantially lower than expected (O/E = 0.37; p &amp;amp;lt; 0.001) and remained so in the sensitivity analysis (O/E = 0.74; p = 0.001). Cross-disease analysis showed no evidence that CCHF and brucellosis occurred closer together in both space and time than expected. Annualized CCHF concentration peaked in 2020&amp;amp;ndash;2021, whereas brucellosis peaked in 2022&amp;amp;ndash;2024. Integrated surveillance may use shared regional infrastructure, but interventions should be tailored to disease-specific settlements, transmission pathways, and periods of risk.</description>
	<pubDate>2026-09-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 255: Co-Endemic Zoonoses, Divergent Dynamics: A Comparative Spatiotemporal Analysis of Crimean&amp;ndash;Congo Hemorrhagic Fever and Brucellosis with Implications for Integrated Surveillance</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/255">doi: 10.3390/tropicalmed11090255</a></p>
	<p>Authors:
		Serdar Karakullukçu
		İrem Dilaver
		Murat Topbaş
		Merve Erdoğan
		Hüsniye Ebru Çolak
		Meral Fidan Uçan
		</p>
	<p>Co-endemic zoonoses may occur in the same broad geographic settings but not necessarily the same communities or time periods. This study investigated whether Crimean&amp;amp;ndash;Congo hemorrhagic fever (CCHF) and brucellosis exhibit convergent or divergent spatiotemporal patterns across geographic scales in a livestock-dependent, CCHF-endemic province of T&amp;amp;uuml;rkiye. This retrospective study analyzed confirmed human CCHF and brucellosis cases reported to the national infectious disease surveillance system between 2011 and 2024. Temporal analyses, kernel density estimation, settlement-level random labeling, and within- and cross-disease Knox tests were performed. Among the 611 eligible cases, CCHF (n = 442; 72.3%) and brucellosis (n = 116; 19.0%) accounted for 91.3%. CCHF was strongly seasonal, with 99.3% of cases occurring between April and September, whereas brucellosis occurred throughout the year. Although broad density surfaces partially overlapped, same-settlement co-occurrence was substantially lower than expected (O/E = 0.37; p &amp;amp;lt; 0.001) and remained so in the sensitivity analysis (O/E = 0.74; p = 0.001). Cross-disease analysis showed no evidence that CCHF and brucellosis occurred closer together in both space and time than expected. Annualized CCHF concentration peaked in 2020&amp;amp;ndash;2021, whereas brucellosis peaked in 2022&amp;amp;ndash;2024. Integrated surveillance may use shared regional infrastructure, but interventions should be tailored to disease-specific settlements, transmission pathways, and periods of risk.</p>
	]]></content:encoded>

	<dc:title>Co-Endemic Zoonoses, Divergent Dynamics: A Comparative Spatiotemporal Analysis of Crimean&amp;amp;ndash;Congo Hemorrhagic Fever and Brucellosis with Implications for Integrated Surveillance</dc:title>
			<dc:creator>Serdar Karakullukçu</dc:creator>
			<dc:creator>İrem Dilaver</dc:creator>
			<dc:creator>Murat Topbaş</dc:creator>
			<dc:creator>Merve Erdoğan</dc:creator>
			<dc:creator>Hüsniye Ebru Çolak</dc:creator>
			<dc:creator>Meral Fidan Uçan</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090255</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>255</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090255</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/255</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/254">

	<title>TropicalMed, Vol. 11, Pages 254: Health-Related Quality of Life of People Living with Hansen&amp;rsquo;s Disease Undergoing Multidrug Therapy</title>
	<link>https://www.mdpi.com/2414-6366/11/9/254</link>
	<description>Background: Multidrug therapy (MDT) is the cornerstone of treatment for Hansen&amp;amp;rsquo;s disease. We aimed to identify factors associated with health-related quality of life (HRQoL) of people with Hansen&amp;amp;rsquo;s disease undergoing MDT. Methods: Sixty-six people of any sex, aged 18 and older, undergoing MDT, without adverse reactions, were enrolled as outpatients at a public health service in Salvador, Brazil. A physical examination was performed, during which the Simplified Neurological Evaluation Form was used to determine the Degree of Physical Disability. The HRQoL was evaluated using the RAND-36 questionnaire and its Physical Component Summary (PCS) and Mental Component Summary (MCS). Results: The PCS and MCS were negatively associated with pain and positively associated with the Degree of Physical Disability after controlling for MDT duration, bacilloscopy, schooling, race/color, age, sex, and monthly income; the PCS was negatively associated with smoking. Patients who reported pain had a PCS 14.282 percent units lower than those who did not report it, and patients that reported pain had an MCS 6.762 units lower. Differences in such magnitude are clinically important for patients with Hansen&amp;amp;rsquo;s disease being treated with MDT. Conclusion: Pain and the Degree of Physical Disability are strongly associated with the HRQoL of patients with Hansen&amp;amp;rsquo;s disease undergoing MDT.</description>
	<pubDate>2026-09-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 254: Health-Related Quality of Life of People Living with Hansen&amp;rsquo;s Disease Undergoing Multidrug Therapy</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/254">doi: 10.3390/tropicalmed11090254</a></p>
	<p>Authors:
		Victor Feitosa de Freitas
		Liliane Lins-Kusterer
		Karen Valadares Trippo
		Herman Henrique Silva Santana
		Fernando Martins Carvalho
		</p>
	<p>Background: Multidrug therapy (MDT) is the cornerstone of treatment for Hansen&amp;amp;rsquo;s disease. We aimed to identify factors associated with health-related quality of life (HRQoL) of people with Hansen&amp;amp;rsquo;s disease undergoing MDT. Methods: Sixty-six people of any sex, aged 18 and older, undergoing MDT, without adverse reactions, were enrolled as outpatients at a public health service in Salvador, Brazil. A physical examination was performed, during which the Simplified Neurological Evaluation Form was used to determine the Degree of Physical Disability. The HRQoL was evaluated using the RAND-36 questionnaire and its Physical Component Summary (PCS) and Mental Component Summary (MCS). Results: The PCS and MCS were negatively associated with pain and positively associated with the Degree of Physical Disability after controlling for MDT duration, bacilloscopy, schooling, race/color, age, sex, and monthly income; the PCS was negatively associated with smoking. Patients who reported pain had a PCS 14.282 percent units lower than those who did not report it, and patients that reported pain had an MCS 6.762 units lower. Differences in such magnitude are clinically important for patients with Hansen&amp;amp;rsquo;s disease being treated with MDT. Conclusion: Pain and the Degree of Physical Disability are strongly associated with the HRQoL of patients with Hansen&amp;amp;rsquo;s disease undergoing MDT.</p>
	]]></content:encoded>

	<dc:title>Health-Related Quality of Life of People Living with Hansen&amp;amp;rsquo;s Disease Undergoing Multidrug Therapy</dc:title>
			<dc:creator>Victor Feitosa de Freitas</dc:creator>
			<dc:creator>Liliane Lins-Kusterer</dc:creator>
			<dc:creator>Karen Valadares Trippo</dc:creator>
			<dc:creator>Herman Henrique Silva Santana</dc:creator>
			<dc:creator>Fernando Martins Carvalho</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090254</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>254</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090254</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/254</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/253">

	<title>TropicalMed, Vol. 11, Pages 253: Dengue and Chikungunya Seroprevalence in an Urban Low-Income Cohort in Delhi: A Cross-Sectional and Nested Longitudinal Study</title>
	<link>https://www.mdpi.com/2414-6366/11/9/253</link>
	<description>Objectives: The aim of this study was to ascertain the seroprevalence and determinants of dengue virus (DENV) and chikungunya virus (CHIKV) seropositivity in Delhi, India. Methods: This cross-sectional serosurvey with a nested longitudinal immunological sub-study was conducted in an urban resettlement and slum settlement in the North-East district of Delhi in individuals aged &amp;amp;ge;2 years. Dengue and Chikungunya virus IgG antibodies were screened using indirect enzyme-linked immunosorbent assay (ELISA), and a longitudinal subset of 100 paired IgG-seropositive samples was further characterized via a plaque reduction neutralization test (&amp;amp;micro;PRNT50) to evaluate changes in functional neutralization over time. Results: A total of 752 participants, including 56.65% female participants, were included in the study. Of the participants studied, 81.91% (95% CI: 78.97, 84.60; n = 616) were positive for IgG antibodies against DENV, and 28.32% (95% CI: 25.13, 31.69; n = 213) were positive for CHIKV IgG antibodies. &amp;amp;micro;PRNT50 confirmed stable, near-universal CHIKV neutralization (97% baseline, 98% endline). However, DENV neutralizing antibody showed a significant contraction for DENV-3 (79% baseline, 60% endline) and DENV-4 (69% baseline, 60% endline), while DENV-1 (76%) and DENV-2 (77% to 80%) antibodies remained stable. Individuals living in households with screened windows had significantly lower odds of contracting DENV infection (AOR: 0.36; 95% CI: 0.21, 0.61) and CHIKV infection (AOR: 0.63; 95% CI: 0.43, 0.90) compared with those living in households without screened windows. Further, individuals from households with uncovered containers with stagnant water had 50% higher odds of CHIKV infection than those without such containers (AOR: 1.55; 95% CI: 1.05, 2.29). Conclusions: This study revealed a high burden of DENV and CHIKV exposure in this high-risk urban population. While neutralization remained stable for CHIKV, DENV-1, and DENV-2, waning DENV-3 and DENV-4 antibodies suggest differential serotype-specific immunity in the participants.</description>
	<pubDate>2026-09-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 253: Dengue and Chikungunya Seroprevalence in an Urban Low-Income Cohort in Delhi: A Cross-Sectional and Nested Longitudinal Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/253">doi: 10.3390/tropicalmed11090253</a></p>
	<p>Authors:
		Nandini Sharma
		Saurav Basu
		Shivani Rao
		Mrunali Zode
		Himanshu Bachawandia
		Meenakshi Bakshi
		Mongjam Meghachandra Singh
		</p>
	<p>Objectives: The aim of this study was to ascertain the seroprevalence and determinants of dengue virus (DENV) and chikungunya virus (CHIKV) seropositivity in Delhi, India. Methods: This cross-sectional serosurvey with a nested longitudinal immunological sub-study was conducted in an urban resettlement and slum settlement in the North-East district of Delhi in individuals aged &amp;amp;ge;2 years. Dengue and Chikungunya virus IgG antibodies were screened using indirect enzyme-linked immunosorbent assay (ELISA), and a longitudinal subset of 100 paired IgG-seropositive samples was further characterized via a plaque reduction neutralization test (&amp;amp;micro;PRNT50) to evaluate changes in functional neutralization over time. Results: A total of 752 participants, including 56.65% female participants, were included in the study. Of the participants studied, 81.91% (95% CI: 78.97, 84.60; n = 616) were positive for IgG antibodies against DENV, and 28.32% (95% CI: 25.13, 31.69; n = 213) were positive for CHIKV IgG antibodies. &amp;amp;micro;PRNT50 confirmed stable, near-universal CHIKV neutralization (97% baseline, 98% endline). However, DENV neutralizing antibody showed a significant contraction for DENV-3 (79% baseline, 60% endline) and DENV-4 (69% baseline, 60% endline), while DENV-1 (76%) and DENV-2 (77% to 80%) antibodies remained stable. Individuals living in households with screened windows had significantly lower odds of contracting DENV infection (AOR: 0.36; 95% CI: 0.21, 0.61) and CHIKV infection (AOR: 0.63; 95% CI: 0.43, 0.90) compared with those living in households without screened windows. Further, individuals from households with uncovered containers with stagnant water had 50% higher odds of CHIKV infection than those without such containers (AOR: 1.55; 95% CI: 1.05, 2.29). Conclusions: This study revealed a high burden of DENV and CHIKV exposure in this high-risk urban population. While neutralization remained stable for CHIKV, DENV-1, and DENV-2, waning DENV-3 and DENV-4 antibodies suggest differential serotype-specific immunity in the participants.</p>
	]]></content:encoded>

	<dc:title>Dengue and Chikungunya Seroprevalence in an Urban Low-Income Cohort in Delhi: A Cross-Sectional and Nested Longitudinal Study</dc:title>
			<dc:creator>Nandini Sharma</dc:creator>
			<dc:creator>Saurav Basu</dc:creator>
			<dc:creator>Shivani Rao</dc:creator>
			<dc:creator>Mrunali Zode</dc:creator>
			<dc:creator>Himanshu Bachawandia</dc:creator>
			<dc:creator>Meenakshi Bakshi</dc:creator>
			<dc:creator>Mongjam Meghachandra Singh</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090253</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>253</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090253</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/253</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/252">

	<title>TropicalMed, Vol. 11, Pages 252: Severe Dengue in Children: Pathogenesis, Early Recognition, and Evidence-Informed Management</title>
	<link>https://www.mdpi.com/2414-6366/11/9/252</link>
	<description>Severe dengue remains an important cause of pediatric hospitalization, morbidity, and mortality in tropical and subtropical regions, particularly where rapid triage and pediatric critical-care capacity are limited. This structured narrative review synthesizes the evidence on the epidemiology, pathogenesis, early recognition, diagnosis, management, and prevention of severe dengue in children. Severe disease reflects interactions among viral factors, pre-existing immunity, dysregulated host responses, and microvascular endothelial injury. Antibody-dependent enhancement, inflammatory mediators, dengue nonstructural protein 1, and endothelial glycocalyx disruption contribute to vascular hyperpermeability, plasma leakage, shock, severe bleeding, and organ impairment. Because deterioration often occurs abruptly around defervescence, serial clinical assessment, hematocrit trends, urine-output monitoring, and timely recognition of warning signs are central to risk stratification. Molecular assays and NS1 antigen testing are most useful during the early febrile phase, although diagnostic performance varies with illness timing and immune status. Carefully titrated isotonic crystalloid therapy remains the cornerstone of treatment; both delayed resuscitation and excessive fluid administration may worsen outcomes. Reducing mortality requires integrated clinical and public-health strategies combining standardized pediatric management, accessible diagnostics, effective referral systems, vaccination where appropriate, surveillance, and vector control.</description>
	<pubDate>2026-09-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 252: Severe Dengue in Children: Pathogenesis, Early Recognition, and Evidence-Informed Management</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/252">doi: 10.3390/tropicalmed11090252</a></p>
	<p>Authors:
		Hsien-Yi Wang
		Shih-Bin Su
		Chung-Yi Li
		Kow-Tong Chen
		</p>
	<p>Severe dengue remains an important cause of pediatric hospitalization, morbidity, and mortality in tropical and subtropical regions, particularly where rapid triage and pediatric critical-care capacity are limited. This structured narrative review synthesizes the evidence on the epidemiology, pathogenesis, early recognition, diagnosis, management, and prevention of severe dengue in children. Severe disease reflects interactions among viral factors, pre-existing immunity, dysregulated host responses, and microvascular endothelial injury. Antibody-dependent enhancement, inflammatory mediators, dengue nonstructural protein 1, and endothelial glycocalyx disruption contribute to vascular hyperpermeability, plasma leakage, shock, severe bleeding, and organ impairment. Because deterioration often occurs abruptly around defervescence, serial clinical assessment, hematocrit trends, urine-output monitoring, and timely recognition of warning signs are central to risk stratification. Molecular assays and NS1 antigen testing are most useful during the early febrile phase, although diagnostic performance varies with illness timing and immune status. Carefully titrated isotonic crystalloid therapy remains the cornerstone of treatment; both delayed resuscitation and excessive fluid administration may worsen outcomes. Reducing mortality requires integrated clinical and public-health strategies combining standardized pediatric management, accessible diagnostics, effective referral systems, vaccination where appropriate, surveillance, and vector control.</p>
	]]></content:encoded>

	<dc:title>Severe Dengue in Children: Pathogenesis, Early Recognition, and Evidence-Informed Management</dc:title>
			<dc:creator>Hsien-Yi Wang</dc:creator>
			<dc:creator>Shih-Bin Su</dc:creator>
			<dc:creator>Chung-Yi Li</dc:creator>
			<dc:creator>Kow-Tong Chen</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090252</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-08</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-08</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>252</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090252</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/252</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/251">

	<title>TropicalMed, Vol. 11, Pages 251: Elevated Levels of Environmental Enteric Dysfunction Biomarkers Among Rural Indonesian Infants: Associations with Water, Sanitation, Hygiene and Linear Growth</title>
	<link>https://www.mdpi.com/2414-6366/11/9/251</link>
	<description>Objective: To investigate the burden of environmental enteric dysfunction (EED) and its association with water, sanitation, and hygiene (WASH) and linear growth amongst infants in rural Central Java, Indonesia. Study design: A longitudinal study of 119 infants aged from 5&amp;amp;ndash;19 months was conducted in five villages of Wonosobo District, Central Java, Indonesia. Infant length and weight were measured at baseline and 5-month follow-up and stool samples were collected for the investigation of alpha-1-antitrypsin (AAT), neopterin (NEO), and myeloperoxidase (MPO) levels. Linear mixed-effects regression (LMER) models estimated the associations between WASH and height-for-age z-score (HAZ) on biomarker concentrations. Results: Biomarkers increased from baseline to follow-up where AAT, NEO, and MPO were elevated in 68.7%, 79.0%, and 71.4% of infants. Breastfed infants and infants with recent diarrhoea had higher biomarker levels than non-breastfed infants. After correction for multiple testing, few significant associations between EED biomarkers and WASH variables or HAZ were detected. EED biomarkers measured at baseline or follow-up were not significantly associated with growth faltering over the follow-up period. In cross-sectional analysis, compared to infants at risk of stunting (&amp;amp;minus;2 &amp;amp;lt; HAZ &amp;amp;le; &amp;amp;minus;1), infants with HAZ &amp;amp;gt; &amp;amp;minus;1 had lower AAT at baseline (&amp;amp;beta; = &amp;amp;minus;0.43, 95% CI = &amp;amp;minus;0.82 to &amp;amp;minus;0.05, padj &amp;amp;lt; 0.05). Conclusions: Elevated EED biomarker levels were frequently observed and had mixed associations with WASH and HAZ, highlighting the complexity of EED and need to understand EED etiology through intervention studies.</description>
	<pubDate>2026-09-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 251: Elevated Levels of Environmental Enteric Dysfunction Biomarkers Among Rural Indonesian Infants: Associations with Water, Sanitation, Hygiene and Linear Growth</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/251">doi: 10.3390/tropicalmed11090251</a></p>
	<p>Authors:
		Callum Lowe
		Tony Arjuna
		Mubasysyir Hasanbasri
		Haribondhu Sarma
		I Nyoman Sutarsa
		Severine Navarro
		Darren Gray
		Matthew Kelly
		</p>
	<p>Objective: To investigate the burden of environmental enteric dysfunction (EED) and its association with water, sanitation, and hygiene (WASH) and linear growth amongst infants in rural Central Java, Indonesia. Study design: A longitudinal study of 119 infants aged from 5&amp;amp;ndash;19 months was conducted in five villages of Wonosobo District, Central Java, Indonesia. Infant length and weight were measured at baseline and 5-month follow-up and stool samples were collected for the investigation of alpha-1-antitrypsin (AAT), neopterin (NEO), and myeloperoxidase (MPO) levels. Linear mixed-effects regression (LMER) models estimated the associations between WASH and height-for-age z-score (HAZ) on biomarker concentrations. Results: Biomarkers increased from baseline to follow-up where AAT, NEO, and MPO were elevated in 68.7%, 79.0%, and 71.4% of infants. Breastfed infants and infants with recent diarrhoea had higher biomarker levels than non-breastfed infants. After correction for multiple testing, few significant associations between EED biomarkers and WASH variables or HAZ were detected. EED biomarkers measured at baseline or follow-up were not significantly associated with growth faltering over the follow-up period. In cross-sectional analysis, compared to infants at risk of stunting (&amp;amp;minus;2 &amp;amp;lt; HAZ &amp;amp;le; &amp;amp;minus;1), infants with HAZ &amp;amp;gt; &amp;amp;minus;1 had lower AAT at baseline (&amp;amp;beta; = &amp;amp;minus;0.43, 95% CI = &amp;amp;minus;0.82 to &amp;amp;minus;0.05, padj &amp;amp;lt; 0.05). Conclusions: Elevated EED biomarker levels were frequently observed and had mixed associations with WASH and HAZ, highlighting the complexity of EED and need to understand EED etiology through intervention studies.</p>
	]]></content:encoded>

	<dc:title>Elevated Levels of Environmental Enteric Dysfunction Biomarkers Among Rural Indonesian Infants: Associations with Water, Sanitation, Hygiene and Linear Growth</dc:title>
			<dc:creator>Callum Lowe</dc:creator>
			<dc:creator>Tony Arjuna</dc:creator>
			<dc:creator>Mubasysyir Hasanbasri</dc:creator>
			<dc:creator>Haribondhu Sarma</dc:creator>
			<dc:creator>I Nyoman Sutarsa</dc:creator>
			<dc:creator>Severine Navarro</dc:creator>
			<dc:creator>Darren Gray</dc:creator>
			<dc:creator>Matthew Kelly</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090251</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-07</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-07</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>251</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090251</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/251</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/250">

	<title>TropicalMed, Vol. 11, Pages 250: West Nile Virus in People with HIV: Immune Vulnerability, Neuroinvasive Disease, and Diagnostic Challenges</title>
	<link>https://www.mdpi.com/2414-6366/11/9/250</link>
	<description>West Nile virus (WNV) is an expanding mosquito-borne orthoflavivirus and an important cause of arboviral neuroinvasive disease. Whether HIV infection modifies WNV susceptibility, severity, or diagnostic performance remains uncertain. This narrative review was supported by structured PubMed/MEDLINE and Scopus searches updated to 22 August 2026 and a supplementary targeted citation search, identifying 23 peer-reviewed reports providing direct clinical or seroepidemiological evidence on WNV in people with HIV (PWH). The evidence remains heterogeneous, but recent data clarify several conclusions. A Northern Italian sero-repository study of 2843 PWH found neutralization-confirmed WNV antibodies in 3.0%, with no neuroinvasive disease and no association with HIV-related immunological variables. Comparative US cohorts likewise do not demonstrate that HIV status alone confers a uniform excess risk of WNV neuroinvasive disease. Conversely, individual reports of advanced HIV disease describe severe neuroinvasive presentations with delayed or absent WNV-specific antibody responses and molecular confirmation. HIV status alone should therefore not be considered a uniform WNV risk marker; the individual immune phenotype may be more clinically informative. In PWH with profound immunosuppression, negative early serology should not prematurely exclude WNV, and molecular testing should be considered when clinical suspicion remains high. Prevention, seasonal vigilance, and prospective HIV-specific studies remain priorities.</description>
	<pubDate>2026-09-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 250: West Nile Virus in People with HIV: Immune Vulnerability, Neuroinvasive Disease, and Diagnostic Challenges</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/250">doi: 10.3390/tropicalmed11090250</a></p>
	<p>Authors:
		Paolo Fusco
		Francesco De Maria
		Alessandro Russo
		</p>
	<p>West Nile virus (WNV) is an expanding mosquito-borne orthoflavivirus and an important cause of arboviral neuroinvasive disease. Whether HIV infection modifies WNV susceptibility, severity, or diagnostic performance remains uncertain. This narrative review was supported by structured PubMed/MEDLINE and Scopus searches updated to 22 August 2026 and a supplementary targeted citation search, identifying 23 peer-reviewed reports providing direct clinical or seroepidemiological evidence on WNV in people with HIV (PWH). The evidence remains heterogeneous, but recent data clarify several conclusions. A Northern Italian sero-repository study of 2843 PWH found neutralization-confirmed WNV antibodies in 3.0%, with no neuroinvasive disease and no association with HIV-related immunological variables. Comparative US cohorts likewise do not demonstrate that HIV status alone confers a uniform excess risk of WNV neuroinvasive disease. Conversely, individual reports of advanced HIV disease describe severe neuroinvasive presentations with delayed or absent WNV-specific antibody responses and molecular confirmation. HIV status alone should therefore not be considered a uniform WNV risk marker; the individual immune phenotype may be more clinically informative. In PWH with profound immunosuppression, negative early serology should not prematurely exclude WNV, and molecular testing should be considered when clinical suspicion remains high. Prevention, seasonal vigilance, and prospective HIV-specific studies remain priorities.</p>
	]]></content:encoded>

	<dc:title>West Nile Virus in People with HIV: Immune Vulnerability, Neuroinvasive Disease, and Diagnostic Challenges</dc:title>
			<dc:creator>Paolo Fusco</dc:creator>
			<dc:creator>Francesco De Maria</dc:creator>
			<dc:creator>Alessandro Russo</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090250</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-03</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-03</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>250</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090250</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/250</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/249">

	<title>TropicalMed, Vol. 11, Pages 249: Diagnostic Sensitivity of the McMaster Technique for Detecting Intestinal Parasites in Human Populations: A Systematic Review and Meta-Analysis</title>
	<link>https://www.mdpi.com/2414-6366/11/9/249</link>
	<description>Intestinal parasitic infections, particularly soil-transmitted helminths (STHs), remain a major public health concern in low- and middle-income countries. As control programs reduce infection intensity, accurate diagnosis becomes increasingly challenging. The McMaster technique has been proposed as an alternative diagnostic method for detecting human intestinal parasites; however, its diagnostic performance in human populations remains unclear. This study aimed to evaluate the diagnostic sensitivity of the McMaster technique for detecting intestinal parasites, particularly STHs. A systematic review and meta-analysis were conducted in accordance with the PRISMA guidelines and registered in PROSPERO (CRD420261298952). Electronic databases (PubMed, Scopus, Web of Science, Ovid, Nursing &amp;amp;amp; Allied Health Premium, and Google Scholar) were searched up to January 2026. Studies assessing the McMaster technique in human populations and reporting sufficient data to calculate sensitivity were included. A random-effects model was used to estimate pooled sensitivity, with subgroup analyses by parasite species, geographic region, and population characteristics. Risk of bias was assessed using the the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Among the 1514 records identified through database searching, 10 studies were included in the final analysis. The pooled sensitivity of the McMaster technique was 73% (95% confidence interval [CI]: 67&amp;amp;ndash;78%; I2 = 91.0%) for detecting any intestinal parasites and 72% (95% CI: 65&amp;amp;ndash;78%; I2 = 93.5%) for STHs. Species-specific sensitivities were 67% (95% CI: 61&amp;amp;ndash;72%; I2 = 80.7%) for Ascaris lumbricoides, 79% (95% CI: 57&amp;amp;ndash;91%; I2 = 96.9%) for Trichuris trichiura, and 71% (95% CI: 61&amp;amp;ndash;80%; I2 = 89.9%) for hookworms. The McMaster technique demonstrates moderate sensitivity for detecting intestinal parasites in humans. While it offers practical advantages for field applications, its reduced sensitivity in low-intensity infections limits its utility as a standalone diagnostic tool in control and elimination settings. Further research should focus on methodological standardization and integration with more sensitive diagnostic approaches.</description>
	<pubDate>2026-09-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 249: Diagnostic Sensitivity of the McMaster Technique for Detecting Intestinal Parasites in Human Populations: A Systematic Review and Meta-Analysis</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/249">doi: 10.3390/tropicalmed11090249</a></p>
	<p>Authors:
		Jurairat Jongthawin
		Aongart Mahittikorn
		Kinley Wangdi
		Frederick Ramirez Masangkay
		Manas Kotepui
		</p>
	<p>Intestinal parasitic infections, particularly soil-transmitted helminths (STHs), remain a major public health concern in low- and middle-income countries. As control programs reduce infection intensity, accurate diagnosis becomes increasingly challenging. The McMaster technique has been proposed as an alternative diagnostic method for detecting human intestinal parasites; however, its diagnostic performance in human populations remains unclear. This study aimed to evaluate the diagnostic sensitivity of the McMaster technique for detecting intestinal parasites, particularly STHs. A systematic review and meta-analysis were conducted in accordance with the PRISMA guidelines and registered in PROSPERO (CRD420261298952). Electronic databases (PubMed, Scopus, Web of Science, Ovid, Nursing &amp;amp;amp; Allied Health Premium, and Google Scholar) were searched up to January 2026. Studies assessing the McMaster technique in human populations and reporting sufficient data to calculate sensitivity were included. A random-effects model was used to estimate pooled sensitivity, with subgroup analyses by parasite species, geographic region, and population characteristics. Risk of bias was assessed using the the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Among the 1514 records identified through database searching, 10 studies were included in the final analysis. The pooled sensitivity of the McMaster technique was 73% (95% confidence interval [CI]: 67&amp;amp;ndash;78%; I2 = 91.0%) for detecting any intestinal parasites and 72% (95% CI: 65&amp;amp;ndash;78%; I2 = 93.5%) for STHs. Species-specific sensitivities were 67% (95% CI: 61&amp;amp;ndash;72%; I2 = 80.7%) for Ascaris lumbricoides, 79% (95% CI: 57&amp;amp;ndash;91%; I2 = 96.9%) for Trichuris trichiura, and 71% (95% CI: 61&amp;amp;ndash;80%; I2 = 89.9%) for hookworms. The McMaster technique demonstrates moderate sensitivity for detecting intestinal parasites in humans. While it offers practical advantages for field applications, its reduced sensitivity in low-intensity infections limits its utility as a standalone diagnostic tool in control and elimination settings. Further research should focus on methodological standardization and integration with more sensitive diagnostic approaches.</p>
	]]></content:encoded>

	<dc:title>Diagnostic Sensitivity of the McMaster Technique for Detecting Intestinal Parasites in Human Populations: A Systematic Review and Meta-Analysis</dc:title>
			<dc:creator>Jurairat Jongthawin</dc:creator>
			<dc:creator>Aongart Mahittikorn</dc:creator>
			<dc:creator>Kinley Wangdi</dc:creator>
			<dc:creator>Frederick Ramirez Masangkay</dc:creator>
			<dc:creator>Manas Kotepui</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090249</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-01</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-01</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>249</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090249</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/249</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/248">

	<title>TropicalMed, Vol. 11, Pages 248: Measles Immunoglobulin G Positivity and Associated Factors Among Suspected Cases in Three Selected Zambian Provinces: A Bayesian Logistic Regression Study</title>
	<link>https://www.mdpi.com/2414-6366/11/9/248</link>
	<description>Measles remains a public-health concern where immunity gaps and incomplete vaccination coverage persist. This study assessed household and geographic factors associated with laboratory-confirmed measles among suspected cases in three Zambian provinces. A prospective cross-sectional study was conducted during measles outbreaks in five selected districts across Luapula, Northern and Northwestern provinces. Suspected cases meeting the IDSR case definition were consecutively enrolled. Blood samples were collected, transported to the UTH Virology Laboratory, and tested using procured IgG test kits. Participant characteristics were summarised descriptively. Bayesian logistic regression estimated associations between laboratory-confirmed (IgG positive) measles and age, sex, vaccination status, household size and previous measles history, with province added in a second model. Results were reported as posterior odds ratios with 95% credible intervals. Among the 172 suspected cases, 45 (26.2%) were laboratory confirmed (IgG positive). Vaccination status was verified using caregiver-provided immunization cards; status was unknown for 110 (64.0%) participants (all of whom tested negative), reflecting missing vaccination documentation. Vaccinated participants had 93% lower adjusted odds of laboratory-confirmed measles than unvaccinated participants (adjusted posterior OR: 0.07, 95% CrI: 0.02&amp;amp;ndash;0.18). Adjusted posterior probabilities were consistently lower among vaccinated participants across all three provinces (34% to 49%) than among unvaccinated participants (86% to 92%). Age, sex and household size were not clearly associated with measles positivity. All four participants reporting a previous measles history tested positive, and the unadjusted association was significant using Fisher&amp;amp;rsquo;s exact test (p = 0.004). Vaccination status was most strongly associated with laboratory-confirmed measles, with substantially lower adjusted odds among vaccinated participants. These findings reinforce the importance of measles vaccination in outbreak prevention and control.</description>
	<pubDate>2026-09-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 248: Measles Immunoglobulin G Positivity and Associated Factors Among Suspected Cases in Three Selected Zambian Provinces: A Bayesian Logistic Regression Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/248">doi: 10.3390/tropicalmed11090248</a></p>
	<p>Authors:
		Priscilla Nkonde Gardner
		Victor Daka
		Paul Simusika
		Walter Azibadighi
		Charles Chileshe
		Leah Kamulaza
		Davie Simwaba
		Roma Chilengi
		</p>
	<p>Measles remains a public-health concern where immunity gaps and incomplete vaccination coverage persist. This study assessed household and geographic factors associated with laboratory-confirmed measles among suspected cases in three Zambian provinces. A prospective cross-sectional study was conducted during measles outbreaks in five selected districts across Luapula, Northern and Northwestern provinces. Suspected cases meeting the IDSR case definition were consecutively enrolled. Blood samples were collected, transported to the UTH Virology Laboratory, and tested using procured IgG test kits. Participant characteristics were summarised descriptively. Bayesian logistic regression estimated associations between laboratory-confirmed (IgG positive) measles and age, sex, vaccination status, household size and previous measles history, with province added in a second model. Results were reported as posterior odds ratios with 95% credible intervals. Among the 172 suspected cases, 45 (26.2%) were laboratory confirmed (IgG positive). Vaccination status was verified using caregiver-provided immunization cards; status was unknown for 110 (64.0%) participants (all of whom tested negative), reflecting missing vaccination documentation. Vaccinated participants had 93% lower adjusted odds of laboratory-confirmed measles than unvaccinated participants (adjusted posterior OR: 0.07, 95% CrI: 0.02&amp;amp;ndash;0.18). Adjusted posterior probabilities were consistently lower among vaccinated participants across all three provinces (34% to 49%) than among unvaccinated participants (86% to 92%). Age, sex and household size were not clearly associated with measles positivity. All four participants reporting a previous measles history tested positive, and the unadjusted association was significant using Fisher&amp;amp;rsquo;s exact test (p = 0.004). Vaccination status was most strongly associated with laboratory-confirmed measles, with substantially lower adjusted odds among vaccinated participants. These findings reinforce the importance of measles vaccination in outbreak prevention and control.</p>
	]]></content:encoded>

	<dc:title>Measles Immunoglobulin G Positivity and Associated Factors Among Suspected Cases in Three Selected Zambian Provinces: A Bayesian Logistic Regression Study</dc:title>
			<dc:creator>Priscilla Nkonde Gardner</dc:creator>
			<dc:creator>Victor Daka</dc:creator>
			<dc:creator>Paul Simusika</dc:creator>
			<dc:creator>Walter Azibadighi</dc:creator>
			<dc:creator>Charles Chileshe</dc:creator>
			<dc:creator>Leah Kamulaza</dc:creator>
			<dc:creator>Davie Simwaba</dc:creator>
			<dc:creator>Roma Chilengi</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090248</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-09-01</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-09-01</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>248</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090248</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/248</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/247">

	<title>TropicalMed, Vol. 11, Pages 247: Longitudinal Surveillance of Invasive Mosquitoes at Points of Entry in Northeastern Italy</title>
	<link>https://www.mdpi.com/2414-6366/11/9/247</link>
	<description>Aedes invasive mosquito (AIM) species are expanding worldwide, increasing the risk of arbovirus introduction and transmission. Points of Entry (PoEs), including airports and seaports, represent critical gateways for the introduction and spread of invasive vectors through international passenger and cargo traffic. This study evaluated the AIM long-term dynamics at three major PoEs (Treviso Airport, Venice Airport, and Venice Port) in northeastern Italy (Veneto region) between 2018 and 2024 through an integrated entomological surveillance programme designed to collect AIMs (adults and eggs) throughout the seasonal activity (June&amp;amp;ndash;October). Mosquitoes were identified morphologically and, where required, by molecular analyses. Aedes albopictus was the dominant AIM throughout the study period (eggs N = 96,192, adults N = 14,231), being detected at all three study sites and showing consistent interannual and seasonal dynamics, with peak abundance during summer despite routine vector control interventions. Aedes koreicus was detected at two of the three study sites, namely Venice and Treviso airports (eggs N = 1, adults N = 3). Phylogenetic analyses based on COI indicated that these specimens belonged to a distinct European lineage, revealing genetic diversity among European populations of Ae. koreicus. No evidence of newly established AIMs was found during the surveillance period. These findings highlight the importance of long-term surveillance at PoEs for the early detection of AIMs, monitoring temporal changes in established vector populations, and supporting integrated control and surveillance strategies to reduce the risk of vector establishment and mosquito-borne disease transmission.</description>
	<pubDate>2026-08-31</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 247: Longitudinal Surveillance of Invasive Mosquitoes at Points of Entry in Northeastern Italy</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/247">doi: 10.3390/tropicalmed11090247</a></p>
	<p>Authors:
		Sara Manzi
		Martina Micocci
		Luca Tassoni
		Stefano Vettore
		Davide Bonetto
		Simone Martini
		Francesco Gradoni
		Federica Toniolo
		Giulia Iandiorio
		Lidia Iustina Danca
		Giulia Chiarello
		Patrizia Visentin
		Matteo Cecconello
		Sara Carlin
		Federica Gobbo
		Matteo Mazzucato
		Francesca Russo
		Chiara Ziprani
		Barbra Bucci
		Sergio Iavicoli
		Vincenzo Severino
		Fabrizio Montarsi
		</p>
	<p>Aedes invasive mosquito (AIM) species are expanding worldwide, increasing the risk of arbovirus introduction and transmission. Points of Entry (PoEs), including airports and seaports, represent critical gateways for the introduction and spread of invasive vectors through international passenger and cargo traffic. This study evaluated the AIM long-term dynamics at three major PoEs (Treviso Airport, Venice Airport, and Venice Port) in northeastern Italy (Veneto region) between 2018 and 2024 through an integrated entomological surveillance programme designed to collect AIMs (adults and eggs) throughout the seasonal activity (June&amp;amp;ndash;October). Mosquitoes were identified morphologically and, where required, by molecular analyses. Aedes albopictus was the dominant AIM throughout the study period (eggs N = 96,192, adults N = 14,231), being detected at all three study sites and showing consistent interannual and seasonal dynamics, with peak abundance during summer despite routine vector control interventions. Aedes koreicus was detected at two of the three study sites, namely Venice and Treviso airports (eggs N = 1, adults N = 3). Phylogenetic analyses based on COI indicated that these specimens belonged to a distinct European lineage, revealing genetic diversity among European populations of Ae. koreicus. No evidence of newly established AIMs was found during the surveillance period. These findings highlight the importance of long-term surveillance at PoEs for the early detection of AIMs, monitoring temporal changes in established vector populations, and supporting integrated control and surveillance strategies to reduce the risk of vector establishment and mosquito-borne disease transmission.</p>
	]]></content:encoded>

	<dc:title>Longitudinal Surveillance of Invasive Mosquitoes at Points of Entry in Northeastern Italy</dc:title>
			<dc:creator>Sara Manzi</dc:creator>
			<dc:creator>Martina Micocci</dc:creator>
			<dc:creator>Luca Tassoni</dc:creator>
			<dc:creator>Stefano Vettore</dc:creator>
			<dc:creator>Davide Bonetto</dc:creator>
			<dc:creator>Simone Martini</dc:creator>
			<dc:creator>Francesco Gradoni</dc:creator>
			<dc:creator>Federica Toniolo</dc:creator>
			<dc:creator>Giulia Iandiorio</dc:creator>
			<dc:creator>Lidia Iustina Danca</dc:creator>
			<dc:creator>Giulia Chiarello</dc:creator>
			<dc:creator>Patrizia Visentin</dc:creator>
			<dc:creator>Matteo Cecconello</dc:creator>
			<dc:creator>Sara Carlin</dc:creator>
			<dc:creator>Federica Gobbo</dc:creator>
			<dc:creator>Matteo Mazzucato</dc:creator>
			<dc:creator>Francesca Russo</dc:creator>
			<dc:creator>Chiara Ziprani</dc:creator>
			<dc:creator>Barbra Bucci</dc:creator>
			<dc:creator>Sergio Iavicoli</dc:creator>
			<dc:creator>Vincenzo Severino</dc:creator>
			<dc:creator>Fabrizio Montarsi</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090247</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-31</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-31</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>247</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090247</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/247</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/246">

	<title>TropicalMed, Vol. 11, Pages 246: Development and Validation of a Computer Vision-Based Artificial Intelligence System (FenoParasite) for the Microscopic Detection of Ascaris lumbricoides and Giardia lamblia in Stool Samples</title>
	<link>https://www.mdpi.com/2414-6366/11/9/246</link>
	<description>Background: Intestinal parasitic infections caused by Giardia lamblia and Ascaris lumbricoides remain a public-health problem in resource-limited settings, where conventional microscopy depends on expert personnel and shows variable sensitivity. Artificial intelligence (AI) could standardize and decentralize diagnosis. This study aimed to design and validate FenoParasite, an AI object-detection software (Azure Custom Vision) for the microscopic identification of G. lamblia cysts and trophozoites and A. lumbricoides eggs in stool samples. Methods: Diagnostic-accuracy study. The reference standard was consensus microscopy by two expert readers, with a third reader for discordant cases. An internal validation set (n = 159) and a prospective pilot validation set (n = 31) were analyzed. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy (95% Clopper&amp;amp;ndash;Pearson CI), AUC-ROC (bootstrap), and Cohen&amp;amp;rsquo;s kappa were computed; the confidence threshold was 90%. Results: The model achieved a mAP@0.30 of 98.3% (precision 98.2%; recall 96.4%). In internal validation, G. lamblia showed 100% sensitivity, 98.9% specificity, 99.4% accuracy, and AUC 0.98; A. lumbricoides reached 100% across all indices (AUC 1.00). In the prospective pilot validation, sensitivity and specificity were 100% for both taxa; however, the confidence intervals were very wide (lower sensitivity bounds of 39.8% and 75.3%, based on only 4 and 13 reference-positive specimens, respectively), and these estimates are correspondingly imprecise. Conclusions: FenoParasite showed high agreement with consensus expert microscopy for both a protozoan and a helminth. Because the reference standard was expert microscopy rather than a molecular assay, the reported performance estimates quantify agreement with microscopic reading rather than absolute diagnostic accuracy. These findings remain preliminary. Multicenter validation against molecular reference standards is required before clinical implementation can be considered.</description>
	<pubDate>2026-08-31</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 246: Development and Validation of a Computer Vision-Based Artificial Intelligence System (FenoParasite) for the Microscopic Detection of Ascaris lumbricoides and Giardia lamblia in Stool Samples</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/246">doi: 10.3390/tropicalmed11090246</a></p>
	<p>Authors:
		Miguel Hueda-Zavaleta
		Exequiel Federico Espeche
		Francisco Zea Gamboa
		Mady Canelu Ramos Rojas
		Enrique Lanchipa Valencia
		Juan Carlos Gómez de la Torre Pretell
		</p>
	<p>Background: Intestinal parasitic infections caused by Giardia lamblia and Ascaris lumbricoides remain a public-health problem in resource-limited settings, where conventional microscopy depends on expert personnel and shows variable sensitivity. Artificial intelligence (AI) could standardize and decentralize diagnosis. This study aimed to design and validate FenoParasite, an AI object-detection software (Azure Custom Vision) for the microscopic identification of G. lamblia cysts and trophozoites and A. lumbricoides eggs in stool samples. Methods: Diagnostic-accuracy study. The reference standard was consensus microscopy by two expert readers, with a third reader for discordant cases. An internal validation set (n = 159) and a prospective pilot validation set (n = 31) were analyzed. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy (95% Clopper&amp;amp;ndash;Pearson CI), AUC-ROC (bootstrap), and Cohen&amp;amp;rsquo;s kappa were computed; the confidence threshold was 90%. Results: The model achieved a mAP@0.30 of 98.3% (precision 98.2%; recall 96.4%). In internal validation, G. lamblia showed 100% sensitivity, 98.9% specificity, 99.4% accuracy, and AUC 0.98; A. lumbricoides reached 100% across all indices (AUC 1.00). In the prospective pilot validation, sensitivity and specificity were 100% for both taxa; however, the confidence intervals were very wide (lower sensitivity bounds of 39.8% and 75.3%, based on only 4 and 13 reference-positive specimens, respectively), and these estimates are correspondingly imprecise. Conclusions: FenoParasite showed high agreement with consensus expert microscopy for both a protozoan and a helminth. Because the reference standard was expert microscopy rather than a molecular assay, the reported performance estimates quantify agreement with microscopic reading rather than absolute diagnostic accuracy. These findings remain preliminary. Multicenter validation against molecular reference standards is required before clinical implementation can be considered.</p>
	]]></content:encoded>

	<dc:title>Development and Validation of a Computer Vision-Based Artificial Intelligence System (FenoParasite) for the Microscopic Detection of Ascaris lumbricoides and Giardia lamblia in Stool Samples</dc:title>
			<dc:creator>Miguel Hueda-Zavaleta</dc:creator>
			<dc:creator>Exequiel Federico Espeche</dc:creator>
			<dc:creator>Francisco Zea Gamboa</dc:creator>
			<dc:creator>Mady Canelu Ramos Rojas</dc:creator>
			<dc:creator>Enrique Lanchipa Valencia</dc:creator>
			<dc:creator>Juan Carlos Gómez de la Torre Pretell</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090246</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-31</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-31</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>246</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090246</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/246</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/245">

	<title>TropicalMed, Vol. 11, Pages 245: Application of Genomics to Prevent and Combat Emerging Infectious Disease Threats in Latin America: Perspectives from an Overseas U.S. Navy Research Command</title>
	<link>https://www.mdpi.com/2414-6366/11/9/245</link>
	<description>Endemic and (re)emerging infectious diseases pose a major threat to public health and military readiness in Central and South America. The high biodiversity and the differing transmission pathways require the use of highly sensitive methods to track the emergence and spread of these diseases. High-throughput sequencing technologies have become a critical resource for the field of infectious disease monitoring, specifically for tracking pathogen evolution, antimicrobial resistance, and transmission. This review provides an overview of the implementation of genomics-informed infectious disease surveillance conducted by the U.S. Naval Medical Research Unit SOUTH, focusing on operational, infrastructural, and logistical challenges in resource-limited settings and outlining strategies for building sustainable regional capacity. Selected case studies focused on prominent biothreats including dengue, Oropouche, malaria, and antimicrobial resistance demonstrate the significance and applicability of targeted and agnostic sequencing approaches to elucidate transmission pathways, pathogen discovery, and guide public health responses and field-deployable applications.</description>
	<pubDate>2026-08-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 245: Application of Genomics to Prevent and Combat Emerging Infectious Disease Threats in Latin America: Perspectives from an Overseas U.S. Navy Research Command</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/245">doi: 10.3390/tropicalmed11090245</a></p>
	<p>Authors:
		Hugo O. Valdivia
		Maria Silva
		Cristopher D. Cruz
		Paul Rios
		Marisa E. Lozano
		Julia S. Ampuero
		Yeny Tinoco
		Jeffrey Spiro
		Yuliya S. Johnson
		Alden S. Estep
		Steev Loyola
		Carmen Flores-Mendoza
		Gissella M. Vasquez
		Jose A. Garcia-Rivera
		Henju Marjuki
		</p>
	<p>Endemic and (re)emerging infectious diseases pose a major threat to public health and military readiness in Central and South America. The high biodiversity and the differing transmission pathways require the use of highly sensitive methods to track the emergence and spread of these diseases. High-throughput sequencing technologies have become a critical resource for the field of infectious disease monitoring, specifically for tracking pathogen evolution, antimicrobial resistance, and transmission. This review provides an overview of the implementation of genomics-informed infectious disease surveillance conducted by the U.S. Naval Medical Research Unit SOUTH, focusing on operational, infrastructural, and logistical challenges in resource-limited settings and outlining strategies for building sustainable regional capacity. Selected case studies focused on prominent biothreats including dengue, Oropouche, malaria, and antimicrobial resistance demonstrate the significance and applicability of targeted and agnostic sequencing approaches to elucidate transmission pathways, pathogen discovery, and guide public health responses and field-deployable applications.</p>
	]]></content:encoded>

	<dc:title>Application of Genomics to Prevent and Combat Emerging Infectious Disease Threats in Latin America: Perspectives from an Overseas U.S. Navy Research Command</dc:title>
			<dc:creator>Hugo O. Valdivia</dc:creator>
			<dc:creator>Maria Silva</dc:creator>
			<dc:creator>Cristopher D. Cruz</dc:creator>
			<dc:creator>Paul Rios</dc:creator>
			<dc:creator>Marisa E. Lozano</dc:creator>
			<dc:creator>Julia S. Ampuero</dc:creator>
			<dc:creator>Yeny Tinoco</dc:creator>
			<dc:creator>Jeffrey Spiro</dc:creator>
			<dc:creator>Yuliya S. Johnson</dc:creator>
			<dc:creator>Alden S. Estep</dc:creator>
			<dc:creator>Steev Loyola</dc:creator>
			<dc:creator>Carmen Flores-Mendoza</dc:creator>
			<dc:creator>Gissella M. Vasquez</dc:creator>
			<dc:creator>Jose A. Garcia-Rivera</dc:creator>
			<dc:creator>Henju Marjuki</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090245</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-28</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-28</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>245</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090245</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/245</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/244">

	<title>TropicalMed, Vol. 11, Pages 244: Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection</title>
	<link>https://www.mdpi.com/2414-6366/11/9/244</link>
	<description>Mpox has emerged as a global public health concern, highlighting the limitations of traditional vaccinia-based vaccination strategies and the urgent need for precision vaccinology approaches. Advances in structural virology and immunoinformatics have enabled the identification of conserved immunodominant antigens from both mature virion and extracellular virion forms, supporting the development of multivalent antigen combinations capable of inducing broad neutralizing antibody (nAb) responses. Emerging delivery technologies including mRNA-lipid nanoparticles, viral vectors, and self-assembling protein nanoparticles offer rapid scalability, enhanced immunogenicity, and improved safety compared with conventional live-attenuated vaccines. Addressing antigenic evolution, vaccine supply limitations, and population-specific immune variability will be crucial for optimizing vaccine effectiveness. This review synthesizes current evidence on antigen design, vaccine delivery platforms, and immunological correlates of protection to outline a framework for next-generation mpox vaccines. Precision vaccinology therefore represents a transformative strategy for developing durable, clade-specific mpox vaccines and strengthening preparedness against future orthopoxvirus outbreaks worldwide.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 244: Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/244">doi: 10.3390/tropicalmed11090244</a></p>
	<p>Authors:
		Yithenthrathevinair K Paramasivam
		Nur Syafiqah Mohamad Nasir
		Mohd Zulkifli Salleh
		</p>
	<p>Mpox has emerged as a global public health concern, highlighting the limitations of traditional vaccinia-based vaccination strategies and the urgent need for precision vaccinology approaches. Advances in structural virology and immunoinformatics have enabled the identification of conserved immunodominant antigens from both mature virion and extracellular virion forms, supporting the development of multivalent antigen combinations capable of inducing broad neutralizing antibody (nAb) responses. Emerging delivery technologies including mRNA-lipid nanoparticles, viral vectors, and self-assembling protein nanoparticles offer rapid scalability, enhanced immunogenicity, and improved safety compared with conventional live-attenuated vaccines. Addressing antigenic evolution, vaccine supply limitations, and population-specific immune variability will be crucial for optimizing vaccine effectiveness. This review synthesizes current evidence on antigen design, vaccine delivery platforms, and immunological correlates of protection to outline a framework for next-generation mpox vaccines. Precision vaccinology therefore represents a transformative strategy for developing durable, clade-specific mpox vaccines and strengthening preparedness against future orthopoxvirus outbreaks worldwide.</p>
	]]></content:encoded>

	<dc:title>Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection</dc:title>
			<dc:creator>Yithenthrathevinair K Paramasivam</dc:creator>
			<dc:creator>Nur Syafiqah Mohamad Nasir</dc:creator>
			<dc:creator>Mohd Zulkifli Salleh</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090244</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>244</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090244</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/244</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/243">

	<title>TropicalMed, Vol. 11, Pages 243: Rabies in Military Personnel: Epidemiology, Clinical Challenges, and Strategies for Prevention and Management</title>
	<link>https://www.mdpi.com/2414-6366/11/9/243</link>
	<description>For deployed military personnel, a single exposure from a rabies-infected animal can become a death sentence. With a case fatality rate approaching 100%, rabies remains a serious, yet insufficiently acknowledged hazard for service members, for whom prevention in operational environments poses unique challenges. We conducted a systematic literature search to identify relevant studies on rabies risk in armed forces personnel. By analysing rabies-related fatalities in the military, this review highlights the operational challenges posed by animal bites during deployment, including underreporting and delayed access to care, which compromise timely post-exposure prophylaxis (PEP) administration. Special emphasis is placed on prevention strategies, including pre-exposure prophylaxis (PrEP) and animal control protocols tailored to military settings. Its aim is to provide a comprehensive, evidence-based resource for healthcare professionals involved in the protection of deployed forces against this ancient yet still deadly infectious disease.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 243: Rabies in Military Personnel: Epidemiology, Clinical Challenges, and Strategies for Prevention and Management</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/243">doi: 10.3390/tropicalmed11090243</a></p>
	<p>Authors:
		Elodie Monchatre-Leroy
		Diana Isabela Costescu Strachinaru
		Oula Itani
		Sophie Wensierski
		Alexandre Servat
		Patrick Soentjens
		</p>
	<p>For deployed military personnel, a single exposure from a rabies-infected animal can become a death sentence. With a case fatality rate approaching 100%, rabies remains a serious, yet insufficiently acknowledged hazard for service members, for whom prevention in operational environments poses unique challenges. We conducted a systematic literature search to identify relevant studies on rabies risk in armed forces personnel. By analysing rabies-related fatalities in the military, this review highlights the operational challenges posed by animal bites during deployment, including underreporting and delayed access to care, which compromise timely post-exposure prophylaxis (PEP) administration. Special emphasis is placed on prevention strategies, including pre-exposure prophylaxis (PrEP) and animal control protocols tailored to military settings. Its aim is to provide a comprehensive, evidence-based resource for healthcare professionals involved in the protection of deployed forces against this ancient yet still deadly infectious disease.</p>
	]]></content:encoded>

	<dc:title>Rabies in Military Personnel: Epidemiology, Clinical Challenges, and Strategies for Prevention and Management</dc:title>
			<dc:creator>Elodie Monchatre-Leroy</dc:creator>
			<dc:creator>Diana Isabela Costescu Strachinaru</dc:creator>
			<dc:creator>Oula Itani</dc:creator>
			<dc:creator>Sophie Wensierski</dc:creator>
			<dc:creator>Alexandre Servat</dc:creator>
			<dc:creator>Patrick Soentjens</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090243</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>243</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090243</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/243</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/242">

	<title>TropicalMed, Vol. 11, Pages 242: Circulating Leukocytes and Antibody Isotype Reactivity in Rats Experimentally Infected with Different Burdens of Strongyloides venezuelensis, Before and After Treatment with Ivermectin or Dexamethasone</title>
	<link>https://www.mdpi.com/2414-6366/11/9/242</link>
	<description>Strongyloidiasis is a neglected, potentially lifelong disease caused by Strongyloides stercoralis that can lead to a high mortality rate in immunocompromised hosts; therefore, it is necessary to increase the accuracy of infection diagnosis. In the current study, we used Wistar rats experimentally infected with different burdens of Strongyloides venezuelensis to characterize circulating leukocytes and IgM, IgG, IgG1, IgG2a, and IgA reactivity before and after anthelmintic treatment or immunosuppression. Infection, especially with 500 L3, induced an increase in circulating leukocytes, particularly during the acute phase. Animals treated with ivermectin showed complete elimination of the parasite and an early reduction in circulating eosinophils. The production of IgM, IgG, and IgG1 anti-L3 (infective larvae) and anti-Sv (adult worm) antigens was significantly elevated in all infected groups but did not allow differentiation between cured and infected animals. Treatment with dexamethasone delayed worm elimination and temporarily reduced cellular response and parasite-specific IgG production but did not alter IgM reactivity. IgG2a anti-L3 and anti-Sv reactivity showed a progressive reduction, returning to baseline levels in ivermectin-treated rats. IgA anti-ES/L3 (excretory and secretory larval antigens) reactivity significantly decreased in intestinal wash after parasitological cure. These data would help the development of more efficient immunodiagnostic alternatives for human strongyloidiasis based on antibody isotype reactivity.</description>
	<pubDate>2026-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 242: Circulating Leukocytes and Antibody Isotype Reactivity in Rats Experimentally Infected with Different Burdens of Strongyloides venezuelensis, Before and After Treatment with Ivermectin or Dexamethasone</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/242">doi: 10.3390/tropicalmed11090242</a></p>
	<p>Authors:
		João Gustavo Mendes Rodrigues
		Guilherme Silva Miranda
		Genil Mororó Araújo Camelo
		Caio Brandão Goes Gouveia
		Deborah Aparecida Negrão-Corrêa
		</p>
	<p>Strongyloidiasis is a neglected, potentially lifelong disease caused by Strongyloides stercoralis that can lead to a high mortality rate in immunocompromised hosts; therefore, it is necessary to increase the accuracy of infection diagnosis. In the current study, we used Wistar rats experimentally infected with different burdens of Strongyloides venezuelensis to characterize circulating leukocytes and IgM, IgG, IgG1, IgG2a, and IgA reactivity before and after anthelmintic treatment or immunosuppression. Infection, especially with 500 L3, induced an increase in circulating leukocytes, particularly during the acute phase. Animals treated with ivermectin showed complete elimination of the parasite and an early reduction in circulating eosinophils. The production of IgM, IgG, and IgG1 anti-L3 (infective larvae) and anti-Sv (adult worm) antigens was significantly elevated in all infected groups but did not allow differentiation between cured and infected animals. Treatment with dexamethasone delayed worm elimination and temporarily reduced cellular response and parasite-specific IgG production but did not alter IgM reactivity. IgG2a anti-L3 and anti-Sv reactivity showed a progressive reduction, returning to baseline levels in ivermectin-treated rats. IgA anti-ES/L3 (excretory and secretory larval antigens) reactivity significantly decreased in intestinal wash after parasitological cure. These data would help the development of more efficient immunodiagnostic alternatives for human strongyloidiasis based on antibody isotype reactivity.</p>
	]]></content:encoded>

	<dc:title>Circulating Leukocytes and Antibody Isotype Reactivity in Rats Experimentally Infected with Different Burdens of Strongyloides venezuelensis, Before and After Treatment with Ivermectin or Dexamethasone</dc:title>
			<dc:creator>João Gustavo Mendes Rodrigues</dc:creator>
			<dc:creator>Guilherme Silva Miranda</dc:creator>
			<dc:creator>Genil Mororó Araújo Camelo</dc:creator>
			<dc:creator>Caio Brandão Goes Gouveia</dc:creator>
			<dc:creator>Deborah Aparecida Negrão-Corrêa</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090242</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-26</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-26</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>242</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090242</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/242</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/241">

	<title>TropicalMed, Vol. 11, Pages 241: Global Prevalence and Distribution of Human Sarcocystosis: A Systematic Review and Meta-Analysis</title>
	<link>https://www.mdpi.com/2414-6366/11/9/241</link>
	<description>Human sarcocystosis is a neglected zoonotic infection caused by protozoa of the genus Sarcocystis. Although sporadic cases and outbreaks have been reported worldwide, the global burden of human infections has not been comprehensively synthesized. This study aimed to estimate the pooled prevalence and global distribution of Sarcocystis infections in humans. A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD420251159944). PubMed, Scopus, Web of Science, Ovid, Nursing &amp;amp;amp; Allied Health Premium, and Google Scholar were used for retrieving relevant studies. Observational studies published from 2000 onward reporting human Sarcocystis infections confirmed by microscopic and/or molecular methods were included. A random-effects model was used to estimate pooled prevalence. Heterogeneity was assessed using the I2 statistic. Subgroup analyses and meta-regression were performed to explore sources of heterogeneity. Seventeen studies comprising 66,329 participants met the inclusion criteria. The pooled prevalence of human Sarcocystis infection was 0.85% (95% confidence interval [CI]: 0.33&amp;amp;ndash;2.19), with substantial heterogeneity (I2 = 98.2%). Prevalence estimates showed marked variation across continents, countries, participant groups, diagnostic methods, Sarcocystis species, and clinical forms of sarcocystosis. Although human Sarcocystis infection appears relatively rare, its prevalence is geographically heterogeneous across studies published between 2000 and 2024. The robustness of the pooled prevalence estimate is limited by the small number of studies, uneven geographical coverage, and substantial heterogeneity. Differences in diagnostic approaches, study populations, infecting species, and disease phenotypes likely contributed to this variability. Enhanced surveillance and standardized application of sensitive molecular diagnostics are essential to better define the epidemiology, burden, and public health significance of human sarcocystosis.</description>
	<pubDate>2026-08-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 241: Global Prevalence and Distribution of Human Sarcocystosis: A Systematic Review and Meta-Analysis</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/241">doi: 10.3390/tropicalmed11090241</a></p>
	<p>Authors:
		Jurairat Jongthawin
		Aongart Mahittikorn
		Kinley Wangdi
		Frederick Ramirez Masangkay
		Manas Kotepui
		</p>
	<p>Human sarcocystosis is a neglected zoonotic infection caused by protozoa of the genus Sarcocystis. Although sporadic cases and outbreaks have been reported worldwide, the global burden of human infections has not been comprehensively synthesized. This study aimed to estimate the pooled prevalence and global distribution of Sarcocystis infections in humans. A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD420251159944). PubMed, Scopus, Web of Science, Ovid, Nursing &amp;amp;amp; Allied Health Premium, and Google Scholar were used for retrieving relevant studies. Observational studies published from 2000 onward reporting human Sarcocystis infections confirmed by microscopic and/or molecular methods were included. A random-effects model was used to estimate pooled prevalence. Heterogeneity was assessed using the I2 statistic. Subgroup analyses and meta-regression were performed to explore sources of heterogeneity. Seventeen studies comprising 66,329 participants met the inclusion criteria. The pooled prevalence of human Sarcocystis infection was 0.85% (95% confidence interval [CI]: 0.33&amp;amp;ndash;2.19), with substantial heterogeneity (I2 = 98.2%). Prevalence estimates showed marked variation across continents, countries, participant groups, diagnostic methods, Sarcocystis species, and clinical forms of sarcocystosis. Although human Sarcocystis infection appears relatively rare, its prevalence is geographically heterogeneous across studies published between 2000 and 2024. The robustness of the pooled prevalence estimate is limited by the small number of studies, uneven geographical coverage, and substantial heterogeneity. Differences in diagnostic approaches, study populations, infecting species, and disease phenotypes likely contributed to this variability. Enhanced surveillance and standardized application of sensitive molecular diagnostics are essential to better define the epidemiology, burden, and public health significance of human sarcocystosis.</p>
	]]></content:encoded>

	<dc:title>Global Prevalence and Distribution of Human Sarcocystosis: A Systematic Review and Meta-Analysis</dc:title>
			<dc:creator>Jurairat Jongthawin</dc:creator>
			<dc:creator>Aongart Mahittikorn</dc:creator>
			<dc:creator>Kinley Wangdi</dc:creator>
			<dc:creator>Frederick Ramirez Masangkay</dc:creator>
			<dc:creator>Manas Kotepui</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090241</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-25</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-25</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>241</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090241</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/241</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/240">

	<title>TropicalMed, Vol. 11, Pages 240: Climate-Aware Self-Retrospective Representation Learning for Spatio-Temporal Epidemic Forecasting</title>
	<link>https://www.mdpi.com/2414-6366/11/9/240</link>
	<description>Spatio-temporal epidemic forecasting aims to predict future outbreak trajectories across interconnected regions from historical epidemiological observations and meteorological covariates. However, existing approaches often fail to preserve historically salient epidemic states or to fully exploit delayed and region-varying meteorological associations, leading to unstable temporal representations and insufficient meteorological-context-aware spatio-temporal context for prediction at later forecast horizons. In this paper, we propose CASRL, a Climate-Aware Self-Retrospective Representation Learning network for stable and meteorological-context-aware spatio-temporal epidemic forecasting. CASRL first employs a Self-Retrospective Epidemic Encoder (SREE) to retrospectively aggregate historically salient epidemic states through query-guided weighting and adaptive gating, thereby preserving informative historical epidemic states within the look-back window. It then introduces a Climate-Adaptive Graph Message Passing (CAGMP) module that breaks away from traditional passive feature concatenation. Instead, it constructs a separate meteorological-view predictive graph conditioned on the static spatial prior and adaptively fuses it with the incidence-associated topology to model complex cross-regional predictive associations. By integrating self-retrospective epidemic representations with meteorological-view spatio-temporal interactions, CASRL produces forecasts with improved predictive stability at later forecast horizons. Extensive experiments on two public influenza benchmarks show that CASRL is competitive at shorter forecast horizons and provides clearer advantages at later forecast horizons, particularly in phase-alignment-related evaluation and 15-week-ahead forecasting.</description>
	<pubDate>2026-08-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 240: Climate-Aware Self-Retrospective Representation Learning for Spatio-Temporal Epidemic Forecasting</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/240">doi: 10.3390/tropicalmed11090240</a></p>
	<p>Authors:
		Qi Yuan
		Han Shu
		Yizhi Pan
		Tianshuo Li
		Hangyi Shen
		Weiqi Jiang
		Zidan Zhu
		Pengpeng Zhang
		Ningli Xi
		Junyi Xin
		Kai Li
		Guanqun Sun
		</p>
	<p>Spatio-temporal epidemic forecasting aims to predict future outbreak trajectories across interconnected regions from historical epidemiological observations and meteorological covariates. However, existing approaches often fail to preserve historically salient epidemic states or to fully exploit delayed and region-varying meteorological associations, leading to unstable temporal representations and insufficient meteorological-context-aware spatio-temporal context for prediction at later forecast horizons. In this paper, we propose CASRL, a Climate-Aware Self-Retrospective Representation Learning network for stable and meteorological-context-aware spatio-temporal epidemic forecasting. CASRL first employs a Self-Retrospective Epidemic Encoder (SREE) to retrospectively aggregate historically salient epidemic states through query-guided weighting and adaptive gating, thereby preserving informative historical epidemic states within the look-back window. It then introduces a Climate-Adaptive Graph Message Passing (CAGMP) module that breaks away from traditional passive feature concatenation. Instead, it constructs a separate meteorological-view predictive graph conditioned on the static spatial prior and adaptively fuses it with the incidence-associated topology to model complex cross-regional predictive associations. By integrating self-retrospective epidemic representations with meteorological-view spatio-temporal interactions, CASRL produces forecasts with improved predictive stability at later forecast horizons. Extensive experiments on two public influenza benchmarks show that CASRL is competitive at shorter forecast horizons and provides clearer advantages at later forecast horizons, particularly in phase-alignment-related evaluation and 15-week-ahead forecasting.</p>
	]]></content:encoded>

	<dc:title>Climate-Aware Self-Retrospective Representation Learning for Spatio-Temporal Epidemic Forecasting</dc:title>
			<dc:creator>Qi Yuan</dc:creator>
			<dc:creator>Han Shu</dc:creator>
			<dc:creator>Yizhi Pan</dc:creator>
			<dc:creator>Tianshuo Li</dc:creator>
			<dc:creator>Hangyi Shen</dc:creator>
			<dc:creator>Weiqi Jiang</dc:creator>
			<dc:creator>Zidan Zhu</dc:creator>
			<dc:creator>Pengpeng Zhang</dc:creator>
			<dc:creator>Ningli Xi</dc:creator>
			<dc:creator>Junyi Xin</dc:creator>
			<dc:creator>Kai Li</dc:creator>
			<dc:creator>Guanqun Sun</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090240</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>240</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090240</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/240</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/239">

	<title>TropicalMed, Vol. 11, Pages 239: Reply to Asgarian et al. Comment on &amp;ldquo;Nejati et al. Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review. Trop. Med. Infect. Dis. 2026, 11, 131&amp;rdquo;</title>
	<link>https://www.mdpi.com/2414-6366/11/9/239</link>
	<description>We thank Asgarian et al [...]</description>
	<pubDate>2026-08-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 239: Reply to Asgarian et al. Comment on &amp;ldquo;Nejati et al. Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review. Trop. Med. Infect. Dis. 2026, 11, 131&amp;rdquo;</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/239">doi: 10.3390/tropicalmed11090239</a></p>
	<p>Authors:
		Jalil Nejati
		Abedin Saghafipour
		Rubén Bueno-Marí
		</p>
	<p>We thank Asgarian et al [...]</p>
	]]></content:encoded>

	<dc:title>Reply to Asgarian et al. Comment on &amp;amp;ldquo;Nejati et al. Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review. Trop. Med. Infect. Dis. 2026, 11, 131&amp;amp;rdquo;</dc:title>
			<dc:creator>Jalil Nejati</dc:creator>
			<dc:creator>Abedin Saghafipour</dc:creator>
			<dc:creator>Rubén Bueno-Marí</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090239</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Reply</prism:section>
	<prism:startingPage>239</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090239</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/239</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/238">

	<title>TropicalMed, Vol. 11, Pages 238: Passive Immunization Hesitancy Among Rabies-Exposed Individuals in China: A Multicenter Cross-Sectional Study</title>
	<link>https://www.mdpi.com/2414-6366/11/9/238</link>
	<description>Background: Rabies is an almost universally fatal disease for which post-exposure prophylaxis (PEP), including passive immunization (PI) with rabies immunoglobulin or monoclonal antibodies, remains the only effective intervention. Despite established clinical guidelines, real-world PI utilization remains suboptimal. This study aimed to investigate the prevalence and determinants of PI hesitancy among previously unvaccinated patients with Category III rabies exposure in China. Methods: This multicenter cross-sectional questionnaire study was conducted at 12 rabies PEP clinics or emergency departments in 12 provinces of mainland China. The analysis included 585 previously unvaccinated adults with Category III rabies exposure who initially hesitated to receive or declined PI. The questionnaire collected sociodemographic characteristics, exposure profiles, awareness of the early protection gap, reasons for initial PI hesitancy or refusal, the decision to receive PI during the same clinical encounter, and PI product selection. Multivariable logistic regression identified factors associated with PI treatment decisions, with results reported as adjusted odds ratios (aORs); reason-specific models used the Benjamini&amp;amp;ndash;Hochberg false discovery rate correction. All inferential analyses were restricted to adults. Results: Among 5068 eligible previously unvaccinated patients with Category III rabies exposure, 2866 (57%) initially hesitated to receive or declined recommended PI. Of 617 questionnaire respondents, 32 minors were excluded, leaving 585 adults for all inferential analyses. The leading reasons for initial hesitancy were lack of understanding of the immediate protective role of PI (199/585, 34%), belief that vaccination alone was sufficient (194/585, 33%), and high cost (178/585, 30%). During the same clinical encounter, 320/585 adults (55%) chose to receive PI. Awareness of the early protection gap (aOR 2.63, 95% CI 1.75&amp;amp;ndash;3.98, p &amp;amp;lt; 0.001) and bachelor&amp;amp;rsquo;s degree or higher (aOR 1.61, 95% CI 1.07&amp;amp;ndash;2.43, p = 0.023) were positively associated with the decision to receive PI, whereas head/face wounds were negatively associated (aOR 0.53, 95% CI 0.30&amp;amp;ndash;0.92, p = 0.026). In reason-specific models, lack of knowledge about immediate protection was associated with higher odds of choosing PI (aOR 2.43, 95% CI 1.62&amp;amp;ndash;3.68, BH-FDR p &amp;amp;lt; 0.001), whereas high cost was associated with lower odds (aOR 0.41, 95% CI 0.27&amp;amp;ndash;0.62, BH-FDR p &amp;amp;lt; 0.001). Conclusion: Hesitancy toward and refusal of PI were observed among previously unvaccinated adults with Category III rabies exposure, yet initial hesitation or refusal is not irreversible. Early protection gap awareness was positively associated with PI choice, whereas cost-related concern was negatively associated. Clear explanation of protection timing and attention to cost-related barriers may support informed PI treatment decisions.</description>
	<pubDate>2026-08-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 238: Passive Immunization Hesitancy Among Rabies-Exposed Individuals in China: A Multicenter Cross-Sectional Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/238">doi: 10.3390/tropicalmed11090238</a></p>
	<p>Authors:
		Qisheng Hou
		Xiaoliang Xu
		Si Liu
		Chen Sun
		Fengfeng Zhu
		Yang Yang
		Jianchao Shao
		Yifan Wang
		Yanqiang Feng
		Yingxiang Liu
		Yan Yan
		Song Wang
		Yan Wang
		Cheng Liu
		</p>
	<p>Background: Rabies is an almost universally fatal disease for which post-exposure prophylaxis (PEP), including passive immunization (PI) with rabies immunoglobulin or monoclonal antibodies, remains the only effective intervention. Despite established clinical guidelines, real-world PI utilization remains suboptimal. This study aimed to investigate the prevalence and determinants of PI hesitancy among previously unvaccinated patients with Category III rabies exposure in China. Methods: This multicenter cross-sectional questionnaire study was conducted at 12 rabies PEP clinics or emergency departments in 12 provinces of mainland China. The analysis included 585 previously unvaccinated adults with Category III rabies exposure who initially hesitated to receive or declined PI. The questionnaire collected sociodemographic characteristics, exposure profiles, awareness of the early protection gap, reasons for initial PI hesitancy or refusal, the decision to receive PI during the same clinical encounter, and PI product selection. Multivariable logistic regression identified factors associated with PI treatment decisions, with results reported as adjusted odds ratios (aORs); reason-specific models used the Benjamini&amp;amp;ndash;Hochberg false discovery rate correction. All inferential analyses were restricted to adults. Results: Among 5068 eligible previously unvaccinated patients with Category III rabies exposure, 2866 (57%) initially hesitated to receive or declined recommended PI. Of 617 questionnaire respondents, 32 minors were excluded, leaving 585 adults for all inferential analyses. The leading reasons for initial hesitancy were lack of understanding of the immediate protective role of PI (199/585, 34%), belief that vaccination alone was sufficient (194/585, 33%), and high cost (178/585, 30%). During the same clinical encounter, 320/585 adults (55%) chose to receive PI. Awareness of the early protection gap (aOR 2.63, 95% CI 1.75&amp;amp;ndash;3.98, p &amp;amp;lt; 0.001) and bachelor&amp;amp;rsquo;s degree or higher (aOR 1.61, 95% CI 1.07&amp;amp;ndash;2.43, p = 0.023) were positively associated with the decision to receive PI, whereas head/face wounds were negatively associated (aOR 0.53, 95% CI 0.30&amp;amp;ndash;0.92, p = 0.026). In reason-specific models, lack of knowledge about immediate protection was associated with higher odds of choosing PI (aOR 2.43, 95% CI 1.62&amp;amp;ndash;3.68, BH-FDR p &amp;amp;lt; 0.001), whereas high cost was associated with lower odds (aOR 0.41, 95% CI 0.27&amp;amp;ndash;0.62, BH-FDR p &amp;amp;lt; 0.001). Conclusion: Hesitancy toward and refusal of PI were observed among previously unvaccinated adults with Category III rabies exposure, yet initial hesitation or refusal is not irreversible. Early protection gap awareness was positively associated with PI choice, whereas cost-related concern was negatively associated. Clear explanation of protection timing and attention to cost-related barriers may support informed PI treatment decisions.</p>
	]]></content:encoded>

	<dc:title>Passive Immunization Hesitancy Among Rabies-Exposed Individuals in China: A Multicenter Cross-Sectional Study</dc:title>
			<dc:creator>Qisheng Hou</dc:creator>
			<dc:creator>Xiaoliang Xu</dc:creator>
			<dc:creator>Si Liu</dc:creator>
			<dc:creator>Chen Sun</dc:creator>
			<dc:creator>Fengfeng Zhu</dc:creator>
			<dc:creator>Yang Yang</dc:creator>
			<dc:creator>Jianchao Shao</dc:creator>
			<dc:creator>Yifan Wang</dc:creator>
			<dc:creator>Yanqiang Feng</dc:creator>
			<dc:creator>Yingxiang Liu</dc:creator>
			<dc:creator>Yan Yan</dc:creator>
			<dc:creator>Song Wang</dc:creator>
			<dc:creator>Yan Wang</dc:creator>
			<dc:creator>Cheng Liu</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090238</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>238</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090238</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/238</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/9/237">

	<title>TropicalMed, Vol. 11, Pages 237: Deciphering the &amp;ldquo;Doxycycline Deficiency Syndrome&amp;rdquo;: Defining the Characteristic Clinical, Laboratory and Imaging Findings in Patients Presenting with Leptospirosis, Q Fever and Rickettsial Diseases in Far North Queensland, Tropical Australia</title>
	<link>https://www.mdpi.com/2414-6366/11/9/237</link>
	<description>Background: The &amp;amp;ldquo;doxycycline deficiency syndrome&amp;amp;rdquo; is a colloquial term used in tropical Australia to describe the overlapping, non-specific findings seen in leptospirosis, Q fever, and the rickettsial diseases scrub typhus and Queensland tick typhus (QTT). A laboratory confirmed diagnosis is frequently delayed, however, early differentiation of these potentially life-threatening infections has important implications for clinical management. Methods: We examined consecutive laboratory-confirmed cases of leptospirosis, Q fever, and rickettsial diseases managed at a referral centre in tropical Australia. The patients&amp;amp;rsquo; symptoms, clinical signs and simple laboratory and radiology investigations at presentation were compared. Results: There were 111 cases of leptospirosis, 59 cases of Q fever, and 34 cases of rickettsial disease (17 cases of QTT and 17 of scrub typhus). Patients with leptospirosis had a shorter duration of symptoms and were more likely to have gastrointestinal symptoms, arthralgia, haemoptysis, hypotension, conjunctival suffusion and abnormal chest auscultation at presentation than patients with the other infections. They were more likely to have renal impairment and an elevated creatine kinase but less likely to have an elevated serum ferritin and serum lactate dehydrogenase. Patients with leptospirosis were more likely to have alveolar and multilobar changes on chest imaging. Patients with Q fever were more likely to have abnormal liver function tests at presentation but were more likely to have preserved renal function and normal chest imaging. Patients with rickettsial disease were more likely to have a rash, an eschar, lymphadenopathy and splenomegaly. Overall, 76/204 (37%) required ICU admission, of whom 56 (74%) had leptospirosis, but all 204 patients survived to hospital discharge. Conclusions: Leptospirosis, Q fever, and rickettsial diseases can have a similar presentation, but simple clinical, laboratory and imaging findings can help distinguish these infections and expedite their optimal management.</description>
	<pubDate>2026-08-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 237: Deciphering the &amp;ldquo;Doxycycline Deficiency Syndrome&amp;rdquo;: Defining the Characteristic Clinical, Laboratory and Imaging Findings in Patients Presenting with Leptospirosis, Q Fever and Rickettsial Diseases in Far North Queensland, Tropical Australia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/9/237">doi: 10.3390/tropicalmed11090237</a></p>
	<p>Authors:
		Hayley Stratton
		Callum Pownell
		Megan Sandeman
		Patrick Rosengren
		Cody Price
		Alexandra G. A. Stewart
		Roderick Gavey
		Toni Kinneally
		Kathy Petoumenos
		Simon Smith
		Josh Hanson
		</p>
	<p>Background: The &amp;amp;ldquo;doxycycline deficiency syndrome&amp;amp;rdquo; is a colloquial term used in tropical Australia to describe the overlapping, non-specific findings seen in leptospirosis, Q fever, and the rickettsial diseases scrub typhus and Queensland tick typhus (QTT). A laboratory confirmed diagnosis is frequently delayed, however, early differentiation of these potentially life-threatening infections has important implications for clinical management. Methods: We examined consecutive laboratory-confirmed cases of leptospirosis, Q fever, and rickettsial diseases managed at a referral centre in tropical Australia. The patients&amp;amp;rsquo; symptoms, clinical signs and simple laboratory and radiology investigations at presentation were compared. Results: There were 111 cases of leptospirosis, 59 cases of Q fever, and 34 cases of rickettsial disease (17 cases of QTT and 17 of scrub typhus). Patients with leptospirosis had a shorter duration of symptoms and were more likely to have gastrointestinal symptoms, arthralgia, haemoptysis, hypotension, conjunctival suffusion and abnormal chest auscultation at presentation than patients with the other infections. They were more likely to have renal impairment and an elevated creatine kinase but less likely to have an elevated serum ferritin and serum lactate dehydrogenase. Patients with leptospirosis were more likely to have alveolar and multilobar changes on chest imaging. Patients with Q fever were more likely to have abnormal liver function tests at presentation but were more likely to have preserved renal function and normal chest imaging. Patients with rickettsial disease were more likely to have a rash, an eschar, lymphadenopathy and splenomegaly. Overall, 76/204 (37%) required ICU admission, of whom 56 (74%) had leptospirosis, but all 204 patients survived to hospital discharge. Conclusions: Leptospirosis, Q fever, and rickettsial diseases can have a similar presentation, but simple clinical, laboratory and imaging findings can help distinguish these infections and expedite their optimal management.</p>
	]]></content:encoded>

	<dc:title>Deciphering the &amp;amp;ldquo;Doxycycline Deficiency Syndrome&amp;amp;rdquo;: Defining the Characteristic Clinical, Laboratory and Imaging Findings in Patients Presenting with Leptospirosis, Q Fever and Rickettsial Diseases in Far North Queensland, Tropical Australia</dc:title>
			<dc:creator>Hayley Stratton</dc:creator>
			<dc:creator>Callum Pownell</dc:creator>
			<dc:creator>Megan Sandeman</dc:creator>
			<dc:creator>Patrick Rosengren</dc:creator>
			<dc:creator>Cody Price</dc:creator>
			<dc:creator>Alexandra G. A. Stewart</dc:creator>
			<dc:creator>Roderick Gavey</dc:creator>
			<dc:creator>Toni Kinneally</dc:creator>
			<dc:creator>Kathy Petoumenos</dc:creator>
			<dc:creator>Simon Smith</dc:creator>
			<dc:creator>Josh Hanson</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11090237</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-22</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-22</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>237</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11090237</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/9/237</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/236">

	<title>TropicalMed, Vol. 11, Pages 236: Comment on Nejati et al. Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review. Trop. Med. Infect. Dis. 2026, 11, 131</title>
	<link>https://www.mdpi.com/2414-6366/11/8/236</link>
	<description>In this paper, we critically review the article entitled &amp;amp;ldquo;Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review&amp;amp;rdquo; published in Tropical Medicine and Infectious Disease (2026, 11, 131) [...]</description>
	<pubDate>2026-08-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 236: Comment on Nejati et al. Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review. Trop. Med. Infect. Dis. 2026, 11, 131</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/236">doi: 10.3390/tropicalmed11080236</a></p>
	<p>Authors:
		Tahereh Sadat Asgarian
		Mohammad Mehdi Sedaghat
		</p>
	<p>In this paper, we critically review the article entitled &amp;amp;ldquo;Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review&amp;amp;rdquo; published in Tropical Medicine and Infectious Disease (2026, 11, 131) [...]</p>
	]]></content:encoded>

	<dc:title>Comment on Nejati et al. Spatiotemporal Patterns and Historical Overview of Aedes Mosquitoes in Iran: A Systematic Review. Trop. Med. Infect. Dis. 2026, 11, 131</dc:title>
			<dc:creator>Tahereh Sadat Asgarian</dc:creator>
			<dc:creator>Mohammad Mehdi Sedaghat</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080236</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-21</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-21</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Comment</prism:section>
	<prism:startingPage>236</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080236</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/236</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/235">

	<title>TropicalMed, Vol. 11, Pages 235: Addressing the Gaps and Challenges of Autochthonous Mucocutaneous Leishmaniasis in Spain</title>
	<link>https://www.mdpi.com/2414-6366/11/8/235</link>
	<description>Autochthonous mucocutaneous leishmaniasis caused by Leishmania infantum is an under-recognised but established manifestation of endemic leishmaniasis in Spain. This review identified 65 confirmed autochthonous cases reported since 1990, showing a relatively consistent clinical pattern. Most patients were adults, predominantly men in the fifth or sixth decade of life. Nearly half were immunosuppressed, mainly due to HIV infection, corticosteroid use, biologic therapy, autoimmune diseases, or solid organ transplantation, although immunocompetent individuals were also affected. The laryngeal, nasal, and oral mucosa were the most commonly involved sites, with occasional tracheal and bronchial disease. Clinical presentation was typically chronic and non-specific, including ulcerative, nodular, polypoid, or tumour-like lesions that frequently mimicked malignancy or inflammatory disorders, often delaying diagnosis. Unlike classical New World mucocutaneous leishmaniasis, Spanish cases generally lacked a preceding cutaneous lesion, supporting recognition as a distinct form of L. infantum infection. Diagnosis required microbiological confirmation, ideally with species identification through culture or molecular methods, while serology showed limited reliability. Treatment approaches varied considerably, reflecting the absence of standardised protocols, although systemic therapy (particularly liposomal amphotericin B) was most commonly used. Improved recognition, surveillance, and inclusion in clinical guidelines are needed to reduce diagnostic delay and therapeutic variability.</description>
	<pubDate>2026-08-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 235: Addressing the Gaps and Challenges of Autochthonous Mucocutaneous Leishmaniasis in Spain</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/235">doi: 10.3390/tropicalmed11080235</a></p>
	<p>Authors:
		Diego Gayoso-Cantero
		Begoña Monge-Maillo
		Jose A. Perez-Molina
		</p>
	<p>Autochthonous mucocutaneous leishmaniasis caused by Leishmania infantum is an under-recognised but established manifestation of endemic leishmaniasis in Spain. This review identified 65 confirmed autochthonous cases reported since 1990, showing a relatively consistent clinical pattern. Most patients were adults, predominantly men in the fifth or sixth decade of life. Nearly half were immunosuppressed, mainly due to HIV infection, corticosteroid use, biologic therapy, autoimmune diseases, or solid organ transplantation, although immunocompetent individuals were also affected. The laryngeal, nasal, and oral mucosa were the most commonly involved sites, with occasional tracheal and bronchial disease. Clinical presentation was typically chronic and non-specific, including ulcerative, nodular, polypoid, or tumour-like lesions that frequently mimicked malignancy or inflammatory disorders, often delaying diagnosis. Unlike classical New World mucocutaneous leishmaniasis, Spanish cases generally lacked a preceding cutaneous lesion, supporting recognition as a distinct form of L. infantum infection. Diagnosis required microbiological confirmation, ideally with species identification through culture or molecular methods, while serology showed limited reliability. Treatment approaches varied considerably, reflecting the absence of standardised protocols, although systemic therapy (particularly liposomal amphotericin B) was most commonly used. Improved recognition, surveillance, and inclusion in clinical guidelines are needed to reduce diagnostic delay and therapeutic variability.</p>
	]]></content:encoded>

	<dc:title>Addressing the Gaps and Challenges of Autochthonous Mucocutaneous Leishmaniasis in Spain</dc:title>
			<dc:creator>Diego Gayoso-Cantero</dc:creator>
			<dc:creator>Begoña Monge-Maillo</dc:creator>
			<dc:creator>Jose A. Perez-Molina</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080235</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-21</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-21</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>235</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080235</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/235</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/234">

	<title>TropicalMed, Vol. 11, Pages 234: How Imported Pathology Becomes Overlooked as Resources Increase: An Example of a Neglected Tropical Disease (NTD)</title>
	<link>https://www.mdpi.com/2414-6366/11/8/234</link>
	<description>This case report highlights how neglected tropical diseases (NTDs) may remain underdiagnosed in high-resource settings despite advanced healthcare systems. We describe an 18-year-old woman from Equatorial Guinea living in Spain who presented with chronic pruritus and episodic ocular symptoms and was ultimately diagnosed with ocular loiasis after the incidental extraction of a conjunctival filaria. Diagnostic evaluation included microscopy, serology, and molecular techniques, confirming Loa loa and Mansonella perstans co-infection alongside evidence of exposure to other parasitic infections. Management involved staged antiparasitic therapy with albendazole, ivermectin, praziquantel, and diethylcarbamazine, combined with corticosteroids to mitigate treatment-related reactions. The patient showed clinical improvement, although follow-up was irregular and microfilaremia persisted. This case illustrates key challenges in non-endemic settings, including low clinical suspicion, fragmented care pathways, and barriers to healthcare access among migrant populations. Despite the availability of sensitive diagnostic tools, delayed recognition remains common when tropical diseases are not considered in the differential diagnosis. Comprehensive, multidisciplinary approaches are essential, particularly in patients from endemic regions who may harbor multiple co-infections. Strengthening clinical awareness, referral pathways, and appropriate screening for NTDs may help reduce diagnostic delays and improve patient outcomes in increasingly globalized healthcare settings.</description>
	<pubDate>2026-08-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 234: How Imported Pathology Becomes Overlooked as Resources Increase: An Example of a Neglected Tropical Disease (NTD)</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/234">doi: 10.3390/tropicalmed11080234</a></p>
	<p>Authors:
		Fernando de la Calle-Prieto
		Lucía Platero
		Jorge Ligero-López
		Marta Díaz-Menéndez
		Guillermo Ruiz-Carrascoso
		</p>
	<p>This case report highlights how neglected tropical diseases (NTDs) may remain underdiagnosed in high-resource settings despite advanced healthcare systems. We describe an 18-year-old woman from Equatorial Guinea living in Spain who presented with chronic pruritus and episodic ocular symptoms and was ultimately diagnosed with ocular loiasis after the incidental extraction of a conjunctival filaria. Diagnostic evaluation included microscopy, serology, and molecular techniques, confirming Loa loa and Mansonella perstans co-infection alongside evidence of exposure to other parasitic infections. Management involved staged antiparasitic therapy with albendazole, ivermectin, praziquantel, and diethylcarbamazine, combined with corticosteroids to mitigate treatment-related reactions. The patient showed clinical improvement, although follow-up was irregular and microfilaremia persisted. This case illustrates key challenges in non-endemic settings, including low clinical suspicion, fragmented care pathways, and barriers to healthcare access among migrant populations. Despite the availability of sensitive diagnostic tools, delayed recognition remains common when tropical diseases are not considered in the differential diagnosis. Comprehensive, multidisciplinary approaches are essential, particularly in patients from endemic regions who may harbor multiple co-infections. Strengthening clinical awareness, referral pathways, and appropriate screening for NTDs may help reduce diagnostic delays and improve patient outcomes in increasingly globalized healthcare settings.</p>
	]]></content:encoded>

	<dc:title>How Imported Pathology Becomes Overlooked as Resources Increase: An Example of a Neglected Tropical Disease (NTD)</dc:title>
			<dc:creator>Fernando de la Calle-Prieto</dc:creator>
			<dc:creator>Lucía Platero</dc:creator>
			<dc:creator>Jorge Ligero-López</dc:creator>
			<dc:creator>Marta Díaz-Menéndez</dc:creator>
			<dc:creator>Guillermo Ruiz-Carrascoso</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080234</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-20</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-20</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>234</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080234</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/234</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/233">

	<title>TropicalMed, Vol. 11, Pages 233: Correction: Khourcha et al. Assessing the Efficacy of Monovalent and Commercialized Antivenoms for Neutralizing Moroccan Cobra Naja haje Venom: A Comparative Study. Trop. Med. Infect. Dis. 2023, 8, 304</title>
	<link>https://www.mdpi.com/2414-6366/11/8/233</link>
	<description>There was an error in the original publication [...]</description>
	<pubDate>2026-08-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 233: Correction: Khourcha et al. Assessing the Efficacy of Monovalent and Commercialized Antivenoms for Neutralizing Moroccan Cobra Naja haje Venom: A Comparative Study. Trop. Med. Infect. Dis. 2023, 8, 304</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/233">doi: 10.3390/tropicalmed11080233</a></p>
	<p>Authors:
		Soukaina Khourcha
		Ines Hilal
		Iatimad Elbejjaj
		Mehdi Karkouri
		Amal Safi
		Abdelaziz Hmyene
		Naoual Oukkache
		</p>
	<p>There was an error in the original publication [...]</p>
	]]></content:encoded>

	<dc:title>Correction: Khourcha et al. Assessing the Efficacy of Monovalent and Commercialized Antivenoms for Neutralizing Moroccan Cobra Naja haje Venom: A Comparative Study. Trop. Med. Infect. Dis. 2023, 8, 304</dc:title>
			<dc:creator>Soukaina Khourcha</dc:creator>
			<dc:creator>Ines Hilal</dc:creator>
			<dc:creator>Iatimad Elbejjaj</dc:creator>
			<dc:creator>Mehdi Karkouri</dc:creator>
			<dc:creator>Amal Safi</dc:creator>
			<dc:creator>Abdelaziz Hmyene</dc:creator>
			<dc:creator>Naoual Oukkache</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080233</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-19</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-19</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Correction</prism:section>
	<prism:startingPage>233</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080233</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/233</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/232">

	<title>TropicalMed, Vol. 11, Pages 232: One Health Prioritization of Rabies Risk in the Republic of Guinea: Integration of Human Knowledge, Canine Immunity, and Spatial Analysis</title>
	<link>https://www.mdpi.com/2414-6366/11/8/232</link>
	<description>Background: Dog-mediated rabies remains a fatal but preventable zoonosis. Its elimination requires sufficient canine vaccination coverage, informed communities, and spatially targeted surveillance. In Guinea, human knowledge, attitudes, and practices (KAP) data and canine serological data had previously been analyzed separately, limiting their translation into operational priorities. Objective: To build an integrated One Health assessment of rabies risk by combining KAP indicators, canine immunity, and spatial analysis. Methods: A secondary integrated analysis was conducted using a KAP survey of 2733 respondents and canine rabies serology from 419 vaccinated dogs tested with the Platelia&amp;amp;trade; Rabies II ELISA, with a protection threshold set at 0.5 IU/mL. Indicators were regionalized, compared, and incorporated into a vulnerability index. Associations were estimated by logistic regression with 95% confidence intervals, and spatial findings were displayed on a real map of Guinea. Results: Knowledge was insufficient or intermediate among most respondents, unfavorable attitudes reached 88.84%, and poor practices reached 73.80%. Declared canine vaccination coverage remained below the 70% programmatic threshold in all regions. Overall canine seroprotection was high (88.78%), but 11.22% of dogs remained insufficiently protected. Among dog owners, knowledge of rabies was associated with dog vaccination (OR = 2.77; 95% CI: 1.49&amp;amp;ndash;6.29). The integrated One Health assessment ranked Kindia as priority 1, Siguiri as priority 2, Bok&amp;amp;eacute; and Lab&amp;amp;eacute; as priority 3, and N&amp;amp;rsquo;Z&amp;amp;eacute;r&amp;amp;eacute;kor&amp;amp;eacute; as priority 4. Conclusions: The integrated analysis shows that a strong immune response among vaccinated dogs is not sufficient when coverage, human practices, and the spatial distribution of risk remain heterogeneous. The recommended strategy is a regionally differentiated intervention combining post-exposure education, proximity-based dog vaccination, and targeted surveillance.</description>
	<pubDate>2026-08-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 232: One Health Prioritization of Rabies Risk in the Republic of Guinea: Integration of Human Knowledge, Canine Immunity, and Spatial Analysis</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/232">doi: 10.3390/tropicalmed11080232</a></p>
	<p>Authors:
		Noumouké Kante
		Abdoulaye Kuan Traore
		Lanceï Kaba
		Nafissatou Ouédraogo
		Nicolas Barro
		</p>
	<p>Background: Dog-mediated rabies remains a fatal but preventable zoonosis. Its elimination requires sufficient canine vaccination coverage, informed communities, and spatially targeted surveillance. In Guinea, human knowledge, attitudes, and practices (KAP) data and canine serological data had previously been analyzed separately, limiting their translation into operational priorities. Objective: To build an integrated One Health assessment of rabies risk by combining KAP indicators, canine immunity, and spatial analysis. Methods: A secondary integrated analysis was conducted using a KAP survey of 2733 respondents and canine rabies serology from 419 vaccinated dogs tested with the Platelia&amp;amp;trade; Rabies II ELISA, with a protection threshold set at 0.5 IU/mL. Indicators were regionalized, compared, and incorporated into a vulnerability index. Associations were estimated by logistic regression with 95% confidence intervals, and spatial findings were displayed on a real map of Guinea. Results: Knowledge was insufficient or intermediate among most respondents, unfavorable attitudes reached 88.84%, and poor practices reached 73.80%. Declared canine vaccination coverage remained below the 70% programmatic threshold in all regions. Overall canine seroprotection was high (88.78%), but 11.22% of dogs remained insufficiently protected. Among dog owners, knowledge of rabies was associated with dog vaccination (OR = 2.77; 95% CI: 1.49&amp;amp;ndash;6.29). The integrated One Health assessment ranked Kindia as priority 1, Siguiri as priority 2, Bok&amp;amp;eacute; and Lab&amp;amp;eacute; as priority 3, and N&amp;amp;rsquo;Z&amp;amp;eacute;r&amp;amp;eacute;kor&amp;amp;eacute; as priority 4. Conclusions: The integrated analysis shows that a strong immune response among vaccinated dogs is not sufficient when coverage, human practices, and the spatial distribution of risk remain heterogeneous. The recommended strategy is a regionally differentiated intervention combining post-exposure education, proximity-based dog vaccination, and targeted surveillance.</p>
	]]></content:encoded>

	<dc:title>One Health Prioritization of Rabies Risk in the Republic of Guinea: Integration of Human Knowledge, Canine Immunity, and Spatial Analysis</dc:title>
			<dc:creator>Noumouké Kante</dc:creator>
			<dc:creator>Abdoulaye Kuan Traore</dc:creator>
			<dc:creator>Lanceï Kaba</dc:creator>
			<dc:creator>Nafissatou Ouédraogo</dc:creator>
			<dc:creator>Nicolas Barro</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080232</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-19</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-19</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>232</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080232</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/232</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/231">

	<title>TropicalMed, Vol. 11, Pages 231: Optimizing Dengue Surveillance Thresholds in Malaysia: A Comparative Evaluation of Endemic Channel Approaches</title>
	<link>https://www.mdpi.com/2414-6366/11/8/231</link>
	<description>Endemic channels are widely used in dengue surveillance to detect unusual increases in case counts. However, conventional approaches that rely on historical averages with fixed standard deviation (SD)-based multipliers may produce unstable thresholds and false alerts. This study compared a conventional SD-based endemic channel with a log-scale SD-based endemic channel incorporating an enhanced alert rule to identify the optimal approach for routine dengue surveillance in Malaysia. Weekly national dengue case data from 2014 to 2024 were analyzed. A rolling validation approach was used to evaluate outbreak detection performance from 2017 to 2023 using three-year historical baselines. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and the Youden Index were calculated and pooled across the validation years. The optimal multiplier was selected based on the highest pooled Youden Index using the rolling validation period (2017&amp;amp;ndash;2023). The selected approach was then applied independently to the 2024 surveillance data as an operational demonstration of its potential use in routine dengue surveillance. A total of 260 epidemiological weeks were analyzed, of which 42 (16.2%) were classified as outbreak weeks. The log-scale SD-based endemic channel incorporating an enhanced alert rule achieved the highest pooled Youden Index of 0.43 at the optimal multiplier of 0.50. At this multiplier, sensitivity was 0.60, specificity 0.82, positive predictive value 0.35, negative predictive value 0.93, and overall accuracy 0.79. Compared with the conventional SD-based endemic channel at its optimal multiplier (1.00), the proposed approach demonstrated improved sensitivity (0.60 vs. 0.56), specificity (0.82 vs. 0.70), positive predictive value (0.35 vs. 0.23), negative predictive value (0.93 vs. 0.91), accuracy (0.79 vs. 0.68), and Youden Index (0.43 vs. 0.26). The log-scale SD-based endemic channel incorporating an enhanced alert rule demonstrated superior overall outbreak detection performance and was selected as the optimal approach for routine dengue surveillance.</description>
	<pubDate>2026-08-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 231: Optimizing Dengue Surveillance Thresholds in Malaysia: A Comparative Evaluation of Endemic Channel Approaches</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/231">doi: 10.3390/tropicalmed11080231</a></p>
	<p>Authors:
		Sarbhan Singh
		Nuur Hafizah Md. Iderus
		Lonny Chen Rong Qi Ahmad
		Sumarni Mohd Ghazali
		Nur’ain Mohd Ghazali
		Mohd Nadzmi Md Nadzri
		Asrul Anuar
		Mohd Kamarulariffin Kamarudin
		Lim Mei Cheng
		Teh Chien Huey
		Chong Zhuo Lin
		Wan Ming Keong
		Chew Cheng Hoon
		</p>
	<p>Endemic channels are widely used in dengue surveillance to detect unusual increases in case counts. However, conventional approaches that rely on historical averages with fixed standard deviation (SD)-based multipliers may produce unstable thresholds and false alerts. This study compared a conventional SD-based endemic channel with a log-scale SD-based endemic channel incorporating an enhanced alert rule to identify the optimal approach for routine dengue surveillance in Malaysia. Weekly national dengue case data from 2014 to 2024 were analyzed. A rolling validation approach was used to evaluate outbreak detection performance from 2017 to 2023 using three-year historical baselines. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and the Youden Index were calculated and pooled across the validation years. The optimal multiplier was selected based on the highest pooled Youden Index using the rolling validation period (2017&amp;amp;ndash;2023). The selected approach was then applied independently to the 2024 surveillance data as an operational demonstration of its potential use in routine dengue surveillance. A total of 260 epidemiological weeks were analyzed, of which 42 (16.2%) were classified as outbreak weeks. The log-scale SD-based endemic channel incorporating an enhanced alert rule achieved the highest pooled Youden Index of 0.43 at the optimal multiplier of 0.50. At this multiplier, sensitivity was 0.60, specificity 0.82, positive predictive value 0.35, negative predictive value 0.93, and overall accuracy 0.79. Compared with the conventional SD-based endemic channel at its optimal multiplier (1.00), the proposed approach demonstrated improved sensitivity (0.60 vs. 0.56), specificity (0.82 vs. 0.70), positive predictive value (0.35 vs. 0.23), negative predictive value (0.93 vs. 0.91), accuracy (0.79 vs. 0.68), and Youden Index (0.43 vs. 0.26). The log-scale SD-based endemic channel incorporating an enhanced alert rule demonstrated superior overall outbreak detection performance and was selected as the optimal approach for routine dengue surveillance.</p>
	]]></content:encoded>

	<dc:title>Optimizing Dengue Surveillance Thresholds in Malaysia: A Comparative Evaluation of Endemic Channel Approaches</dc:title>
			<dc:creator>Sarbhan Singh</dc:creator>
			<dc:creator>Nuur Hafizah Md. Iderus</dc:creator>
			<dc:creator>Lonny Chen Rong Qi Ahmad</dc:creator>
			<dc:creator>Sumarni Mohd Ghazali</dc:creator>
			<dc:creator>Nur’ain Mohd Ghazali</dc:creator>
			<dc:creator>Mohd Nadzmi Md Nadzri</dc:creator>
			<dc:creator>Asrul Anuar</dc:creator>
			<dc:creator>Mohd Kamarulariffin Kamarudin</dc:creator>
			<dc:creator>Lim Mei Cheng</dc:creator>
			<dc:creator>Teh Chien Huey</dc:creator>
			<dc:creator>Chong Zhuo Lin</dc:creator>
			<dc:creator>Wan Ming Keong</dc:creator>
			<dc:creator>Chew Cheng Hoon</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080231</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-19</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-19</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>231</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080231</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/231</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/230">

	<title>TropicalMed, Vol. 11, Pages 230: Socio-Demographic Factors Associated with Alcohol and Tobacco Use Among Virally Suppressed People Living with HIV in the Eastern Cape, South Africa</title>
	<link>https://www.mdpi.com/2414-6366/11/8/230</link>
	<description>Background: Alcohol and tobacco use remain important public health concerns among people living with HIV (PLWH), even after achieving viral load suppression. This study examined the socio-demographic factors associated with alcohol and tobacco use among virally suppressed PLWH in the Eastern Cape Province, South Africa. Methods: A cross-sectional study was conducted among 244 adults receiving antiretroviral therapy with suppressed viral loads at public healthcare facilities in the Eastern Cape Province. Data were collected using the Alcohol Use Disorders Identification Test (AUDIT) and the WHO STEPwise questionnaire. Alcohol use was classified according to the AUDIT, and participants were further categorised into low-risk (AUDIT score &amp;amp;lt; 8) and risky drinking (AUDIT score &amp;amp;ge; 8) for regression analyses. Associations between socio-demographic characteristics and alcohol use were initially examined using cross-tabulations and exact tests where appropriate. Univariable and multivariable binary logistic regression analyses were subsequently performed to identify factors independently associated with risky alcohol use and smoking. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported, with statistical significance set at p &amp;amp;lt; 0.05. Results: Of the 244 participants, 57.0% were female, and 61.5% were employed. Based on the total AUDIT score, 60.2% of participants were classified as risky drinkers, while 44.3% were current smokers. In the multivariable analysis, employment was independently associated with risky alcohol use (AOR = 2.03, 95% CI: 1.11&amp;amp;ndash;3.73) and current smoking (AOR = 3.75, 95% CI: 1.98&amp;amp;ndash;7.08). Compared with single participants, married (AOR = 2.61, 95% CI: 1.25&amp;amp;ndash;5.45), separated (AOR = 5.19, 95% CI: 1.98&amp;amp;ndash;13.60), and divorced participants (AOR = 3.32, 95% CI: 1.05&amp;amp;ndash;10.49) had higher odds of risky alcohol use. Conclusion: Alcohol use and tobacco smoking remain common among virally suppressed PLWH in the Eastern Cape Province. Although viral load suppression is an important treatment outcome, it does not fully reflect broader health behaviours that may compromise long-term health. Integrating routine screening for alcohol and tobacco use, together with targeted behavioural interventions and harm reduction strategies, into comprehensive HIV care may improve long-term health outcomes.</description>
	<pubDate>2026-08-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 230: Socio-Demographic Factors Associated with Alcohol and Tobacco Use Among Virally Suppressed People Living with HIV in the Eastern Cape, South Africa</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/230">doi: 10.3390/tropicalmed11080230</a></p>
	<p>Authors:
		Zanele Bennedict Nomatshila
		Guillermo Alfredo Pulido Estrada
		Sibusiso Cyprian Nomatshila
		Teke Ruffin Apalata
		</p>
	<p>Background: Alcohol and tobacco use remain important public health concerns among people living with HIV (PLWH), even after achieving viral load suppression. This study examined the socio-demographic factors associated with alcohol and tobacco use among virally suppressed PLWH in the Eastern Cape Province, South Africa. Methods: A cross-sectional study was conducted among 244 adults receiving antiretroviral therapy with suppressed viral loads at public healthcare facilities in the Eastern Cape Province. Data were collected using the Alcohol Use Disorders Identification Test (AUDIT) and the WHO STEPwise questionnaire. Alcohol use was classified according to the AUDIT, and participants were further categorised into low-risk (AUDIT score &amp;amp;lt; 8) and risky drinking (AUDIT score &amp;amp;ge; 8) for regression analyses. Associations between socio-demographic characteristics and alcohol use were initially examined using cross-tabulations and exact tests where appropriate. Univariable and multivariable binary logistic regression analyses were subsequently performed to identify factors independently associated with risky alcohol use and smoking. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported, with statistical significance set at p &amp;amp;lt; 0.05. Results: Of the 244 participants, 57.0% were female, and 61.5% were employed. Based on the total AUDIT score, 60.2% of participants were classified as risky drinkers, while 44.3% were current smokers. In the multivariable analysis, employment was independently associated with risky alcohol use (AOR = 2.03, 95% CI: 1.11&amp;amp;ndash;3.73) and current smoking (AOR = 3.75, 95% CI: 1.98&amp;amp;ndash;7.08). Compared with single participants, married (AOR = 2.61, 95% CI: 1.25&amp;amp;ndash;5.45), separated (AOR = 5.19, 95% CI: 1.98&amp;amp;ndash;13.60), and divorced participants (AOR = 3.32, 95% CI: 1.05&amp;amp;ndash;10.49) had higher odds of risky alcohol use. Conclusion: Alcohol use and tobacco smoking remain common among virally suppressed PLWH in the Eastern Cape Province. Although viral load suppression is an important treatment outcome, it does not fully reflect broader health behaviours that may compromise long-term health. Integrating routine screening for alcohol and tobacco use, together with targeted behavioural interventions and harm reduction strategies, into comprehensive HIV care may improve long-term health outcomes.</p>
	]]></content:encoded>

	<dc:title>Socio-Demographic Factors Associated with Alcohol and Tobacco Use Among Virally Suppressed People Living with HIV in the Eastern Cape, South Africa</dc:title>
			<dc:creator>Zanele Bennedict Nomatshila</dc:creator>
			<dc:creator>Guillermo Alfredo Pulido Estrada</dc:creator>
			<dc:creator>Sibusiso Cyprian Nomatshila</dc:creator>
			<dc:creator>Teke Ruffin Apalata</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080230</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>230</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080230</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/230</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/229">

	<title>TropicalMed, Vol. 11, Pages 229: National Implementation of a Tuberculosis Sample Referral Network to Expand Access to Molecular Diagnosis in the Republic of Congo: Pilot Evaluation and Programmatic Analysis (2023&amp;ndash;2025)</title>
	<link>https://www.mdpi.com/2414-6366/11/8/229</link>
	<description>Background: Limited access to rapid molecular diagnostics remains a major barrier to timely tuberculosis (TB) detection and drug-resistance surveillance in resource-constrained settings. In the Republic of Congo, GeneXpert MTB/RIF platforms remain concentrated in a few laboratories, while peripheral facilities rely predominantly on smear microscopy, highlighting the need for a structured sample referral system. Methods: We conducted a three-year mixed-methods operational study comprising a six-month pilot phase (January&amp;amp;ndash;June 2023), initially enrolling 29 TB diagnostic and treatment centers in urban and rural settings followed by a 30-month national roll-out phase (July 2023&amp;amp;ndash;December 2025), evaluated retrospectively using routine programmatic surveillance data. Results: During the pilot phase, 962 sputum samples were transported. 294 (30.6%) were TB cases, including 12 (4.1%) RR-TB. Median total turnaround time was 53 h (19&amp;amp;ndash;168) in urban and 62 h (26&amp;amp;ndash;204) in rural, with 86% overall site participation (92% urban vs. 60% rural). During scale-up, samples increased from 2154 (2023) to 5160 (2024), achieving full national coverage (12/12 departments). Over three years, 2587 TB and 84 RR-TB cases were detected. The system&amp;amp;rsquo;s contribution to national TB detection grew from 9.2% to 16.0%, and RR-TB detection from 10.4% to 18.7%. Conclusions: Implementation of the structured sample referral system was associated with improved equitable access to molecular TB diagnosis, turnaround times within national targets, and strengthened the RR-TB surveillance. Scalable transport networks integrated into national guidelines may enhance diagnostic equity and drug-resistance detection in centralized laboratory systems.</description>
	<pubDate>2026-08-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 229: National Implementation of a Tuberculosis Sample Referral Network to Expand Access to Molecular Diagnosis in the Republic of Congo: Pilot Evaluation and Programmatic Analysis (2023&amp;ndash;2025)</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/229">doi: 10.3390/tropicalmed11080229</a></p>
	<p>Authors:
		Darrel Ornelle Elion Assiana
		Hugues Check Asken Traoré
		Franck Hardain Okemba-Okombi
		Emmanuel Fonfon Ebata-Mboussa
		Freisnel Hermeland Mouzinga
		Erudit Beny Elenga
		Asta-Wabi Fozia Hamed Belo
		Mary Vincent Pabie Passy Mambou
		Juliette Burchelle Ayessa Ondzie
		Alain Disu Kamalandua
		Tanou Joseph Kalivogui
		Romeance Juvick Lepoupou
		Bermeland Ewuinh Tsiobinda
		Edrene Likoyo Mampouyath
		Rachel Laure Nguela
		Viviane Gisele Lompo Ouedraogo
		Prudence Théoline Ovoulaka
		Jessica Jeielle Ayande
		Jacques Ndion Ngandzien
		Baurel Arnaud Akiera
		Salomon Tchuandom Bonsi
		Jean Akiana
		</p>
	<p>Background: Limited access to rapid molecular diagnostics remains a major barrier to timely tuberculosis (TB) detection and drug-resistance surveillance in resource-constrained settings. In the Republic of Congo, GeneXpert MTB/RIF platforms remain concentrated in a few laboratories, while peripheral facilities rely predominantly on smear microscopy, highlighting the need for a structured sample referral system. Methods: We conducted a three-year mixed-methods operational study comprising a six-month pilot phase (January&amp;amp;ndash;June 2023), initially enrolling 29 TB diagnostic and treatment centers in urban and rural settings followed by a 30-month national roll-out phase (July 2023&amp;amp;ndash;December 2025), evaluated retrospectively using routine programmatic surveillance data. Results: During the pilot phase, 962 sputum samples were transported. 294 (30.6%) were TB cases, including 12 (4.1%) RR-TB. Median total turnaround time was 53 h (19&amp;amp;ndash;168) in urban and 62 h (26&amp;amp;ndash;204) in rural, with 86% overall site participation (92% urban vs. 60% rural). During scale-up, samples increased from 2154 (2023) to 5160 (2024), achieving full national coverage (12/12 departments). Over three years, 2587 TB and 84 RR-TB cases were detected. The system&amp;amp;rsquo;s contribution to national TB detection grew from 9.2% to 16.0%, and RR-TB detection from 10.4% to 18.7%. Conclusions: Implementation of the structured sample referral system was associated with improved equitable access to molecular TB diagnosis, turnaround times within national targets, and strengthened the RR-TB surveillance. Scalable transport networks integrated into national guidelines may enhance diagnostic equity and drug-resistance detection in centralized laboratory systems.</p>
	]]></content:encoded>

	<dc:title>National Implementation of a Tuberculosis Sample Referral Network to Expand Access to Molecular Diagnosis in the Republic of Congo: Pilot Evaluation and Programmatic Analysis (2023&amp;amp;ndash;2025)</dc:title>
			<dc:creator>Darrel Ornelle Elion Assiana</dc:creator>
			<dc:creator>Hugues Check Asken Traoré</dc:creator>
			<dc:creator>Franck Hardain Okemba-Okombi</dc:creator>
			<dc:creator>Emmanuel Fonfon Ebata-Mboussa</dc:creator>
			<dc:creator>Freisnel Hermeland Mouzinga</dc:creator>
			<dc:creator>Erudit Beny Elenga</dc:creator>
			<dc:creator>Asta-Wabi Fozia Hamed Belo</dc:creator>
			<dc:creator>Mary Vincent Pabie Passy Mambou</dc:creator>
			<dc:creator>Juliette Burchelle Ayessa Ondzie</dc:creator>
			<dc:creator>Alain Disu Kamalandua</dc:creator>
			<dc:creator>Tanou Joseph Kalivogui</dc:creator>
			<dc:creator>Romeance Juvick Lepoupou</dc:creator>
			<dc:creator>Bermeland Ewuinh Tsiobinda</dc:creator>
			<dc:creator>Edrene Likoyo Mampouyath</dc:creator>
			<dc:creator>Rachel Laure Nguela</dc:creator>
			<dc:creator>Viviane Gisele Lompo Ouedraogo</dc:creator>
			<dc:creator>Prudence Théoline Ovoulaka</dc:creator>
			<dc:creator>Jessica Jeielle Ayande</dc:creator>
			<dc:creator>Jacques Ndion Ngandzien</dc:creator>
			<dc:creator>Baurel Arnaud Akiera</dc:creator>
			<dc:creator>Salomon Tchuandom Bonsi</dc:creator>
			<dc:creator>Jean Akiana</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080229</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-17</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-17</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>229</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080229</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/229</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/228">

	<title>TropicalMed, Vol. 11, Pages 228: Modelling African Swine Fever Transmission and Epidemiology: A Scoping Review of Mechanistic, Statistical, and Machine Learning Approaches</title>
	<link>https://www.mdpi.com/2414-6366/11/8/228</link>
	<description>African swine fever (ASF) is a viral disease of domestic and wild pigs that has re-emerged as a major transboundary disease. Modelling using mechanistic, statistical, and machine learning (ML) approaches plays a key role in understanding ASF transmission and informing disease control, but the literature remains fragmented. To synthesise global ASF modelling efforts, we systematically reviewed studies applying these three approaches. We examined temporal and geographic trends, modelling objectives, explanatory variables, and model evaluation practices. A total of 151 papers published through 2024 met the inclusion criteria. Mechanistic (54.3%) and statistical (40.4%) approaches predominated, whereas ML (9.3%) was increasingly applied in recent years. Mechanistic models were primarily used to assess control strategies (48.8%) and transmission drivers (41.5%), statistical models to identify risk factors (63.9%) and spatiotemporal spread (32.8%), and ML for environmental suitability modelling (64.3%). Most were published from 2011 (99.3%) and focused on Europe (43.0%) and Asia (26.5%). Model evaluation remained inconsistent, with mechanistic papers frequently lacking model output uncertainty quantification (47.0%) and statistical papers often omitting model adequacy assessment (49.2%) and assumption checking (50.8%). Overall, ASF modelling approaches have developed complementary methodological roles, while geographic underrepresentation, limited representation of some transmission pathways, and inconsistent model evaluation remain important gaps.</description>
	<pubDate>2026-08-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 228: Modelling African Swine Fever Transmission and Epidemiology: A Scoping Review of Mechanistic, Statistical, and Machine Learning Approaches</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/228">doi: 10.3390/tropicalmed11080228</a></p>
	<p>Authors:
		Kim Dianne B. Ligue-Sabio
		Yoni Nazarathy
		Kien Quoc Do
		Luis Furuya-Kanamori
		Yusuf A. Sucol
		Benn Sartorius
		Colleen L. Lau
		</p>
	<p>African swine fever (ASF) is a viral disease of domestic and wild pigs that has re-emerged as a major transboundary disease. Modelling using mechanistic, statistical, and machine learning (ML) approaches plays a key role in understanding ASF transmission and informing disease control, but the literature remains fragmented. To synthesise global ASF modelling efforts, we systematically reviewed studies applying these three approaches. We examined temporal and geographic trends, modelling objectives, explanatory variables, and model evaluation practices. A total of 151 papers published through 2024 met the inclusion criteria. Mechanistic (54.3%) and statistical (40.4%) approaches predominated, whereas ML (9.3%) was increasingly applied in recent years. Mechanistic models were primarily used to assess control strategies (48.8%) and transmission drivers (41.5%), statistical models to identify risk factors (63.9%) and spatiotemporal spread (32.8%), and ML for environmental suitability modelling (64.3%). Most were published from 2011 (99.3%) and focused on Europe (43.0%) and Asia (26.5%). Model evaluation remained inconsistent, with mechanistic papers frequently lacking model output uncertainty quantification (47.0%) and statistical papers often omitting model adequacy assessment (49.2%) and assumption checking (50.8%). Overall, ASF modelling approaches have developed complementary methodological roles, while geographic underrepresentation, limited representation of some transmission pathways, and inconsistent model evaluation remain important gaps.</p>
	]]></content:encoded>

	<dc:title>Modelling African Swine Fever Transmission and Epidemiology: A Scoping Review of Mechanistic, Statistical, and Machine Learning Approaches</dc:title>
			<dc:creator>Kim Dianne B. Ligue-Sabio</dc:creator>
			<dc:creator>Yoni Nazarathy</dc:creator>
			<dc:creator>Kien Quoc Do</dc:creator>
			<dc:creator>Luis Furuya-Kanamori</dc:creator>
			<dc:creator>Yusuf A. Sucol</dc:creator>
			<dc:creator>Benn Sartorius</dc:creator>
			<dc:creator>Colleen L. Lau</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080228</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-14</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-14</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>228</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080228</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/228</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/227">

	<title>TropicalMed, Vol. 11, Pages 227: Molecular Epidemiology and Genotyping of Blastocystis sp. Among Patients in Guilan, Northern Iran</title>
	<link>https://www.mdpi.com/2414-6366/11/8/227</link>
	<description>Background: Blastocystis sp. is an anaerobic intestinal protozoan with extensive genetic diversity and controversial pathogenicity. The distribution and molecular subtypes of this entity in Guilan province, northern Iran, remain under-investigated. Objective: This study aimed to determine the prevalence and molecular subtypes of Blastocystis sp. in Rasht, Guilan Province, Iran. Methods: In this cross-sectional study (2023&amp;amp;ndash;2024), 300 stool samples were collected from patients referred to the medical laboratory at Razi Hospital. Microscopic examination and PCR amplification targeting the SSU rDNA gene were performed. Sequencing was performed on the positive isolates, and subtyping was achieved through BLAST alignment and subsequent phylogenetic analysis. Results: The overall prevalence of Blastocystis sp. was 12.3% (n = 37). No significant associations were found between infection and age, sex, or place of residence (p &amp;amp;gt; 0.05). Molecular characterisation (23.08%). No statistically significant correlation was observed between subtypes and clinical symptoms, although ST1 and ST7 were more frequently detected in symptomatic individuals. Conclusions: Blastocystis sp. showed notable subtype diversity in the studied population, including the potentially zoonotic ST7. However, no significant association was found between subtypes and clinical manifestations. These findings support sustained molecular epidemiological surveillance and larger-scale studies to clarify subtype-specific pathogenesis and transmission dynamics.</description>
	<pubDate>2026-08-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 227: Molecular Epidemiology and Genotyping of Blastocystis sp. Among Patients in Guilan, Northern Iran</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/227">doi: 10.3390/tropicalmed11080227</a></p>
	<p>Authors:
		Mohammad Reza Mahmoudi
		Zahra Naemi
		Meysam Sharifdini
		Nozhat Zebardast
		Somayeh Abbaszadeh
		Panagiotis Karanis
		</p>
	<p>Background: Blastocystis sp. is an anaerobic intestinal protozoan with extensive genetic diversity and controversial pathogenicity. The distribution and molecular subtypes of this entity in Guilan province, northern Iran, remain under-investigated. Objective: This study aimed to determine the prevalence and molecular subtypes of Blastocystis sp. in Rasht, Guilan Province, Iran. Methods: In this cross-sectional study (2023&amp;amp;ndash;2024), 300 stool samples were collected from patients referred to the medical laboratory at Razi Hospital. Microscopic examination and PCR amplification targeting the SSU rDNA gene were performed. Sequencing was performed on the positive isolates, and subtyping was achieved through BLAST alignment and subsequent phylogenetic analysis. Results: The overall prevalence of Blastocystis sp. was 12.3% (n = 37). No significant associations were found between infection and age, sex, or place of residence (p &amp;amp;gt; 0.05). Molecular characterisation (23.08%). No statistically significant correlation was observed between subtypes and clinical symptoms, although ST1 and ST7 were more frequently detected in symptomatic individuals. Conclusions: Blastocystis sp. showed notable subtype diversity in the studied population, including the potentially zoonotic ST7. However, no significant association was found between subtypes and clinical manifestations. These findings support sustained molecular epidemiological surveillance and larger-scale studies to clarify subtype-specific pathogenesis and transmission dynamics.</p>
	]]></content:encoded>

	<dc:title>Molecular Epidemiology and Genotyping of Blastocystis sp. Among Patients in Guilan, Northern Iran</dc:title>
			<dc:creator>Mohammad Reza Mahmoudi</dc:creator>
			<dc:creator>Zahra Naemi</dc:creator>
			<dc:creator>Meysam Sharifdini</dc:creator>
			<dc:creator>Nozhat Zebardast</dc:creator>
			<dc:creator>Somayeh Abbaszadeh</dc:creator>
			<dc:creator>Panagiotis Karanis</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080227</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-12</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-12</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>227</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080227</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/227</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/226">

	<title>TropicalMed, Vol. 11, Pages 226: Climate Change, Urbanization, and the Emerging Urban Threat of Rift Valley Fever in Tropical and Subtropical Cities: A Narrative Review</title>
	<link>https://www.mdpi.com/2414-6366/11/8/226</link>
	<description>Rift Valley fever (RVF) is a climate-sensitive mosquito-borne zoonosis long regarded as a rural, pastoral disease, yet accelerating tropical urbanization and intensifying climate variability may be reshaping its epidemiology at the urban&amp;amp;ndash;peri-urban interface. This narrative review examines how global climate change and urban-specific climatic conditions jointly shape RVF virus (RVFV) vector habitats, transmission, and burden in tropical and subtropical cities, synthesizing 51 of 412 English-language records identified by a structured, non-systematic search of PubMed, Scopus, Web of Science, and Google Scholar (2009&amp;amp;ndash;2026) and selected for relevance to urban and peri-urban RVF. This research draws on human, livestock, and vector evidence from Sub-Saharan Africa, the Arabian Peninsula, and Indian Ocean islands across epidemic and inter-epidemic periods. The synthesis indicates that impervious surfaces, poor drainage, and open water storage can recreate the water-retaining function of rural dambos, sustaining a year-round larval habitat, and that Culex quinquefasciatus dominance together with peri-urban cattle may form an amplification bridge to humans. Direct evidence remains scarce, anchored by a single peri-urban serosurvey and limited urban slaughterhouse entomology. Critical gaps include urban primary-vector ecology, infection-rate data, urban-heat effects, city-specific exposure studies, and coupled climate&amp;amp;ndash;urban burden models. We conclude that RVF is a plausible emerging urban threat warranting proactive inter-epidemic surveillance and integration of RVF into urban planning and One Health systems.</description>
	<pubDate>2026-08-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 226: Climate Change, Urbanization, and the Emerging Urban Threat of Rift Valley Fever in Tropical and Subtropical Cities: A Narrative Review</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/226">doi: 10.3390/tropicalmed11080226</a></p>
	<p>Authors:
		Ahmad Y. Alqassim
		</p>
	<p>Rift Valley fever (RVF) is a climate-sensitive mosquito-borne zoonosis long regarded as a rural, pastoral disease, yet accelerating tropical urbanization and intensifying climate variability may be reshaping its epidemiology at the urban&amp;amp;ndash;peri-urban interface. This narrative review examines how global climate change and urban-specific climatic conditions jointly shape RVF virus (RVFV) vector habitats, transmission, and burden in tropical and subtropical cities, synthesizing 51 of 412 English-language records identified by a structured, non-systematic search of PubMed, Scopus, Web of Science, and Google Scholar (2009&amp;amp;ndash;2026) and selected for relevance to urban and peri-urban RVF. This research draws on human, livestock, and vector evidence from Sub-Saharan Africa, the Arabian Peninsula, and Indian Ocean islands across epidemic and inter-epidemic periods. The synthesis indicates that impervious surfaces, poor drainage, and open water storage can recreate the water-retaining function of rural dambos, sustaining a year-round larval habitat, and that Culex quinquefasciatus dominance together with peri-urban cattle may form an amplification bridge to humans. Direct evidence remains scarce, anchored by a single peri-urban serosurvey and limited urban slaughterhouse entomology. Critical gaps include urban primary-vector ecology, infection-rate data, urban-heat effects, city-specific exposure studies, and coupled climate&amp;amp;ndash;urban burden models. We conclude that RVF is a plausible emerging urban threat warranting proactive inter-epidemic surveillance and integration of RVF into urban planning and One Health systems.</p>
	]]></content:encoded>

	<dc:title>Climate Change, Urbanization, and the Emerging Urban Threat of Rift Valley Fever in Tropical and Subtropical Cities: A Narrative Review</dc:title>
			<dc:creator>Ahmad Y. Alqassim</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080226</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-12</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-12</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>226</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080226</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/226</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/225">

	<title>TropicalMed, Vol. 11, Pages 225: Understanding Barriers to Uptake of TB Preventive Treatment Among People Living with HIV in Zimbabwe: A Qualitative Assessment of Healthcare Workers&amp;rsquo; Perspectives</title>
	<link>https://www.mdpi.com/2414-6366/11/8/225</link>
	<description>People living with HIV (PLHIV) are at an increased risk of progressing from Mycobacterium tuberculosis (TB) infection to TB disease. Tuberculosis preventive treatment (TPT) is recommended for PLHIV; however, its uptake remains suboptimal. In Zimbabwe, three months of weekly rifapentine and isoniazid (3HP) and six months of daily isoniazid (6H) are the most commonly prescribed TPT regimens. We explored barriers to TPT uptake among PLHIV from the perspective of healthcare workers (HCWs) in Zimbabwe. Facility nurses who had been implementing TPT for at least six months were invited to participate in in-depth interviews and/or focus group discussions conducted in March 2023. Audio recordings were transcribed into English, coded using NVivo 12 (QSR International), and analyzed thematically. Eleven HCWs participated in in-depth interviews and 15 in focus group discussions. Barriers were categorized as person- and health system-related. Person-related barriers included misconceptions about TPT, fear of adverse events, and pill burden. Health system barriers included stock-outs of TPT medications, limited HCW knowledge and skills to promote TPT, limited expertise in initiating TPT among children under five years of age, and limited access to chest radiography. Barriers to TPT uptake and completion remain in Zimbabwe and contribute to missed opportunities for TB prevention among PLHIV. TPT implementation could be strengthened through an uninterrupted supply of TPT medications, continuous training and mentorship of HCWs, and community engagement to improve awareness of the benefits and risks of TPT.</description>
	<pubDate>2026-08-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 225: Understanding Barriers to Uptake of TB Preventive Treatment Among People Living with HIV in Zimbabwe: A Qualitative Assessment of Healthcare Workers&amp;rsquo; Perspectives</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/225">doi: 10.3390/tropicalmed11080225</a></p>
	<p>Authors:
		Tawanda Mapuranga
		Collins Timire
		Ronald T. Ncube
		Sithabiso Dube
		Nqobile Mlilo
		Cynthia Chiteve
		Owen Mugurungi
		Tsitsi Mutasa-Apollo
		Fungai Kavenga
		Clorata Gwanzura
		Manners Ncube
		Nicholas Siziba
		Selma Dar Berger
		Talent Maphosa
		Macarthur Charles
		Riitta A. Dlodlo
		Julia Ershova
		</p>
	<p>People living with HIV (PLHIV) are at an increased risk of progressing from Mycobacterium tuberculosis (TB) infection to TB disease. Tuberculosis preventive treatment (TPT) is recommended for PLHIV; however, its uptake remains suboptimal. In Zimbabwe, three months of weekly rifapentine and isoniazid (3HP) and six months of daily isoniazid (6H) are the most commonly prescribed TPT regimens. We explored barriers to TPT uptake among PLHIV from the perspective of healthcare workers (HCWs) in Zimbabwe. Facility nurses who had been implementing TPT for at least six months were invited to participate in in-depth interviews and/or focus group discussions conducted in March 2023. Audio recordings were transcribed into English, coded using NVivo 12 (QSR International), and analyzed thematically. Eleven HCWs participated in in-depth interviews and 15 in focus group discussions. Barriers were categorized as person- and health system-related. Person-related barriers included misconceptions about TPT, fear of adverse events, and pill burden. Health system barriers included stock-outs of TPT medications, limited HCW knowledge and skills to promote TPT, limited expertise in initiating TPT among children under five years of age, and limited access to chest radiography. Barriers to TPT uptake and completion remain in Zimbabwe and contribute to missed opportunities for TB prevention among PLHIV. TPT implementation could be strengthened through an uninterrupted supply of TPT medications, continuous training and mentorship of HCWs, and community engagement to improve awareness of the benefits and risks of TPT.</p>
	]]></content:encoded>

	<dc:title>Understanding Barriers to Uptake of TB Preventive Treatment Among People Living with HIV in Zimbabwe: A Qualitative Assessment of Healthcare Workers&amp;amp;rsquo; Perspectives</dc:title>
			<dc:creator>Tawanda Mapuranga</dc:creator>
			<dc:creator>Collins Timire</dc:creator>
			<dc:creator>Ronald T. Ncube</dc:creator>
			<dc:creator>Sithabiso Dube</dc:creator>
			<dc:creator>Nqobile Mlilo</dc:creator>
			<dc:creator>Cynthia Chiteve</dc:creator>
			<dc:creator>Owen Mugurungi</dc:creator>
			<dc:creator>Tsitsi Mutasa-Apollo</dc:creator>
			<dc:creator>Fungai Kavenga</dc:creator>
			<dc:creator>Clorata Gwanzura</dc:creator>
			<dc:creator>Manners Ncube</dc:creator>
			<dc:creator>Nicholas Siziba</dc:creator>
			<dc:creator>Selma Dar Berger</dc:creator>
			<dc:creator>Talent Maphosa</dc:creator>
			<dc:creator>Macarthur Charles</dc:creator>
			<dc:creator>Riitta A. Dlodlo</dc:creator>
			<dc:creator>Julia Ershova</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080225</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-11</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-11</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>225</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080225</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/225</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/224">

	<title>TropicalMed, Vol. 11, Pages 224: Exploiting the Property of a New Series of 1,2,3-Triazole Compounds as Inhibitors of In Vivo and In Vitro Toxic Effects Caused by Bothrops jararacussu Snake Venom</title>
	<link>https://www.mdpi.com/2414-6366/11/8/224</link>
	<description>(1) Background: Snake bite envenomation is a neglected disease that affects impoverished and rural areas, causing deaths and physical sequelae. (2) Objective: A novel series of eight 1,2,3-triazole compounds, AM50, AM51, AM52, AM53, AM54, AM55, AM56, and AM57, were synthesized and assessed as inhibitors of toxic activities of B. jararacussu venom. Methods: B. jararacussu venom was pre-incubated with each of the compounds and after the coagulant, proteolytic, hemorrhagic, edematogenic, and lethal activities were assessed. The structure of compounds was analyzed by NMR and FT-IR spectroscopy techniques, and toxicity was predicted through OSIRIS and SwissADME. (3) Results: AM56 and AM57 inhibited the plasma coagulant and prevented hemorrhagic activity of the venom. Proteolysis and hemorrhage were inhibited by AM52, AM54, AM55, and AM56 (20&amp;amp;ndash;30%), as well as AM50, AM51, and AM57 (30&amp;amp;ndash;60%). AM57 fully protected the mice from death caused by venom, and AM50, AM53&amp;amp;ndash;AM57 inhibited edema of venom by 10&amp;amp;ndash;20%; AM51 and AM52 did not inhibit edema. In silico analysis of compounds revealed satisfactory parameters for drug discovery. (4) Conclusions: 1,2,3&amp;amp;ndash;triazole compounds inhibited the major toxic activities of B. jararacussu venom and should be considered as a lead for further investigation as adjunct of antivenom therapeutics.</description>
	<pubDate>2026-08-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 224: Exploiting the Property of a New Series of 1,2,3-Triazole Compounds as Inhibitors of In Vivo and In Vitro Toxic Effects Caused by Bothrops jararacussu Snake Venom</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/224">doi: 10.3390/tropicalmed11080224</a></p>
	<p>Authors:
		Aldo Rodrigues da Silva
		Ana Cláudia Rodrigues da Silva
		Eladio Flores Sanchez
		Gabriel Alves Souto de Aquino
		Vitor Francisco Ferreira
		Sabrina Baptista Ferreira
		André Lopes Fuly
		</p>
	<p>(1) Background: Snake bite envenomation is a neglected disease that affects impoverished and rural areas, causing deaths and physical sequelae. (2) Objective: A novel series of eight 1,2,3-triazole compounds, AM50, AM51, AM52, AM53, AM54, AM55, AM56, and AM57, were synthesized and assessed as inhibitors of toxic activities of B. jararacussu venom. Methods: B. jararacussu venom was pre-incubated with each of the compounds and after the coagulant, proteolytic, hemorrhagic, edematogenic, and lethal activities were assessed. The structure of compounds was analyzed by NMR and FT-IR spectroscopy techniques, and toxicity was predicted through OSIRIS and SwissADME. (3) Results: AM56 and AM57 inhibited the plasma coagulant and prevented hemorrhagic activity of the venom. Proteolysis and hemorrhage were inhibited by AM52, AM54, AM55, and AM56 (20&amp;amp;ndash;30%), as well as AM50, AM51, and AM57 (30&amp;amp;ndash;60%). AM57 fully protected the mice from death caused by venom, and AM50, AM53&amp;amp;ndash;AM57 inhibited edema of venom by 10&amp;amp;ndash;20%; AM51 and AM52 did not inhibit edema. In silico analysis of compounds revealed satisfactory parameters for drug discovery. (4) Conclusions: 1,2,3&amp;amp;ndash;triazole compounds inhibited the major toxic activities of B. jararacussu venom and should be considered as a lead for further investigation as adjunct of antivenom therapeutics.</p>
	]]></content:encoded>

	<dc:title>Exploiting the Property of a New Series of 1,2,3-Triazole Compounds as Inhibitors of In Vivo and In Vitro Toxic Effects Caused by Bothrops jararacussu Snake Venom</dc:title>
			<dc:creator>Aldo Rodrigues da Silva</dc:creator>
			<dc:creator>Ana Cláudia Rodrigues da Silva</dc:creator>
			<dc:creator>Eladio Flores Sanchez</dc:creator>
			<dc:creator>Gabriel Alves Souto de Aquino</dc:creator>
			<dc:creator>Vitor Francisco Ferreira</dc:creator>
			<dc:creator>Sabrina Baptista Ferreira</dc:creator>
			<dc:creator>André Lopes Fuly</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080224</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-11</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-11</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>224</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080224</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/224</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/223">

	<title>TropicalMed, Vol. 11, Pages 223: Venomics of the Anchor Coral Snake Micrurus ancoralis: Composition, Toxicological Profile, and Neutralization by Commercial Antivenom</title>
	<link>https://www.mdpi.com/2414-6366/11/8/223</link>
	<description>Coral snakes of the American continent are classified into two genera, Micruroides and Micrurus, with as many as 91 species recognized in the latter. Although envenomings caused by Micrurus are rare, they can be life-threatening due to neurotoxic effects leading to flaccid paralysis and potential respiratory failure. Micrurus ancoralis is found in the Pacific lowlands and along the western slope of the cordillera occidental Cordillera in Colombia. Although this species is relatively common within its distribution range, its phylogenetic position and the characterization of its venom have not been investigated. The results of phylogenetic analysis placed M. ancoralis within the triadal/bicolor clade of species with the characteristic triad pattern and group bicolor. Proteomic characterization of the venom showed predominance of phospholipase A2 (PLA2) enzymes in its composition, with 51.7% of the total protein content, followed by three-finger toxins (3FTxs; 23.2%) and lower proportions of proteins belonging to several other minor families. Out of 28 chromatographic venom fractions obtained, the seven most abundant were evaluated for toxicity, with three of them (F7, identified as a 3FTx, and F18 and F20 (both identified as PLA2s)) showing lethal activity by the intraperitoneal route in mice. The PLA2 activity of F20 was confirmed and its edema-inducing, myotoxic, and lethal effects in mice were demonstrated. A therapeutic equine anti-coral antivenom (INS, Colombia) against coral snake envenomings immunorecognized the whole venom and its fractions in ELISA tests and was able to neutralize 2 &amp;amp;times; LD50 (medial lethal dose) of M. ancoralis venom by preincubation, with an estimated potency of at least 0.2 mg venom/mL antivenom. This result suggests that envenomings by M. ancoralis could be effectively treated by this antivenom.</description>
	<pubDate>2026-08-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 223: Venomics of the Anchor Coral Snake Micrurus ancoralis: Composition, Toxicological Profile, and Neutralization by Commercial Antivenom</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/223">doi: 10.3390/tropicalmed11080223</a></p>
	<p>Authors:
		Paola Rey-Suárez
		Jonard David Echavarría-Rentería
		Jeisson Gómez-Robles
		Jaime Andrés Pereañez
		Mónica Saldarriaga-Córdoba
		Bruno Lomonte
		Julián Fernández
		Vitelbina Núñez
		</p>
	<p>Coral snakes of the American continent are classified into two genera, Micruroides and Micrurus, with as many as 91 species recognized in the latter. Although envenomings caused by Micrurus are rare, they can be life-threatening due to neurotoxic effects leading to flaccid paralysis and potential respiratory failure. Micrurus ancoralis is found in the Pacific lowlands and along the western slope of the cordillera occidental Cordillera in Colombia. Although this species is relatively common within its distribution range, its phylogenetic position and the characterization of its venom have not been investigated. The results of phylogenetic analysis placed M. ancoralis within the triadal/bicolor clade of species with the characteristic triad pattern and group bicolor. Proteomic characterization of the venom showed predominance of phospholipase A2 (PLA2) enzymes in its composition, with 51.7% of the total protein content, followed by three-finger toxins (3FTxs; 23.2%) and lower proportions of proteins belonging to several other minor families. Out of 28 chromatographic venom fractions obtained, the seven most abundant were evaluated for toxicity, with three of them (F7, identified as a 3FTx, and F18 and F20 (both identified as PLA2s)) showing lethal activity by the intraperitoneal route in mice. The PLA2 activity of F20 was confirmed and its edema-inducing, myotoxic, and lethal effects in mice were demonstrated. A therapeutic equine anti-coral antivenom (INS, Colombia) against coral snake envenomings immunorecognized the whole venom and its fractions in ELISA tests and was able to neutralize 2 &amp;amp;times; LD50 (medial lethal dose) of M. ancoralis venom by preincubation, with an estimated potency of at least 0.2 mg venom/mL antivenom. This result suggests that envenomings by M. ancoralis could be effectively treated by this antivenom.</p>
	]]></content:encoded>

	<dc:title>Venomics of the Anchor Coral Snake Micrurus ancoralis: Composition, Toxicological Profile, and Neutralization by Commercial Antivenom</dc:title>
			<dc:creator>Paola Rey-Suárez</dc:creator>
			<dc:creator>Jonard David Echavarría-Rentería</dc:creator>
			<dc:creator>Jeisson Gómez-Robles</dc:creator>
			<dc:creator>Jaime Andrés Pereañez</dc:creator>
			<dc:creator>Mónica Saldarriaga-Córdoba</dc:creator>
			<dc:creator>Bruno Lomonte</dc:creator>
			<dc:creator>Julián Fernández</dc:creator>
			<dc:creator>Vitelbina Núñez</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080223</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-10</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-10</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>223</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080223</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/223</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/222">

	<title>TropicalMed, Vol. 11, Pages 222: Global Trends in Antimicrobial Resistance-Related Mortality from Klebsiella pneumoniae-Associated Lower Respiratory Infections: A GBD 2021 Analysis, 1990&amp;ndash;2021</title>
	<link>https://www.mdpi.com/2414-6366/11/8/222</link>
	<description>Klebsiella pneumoniae (K. pneumoniae) is a leading cause of hospital- and community-acquired lower respiratory infections (LRI). The emergence of antimicrobial resistance (AMR), especially carbapenem-resistant strains (CRKP), poses a serious global health threat. Using Global Burden of Disease (GBD) 2021 data, we estimated AMR-related mortality for K. pneumoniae-associated LRI across regions from 1990 to 2021. Joinpoint regression analysis identified temporal trends. Global mortality declined overall, with a 70% reduction in under-5 deaths but a doubling among adults over 70 years. Deaths associated with and attributable to AMR decreased by 18.9% and 4.5%, respectively. The age-standardized mortality rate (ASMR) fell by nearly 50%. In contrast, the mortality burden associated with carbapenem resistance increased markedly, with AMR-associated deaths rising by 157% and disproportionately affecting high-burden regions such as Sub-Saharan Africa and South Asia. Despite overall progress, the increasing mortality burden associated with carbapenem resistance in K. pneumoniae-associated LRI poses a critical and persistent global health threat.</description>
	<pubDate>2026-08-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 222: Global Trends in Antimicrobial Resistance-Related Mortality from Klebsiella pneumoniae-Associated Lower Respiratory Infections: A GBD 2021 Analysis, 1990&amp;ndash;2021</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/222">doi: 10.3390/tropicalmed11080222</a></p>
	<p>Authors:
		Hongquan Chen
		Shiyi Wang
		Min Yuan
		Zhiguo Liu
		Zhenjun Li
		</p>
	<p>Klebsiella pneumoniae (K. pneumoniae) is a leading cause of hospital- and community-acquired lower respiratory infections (LRI). The emergence of antimicrobial resistance (AMR), especially carbapenem-resistant strains (CRKP), poses a serious global health threat. Using Global Burden of Disease (GBD) 2021 data, we estimated AMR-related mortality for K. pneumoniae-associated LRI across regions from 1990 to 2021. Joinpoint regression analysis identified temporal trends. Global mortality declined overall, with a 70% reduction in under-5 deaths but a doubling among adults over 70 years. Deaths associated with and attributable to AMR decreased by 18.9% and 4.5%, respectively. The age-standardized mortality rate (ASMR) fell by nearly 50%. In contrast, the mortality burden associated with carbapenem resistance increased markedly, with AMR-associated deaths rising by 157% and disproportionately affecting high-burden regions such as Sub-Saharan Africa and South Asia. Despite overall progress, the increasing mortality burden associated with carbapenem resistance in K. pneumoniae-associated LRI poses a critical and persistent global health threat.</p>
	]]></content:encoded>

	<dc:title>Global Trends in Antimicrobial Resistance-Related Mortality from Klebsiella pneumoniae-Associated Lower Respiratory Infections: A GBD 2021 Analysis, 1990&amp;amp;ndash;2021</dc:title>
			<dc:creator>Hongquan Chen</dc:creator>
			<dc:creator>Shiyi Wang</dc:creator>
			<dc:creator>Min Yuan</dc:creator>
			<dc:creator>Zhiguo Liu</dc:creator>
			<dc:creator>Zhenjun Li</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080222</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-10</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-10</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>222</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080222</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/222</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/221">

	<title>TropicalMed, Vol. 11, Pages 221: Chikungunya Vaccines in Travel Medicine: From Regulatory Approval to Real-World Challenges</title>
	<link>https://www.mdpi.com/2414-6366/11/8/221</link>
	<description>Background: Chikungunya virus (CHIKV) infection is an emerging disease of growing concern to international travelers due to the expanding geographic distribution of competent vectors, climate change, and frequent outbreaks in endemic and previously unaffected regions. Until recently, prevention relied exclusively on vector control and bite prevention; however, the recent approval of chikungunya vaccines has introduced a new preventive strategy. Methods: We conducted a narrative review of currently licensed chikungunya vaccines and candidates in clinical development, focusing on immunogenicity, safety, regulatory status, and implications for travel medicine practice. Results: Two vaccines have recently received regulatory approval: the live-attenuated vaccine IXCHIQ&amp;amp;reg; and the virus-like particle vaccine Vimkunya&amp;amp;reg;. Both demonstrated high immunogenicity based on neutralizing antibody thresholds accepted as surrogate markers of protection. Post-marketing safety signals associated with IXCHIQ&amp;amp;reg;, particularly in older adults, have led to divergent regulatory decisions between authorities. The indication of vaccination in national recommendations varies somewhat depending on age, duration of travel, and individual risk factors. Several additional vaccine platforms remain under investigation, although some candidates have been discontinued. Conclusions: The recent approval of chikungunya vaccines marks a significant milestone in the field of travel medicine. However, uncertainties regarding long-term protection, safety in specific populations, and optimal targeting of travelers remain. Individualized risk&amp;amp;ndash;benefit assessment is essential, and further data are needed to refine vaccination strategies for travelers and populations at risk.</description>
	<pubDate>2026-08-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 221: Chikungunya Vaccines in Travel Medicine: From Regulatory Approval to Real-World Challenges</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/221">doi: 10.3390/tropicalmed11080221</a></p>
	<p>Authors:
		Yann Hervigo
		Cornelia Staehelin
		Olivia Veit
		François Chappuis
		Gilles Eperon
		Stefano Musumeci
		</p>
	<p>Background: Chikungunya virus (CHIKV) infection is an emerging disease of growing concern to international travelers due to the expanding geographic distribution of competent vectors, climate change, and frequent outbreaks in endemic and previously unaffected regions. Until recently, prevention relied exclusively on vector control and bite prevention; however, the recent approval of chikungunya vaccines has introduced a new preventive strategy. Methods: We conducted a narrative review of currently licensed chikungunya vaccines and candidates in clinical development, focusing on immunogenicity, safety, regulatory status, and implications for travel medicine practice. Results: Two vaccines have recently received regulatory approval: the live-attenuated vaccine IXCHIQ&amp;amp;reg; and the virus-like particle vaccine Vimkunya&amp;amp;reg;. Both demonstrated high immunogenicity based on neutralizing antibody thresholds accepted as surrogate markers of protection. Post-marketing safety signals associated with IXCHIQ&amp;amp;reg;, particularly in older adults, have led to divergent regulatory decisions between authorities. The indication of vaccination in national recommendations varies somewhat depending on age, duration of travel, and individual risk factors. Several additional vaccine platforms remain under investigation, although some candidates have been discontinued. Conclusions: The recent approval of chikungunya vaccines marks a significant milestone in the field of travel medicine. However, uncertainties regarding long-term protection, safety in specific populations, and optimal targeting of travelers remain. Individualized risk&amp;amp;ndash;benefit assessment is essential, and further data are needed to refine vaccination strategies for travelers and populations at risk.</p>
	]]></content:encoded>

	<dc:title>Chikungunya Vaccines in Travel Medicine: From Regulatory Approval to Real-World Challenges</dc:title>
			<dc:creator>Yann Hervigo</dc:creator>
			<dc:creator>Cornelia Staehelin</dc:creator>
			<dc:creator>Olivia Veit</dc:creator>
			<dc:creator>François Chappuis</dc:creator>
			<dc:creator>Gilles Eperon</dc:creator>
			<dc:creator>Stefano Musumeci</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080221</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-07</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-07</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>221</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080221</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/221</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/220">

	<title>TropicalMed, Vol. 11, Pages 220: Barriers to Antiretroviral Therapy Adherence in Rural and Urban Areas in Indonesia: Perspectives of People Living with HIV and Healthcare Professionals</title>
	<link>https://www.mdpi.com/2414-6366/11/8/220</link>
	<description>Antiretroviral therapy (ART) is essential for preventing HIV transmission and improving the health outcomes of people living with HIV (PLHIV). However, many barriers limit PLHIV from starting and adhering to ART, which explains why HIV responses in many settings, including Indonesia, have produced limited gains. This qualitative phenomenological study explored multilevel barriers to ART adherence in urban Yogyakarta (locally known as Jogja) and rural Belu, Indonesia, from the perspectives of PLHIV and healthcare professionals (HCPs). Data were collected through one-on-one in-depth interviews with 92 PLHIV and 20 HCPs. Participants were recruited using the snowball sampling technique. Data were analysed using framework analysis informed by the Access to Healthcare Framework. The findings showed that PLHIV in Belu and Jogja had different experiences in terms of the provision of and ability to access and adhere to ART or HIV treatment. In rural Belu, ART was less available and visible, harder to approach, often unaffordable, less aligned with patients&amp;amp;rsquo; needs, and strongly influenced by the widespread use of traditional medicine. PLHIV in Belu also reported a more limited ability to perceive the need for ART, reach services, pay costs, engage in care, and seek ART than those in urban Jogja. Personal, psychological, and social barriers were also reported to hinder PLHIV&amp;amp;rsquo;s ART adherence in both settings. These findings highlight the need for HIV policies that promote the equitable distribution of ART services and targeted interventions to improve understanding and acceptance of HIV care among PLHIV and the wider community.</description>
	<pubDate>2026-08-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 220: Barriers to Antiretroviral Therapy Adherence in Rural and Urban Areas in Indonesia: Perspectives of People Living with HIV and Healthcare Professionals</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/220">doi: 10.3390/tropicalmed11080220</a></p>
	<p>Authors:
		Nelsensius Klau Fauk
		</p>
	<p>Antiretroviral therapy (ART) is essential for preventing HIV transmission and improving the health outcomes of people living with HIV (PLHIV). However, many barriers limit PLHIV from starting and adhering to ART, which explains why HIV responses in many settings, including Indonesia, have produced limited gains. This qualitative phenomenological study explored multilevel barriers to ART adherence in urban Yogyakarta (locally known as Jogja) and rural Belu, Indonesia, from the perspectives of PLHIV and healthcare professionals (HCPs). Data were collected through one-on-one in-depth interviews with 92 PLHIV and 20 HCPs. Participants were recruited using the snowball sampling technique. Data were analysed using framework analysis informed by the Access to Healthcare Framework. The findings showed that PLHIV in Belu and Jogja had different experiences in terms of the provision of and ability to access and adhere to ART or HIV treatment. In rural Belu, ART was less available and visible, harder to approach, often unaffordable, less aligned with patients&amp;amp;rsquo; needs, and strongly influenced by the widespread use of traditional medicine. PLHIV in Belu also reported a more limited ability to perceive the need for ART, reach services, pay costs, engage in care, and seek ART than those in urban Jogja. Personal, psychological, and social barriers were also reported to hinder PLHIV&amp;amp;rsquo;s ART adherence in both settings. These findings highlight the need for HIV policies that promote the equitable distribution of ART services and targeted interventions to improve understanding and acceptance of HIV care among PLHIV and the wider community.</p>
	]]></content:encoded>

	<dc:title>Barriers to Antiretroviral Therapy Adherence in Rural and Urban Areas in Indonesia: Perspectives of People Living with HIV and Healthcare Professionals</dc:title>
			<dc:creator>Nelsensius Klau Fauk</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080220</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-07</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-07</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>220</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080220</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/220</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/219">

	<title>TropicalMed, Vol. 11, Pages 219: Detection of Leishmania infantum DNA in Sand Flies and Assessment of Zoonotic Transmission Risk in Central Honduras: A One Health Approach</title>
	<link>https://www.mdpi.com/2414-6366/11/8/219</link>
	<description>Integrated One Health studies are essential for assessing the risks of leishmaniasis transmission. In Honduras, the most prevalent clinical presentation of leishmaniasis is the non-ulcerated cutaneous form caused by Leishmania infantum; however, research on its transmission dynamics remains limited. This study aimed to characterize the eco-epidemiology of leishmaniasis and identify potential zoonotic risk factors in the municipality of Ojos de Agua, Department of Comayagua, central Honduras, using a One Health approach. We collected sand flies using CDC light traps placed in intra- and peridomestic settings of households with a history of leishmaniasis. Concurrently, we evaluated domestic dogs and collected blood samples for serological and molecular testing. We also conducted active surveillance among community residents to identify human infections. We collected a total of 644 phlebotomine sand flies, including 186 females. We identified eight sandfly species, with Lutzomyia (Lutzomyia) longipalpis as the predominant species, followed by Pintomyia (Pifanomyia) evansi. Among the 64 engorged females screened, the overall PCR positivity rate for Leishmania spp. was 14.1% (9/64). Blood meal analysis of PCR-positive sand flies identified humans and pigs as blood and meal sources. Additionally, 18.6% (8/43) of domestic dogs were seropositive for Leishmania spp., and 23.3% (10/43) tested positive by PCR. DNA sequencing identified the infecting species as Leishmania infantum. We detected no active human cases during the study period. These findings highlight the value of a One Health approach for improving transmission risk monitoring in newly emerging areas with a history of ulcerative cutaneous leishmaniasis in Honduras.</description>
	<pubDate>2026-08-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 219: Detection of Leishmania infantum DNA in Sand Flies and Assessment of Zoonotic Transmission Risk in Central Honduras: A One Health Approach</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/219">doi: 10.3390/tropicalmed11080219</a></p>
	<p>Authors:
		Elisa Alcántara-Henríquez
		Hugo O. Valdivia
		Gissella M. Vásquez
		Joel García
		Estela Guevara
		Juan F. Sanchez
		Adalid Palma
		Arnold Houghton
		Allan Iván Izaguirre González
		Marcia D. Laurenti
		Wilfredo Sosa-Ochoa
		</p>
	<p>Integrated One Health studies are essential for assessing the risks of leishmaniasis transmission. In Honduras, the most prevalent clinical presentation of leishmaniasis is the non-ulcerated cutaneous form caused by Leishmania infantum; however, research on its transmission dynamics remains limited. This study aimed to characterize the eco-epidemiology of leishmaniasis and identify potential zoonotic risk factors in the municipality of Ojos de Agua, Department of Comayagua, central Honduras, using a One Health approach. We collected sand flies using CDC light traps placed in intra- and peridomestic settings of households with a history of leishmaniasis. Concurrently, we evaluated domestic dogs and collected blood samples for serological and molecular testing. We also conducted active surveillance among community residents to identify human infections. We collected a total of 644 phlebotomine sand flies, including 186 females. We identified eight sandfly species, with Lutzomyia (Lutzomyia) longipalpis as the predominant species, followed by Pintomyia (Pifanomyia) evansi. Among the 64 engorged females screened, the overall PCR positivity rate for Leishmania spp. was 14.1% (9/64). Blood meal analysis of PCR-positive sand flies identified humans and pigs as blood and meal sources. Additionally, 18.6% (8/43) of domestic dogs were seropositive for Leishmania spp., and 23.3% (10/43) tested positive by PCR. DNA sequencing identified the infecting species as Leishmania infantum. We detected no active human cases during the study period. These findings highlight the value of a One Health approach for improving transmission risk monitoring in newly emerging areas with a history of ulcerative cutaneous leishmaniasis in Honduras.</p>
	]]></content:encoded>

	<dc:title>Detection of Leishmania infantum DNA in Sand Flies and Assessment of Zoonotic Transmission Risk in Central Honduras: A One Health Approach</dc:title>
			<dc:creator>Elisa Alcántara-Henríquez</dc:creator>
			<dc:creator>Hugo O. Valdivia</dc:creator>
			<dc:creator>Gissella M. Vásquez</dc:creator>
			<dc:creator>Joel García</dc:creator>
			<dc:creator>Estela Guevara</dc:creator>
			<dc:creator>Juan F. Sanchez</dc:creator>
			<dc:creator>Adalid Palma</dc:creator>
			<dc:creator>Arnold Houghton</dc:creator>
			<dc:creator>Allan Iván Izaguirre González</dc:creator>
			<dc:creator>Marcia D. Laurenti</dc:creator>
			<dc:creator>Wilfredo Sosa-Ochoa</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080219</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-05</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-05</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>219</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080219</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/219</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/218">

	<title>TropicalMed, Vol. 11, Pages 218: Guinea Worm Eradication: New Clinical and Public Health Challenges at the Last Mile</title>
	<link>https://www.mdpi.com/2414-6366/11/8/218</link>
	<description>Guinea worm disease is approaching eradication, with only 10 human cases reported worldwide in 2025, the lowest annual total recorded. Yet the final phase of eradication presents complex clinical and public health challenges that differ from earlier stages of control. Persistent animal infections, particularly in dogs, civil conflict, fragile health systems, financing disruptions, and the need for prolonged surveillance threaten progress at the point when global attention may wane. Unlike smallpox, Guinea worm has been driven to near-eradication without a vaccine, curative drug, or rapid diagnostic test, relying instead on safe water, filtration, vector control, case containment, community education, reporting incentives, and sustained field operations. This Perspective argues that eradication remains achievable but requires a specific policy agenda: protected financing for surveillance, animal-source transmission control, safe-water measures, operational access, and certification through 2030. Completing the final mile would represent a permanent preventive achievement and a durable victory for neglected populations too often overlooked.</description>
	<pubDate>2026-08-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 218: Guinea Worm Eradication: New Clinical and Public Health Challenges at the Last Mile</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/218">doi: 10.3390/tropicalmed11080218</a></p>
	<p>Authors:
		Barry R. Davis
		John Dunn
		Lisette V. Alcantara
		Dennis G. Maki
		Timothy D. Dye
		Charles H. Hennekens
		</p>
	<p>Guinea worm disease is approaching eradication, with only 10 human cases reported worldwide in 2025, the lowest annual total recorded. Yet the final phase of eradication presents complex clinical and public health challenges that differ from earlier stages of control. Persistent animal infections, particularly in dogs, civil conflict, fragile health systems, financing disruptions, and the need for prolonged surveillance threaten progress at the point when global attention may wane. Unlike smallpox, Guinea worm has been driven to near-eradication without a vaccine, curative drug, or rapid diagnostic test, relying instead on safe water, filtration, vector control, case containment, community education, reporting incentives, and sustained field operations. This Perspective argues that eradication remains achievable but requires a specific policy agenda: protected financing for surveillance, animal-source transmission control, safe-water measures, operational access, and certification through 2030. Completing the final mile would represent a permanent preventive achievement and a durable victory for neglected populations too often overlooked.</p>
	]]></content:encoded>

	<dc:title>Guinea Worm Eradication: New Clinical and Public Health Challenges at the Last Mile</dc:title>
			<dc:creator>Barry R. Davis</dc:creator>
			<dc:creator>John Dunn</dc:creator>
			<dc:creator>Lisette V. Alcantara</dc:creator>
			<dc:creator>Dennis G. Maki</dc:creator>
			<dc:creator>Timothy D. Dye</dc:creator>
			<dc:creator>Charles H. Hennekens</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080218</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-04</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-04</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Perspective</prism:section>
	<prism:startingPage>218</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080218</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/218</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/217">

	<title>TropicalMed, Vol. 11, Pages 217: The First Cases of Imported Leprosy in Romania After More than Four Decades of Absence of New Cases</title>
	<link>https://www.mdpi.com/2414-6366/11/8/217</link>
	<description>Although in Romania an increase in migrant population has been reported in the last years, there are no screening programs for infectious diseases implemented for migrants. We report the first two cases of leprosy (Hansen&amp;amp;rsquo;s disease) since 1981 and the first imported ones in Romania, in two sisters originating from Indonesia, employed as massage therapists at a SPA center. Case one was diagnosed with multibacillary Hansen&amp;amp;rsquo;s disease of mid-borderline type, and case two with paucibacillary Hansen&amp;amp;rsquo;s disease borderline tuberculoid form based on epidemiological, clinical, histopathological and molecular diagnosis. Both patients have started multidrug therapy with dapsone, rifampicin and clofazimine provided by WHO. Both patients developed dapsone induced anemia under therapy, even though no G6PD deficiency was present, and dapsone was stopped. The clinical evolution of skin lesions was favorable under therapy, and the haemoglobin level started to increase after dapsone was stopped. This publication underlines the risk of importing rare diseases in Romania and in other European countries and the delay in diagnosis due to insufficient awareness among occupational medicine doctors. Improved strategies are needed at national level in order to increase awareness on rare imported infectious diseases and introduce screening programs in migrant population from high-risk areas.</description>
	<pubDate>2026-08-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 217: The First Cases of Imported Leprosy in Romania After More than Four Decades of Absence of New Cases</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/217">doi: 10.3390/tropicalmed11080217</a></p>
	<p>Authors:
		Violeta Briciu
		Mihaela Lupşe
		Adrian Baican
		Bogdan Fetica
		Angela Monica Ionică
		Georgiana Coroiu
		Mirela Flonta
		Andreea Jodal
		Vladimir Filip
		Oana Stan
		Dana Marcu
		Andrada-Luciana Lazar
		Carmen Varodi
		Corina Baican
		</p>
	<p>Although in Romania an increase in migrant population has been reported in the last years, there are no screening programs for infectious diseases implemented for migrants. We report the first two cases of leprosy (Hansen&amp;amp;rsquo;s disease) since 1981 and the first imported ones in Romania, in two sisters originating from Indonesia, employed as massage therapists at a SPA center. Case one was diagnosed with multibacillary Hansen&amp;amp;rsquo;s disease of mid-borderline type, and case two with paucibacillary Hansen&amp;amp;rsquo;s disease borderline tuberculoid form based on epidemiological, clinical, histopathological and molecular diagnosis. Both patients have started multidrug therapy with dapsone, rifampicin and clofazimine provided by WHO. Both patients developed dapsone induced anemia under therapy, even though no G6PD deficiency was present, and dapsone was stopped. The clinical evolution of skin lesions was favorable under therapy, and the haemoglobin level started to increase after dapsone was stopped. This publication underlines the risk of importing rare diseases in Romania and in other European countries and the delay in diagnosis due to insufficient awareness among occupational medicine doctors. Improved strategies are needed at national level in order to increase awareness on rare imported infectious diseases and introduce screening programs in migrant population from high-risk areas.</p>
	]]></content:encoded>

	<dc:title>The First Cases of Imported Leprosy in Romania After More than Four Decades of Absence of New Cases</dc:title>
			<dc:creator>Violeta Briciu</dc:creator>
			<dc:creator>Mihaela Lupşe</dc:creator>
			<dc:creator>Adrian Baican</dc:creator>
			<dc:creator>Bogdan Fetica</dc:creator>
			<dc:creator>Angela Monica Ionică</dc:creator>
			<dc:creator>Georgiana Coroiu</dc:creator>
			<dc:creator>Mirela Flonta</dc:creator>
			<dc:creator>Andreea Jodal</dc:creator>
			<dc:creator>Vladimir Filip</dc:creator>
			<dc:creator>Oana Stan</dc:creator>
			<dc:creator>Dana Marcu</dc:creator>
			<dc:creator>Andrada-Luciana Lazar</dc:creator>
			<dc:creator>Carmen Varodi</dc:creator>
			<dc:creator>Corina Baican</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080217</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-03</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-03</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>217</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080217</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/217</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/216">

	<title>TropicalMed, Vol. 11, Pages 216: Malaria Vectors&amp;rsquo; Diversity and Seasonality in Sustaining Disease Transmission in an Endemic Area of Faladie, Mali</title>
	<link>https://www.mdpi.com/2414-6366/11/8/216</link>
	<description>The widespread circulation of the Anopheles vector is observed during the rainy season and clearly decreases during the dry season, when only a few mosquitoes are able to survive. This study aimed to identify the major species sustaining continued malaria transmission across seasons. This cross-sectional study was conducted in a malaria-endemic area. Mosquitoes were captured in Faladie using pyrethroid spray catches during rainy and dry seasons. The collected mosquitoes were identified using morphological keys, combined with molecular techniques such as PCR-RFLP (IGS regions) for Anopheles (An.) gambiae s.l. identification. Plasmodium spp. positivity in each mosquito was characterized by qPCR using parasite 18 S genes. A total of 1082 and 1705 mosquitoes were captured inside the same houses in the rainy and dry seasons, respectively. In the rainy season, 454 (41.9%) were Anopheles, 624 (57.7%) Culex and 4 (0.4%) Aedes. During the dry season, 65 (3.81%) mosquitoes were Anopheles, while 1,640 (96.19%) were Culex. Morphologically, the anopheline population consisted of 100% An. gambiae s.l. The Anopheles species diversity in the rainy season comprised the sister taxa, An. gambiae s.s. and An. Coluzzii, followed by an An. gambiae/An. coluzzii hybrid and An. arabiensis. However, An. coluzzii was found as the only vector across the rainy and dry seasons that sustained malaria transmission. Plasmodium falciparum infection rates were 9.7% and 1.7%, respectively, for the rainy and dry seasons. An. coluzzii species can survive both the dry and the rainy seasons and sustain malaria through cross-seasonal transmission. This highlights the importance of tackling An. coluzzii species and residual malaria transmission to eradicate the disease in endemic areas.</description>
	<pubDate>2026-08-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 216: Malaria Vectors&amp;rsquo; Diversity and Seasonality in Sustaining Disease Transmission in an Endemic Area of Faladie, Mali</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/216">doi: 10.3390/tropicalmed11080216</a></p>
	<p>Authors:
		Fatalmoudou Tandina
		Safiatou Niare Doumbo
		Moussa Djimdé
		Sékou Sissoko
		Privat Agniwo
		Amagoron Mathias Dolo
		Abdrahamane S. Kamaté
		Amatigue Zeguime
		Salif Yirampo
		Boucary Ouologuem
		Aichata Dembélé
		Hawa Dembélé
		Mohamed Touré
		Abdoulaye Kaloga
		Francois Dao
		Siaka Goita
		Mamadou M. Tekete
		Mahamadou A. Thera
		Abdoulaye K. Koné
		Abdoulaye A. Djimdé
		Laurent Dembele
		</p>
	<p>The widespread circulation of the Anopheles vector is observed during the rainy season and clearly decreases during the dry season, when only a few mosquitoes are able to survive. This study aimed to identify the major species sustaining continued malaria transmission across seasons. This cross-sectional study was conducted in a malaria-endemic area. Mosquitoes were captured in Faladie using pyrethroid spray catches during rainy and dry seasons. The collected mosquitoes were identified using morphological keys, combined with molecular techniques such as PCR-RFLP (IGS regions) for Anopheles (An.) gambiae s.l. identification. Plasmodium spp. positivity in each mosquito was characterized by qPCR using parasite 18 S genes. A total of 1082 and 1705 mosquitoes were captured inside the same houses in the rainy and dry seasons, respectively. In the rainy season, 454 (41.9%) were Anopheles, 624 (57.7%) Culex and 4 (0.4%) Aedes. During the dry season, 65 (3.81%) mosquitoes were Anopheles, while 1,640 (96.19%) were Culex. Morphologically, the anopheline population consisted of 100% An. gambiae s.l. The Anopheles species diversity in the rainy season comprised the sister taxa, An. gambiae s.s. and An. Coluzzii, followed by an An. gambiae/An. coluzzii hybrid and An. arabiensis. However, An. coluzzii was found as the only vector across the rainy and dry seasons that sustained malaria transmission. Plasmodium falciparum infection rates were 9.7% and 1.7%, respectively, for the rainy and dry seasons. An. coluzzii species can survive both the dry and the rainy seasons and sustain malaria through cross-seasonal transmission. This highlights the importance of tackling An. coluzzii species and residual malaria transmission to eradicate the disease in endemic areas.</p>
	]]></content:encoded>

	<dc:title>Malaria Vectors&amp;amp;rsquo; Diversity and Seasonality in Sustaining Disease Transmission in an Endemic Area of Faladie, Mali</dc:title>
			<dc:creator>Fatalmoudou Tandina</dc:creator>
			<dc:creator>Safiatou Niare Doumbo</dc:creator>
			<dc:creator>Moussa Djimdé</dc:creator>
			<dc:creator>Sékou Sissoko</dc:creator>
			<dc:creator>Privat Agniwo</dc:creator>
			<dc:creator>Amagoron Mathias Dolo</dc:creator>
			<dc:creator>Abdrahamane S. Kamaté</dc:creator>
			<dc:creator>Amatigue Zeguime</dc:creator>
			<dc:creator>Salif Yirampo</dc:creator>
			<dc:creator>Boucary Ouologuem</dc:creator>
			<dc:creator>Aichata Dembélé</dc:creator>
			<dc:creator>Hawa Dembélé</dc:creator>
			<dc:creator>Mohamed Touré</dc:creator>
			<dc:creator>Abdoulaye Kaloga</dc:creator>
			<dc:creator>Francois Dao</dc:creator>
			<dc:creator>Siaka Goita</dc:creator>
			<dc:creator>Mamadou M. Tekete</dc:creator>
			<dc:creator>Mahamadou A. Thera</dc:creator>
			<dc:creator>Abdoulaye K. Koné</dc:creator>
			<dc:creator>Abdoulaye A. Djimdé</dc:creator>
			<dc:creator>Laurent Dembele</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080216</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-03</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-03</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>216</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080216</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/216</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/215">

	<title>TropicalMed, Vol. 11, Pages 215: Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model</title>
	<link>https://www.mdpi.com/2414-6366/11/8/215</link>
	<description>The World Health Organization targets hepatitis C virus (HCV) elimination as a public-health threat by 2030. Phetchabun province, in lower northern Thailand, has historically reported one of the country&amp;amp;rsquo;s highest HCV seroprevalence rates. We describe a province-wide, decentralized test-to-treat micro-elimination program implemented within Thailand&amp;amp;rsquo;s universal health-coverage system. Adults aged 35&amp;amp;ndash;64 years (2020&amp;amp;ndash;2024) and individuals born before 1992 (late 2023) across all 11 districts were screened using fingerstick anti-HCV rapid diagnostic tests at sub-district health-promoting hospitals. Reactive participants underwent confirmatory HCV-RNA testing at three regional nodes. Eligible patients received pangenotypic sofosbuvir/velpatasvir for 12 weeks, with ribavirin added for cirrhosis. Sustained virological response at 12 weeks post-treatment (SVR12) was the primary outcome. Of 400,567 targeted individuals, 389,547 (97.3%) were screened; 18,340 (4.71%) were anti-HCV reactive. Confirmatory HCV-RNA testing was completed in 14,845 (80.9%), of whom 10,996 (74.1%) had active infection. Of 8961 treatment-eligible patients, 8842 (98.7%) received DAA therapy. Among 6719 evaluable for SVR12, 6474 (96.4%) achieved cure. This simplified, domestically financed, decentralized test-to-treat model achieved WHO-target-level diagnosis, treatment, and cure rates at provincial scale, offering a scalable framework for HCV micro-elimination in low- and middle-income countries.</description>
	<pubDate>2026-08-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 215: Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/215">doi: 10.3390/tropicalmed11080215</a></p>
	<p>Authors:
		Wijitra Phaengkha
		Pornjarim Nilyanimit
		Nungruthai Suntronwong
		Jiratchaya Puenpa
		Duong Hoang Huy Le
		Saranya Ngamnimit
		Pattama Janpathip
		Lapasrada Kamput
		Kawin Thongnoi
		Wanalee Toomta
		Phatcha Wohanklong
		Jarunlak Saokeaw
		Niphapornt Thammajit
		Suwannee Rerngleum
		Ananyalak Yoisara
		Nitiya Srisuk
		Jidapa Suwannachat
		Anchalee Karagate
		Rujipat Wasitthankasem
		Yong Poovorawan
		</p>
	<p>The World Health Organization targets hepatitis C virus (HCV) elimination as a public-health threat by 2030. Phetchabun province, in lower northern Thailand, has historically reported one of the country&amp;amp;rsquo;s highest HCV seroprevalence rates. We describe a province-wide, decentralized test-to-treat micro-elimination program implemented within Thailand&amp;amp;rsquo;s universal health-coverage system. Adults aged 35&amp;amp;ndash;64 years (2020&amp;amp;ndash;2024) and individuals born before 1992 (late 2023) across all 11 districts were screened using fingerstick anti-HCV rapid diagnostic tests at sub-district health-promoting hospitals. Reactive participants underwent confirmatory HCV-RNA testing at three regional nodes. Eligible patients received pangenotypic sofosbuvir/velpatasvir for 12 weeks, with ribavirin added for cirrhosis. Sustained virological response at 12 weeks post-treatment (SVR12) was the primary outcome. Of 400,567 targeted individuals, 389,547 (97.3%) were screened; 18,340 (4.71%) were anti-HCV reactive. Confirmatory HCV-RNA testing was completed in 14,845 (80.9%), of whom 10,996 (74.1%) had active infection. Of 8961 treatment-eligible patients, 8842 (98.7%) received DAA therapy. Among 6719 evaluable for SVR12, 6474 (96.4%) achieved cure. This simplified, domestically financed, decentralized test-to-treat model achieved WHO-target-level diagnosis, treatment, and cure rates at provincial scale, offering a scalable framework for HCV micro-elimination in low- and middle-income countries.</p>
	]]></content:encoded>

	<dc:title>Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model</dc:title>
			<dc:creator>Wijitra Phaengkha</dc:creator>
			<dc:creator>Pornjarim Nilyanimit</dc:creator>
			<dc:creator>Nungruthai Suntronwong</dc:creator>
			<dc:creator>Jiratchaya Puenpa</dc:creator>
			<dc:creator>Duong Hoang Huy Le</dc:creator>
			<dc:creator>Saranya Ngamnimit</dc:creator>
			<dc:creator>Pattama Janpathip</dc:creator>
			<dc:creator>Lapasrada Kamput</dc:creator>
			<dc:creator>Kawin Thongnoi</dc:creator>
			<dc:creator>Wanalee Toomta</dc:creator>
			<dc:creator>Phatcha Wohanklong</dc:creator>
			<dc:creator>Jarunlak Saokeaw</dc:creator>
			<dc:creator>Niphapornt Thammajit</dc:creator>
			<dc:creator>Suwannee Rerngleum</dc:creator>
			<dc:creator>Ananyalak Yoisara</dc:creator>
			<dc:creator>Nitiya Srisuk</dc:creator>
			<dc:creator>Jidapa Suwannachat</dc:creator>
			<dc:creator>Anchalee Karagate</dc:creator>
			<dc:creator>Rujipat Wasitthankasem</dc:creator>
			<dc:creator>Yong Poovorawan</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080215</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-08-01</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-08-01</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>215</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080215</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/215</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/214">

	<title>TropicalMed, Vol. 11, Pages 214: Expanding the Frontiers of Tuberculosis Prevention: Moving from Targeted Preventive Therapy to Integrated Public Health Strategies</title>
	<link>https://www.mdpi.com/2414-6366/11/8/214</link>
	<description>Tuberculosis (TB) remains a leading cause of infectious disease-related mortality worldwide despite major advances in diagnostics, treatment, and programmatic control. Achieving the goals of the World Health Organization End TB Strategy requires a greater emphasis on prevention alongside improvements in diagnosis and treatment. This viewpoint examines evolving priorities in TB prevention and highlights key insights from studies included in the Special Issue &amp;amp;lsquo;New Perspectives in Tuberculosis Prevention and Control&amp;amp;rsquo;. The articles published in the Special Issue highlight the importance of identifying populations at increased risk of infection, disease transmission, and disease progression; strengthening the implementation of tuberculosis preventive treatment among household contacts and people living with HIV; and addressing the behavioral, social, and structural determinants that influence access to TB prevention and care. They also demonstrate persistent challenges related to medicine availability, healthcare worker capacity, patient initiation and follow-up, program monitoring, and the implementation of preventive interventions in resource-constrained settings. Emerging developments in diagnostics, biomarkers, vaccines, and digital health may contribute to the longer-term TB prevention agenda but require further evaluation of their feasibility, affordability, and programmatic relevance. Collectively, the evidence indicates that effective TB prevention extends beyond individual biomedical interventions and requires coordinated approaches involving healthcare systems, communities, surveillance systems, and social support mechanisms. Continued investment in implementation research, health-system strengthening, program management, economic evaluation, and multisectoral action will be critical to translate existing evidence into sustainable, equitable, and context-specific strategies for reducing the global burden of TB.</description>
	<pubDate>2026-07-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 214: Expanding the Frontiers of Tuberculosis Prevention: Moving from Targeted Preventive Therapy to Integrated Public Health Strategies</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/214">doi: 10.3390/tropicalmed11080214</a></p>
	<p>Authors:
		Kannamkottapilly Chandrasekharan Prajitha
		Anam Anil Alwani
		Pruthu Thekkur
		</p>
	<p>Tuberculosis (TB) remains a leading cause of infectious disease-related mortality worldwide despite major advances in diagnostics, treatment, and programmatic control. Achieving the goals of the World Health Organization End TB Strategy requires a greater emphasis on prevention alongside improvements in diagnosis and treatment. This viewpoint examines evolving priorities in TB prevention and highlights key insights from studies included in the Special Issue &amp;amp;lsquo;New Perspectives in Tuberculosis Prevention and Control&amp;amp;rsquo;. The articles published in the Special Issue highlight the importance of identifying populations at increased risk of infection, disease transmission, and disease progression; strengthening the implementation of tuberculosis preventive treatment among household contacts and people living with HIV; and addressing the behavioral, social, and structural determinants that influence access to TB prevention and care. They also demonstrate persistent challenges related to medicine availability, healthcare worker capacity, patient initiation and follow-up, program monitoring, and the implementation of preventive interventions in resource-constrained settings. Emerging developments in diagnostics, biomarkers, vaccines, and digital health may contribute to the longer-term TB prevention agenda but require further evaluation of their feasibility, affordability, and programmatic relevance. Collectively, the evidence indicates that effective TB prevention extends beyond individual biomedical interventions and requires coordinated approaches involving healthcare systems, communities, surveillance systems, and social support mechanisms. Continued investment in implementation research, health-system strengthening, program management, economic evaluation, and multisectoral action will be critical to translate existing evidence into sustainable, equitable, and context-specific strategies for reducing the global burden of TB.</p>
	]]></content:encoded>

	<dc:title>Expanding the Frontiers of Tuberculosis Prevention: Moving from Targeted Preventive Therapy to Integrated Public Health Strategies</dc:title>
			<dc:creator>Kannamkottapilly Chandrasekharan Prajitha</dc:creator>
			<dc:creator>Anam Anil Alwani</dc:creator>
			<dc:creator>Pruthu Thekkur</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080214</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-29</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-29</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Viewpoint</prism:section>
	<prism:startingPage>214</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080214</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/214</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/213">

	<title>TropicalMed, Vol. 11, Pages 213: Current and Emerging Diagnostic Approaches for Tuberculosis in People Living with HIV: Challenges and Future Perspectives</title>
	<link>https://www.mdpi.com/2414-6366/11/8/213</link>
	<description>Tuberculosis (TB) remains a leading cause of morbidity and mortality among people living with human immunodeficiency virus (HIV), in whom immunosuppression often results in atypical clinical manifestations, paucibacillary disease, extrapulmonary involvement, and disseminated forms that complicate timely diagnosis. This narrative review summarizes current and emerging diagnostic approaches for TB-HIV, with emphasis on their diagnostic performance, clinical applicability, implementation challenges, and potential integration into future algorithms. Conventional methods, including sputum smear microscopy, mycobacterial culture, and chest radiography, remain relevant but have important limitations in people living with HIV (PLHIV), particularly in advanced immunosuppression. Rapid molecular tests, especially Xpert MTB/RIF and Xpert MTB/RIF Ultra, have improved early detection of Mycobacterium tuberculosis and rifampicin resistance, although diagnostic gaps persist in sputum-scarce and extrapulmonary disease. Non-sputum-based tests, particularly WHO-recommended urine LF-LAM and emerging next-generation assays such as FujiLAM II, offer important opportunities for severely ill patients and those with advanced HIV disease. Host-derived biomarkers, transcriptomic signatures, and artificial intelligence-assisted chest imaging may further strengthen screening, triage, and diagnostic prioritization. Integrated, context-adapted diagnostic algorithms combining microbiological, molecular, urinary, imaging, and host-response tools are needed to improve early TB detection and reduce mortality in resource-limited settings.</description>
	<pubDate>2026-07-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 213: Current and Emerging Diagnostic Approaches for Tuberculosis in People Living with HIV: Challenges and Future Perspectives</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/213">doi: 10.3390/tropicalmed11080213</a></p>
	<p>Authors:
		Guillermo Eduardo Cuéllar-Nevárez
		José Rafael Linares Morales
		Luis Arturo Camacho Silvas
		Sandra Guadalupe Chavarría Hidalgo
		Guadalupe Virginia Nevárez-Moorillón
		Karla Elva Loza Solano
		</p>
	<p>Tuberculosis (TB) remains a leading cause of morbidity and mortality among people living with human immunodeficiency virus (HIV), in whom immunosuppression often results in atypical clinical manifestations, paucibacillary disease, extrapulmonary involvement, and disseminated forms that complicate timely diagnosis. This narrative review summarizes current and emerging diagnostic approaches for TB-HIV, with emphasis on their diagnostic performance, clinical applicability, implementation challenges, and potential integration into future algorithms. Conventional methods, including sputum smear microscopy, mycobacterial culture, and chest radiography, remain relevant but have important limitations in people living with HIV (PLHIV), particularly in advanced immunosuppression. Rapid molecular tests, especially Xpert MTB/RIF and Xpert MTB/RIF Ultra, have improved early detection of Mycobacterium tuberculosis and rifampicin resistance, although diagnostic gaps persist in sputum-scarce and extrapulmonary disease. Non-sputum-based tests, particularly WHO-recommended urine LF-LAM and emerging next-generation assays such as FujiLAM II, offer important opportunities for severely ill patients and those with advanced HIV disease. Host-derived biomarkers, transcriptomic signatures, and artificial intelligence-assisted chest imaging may further strengthen screening, triage, and diagnostic prioritization. Integrated, context-adapted diagnostic algorithms combining microbiological, molecular, urinary, imaging, and host-response tools are needed to improve early TB detection and reduce mortality in resource-limited settings.</p>
	]]></content:encoded>

	<dc:title>Current and Emerging Diagnostic Approaches for Tuberculosis in People Living with HIV: Challenges and Future Perspectives</dc:title>
			<dc:creator>Guillermo Eduardo Cuéllar-Nevárez</dc:creator>
			<dc:creator>José Rafael Linares Morales</dc:creator>
			<dc:creator>Luis Arturo Camacho Silvas</dc:creator>
			<dc:creator>Sandra Guadalupe Chavarría Hidalgo</dc:creator>
			<dc:creator>Guadalupe Virginia Nevárez-Moorillón</dc:creator>
			<dc:creator>Karla Elva Loza Solano</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080213</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-28</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-28</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>213</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080213</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/213</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/212">

	<title>TropicalMed, Vol. 11, Pages 212: A Successful Cross-Agency Model for Collaborative Response to Imported Infectious Disease: Investigation and Management of the First Confirmed Clade Ia Mpox Case in Shanghai, China</title>
	<link>https://www.mdpi.com/2414-6366/11/8/212</link>
	<description>Introduction: Historically, human infections with clade Ia monkeypox virus (MPXV) primarily occurred through zoonotic transmission with limited secondary human-to-human transmission. Recent studies suggest increasing evidence of human-to-human transmission of some clade Ia lineages. This report documents the first imported clade Ia mpox case in Shanghai, representing the second documented case in China. Methods: Patient demographics, clinical profiles, epidemiological history, and close contacts were obtained through interviews with the patient and attending physicians. Clinical specimens were collected for real-time fluorescent quantitative polymerase chain reaction (qPCR) and whole-genome sequencing. Contact tracing was implemented, involving a 21-day health monitoring of close contacts. Results: The patient presented with moderate symptoms, including fever, rash, and respiratory manifestations. Genome sequencing identified the virus as clade Ia, showing 99.96% nucleotide identity to a strain from the Democratic Republic of Congo (DRC). Eight close contacts were identified with no secondary infection reported. Conclusions: This case was confirmed as an imported clade Ia mpox case originating in the DRC. The &amp;amp;ldquo;four JOINTs&amp;amp;rdquo; cross-agency collaborative mechanism between the CDC and customs played a significant role in effectively stopping local transmission. Challenges in remote investigation highlight the need for stronger international collaboration. Establishing an integrated &amp;amp;ldquo;early warning-control-tracking&amp;amp;rdquo; system, coupled with public health intervention, is crucial for reducing importation risks and safeguarding national health security.</description>
	<pubDate>2026-07-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 212: A Successful Cross-Agency Model for Collaborative Response to Imported Infectious Disease: Investigation and Management of the First Confirmed Clade Ia Mpox Case in Shanghai, China</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/212">doi: 10.3390/tropicalmed11080212</a></p>
	<p>Authors:
		Zilian Cao
		Fang Xu
		Xiaoyan Huang
		Yifeng Shen
		Xin Xin
		Lin Ai
		Hao Pan
		Huanyu Wu
		</p>
	<p>Introduction: Historically, human infections with clade Ia monkeypox virus (MPXV) primarily occurred through zoonotic transmission with limited secondary human-to-human transmission. Recent studies suggest increasing evidence of human-to-human transmission of some clade Ia lineages. This report documents the first imported clade Ia mpox case in Shanghai, representing the second documented case in China. Methods: Patient demographics, clinical profiles, epidemiological history, and close contacts were obtained through interviews with the patient and attending physicians. Clinical specimens were collected for real-time fluorescent quantitative polymerase chain reaction (qPCR) and whole-genome sequencing. Contact tracing was implemented, involving a 21-day health monitoring of close contacts. Results: The patient presented with moderate symptoms, including fever, rash, and respiratory manifestations. Genome sequencing identified the virus as clade Ia, showing 99.96% nucleotide identity to a strain from the Democratic Republic of Congo (DRC). Eight close contacts were identified with no secondary infection reported. Conclusions: This case was confirmed as an imported clade Ia mpox case originating in the DRC. The &amp;amp;ldquo;four JOINTs&amp;amp;rdquo; cross-agency collaborative mechanism between the CDC and customs played a significant role in effectively stopping local transmission. Challenges in remote investigation highlight the need for stronger international collaboration. Establishing an integrated &amp;amp;ldquo;early warning-control-tracking&amp;amp;rdquo; system, coupled with public health intervention, is crucial for reducing importation risks and safeguarding national health security.</p>
	]]></content:encoded>

	<dc:title>A Successful Cross-Agency Model for Collaborative Response to Imported Infectious Disease: Investigation and Management of the First Confirmed Clade Ia Mpox Case in Shanghai, China</dc:title>
			<dc:creator>Zilian Cao</dc:creator>
			<dc:creator>Fang Xu</dc:creator>
			<dc:creator>Xiaoyan Huang</dc:creator>
			<dc:creator>Yifeng Shen</dc:creator>
			<dc:creator>Xin Xin</dc:creator>
			<dc:creator>Lin Ai</dc:creator>
			<dc:creator>Hao Pan</dc:creator>
			<dc:creator>Huanyu Wu</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080212</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-28</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-28</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>212</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080212</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/212</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/211">

	<title>TropicalMed, Vol. 11, Pages 211: Enhancing Infectious Disease Preparedness in Rome: The Lazio Regional Network During the 2025 Jubilee</title>
	<link>https://www.mdpi.com/2414-6366/11/8/211</link>
	<description>In 2025, Rome hosted the Catholic Jubilee, recording over 33 million cumulative pilgrim attendances while simultaneously facing the death of Pope Francis, the election of Pope Leo XIV, and a regional West Nile Virus (WNV) outbreak. This commentary describes the Lazio Region&amp;amp;rsquo;s preparedness strategy, based on adapting an existing Hub-and-Spoke infectious diseases network integrating surveillance with Regional Service for Epidemiology, Surveillance and Control of Infectious Diseases (SERESMI) laboratory support, telemedicine, and clinical management. Preparatory measures included an additional Hub, updated syndromic pathways, multidisciplinary coordination, and enhanced surveillance. Emergency department visits increased by 14.8%, while the proportion of infectious syndromes remained stable. This experience highlights the potential value of strengthening existing healthcare networks for mass gathering preparedness.</description>
	<pubDate>2026-07-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 211: Enhancing Infectious Disease Preparedness in Rome: The Lazio Regional Network During the 2025 Jubilee</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/211">doi: 10.3390/tropicalmed11080211</a></p>
	<p>Authors:
		Gaetano Maffongelli
		Andrea Bongiovanni
		Alessandra D’Abramo
		Erica Binetti
		Laura Scorzolini
		Claudia Palazzolo
		Gabriella De Carli
		Alessandro Agresta
		Francesco Vairo
		Emanuele Nicastri
		</p>
	<p>In 2025, Rome hosted the Catholic Jubilee, recording over 33 million cumulative pilgrim attendances while simultaneously facing the death of Pope Francis, the election of Pope Leo XIV, and a regional West Nile Virus (WNV) outbreak. This commentary describes the Lazio Region&amp;amp;rsquo;s preparedness strategy, based on adapting an existing Hub-and-Spoke infectious diseases network integrating surveillance with Regional Service for Epidemiology, Surveillance and Control of Infectious Diseases (SERESMI) laboratory support, telemedicine, and clinical management. Preparatory measures included an additional Hub, updated syndromic pathways, multidisciplinary coordination, and enhanced surveillance. Emergency department visits increased by 14.8%, while the proportion of infectious syndromes remained stable. This experience highlights the potential value of strengthening existing healthcare networks for mass gathering preparedness.</p>
	]]></content:encoded>

	<dc:title>Enhancing Infectious Disease Preparedness in Rome: The Lazio Regional Network During the 2025 Jubilee</dc:title>
			<dc:creator>Gaetano Maffongelli</dc:creator>
			<dc:creator>Andrea Bongiovanni</dc:creator>
			<dc:creator>Alessandra D’Abramo</dc:creator>
			<dc:creator>Erica Binetti</dc:creator>
			<dc:creator>Laura Scorzolini</dc:creator>
			<dc:creator>Claudia Palazzolo</dc:creator>
			<dc:creator>Gabriella De Carli</dc:creator>
			<dc:creator>Alessandro Agresta</dc:creator>
			<dc:creator>Francesco Vairo</dc:creator>
			<dc:creator>Emanuele Nicastri</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080211</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-26</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-26</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Commentary</prism:section>
	<prism:startingPage>211</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080211</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/211</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/210">

	<title>TropicalMed, Vol. 11, Pages 210: Oviposition Activity and Ecological Patterns of Medically Important Culicidae in an Agroforestry System in the Atlantic Forest, Rio de Janeiro, Brazil</title>
	<link>https://www.mdpi.com/2414-6366/11/8/210</link>
	<description>Understanding mosquito diversity in natural environments under anthropogenic influence or undergoing vegetation recovery is essential for comprehending potential behavioral changes and adaptations in the activity patterns of these populations. Within this context, this study aimed to investigate the oviposition activity, seasonal abundance, hatching dynamics, and sex ratio of medically important Culicidae species using ovitraps as an entomological surveillance tool, with special attention to Haemagogus leucocelaenus, Aedes terrens, and Aedes albopictus, and to analyze their distribution within an agroforestry area. The study was conducted at S&amp;amp;iacute;tio Terra Boa, a rural property managed under an agroforestry system, in the municipality of Silva Jardim, state of Rio de Janeiro, Brazil, between August 2021 and June 2025. Ten ovitraps were installed at a height of approximately 2 m above ground level and randomly distributed around an area cultivated with a&amp;amp;ccedil;a&amp;amp;iacute; (Euterpe oleracea) and peach palm (Bactris gasipaes). Collections were conducted monthly, and the paddles were replaced and subsequently sent to the laboratory for analysis. The 47-month study provided valuable data regarding the ecology of these species in an agroforestry environment. Haemagogus leucocelaenus was the dominant species throughout the study, and mosquito abundance peaked during the warmer months, particularly from December to April. The results revealed seasonal fluctuations in populations, species-specific oviposition patterns in response to environmental changes, displacement of sylvatic species such as Hg. leucocelaenus toward anthropized areas, and the expansion of urban vectors such as Ae. albopictus into forest matrices. The higher abundance of Hg. leucocelaenus in the ovitraps suggests that this species may persist in agroforestry areas; however, comparative studies across different landscape types are needed to evaluate its ecological adaptation. The coexistence of Haemagogus and Aedes species within the same forest fragment under anthropogenic interference reinforces the need for continuous entomological surveillance in these environments. These findings contribute to understanding vector ecology in recovering Atlantic Forest environments and provide support for future control programs.</description>
	<pubDate>2026-07-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 210: Oviposition Activity and Ecological Patterns of Medically Important Culicidae in an Agroforestry System in the Atlantic Forest, Rio de Janeiro, Brazil</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/210">doi: 10.3390/tropicalmed11080210</a></p>
	<p>Authors:
		Júlia dos Santos Silva
		Cecilia Ferreira de Mello
		Shayenne Olsson Freitas Silva
		Amanda Queiroz Bastos
		Ana Laura Carbajal-de-la-Fuente
		Thamires Rezende Araújo
		Jeronimo Alencar
		</p>
	<p>Understanding mosquito diversity in natural environments under anthropogenic influence or undergoing vegetation recovery is essential for comprehending potential behavioral changes and adaptations in the activity patterns of these populations. Within this context, this study aimed to investigate the oviposition activity, seasonal abundance, hatching dynamics, and sex ratio of medically important Culicidae species using ovitraps as an entomological surveillance tool, with special attention to Haemagogus leucocelaenus, Aedes terrens, and Aedes albopictus, and to analyze their distribution within an agroforestry area. The study was conducted at S&amp;amp;iacute;tio Terra Boa, a rural property managed under an agroforestry system, in the municipality of Silva Jardim, state of Rio de Janeiro, Brazil, between August 2021 and June 2025. Ten ovitraps were installed at a height of approximately 2 m above ground level and randomly distributed around an area cultivated with a&amp;amp;ccedil;a&amp;amp;iacute; (Euterpe oleracea) and peach palm (Bactris gasipaes). Collections were conducted monthly, and the paddles were replaced and subsequently sent to the laboratory for analysis. The 47-month study provided valuable data regarding the ecology of these species in an agroforestry environment. Haemagogus leucocelaenus was the dominant species throughout the study, and mosquito abundance peaked during the warmer months, particularly from December to April. The results revealed seasonal fluctuations in populations, species-specific oviposition patterns in response to environmental changes, displacement of sylvatic species such as Hg. leucocelaenus toward anthropized areas, and the expansion of urban vectors such as Ae. albopictus into forest matrices. The higher abundance of Hg. leucocelaenus in the ovitraps suggests that this species may persist in agroforestry areas; however, comparative studies across different landscape types are needed to evaluate its ecological adaptation. The coexistence of Haemagogus and Aedes species within the same forest fragment under anthropogenic interference reinforces the need for continuous entomological surveillance in these environments. These findings contribute to understanding vector ecology in recovering Atlantic Forest environments and provide support for future control programs.</p>
	]]></content:encoded>

	<dc:title>Oviposition Activity and Ecological Patterns of Medically Important Culicidae in an Agroforestry System in the Atlantic Forest, Rio de Janeiro, Brazil</dc:title>
			<dc:creator>Júlia dos Santos Silva</dc:creator>
			<dc:creator>Cecilia Ferreira de Mello</dc:creator>
			<dc:creator>Shayenne Olsson Freitas Silva</dc:creator>
			<dc:creator>Amanda Queiroz Bastos</dc:creator>
			<dc:creator>Ana Laura Carbajal-de-la-Fuente</dc:creator>
			<dc:creator>Thamires Rezende Araújo</dc:creator>
			<dc:creator>Jeronimo Alencar</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080210</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-25</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-25</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>210</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080210</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/210</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/209">

	<title>TropicalMed, Vol. 11, Pages 209: Correction: Moyo et al. Profiling HIV Risk and Determined, Resilient, Empowered AIDS-Free, Mentored, and Safe (DREAMS) Program Reach Among Adolescent Girls and Young Women (AGYW) in Namibia: Secondary Analysis of Population and Program Data. Trop. Med. Infect. Dis. 2025, 10, 240</title>
	<link>https://www.mdpi.com/2414-6366/11/8/209</link>
	<description>In the original publication [...]</description>
	<pubDate>2026-07-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 209: Correction: Moyo et al. Profiling HIV Risk and Determined, Resilient, Empowered AIDS-Free, Mentored, and Safe (DREAMS) Program Reach Among Adolescent Girls and Young Women (AGYW) in Namibia: Secondary Analysis of Population and Program Data. Trop. Med. Infect. Dis. 2025, 10, 240</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/209">doi: 10.3390/tropicalmed11080209</a></p>
	<p>Authors:
		Enos Moyo
		Endalkachew Melese
		Hadrian Mangwana
		Simon Takawira
		Rosalia Indongo
		Bernadette Harases
		Perseverance Moyo
		Ntombizodwa Makurira Nyoni
		Kopano Robert
		Tafadzwa Dzinamarira
		</p>
	<p>In the original publication [...]</p>
	]]></content:encoded>

	<dc:title>Correction: Moyo et al. Profiling HIV Risk and Determined, Resilient, Empowered AIDS-Free, Mentored, and Safe (DREAMS) Program Reach Among Adolescent Girls and Young Women (AGYW) in Namibia: Secondary Analysis of Population and Program Data. Trop. Med. Infect. Dis. 2025, 10, 240</dc:title>
			<dc:creator>Enos Moyo</dc:creator>
			<dc:creator>Endalkachew Melese</dc:creator>
			<dc:creator>Hadrian Mangwana</dc:creator>
			<dc:creator>Simon Takawira</dc:creator>
			<dc:creator>Rosalia Indongo</dc:creator>
			<dc:creator>Bernadette Harases</dc:creator>
			<dc:creator>Perseverance Moyo</dc:creator>
			<dc:creator>Ntombizodwa Makurira Nyoni</dc:creator>
			<dc:creator>Kopano Robert</dc:creator>
			<dc:creator>Tafadzwa Dzinamarira</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080209</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Correction</prism:section>
	<prism:startingPage>209</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080209</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/209</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/8/208">

	<title>TropicalMed, Vol. 11, Pages 208: Non-Neonatal Tetanus in Mogadishu, Somalia: Clinical Characteristics, Management, and Outcomes&amp;mdash;First Report from a Tetanus Referral Centre</title>
	<link>https://www.mdpi.com/2414-6366/11/8/208</link>
	<description>Background: Tetanus remains a life-threatening yet preventable disease, with a disproportionate burden in low- and middle-income countries. Data on non-neonatal tetanus in Somalia, particularly from referral centres managing severe cases, are limited. This study aimed to describe the clinical characteristics, management, and outcomes of patients with non-neonatal tetanus in Mogadishu, Somalia. Methods: This retrospective observational study was conducted at Madina Hospital between July 2024 and January 2026. All patients with clinically diagnosed non-neonatal tetanus presenting to the Emergency Department were included. Data on demographics, clinical features, management, complications, and outcomes were extracted from medical records. Continuous variables were summarized as mean &amp;amp;plusmn; standard deviation or median (interquartile range), while categorical variables were presented as frequencies and percentages. Associations were assessed using Fisher&amp;amp;rsquo;s exact test, with p &amp;amp;lt; 0.05 considered statistically significant. Results: A total of 50 patients were included (mean age 22.24 &amp;amp;plusmn; 15.49 years; 84.0% male). Most patients were unvaccinated (80.0%), and severe or very severe disease was present in 64.0% of cases. Generalized muscle spasm was the most common presentation (50.0%). Dysautonomia (42.0%) and respiratory failure (18.0%) were the most frequent complications. The overall in-hospital mortality rate was 26.0%, with respiratory failure accounting for 69.2% of deaths. Mortality was significantly associated with disease severity (p &amp;amp;lt; 0.001), complications (p = 0.006), antibiotic category (p = 0.043), and vaccination status (p = 0.0265). Conclusions: Non-neonatal tetanus in this referral-based setting is associated with high mortality, predominantly affecting young, unvaccinated individuals presenting with advanced disease. Disease severity and complications, particularly respiratory failure, are the main drivers of outcomes. Strengthening adult immunization, improving early recognition and referral, and expanding access to critical care are essential to reduce tetanus-related mortality.</description>
	<pubDate>2026-07-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 208: Non-Neonatal Tetanus in Mogadishu, Somalia: Clinical Characteristics, Management, and Outcomes&amp;mdash;First Report from a Tetanus Referral Centre</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/8/208">doi: 10.3390/tropicalmed11080208</a></p>
	<p>Authors:
		Mohamed Mukhtar Mohamed
		Rukia Abukar Abdi
		Mohamed Ahmed Ali
		Mohamed Abdirahman Jama
		Rahma Yusuf Haji Mohamud
		</p>
	<p>Background: Tetanus remains a life-threatening yet preventable disease, with a disproportionate burden in low- and middle-income countries. Data on non-neonatal tetanus in Somalia, particularly from referral centres managing severe cases, are limited. This study aimed to describe the clinical characteristics, management, and outcomes of patients with non-neonatal tetanus in Mogadishu, Somalia. Methods: This retrospective observational study was conducted at Madina Hospital between July 2024 and January 2026. All patients with clinically diagnosed non-neonatal tetanus presenting to the Emergency Department were included. Data on demographics, clinical features, management, complications, and outcomes were extracted from medical records. Continuous variables were summarized as mean &amp;amp;plusmn; standard deviation or median (interquartile range), while categorical variables were presented as frequencies and percentages. Associations were assessed using Fisher&amp;amp;rsquo;s exact test, with p &amp;amp;lt; 0.05 considered statistically significant. Results: A total of 50 patients were included (mean age 22.24 &amp;amp;plusmn; 15.49 years; 84.0% male). Most patients were unvaccinated (80.0%), and severe or very severe disease was present in 64.0% of cases. Generalized muscle spasm was the most common presentation (50.0%). Dysautonomia (42.0%) and respiratory failure (18.0%) were the most frequent complications. The overall in-hospital mortality rate was 26.0%, with respiratory failure accounting for 69.2% of deaths. Mortality was significantly associated with disease severity (p &amp;amp;lt; 0.001), complications (p = 0.006), antibiotic category (p = 0.043), and vaccination status (p = 0.0265). Conclusions: Non-neonatal tetanus in this referral-based setting is associated with high mortality, predominantly affecting young, unvaccinated individuals presenting with advanced disease. Disease severity and complications, particularly respiratory failure, are the main drivers of outcomes. Strengthening adult immunization, improving early recognition and referral, and expanding access to critical care are essential to reduce tetanus-related mortality.</p>
	]]></content:encoded>

	<dc:title>Non-Neonatal Tetanus in Mogadishu, Somalia: Clinical Characteristics, Management, and Outcomes&amp;amp;mdash;First Report from a Tetanus Referral Centre</dc:title>
			<dc:creator>Mohamed Mukhtar Mohamed</dc:creator>
			<dc:creator>Rukia Abukar Abdi</dc:creator>
			<dc:creator>Mohamed Ahmed Ali</dc:creator>
			<dc:creator>Mohamed Abdirahman Jama</dc:creator>
			<dc:creator>Rahma Yusuf Haji Mohamud</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11080208</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>208</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11080208</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/8/208</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/207">

	<title>TropicalMed, Vol. 11, Pages 207: Evaluation of the Loop-Mediated Isothermal Amplification (LAMP) Technique in Swab Samples from Ulcerated Cutaneous Lesions Compared with Conventional Diagnostic Methods for American Tegumentary Leishmaniasis in Patients Treated at a Reference Center in Rio de Janeiro, Brazil</title>
	<link>https://www.mdpi.com/2414-6366/11/7/207</link>
	<description>Cutaneous leishmaniasis (CL) is a vector-borne disease caused by Leishmania spp. Molecular methods such as conventional PCR (cPCR) and real-time PCR (qPCR) show high accuracy but remain restricted to reference centers. Loop-mediated isothermal amplification (LAMP) enables rapid DNA amplification under isothermal conditions. LAMP targeting 18S rDNA using WarmStart&amp;amp;reg; Colorimetric LAMP 2&amp;amp;times; Master Mix and Bst 2.0 DNA Polymerase with SYBR&amp;amp;reg; Green I (BstSg) was evaluated in swab samples (extracted by kit&amp;amp;mdash;SW-kit and direct boil&amp;amp;mdash;SW-DB) and specimens collected through biopsy from ulcerated lesions of patients attending a reference center in Rio de Janeiro, Brazil. The reference standard was defined as at least one positive parasitological or molecular (cPCR) test plus clinical confirmation. Analytical sensitivity reached 10 fg with WS and 10 pg with BstSg. The diagnostic accuracy of LAMP ranged from 51.8% to 78.6%, with sensitivity from 52.5% to 81% and specificity from 39.6% to 89.4%. LAMP, particularly when applied to swab samples with DNA extracted using the SW-kit protocol and amplified with BstSg, showed promising diagnostic accuracy and operational feasibility as a less invasive approach for CL diagnosis, eliminating the need for skin biopsy and reducing patient discomfort during sample collection.</description>
	<pubDate>2026-07-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 207: Evaluation of the Loop-Mediated Isothermal Amplification (LAMP) Technique in Swab Samples from Ulcerated Cutaneous Lesions Compared with Conventional Diagnostic Methods for American Tegumentary Leishmaniasis in Patients Treated at a Reference Center in Rio de Janeiro, Brazil</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/207">doi: 10.3390/tropicalmed11070207</a></p>
	<p>Authors:
		Elizabeth Cristina Araújo Ferreira Faulhaber
		Daniel Moreira de Avelar
		Liliane de F. Antonio Oliveira
		Luciana de F. Campos Miranda
		Cintia Xavier de Mello
		Gabrielle Baldan Stanciola
		Luanna da S. Ventura
		Marcelo Rosandiski Lyra
		Caio Thomaz de Lima e Silva
		Aline Fagundes da Silva
		Rosely Maria Zancope-Oliveira
		Maria Inês Fernandes Pimentel
		Andreza Pain Marcelino
		</p>
	<p>Cutaneous leishmaniasis (CL) is a vector-borne disease caused by Leishmania spp. Molecular methods such as conventional PCR (cPCR) and real-time PCR (qPCR) show high accuracy but remain restricted to reference centers. Loop-mediated isothermal amplification (LAMP) enables rapid DNA amplification under isothermal conditions. LAMP targeting 18S rDNA using WarmStart&amp;amp;reg; Colorimetric LAMP 2&amp;amp;times; Master Mix and Bst 2.0 DNA Polymerase with SYBR&amp;amp;reg; Green I (BstSg) was evaluated in swab samples (extracted by kit&amp;amp;mdash;SW-kit and direct boil&amp;amp;mdash;SW-DB) and specimens collected through biopsy from ulcerated lesions of patients attending a reference center in Rio de Janeiro, Brazil. The reference standard was defined as at least one positive parasitological or molecular (cPCR) test plus clinical confirmation. Analytical sensitivity reached 10 fg with WS and 10 pg with BstSg. The diagnostic accuracy of LAMP ranged from 51.8% to 78.6%, with sensitivity from 52.5% to 81% and specificity from 39.6% to 89.4%. LAMP, particularly when applied to swab samples with DNA extracted using the SW-kit protocol and amplified with BstSg, showed promising diagnostic accuracy and operational feasibility as a less invasive approach for CL diagnosis, eliminating the need for skin biopsy and reducing patient discomfort during sample collection.</p>
	]]></content:encoded>

	<dc:title>Evaluation of the Loop-Mediated Isothermal Amplification (LAMP) Technique in Swab Samples from Ulcerated Cutaneous Lesions Compared with Conventional Diagnostic Methods for American Tegumentary Leishmaniasis in Patients Treated at a Reference Center in Rio de Janeiro, Brazil</dc:title>
			<dc:creator>Elizabeth Cristina Araújo Ferreira Faulhaber</dc:creator>
			<dc:creator>Daniel Moreira de Avelar</dc:creator>
			<dc:creator>Liliane de F. Antonio Oliveira</dc:creator>
			<dc:creator>Luciana de F. Campos Miranda</dc:creator>
			<dc:creator>Cintia Xavier de Mello</dc:creator>
			<dc:creator>Gabrielle Baldan Stanciola</dc:creator>
			<dc:creator>Luanna da S. Ventura</dc:creator>
			<dc:creator>Marcelo Rosandiski Lyra</dc:creator>
			<dc:creator>Caio Thomaz de Lima e Silva</dc:creator>
			<dc:creator>Aline Fagundes da Silva</dc:creator>
			<dc:creator>Rosely Maria Zancope-Oliveira</dc:creator>
			<dc:creator>Maria Inês Fernandes Pimentel</dc:creator>
			<dc:creator>Andreza Pain Marcelino</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070207</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-22</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-22</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>207</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070207</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/207</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/206">

	<title>TropicalMed, Vol. 11, Pages 206: Malaria Coinfections Worldwide: An Umbrella Systematic Review of Prevalence and Epidemiological Patterns</title>
	<link>https://www.mdpi.com/2414-6366/11/7/206</link>
	<description>Malaria coinfections with other infectious agents represent a clinically relevant epidemiological challenge, but evidence remains fragmented across individual systematic reviews. This umbrella systematic review synthesized review-level evidence on the prevalence and epidemiological patterns of concurrent malaria coinfections in human populations. PubMed/MEDLINE, Scopus, Web of Science, Embase, and LILACS/BVS were searched for systematic reviews published from 1 January 2000 to March 2026. Risk of bias, certainty of evidence, and primary-study overlap were assessed using ROBIS, an adapted GRADE framework for prevalence evidence, and citation-matrix/corrected-covered-area methods, respectively. Twenty-one systematic reviews were included, of which 16 contributed meta-analytical prevalence estimates. Among acute-pattern coinfections, review-level prevalence estimates ranged from 3.0% (95% CI: 2.0&amp;amp;ndash;5.0) for malaria&amp;amp;ndash;influenza to 21.7% (95% CI: 18.7&amp;amp;ndash;25.1) for malaria&amp;amp;ndash;Ebola virus disease. Among chronic or persistent-pattern coinfections, estimates ranged from 6.0% (95% CI: 4.0&amp;amp;ndash;7.0) for malaria&amp;amp;ndash;hepatitis B to 50.0% (95% CI: 28.0&amp;amp;ndash;72.0) for malaria&amp;amp;ndash;human African trypanosomiasis; the latter reflects Plasmodium positivity among patients with human African trypanosomiasis and should not be interpreted as a population-level prevalence. Sub-Saharan Africa was the most represented region. Certainty of evidence was generally low or very low, largely because of substantial heterogeneity, diagnostic variability, geographic concentration, and overlap among some source reviews. Malaria coinfections are clinically and epidemiologically relevant in endemic settings, but available prevalence estimates should be interpreted as context-dependent review-level summaries rather than globally comparable burden estimates.</description>
	<pubDate>2026-07-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 206: Malaria Coinfections Worldwide: An Umbrella Systematic Review of Prevalence and Epidemiological Patterns</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/206">doi: 10.3390/tropicalmed11070206</a></p>
	<p>Authors:
		Víctor Juan Vera-Ponce
		Jhosmer Ballena-Caicedo
		Holly E. Delgado-Toro
		Adriana Mishell Yoplac-Oyarce
		Lily Mabel Portal-Valqui
		Fiorella E. Zuzunaga-Montoya
		</p>
	<p>Malaria coinfections with other infectious agents represent a clinically relevant epidemiological challenge, but evidence remains fragmented across individual systematic reviews. This umbrella systematic review synthesized review-level evidence on the prevalence and epidemiological patterns of concurrent malaria coinfections in human populations. PubMed/MEDLINE, Scopus, Web of Science, Embase, and LILACS/BVS were searched for systematic reviews published from 1 January 2000 to March 2026. Risk of bias, certainty of evidence, and primary-study overlap were assessed using ROBIS, an adapted GRADE framework for prevalence evidence, and citation-matrix/corrected-covered-area methods, respectively. Twenty-one systematic reviews were included, of which 16 contributed meta-analytical prevalence estimates. Among acute-pattern coinfections, review-level prevalence estimates ranged from 3.0% (95% CI: 2.0&amp;amp;ndash;5.0) for malaria&amp;amp;ndash;influenza to 21.7% (95% CI: 18.7&amp;amp;ndash;25.1) for malaria&amp;amp;ndash;Ebola virus disease. Among chronic or persistent-pattern coinfections, estimates ranged from 6.0% (95% CI: 4.0&amp;amp;ndash;7.0) for malaria&amp;amp;ndash;hepatitis B to 50.0% (95% CI: 28.0&amp;amp;ndash;72.0) for malaria&amp;amp;ndash;human African trypanosomiasis; the latter reflects Plasmodium positivity among patients with human African trypanosomiasis and should not be interpreted as a population-level prevalence. Sub-Saharan Africa was the most represented region. Certainty of evidence was generally low or very low, largely because of substantial heterogeneity, diagnostic variability, geographic concentration, and overlap among some source reviews. Malaria coinfections are clinically and epidemiologically relevant in endemic settings, but available prevalence estimates should be interpreted as context-dependent review-level summaries rather than globally comparable burden estimates.</p>
	]]></content:encoded>

	<dc:title>Malaria Coinfections Worldwide: An Umbrella Systematic Review of Prevalence and Epidemiological Patterns</dc:title>
			<dc:creator>Víctor Juan Vera-Ponce</dc:creator>
			<dc:creator>Jhosmer Ballena-Caicedo</dc:creator>
			<dc:creator>Holly E. Delgado-Toro</dc:creator>
			<dc:creator>Adriana Mishell Yoplac-Oyarce</dc:creator>
			<dc:creator>Lily Mabel Portal-Valqui</dc:creator>
			<dc:creator>Fiorella E. Zuzunaga-Montoya</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070206</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-22</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-22</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>206</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070206</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/206</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/205">

	<title>TropicalMed, Vol. 11, Pages 205: HIV/AIDS Mortality in the Eastern Cape Province of South Africa, 2000&amp;ndash;2023: Trends, Age&amp;ndash;Sex Composition, and a Persistent Provincial Burden</title>
	<link>https://www.mdpi.com/2414-6366/11/7/205</link>
	<description>The Eastern Cape of South Africa carries the highest crude AIDS mortality rate nationally (135.86 per 100,000 in 2023), yet a province-specific, age-sex disaggregated analysis extending beyond 2012 does not exist. This study examined AIDS mortality trends in the Eastern Cape from 2000 to 2023. A quantitative ecological design was employed using secondary analysis of modelled estimates from the Thembisa Provincial HIV Model version 4.8. Annual AIDS deaths across nine age&amp;amp;ndash;sex subgroups and crude AIDS mortality rate were extracted from the Eastern Cape, 2000&amp;amp;ndash;2023, with provincial comparisons for 2023. Total AIDS deaths declined by 72.1% from 33,301 in 2005 to 9300 in 2023. Child deaths fell 96.1% from peak. Male youth deaths (15&amp;amp;ndash;24) plateaued after 2015. Adults aged 50 and older constituted 24.1% of deaths in 2023, with numbers increasing since 2019. Despite substantial gains, three unresolved gaps persist: a male youth mortality plateau, an ageing epidemic burden, and the highest provincial AIDS mortality rate nationally. Targeted differentiated interventions are urgently needed.</description>
	<pubDate>2026-07-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 205: HIV/AIDS Mortality in the Eastern Cape Province of South Africa, 2000&amp;ndash;2023: Trends, Age&amp;ndash;Sex Composition, and a Persistent Provincial Burden</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/205">doi: 10.3390/tropicalmed11070205</a></p>
	<p>Authors:
		Tronic Sithole
		Ziphelele Peter
		Ayanda Princess Myeni
		</p>
	<p>The Eastern Cape of South Africa carries the highest crude AIDS mortality rate nationally (135.86 per 100,000 in 2023), yet a province-specific, age-sex disaggregated analysis extending beyond 2012 does not exist. This study examined AIDS mortality trends in the Eastern Cape from 2000 to 2023. A quantitative ecological design was employed using secondary analysis of modelled estimates from the Thembisa Provincial HIV Model version 4.8. Annual AIDS deaths across nine age&amp;amp;ndash;sex subgroups and crude AIDS mortality rate were extracted from the Eastern Cape, 2000&amp;amp;ndash;2023, with provincial comparisons for 2023. Total AIDS deaths declined by 72.1% from 33,301 in 2005 to 9300 in 2023. Child deaths fell 96.1% from peak. Male youth deaths (15&amp;amp;ndash;24) plateaued after 2015. Adults aged 50 and older constituted 24.1% of deaths in 2023, with numbers increasing since 2019. Despite substantial gains, three unresolved gaps persist: a male youth mortality plateau, an ageing epidemic burden, and the highest provincial AIDS mortality rate nationally. Targeted differentiated interventions are urgently needed.</p>
	]]></content:encoded>

	<dc:title>HIV/AIDS Mortality in the Eastern Cape Province of South Africa, 2000&amp;amp;ndash;2023: Trends, Age&amp;amp;ndash;Sex Composition, and a Persistent Provincial Burden</dc:title>
			<dc:creator>Tronic Sithole</dc:creator>
			<dc:creator>Ziphelele Peter</dc:creator>
			<dc:creator>Ayanda Princess Myeni</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070205</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-22</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-22</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>205</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070205</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/205</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/203">

	<title>TropicalMed, Vol. 11, Pages 203: Beyond Cure: A Scoping Review of Post-Tuberculosis Long-Term Health Outcomes</title>
	<link>https://www.mdpi.com/2414-6366/11/7/203</link>
	<description>Background: Tuberculosis (TB) remains a leading cause of global morbidity and mortality, yet its impact extends far beyond microbiological cure. Many TB survivors experience persistent structural lung damage or functional impairment consistent with post-TB lung disease, while growing evidence highlights long-term non-respiratory health outcomes. Synthesizing evidence across lung and non- respiratory health outcomes, along with their risk factors, is critical to inform long-term TB care. Methods: We conducted a scoping review including systematic reviews reporting on post-TB long-term health outcomes. A search was performed in PubMed/MEDLINE on 27 July 2025, using terms related to &amp;amp;ldquo;tuberculosis,&amp;amp;rdquo; &amp;amp;ldquo;systematic review,&amp;amp;rdquo; &amp;amp;ldquo;meta-analysis,&amp;amp;rdquo; &amp;amp;ldquo;sequelae&amp;amp;rdquo; and &amp;amp;ldquo;long-term health outcomes,&amp;amp;rdquo; without language restrictions. Results: Nine systematic reviews met inclusion criteria. Most focused on pulmonary outcomes and consistently demonstrated that TB is associated with chronic airflow obstruction, reduced lung function, and an increased long-term risk of lung cancer, although residual confounding from environmental, clinical, and socioeconomic factors cannot be excluded. While younger adults are more prone to developing COPD after TB in high TB burden settings, older individuals face a higher risk of broader post-TB lung sequelae. Evidence suggested that TB survivors are at increased risk of non-respiratory complications. HIV co-infection, low CD4 counts, older age, pre-existing hepatitis, prior TB treatment, and hypoalbuminemia were associated with post-TB liver injury, while baseline hearing impairment and HIV co-infection increased the likelihood of post-TB hearing loss. TB was also linked to elevated risk of several non-pulmonary cancers, including oesophageal, cervical, hematological, pancreatic, and gastric malignancies, with the highest risk within the first year after TB diagnosis and persisting, though attenuated, in subsequent years. Conclusion: TB should be viewed as a chronic condition with enduring lung and non-respiratory health outcomes. TB survivors face increased risks of COPD, lung cancer, and a range of non-respiratory health outcomes, including hepatic and auditory complications, particularly among high-risk groups, such as those living with HIV infection, along with baseline hearing and hepatic impairment. Public health programmes must extend care beyond microbiological cure to include integrated, post-TB long-term monitoring of lung, hepatic and hearing across all ages, including malignancy surveillance, after baseline assessments to identify high-risk TB survivors. Future research should also elucidate risk factors for post-TB malignancy, and clarify the relationship between neurological, renal, and musculoskeletal sequelae and TB to inform evidence-based TB survivorship care.</description>
	<pubDate>2026-07-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 203: Beyond Cure: A Scoping Review of Post-Tuberculosis Long-Term Health Outcomes</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/203">doi: 10.3390/tropicalmed11070203</a></p>
	<p>Authors:
		Sonia Menon
		Anthony D. Harries
		Riitta A. Dlodlo
		Gisèle Badoum
		Mohammed F. Dogo
		Olivia B. Mbitikon
		Pranay Sinha
		Yan Lin
		Jyoti Jaju
		Aung Naing Soe
		Anisha Singh
		Bharati Kalottee
		Kobto G. Koura
		</p>
	<p>Background: Tuberculosis (TB) remains a leading cause of global morbidity and mortality, yet its impact extends far beyond microbiological cure. Many TB survivors experience persistent structural lung damage or functional impairment consistent with post-TB lung disease, while growing evidence highlights long-term non-respiratory health outcomes. Synthesizing evidence across lung and non- respiratory health outcomes, along with their risk factors, is critical to inform long-term TB care. Methods: We conducted a scoping review including systematic reviews reporting on post-TB long-term health outcomes. A search was performed in PubMed/MEDLINE on 27 July 2025, using terms related to &amp;amp;ldquo;tuberculosis,&amp;amp;rdquo; &amp;amp;ldquo;systematic review,&amp;amp;rdquo; &amp;amp;ldquo;meta-analysis,&amp;amp;rdquo; &amp;amp;ldquo;sequelae&amp;amp;rdquo; and &amp;amp;ldquo;long-term health outcomes,&amp;amp;rdquo; without language restrictions. Results: Nine systematic reviews met inclusion criteria. Most focused on pulmonary outcomes and consistently demonstrated that TB is associated with chronic airflow obstruction, reduced lung function, and an increased long-term risk of lung cancer, although residual confounding from environmental, clinical, and socioeconomic factors cannot be excluded. While younger adults are more prone to developing COPD after TB in high TB burden settings, older individuals face a higher risk of broader post-TB lung sequelae. Evidence suggested that TB survivors are at increased risk of non-respiratory complications. HIV co-infection, low CD4 counts, older age, pre-existing hepatitis, prior TB treatment, and hypoalbuminemia were associated with post-TB liver injury, while baseline hearing impairment and HIV co-infection increased the likelihood of post-TB hearing loss. TB was also linked to elevated risk of several non-pulmonary cancers, including oesophageal, cervical, hematological, pancreatic, and gastric malignancies, with the highest risk within the first year after TB diagnosis and persisting, though attenuated, in subsequent years. Conclusion: TB should be viewed as a chronic condition with enduring lung and non-respiratory health outcomes. TB survivors face increased risks of COPD, lung cancer, and a range of non-respiratory health outcomes, including hepatic and auditory complications, particularly among high-risk groups, such as those living with HIV infection, along with baseline hearing and hepatic impairment. Public health programmes must extend care beyond microbiological cure to include integrated, post-TB long-term monitoring of lung, hepatic and hearing across all ages, including malignancy surveillance, after baseline assessments to identify high-risk TB survivors. Future research should also elucidate risk factors for post-TB malignancy, and clarify the relationship between neurological, renal, and musculoskeletal sequelae and TB to inform evidence-based TB survivorship care.</p>
	]]></content:encoded>

	<dc:title>Beyond Cure: A Scoping Review of Post-Tuberculosis Long-Term Health Outcomes</dc:title>
			<dc:creator>Sonia Menon</dc:creator>
			<dc:creator>Anthony D. Harries</dc:creator>
			<dc:creator>Riitta A. Dlodlo</dc:creator>
			<dc:creator>Gisèle Badoum</dc:creator>
			<dc:creator>Mohammed F. Dogo</dc:creator>
			<dc:creator>Olivia B. Mbitikon</dc:creator>
			<dc:creator>Pranay Sinha</dc:creator>
			<dc:creator>Yan Lin</dc:creator>
			<dc:creator>Jyoti Jaju</dc:creator>
			<dc:creator>Aung Naing Soe</dc:creator>
			<dc:creator>Anisha Singh</dc:creator>
			<dc:creator>Bharati Kalottee</dc:creator>
			<dc:creator>Kobto G. Koura</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070203</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-20</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-20</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>203</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070203</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/203</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/204">

	<title>TropicalMed, Vol. 11, Pages 204: Evaluation of Bait Acceptance and Immune Response in a Local Dog Population During an Oral Rabies Vaccination Field Study in Cambodia</title>
	<link>https://www.mdpi.com/2414-6366/11/7/204</link>
	<description>(1) Background: Dog-mediated human rabies remains a serious public health problem in Cambodia, partially due to the high abundance of dogs. As most dogs are free-roaming and cannot easily be handled and restrained, the rabies vaccination coverage is very low. Oral rabies vaccination (ORV) could increase the vaccination coverage to levels required for interrupting the transmission cycle. (2) Methods: In this study, the bait acceptance and immunogenicity of a commercially available vaccine bait were tested in local free-roaming dogs in the northern part of Takeo province in Cambodia. (3) Results: In total, 75.4% (515/683) of dogs initially showed interest when offered an egg-flavored bait containing the SPBN GASGAS rabies virus vaccine. Subsequently, 89.9% of these dogs consumed the bait, and almost all of them (98.3%) were considered successfully vaccinated. Blood samples were collected from 50 dogs prior to vaccination. Eight of these fifty dogs tested sero-positive for rabies antibodies (ELISA) and were excluded from follow-up samples. Thirty and ninety days post-vaccination, 91.4% and 68.2% of the relocated vaccinated dogs tested sero-positive, respectively. (4) Conclusions: Bait acceptance and immunogenicity showed similar results as observed in studies with the same vaccine bait conducted in other countries. Hence, ORV seems to be a very promising tool for dog rabies control in Cambodia, which has a large owned but free-roaming dog population.</description>
	<pubDate>2026-07-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 204: Evaluation of Bait Acceptance and Immune Response in a Local Dog Population During an Oral Rabies Vaccination Field Study in Cambodia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/204">doi: 10.3390/tropicalmed11070204</a></p>
	<p>Authors:
		Bengthay Tep
		Sochetra Hak
		Nouv Sophorn
		Sin Grandy
		Ad Vos
		Dim Kanan
		Kinzang Dukpa
		</p>
	<p>(1) Background: Dog-mediated human rabies remains a serious public health problem in Cambodia, partially due to the high abundance of dogs. As most dogs are free-roaming and cannot easily be handled and restrained, the rabies vaccination coverage is very low. Oral rabies vaccination (ORV) could increase the vaccination coverage to levels required for interrupting the transmission cycle. (2) Methods: In this study, the bait acceptance and immunogenicity of a commercially available vaccine bait were tested in local free-roaming dogs in the northern part of Takeo province in Cambodia. (3) Results: In total, 75.4% (515/683) of dogs initially showed interest when offered an egg-flavored bait containing the SPBN GASGAS rabies virus vaccine. Subsequently, 89.9% of these dogs consumed the bait, and almost all of them (98.3%) were considered successfully vaccinated. Blood samples were collected from 50 dogs prior to vaccination. Eight of these fifty dogs tested sero-positive for rabies antibodies (ELISA) and were excluded from follow-up samples. Thirty and ninety days post-vaccination, 91.4% and 68.2% of the relocated vaccinated dogs tested sero-positive, respectively. (4) Conclusions: Bait acceptance and immunogenicity showed similar results as observed in studies with the same vaccine bait conducted in other countries. Hence, ORV seems to be a very promising tool for dog rabies control in Cambodia, which has a large owned but free-roaming dog population.</p>
	]]></content:encoded>

	<dc:title>Evaluation of Bait Acceptance and Immune Response in a Local Dog Population During an Oral Rabies Vaccination Field Study in Cambodia</dc:title>
			<dc:creator>Bengthay Tep</dc:creator>
			<dc:creator>Sochetra Hak</dc:creator>
			<dc:creator>Nouv Sophorn</dc:creator>
			<dc:creator>Sin Grandy</dc:creator>
			<dc:creator>Ad Vos</dc:creator>
			<dc:creator>Dim Kanan</dc:creator>
			<dc:creator>Kinzang Dukpa</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070204</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-20</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-20</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>204</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070204</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/204</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/202">

	<title>TropicalMed, Vol. 11, Pages 202: Optimising Post-Delivery Viral Load Monitoring and HIV Care to Eliminate Breastfeeding-Associated HIV Transmission in Sub-Saharan Africa: A Review</title>
	<link>https://www.mdpi.com/2414-6366/11/7/202</link>
	<description>Sustained maternal HIV viral-load (VL) suppression during breastfeeding is essential for eliminating vertical HIV transmission in Sub-Saharan Africa. Although vertical transmission prevention programmes have improved antiretroviral therapy coverage and peripartum outcomes, viral control may deteriorate after delivery. This decline may result from psychosocial stressors, fragmented mother&amp;amp;ndash;infant services, and delayed return of results. This review examines post-delivery VL dynamics, breastfeeding-associated transmission risk, and the limitations of binary suppression thresholds. We suggest that post-delivery VL monitoring should be implemented as a rapid-action pathway. In this approach, detectable viraemia during breastfeeding should prompt a timely reassessment of adherence and repeat VL testing. Regimen review and additional measures to reduce the risks for both the mother and infant should be implemented where indicated. We also examine the individual, relational, structural, and health system determinants of post-delivery viraemia and lost to follow-up, including intimate partner violence. Finally, we highlight service delivery innovations that may improve maternal VL suppression and HIV-free infant survival rates.</description>
	<pubDate>2026-07-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 202: Optimising Post-Delivery Viral Load Monitoring and HIV Care to Eliminate Breastfeeding-Associated HIV Transmission in Sub-Saharan Africa: A Review</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/202">doi: 10.3390/tropicalmed11070202</a></p>
	<p>Authors:
		Joycelyn A. Dame
		Yemah Bockarie
		Adraina N. M. Asante
		Anthony Enimil
		</p>
	<p>Sustained maternal HIV viral-load (VL) suppression during breastfeeding is essential for eliminating vertical HIV transmission in Sub-Saharan Africa. Although vertical transmission prevention programmes have improved antiretroviral therapy coverage and peripartum outcomes, viral control may deteriorate after delivery. This decline may result from psychosocial stressors, fragmented mother&amp;amp;ndash;infant services, and delayed return of results. This review examines post-delivery VL dynamics, breastfeeding-associated transmission risk, and the limitations of binary suppression thresholds. We suggest that post-delivery VL monitoring should be implemented as a rapid-action pathway. In this approach, detectable viraemia during breastfeeding should prompt a timely reassessment of adherence and repeat VL testing. Regimen review and additional measures to reduce the risks for both the mother and infant should be implemented where indicated. We also examine the individual, relational, structural, and health system determinants of post-delivery viraemia and lost to follow-up, including intimate partner violence. Finally, we highlight service delivery innovations that may improve maternal VL suppression and HIV-free infant survival rates.</p>
	]]></content:encoded>

	<dc:title>Optimising Post-Delivery Viral Load Monitoring and HIV Care to Eliminate Breastfeeding-Associated HIV Transmission in Sub-Saharan Africa: A Review</dc:title>
			<dc:creator>Joycelyn A. Dame</dc:creator>
			<dc:creator>Yemah Bockarie</dc:creator>
			<dc:creator>Adraina N. M. Asante</dc:creator>
			<dc:creator>Anthony Enimil</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070202</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>202</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070202</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/202</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/201">

	<title>TropicalMed, Vol. 11, Pages 201: Global, Regional, and National Burden of Malaria and Dengue from 1992 to 2021, with Projections to 2036: An Age&amp;ndash;Period&amp;ndash;Cohort Analysis</title>
	<link>https://www.mdpi.com/2414-6366/11/7/201</link>
	<description>This study aimed to compare the burden of malaria and dengue worldwide and to project future incidence trends. Incidence and disability-adjusted life-years (DALYs) were obtained from the Global Burden of Disease Study 2021 (GBD 2021). Temporal trends were quantified using estimated annual percentage change (EAPC), age&amp;amp;ndash;period&amp;amp;ndash;cohort analysis was used to assess age, period, and cohort effects, and Bayesian age&amp;amp;ndash;period&amp;amp;ndash;cohort models were applied to project incidence to 2036. From 1992 to 2021, the global age-standardized incidence rate (ASIR) of malaria decreased (EAPC= &amp;amp;minus;0.55%), whereas that of dengue increased (EAPC = 1.83%); the corresponding age-standardized DALY rates showed EAPCs of &amp;amp;minus;1.64% and 1.29%, respectively. Across 21 GBD regions, SDI was inversely correlated with ASIR for malaria (r = &amp;amp;minus;0.848) and dengue (r = &amp;amp;minus;0.521), and with age-standardized DALY rates for malaria (r = &amp;amp;minus;0.849) and dengue (r = &amp;amp;minus;0.497). Malaria burden remained concentrated in low-SDI regions, particularly sub-Saharan Africa and Oceania, whereas dengue burden was highest in middle-SDI regions, especially tropical Latin America. From 2021 to 2036, the global ASIR of malaria was projected to decrease slightly by 1.36% (3485.27 to 3437.72). Whereas that of dengue was projected to increase by 10.58% (752.04 to 831.63). In males, the projected ASIR of malaria and dengue increased by 4.18% (3193.24 to 3326.58) and 9.96% (704.83 to 775.06), respectively. In females, the corresponding increases were 4.87% (3379.82 to 3544.27) and 8.83% (819.74 to 892.13). These findings suggest divergent epidemiological trajectories for malaria and dengue. The projections further suggest a consistent upward trajectory for dengue, with sex-specific relative changes differing descriptively by disease: the projected relative increase was numerically greater in females for malaria and in males for dengue.</description>
	<pubDate>2026-07-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 201: Global, Regional, and National Burden of Malaria and Dengue from 1992 to 2021, with Projections to 2036: An Age&amp;ndash;Period&amp;ndash;Cohort Analysis</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/201">doi: 10.3390/tropicalmed11070201</a></p>
	<p>Authors:
		Yu Wang
		Qilan Wen
		Jinwei Chen
		Yikun Chang
		Na Cao
		Xin Sun
		Yuantao Hao
		Wangjian Zhang
		Zhicheng Du
		</p>
	<p>This study aimed to compare the burden of malaria and dengue worldwide and to project future incidence trends. Incidence and disability-adjusted life-years (DALYs) were obtained from the Global Burden of Disease Study 2021 (GBD 2021). Temporal trends were quantified using estimated annual percentage change (EAPC), age&amp;amp;ndash;period&amp;amp;ndash;cohort analysis was used to assess age, period, and cohort effects, and Bayesian age&amp;amp;ndash;period&amp;amp;ndash;cohort models were applied to project incidence to 2036. From 1992 to 2021, the global age-standardized incidence rate (ASIR) of malaria decreased (EAPC= &amp;amp;minus;0.55%), whereas that of dengue increased (EAPC = 1.83%); the corresponding age-standardized DALY rates showed EAPCs of &amp;amp;minus;1.64% and 1.29%, respectively. Across 21 GBD regions, SDI was inversely correlated with ASIR for malaria (r = &amp;amp;minus;0.848) and dengue (r = &amp;amp;minus;0.521), and with age-standardized DALY rates for malaria (r = &amp;amp;minus;0.849) and dengue (r = &amp;amp;minus;0.497). Malaria burden remained concentrated in low-SDI regions, particularly sub-Saharan Africa and Oceania, whereas dengue burden was highest in middle-SDI regions, especially tropical Latin America. From 2021 to 2036, the global ASIR of malaria was projected to decrease slightly by 1.36% (3485.27 to 3437.72). Whereas that of dengue was projected to increase by 10.58% (752.04 to 831.63). In males, the projected ASIR of malaria and dengue increased by 4.18% (3193.24 to 3326.58) and 9.96% (704.83 to 775.06), respectively. In females, the corresponding increases were 4.87% (3379.82 to 3544.27) and 8.83% (819.74 to 892.13). These findings suggest divergent epidemiological trajectories for malaria and dengue. The projections further suggest a consistent upward trajectory for dengue, with sex-specific relative changes differing descriptively by disease: the projected relative increase was numerically greater in females for malaria and in males for dengue.</p>
	]]></content:encoded>

	<dc:title>Global, Regional, and National Burden of Malaria and Dengue from 1992 to 2021, with Projections to 2036: An Age&amp;amp;ndash;Period&amp;amp;ndash;Cohort Analysis</dc:title>
			<dc:creator>Yu Wang</dc:creator>
			<dc:creator>Qilan Wen</dc:creator>
			<dc:creator>Jinwei Chen</dc:creator>
			<dc:creator>Yikun Chang</dc:creator>
			<dc:creator>Na Cao</dc:creator>
			<dc:creator>Xin Sun</dc:creator>
			<dc:creator>Yuantao Hao</dc:creator>
			<dc:creator>Wangjian Zhang</dc:creator>
			<dc:creator>Zhicheng Du</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070201</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-17</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-17</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>201</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070201</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/201</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/200">

	<title>TropicalMed, Vol. 11, Pages 200: Perinatal HIV in Europe: Clinical Advances and Psychosocial Challenges&amp;mdash;A Scoping Review</title>
	<link>https://www.mdpi.com/2414-6366/11/7/200</link>
	<description>Despite significant biomedical advances in the prevention of mother-to-child transmission (MTCT) of HIV, residual transmission and suboptimal maternal outcomes persist across Europe. The challenge is no longer primarily virological but structural: aggregated ART coverage indicators mask important discontinuities across the perinatal care pathway. This scoping review maps evidence on clinical and psychosocial dimensions of the perinatal HIV pathway among adult women living with HIV (WLHIV) in Europe, and identifies key gaps in their integration across the continuum of care. Following PRISMA-ScR guidelines, five databases were searched for studies published between 2010 and 2026. Of 1881 records identified, 109 met inclusion criteria. Findings were synthesized thematically using an inductively developed framework spanning preconception through long-term postpartum outcomes. MTCT rates declined from approximately 1&amp;amp;ndash;1.2% in the mid-2000s to below 0.5% in recent data, and vaginal delivery rates increased markedly with sustained viral suppression. However, persistent inequalities remain among younger women, migrants, and those with histories of injecting drug use. Stigma, migration-related vulnerability, mental health difficulties, constrained disclosure, and socioeconomic insecurity shape engagement with care, influencing treatment continuity, retention, and virological outcomes, particularly during the postpartum period. Equitable perinatal HIV outcomes require integrated care models that combine clinical HIV and obstetric services with mental health support, social needs screening, and migration-sensitive services to address the structural conditions shaping care trajectories. A substantial proportion of WLHIV in Europe originate from high-prevalence regions, making perinatal HIV in this context a direct interface between global infectious disease burden and migration health. Addressing care in European settings therefore contributes to broader global health equity goals in HIV elimination. The protocol was pre-registered on Open Science Framework with registration number: 10.17605/OSF.IO/9BZGY.</description>
	<pubDate>2026-07-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 200: Perinatal HIV in Europe: Clinical Advances and Psychosocial Challenges&amp;mdash;A Scoping Review</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/200">doi: 10.3390/tropicalmed11070200</a></p>
	<p>Authors:
		Helena Lutchman
		Cannelle Michel
		Audrey Murat-Ringot
		Florence Carrouel
		</p>
	<p>Despite significant biomedical advances in the prevention of mother-to-child transmission (MTCT) of HIV, residual transmission and suboptimal maternal outcomes persist across Europe. The challenge is no longer primarily virological but structural: aggregated ART coverage indicators mask important discontinuities across the perinatal care pathway. This scoping review maps evidence on clinical and psychosocial dimensions of the perinatal HIV pathway among adult women living with HIV (WLHIV) in Europe, and identifies key gaps in their integration across the continuum of care. Following PRISMA-ScR guidelines, five databases were searched for studies published between 2010 and 2026. Of 1881 records identified, 109 met inclusion criteria. Findings were synthesized thematically using an inductively developed framework spanning preconception through long-term postpartum outcomes. MTCT rates declined from approximately 1&amp;amp;ndash;1.2% in the mid-2000s to below 0.5% in recent data, and vaginal delivery rates increased markedly with sustained viral suppression. However, persistent inequalities remain among younger women, migrants, and those with histories of injecting drug use. Stigma, migration-related vulnerability, mental health difficulties, constrained disclosure, and socioeconomic insecurity shape engagement with care, influencing treatment continuity, retention, and virological outcomes, particularly during the postpartum period. Equitable perinatal HIV outcomes require integrated care models that combine clinical HIV and obstetric services with mental health support, social needs screening, and migration-sensitive services to address the structural conditions shaping care trajectories. A substantial proportion of WLHIV in Europe originate from high-prevalence regions, making perinatal HIV in this context a direct interface between global infectious disease burden and migration health. Addressing care in European settings therefore contributes to broader global health equity goals in HIV elimination. The protocol was pre-registered on Open Science Framework with registration number: 10.17605/OSF.IO/9BZGY.</p>
	]]></content:encoded>

	<dc:title>Perinatal HIV in Europe: Clinical Advances and Psychosocial Challenges&amp;amp;mdash;A Scoping Review</dc:title>
			<dc:creator>Helena Lutchman</dc:creator>
			<dc:creator>Cannelle Michel</dc:creator>
			<dc:creator>Audrey Murat-Ringot</dc:creator>
			<dc:creator>Florence Carrouel</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070200</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-16</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-16</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>200</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070200</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/200</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/199">

	<title>TropicalMed, Vol. 11, Pages 199: Acceptability of Integrated Vector Management of Aedes in the iDEM Project: Findings from a Community-Based Survey in Urban Malaysia</title>
	<link>https://www.mdpi.com/2414-6366/11/7/199</link>
	<description>For dengue, there is little evidence regarding community-level acceptance, facilitators and barriers for integrated vector management (IVM). We carried out a survey to measure these aspects in the context of a large cluster-randomized controlled trial of IVM against dengue vectors in urban Malaysia, in which the component control methods were (i) outdoor residual spraying, (ii) autodissemination devices (ADDs) and (iii) community engagement. The survey population comprised (i) members of the Joint Management Body (JMB) of building developments in both arms, and (ii) residents in the intervention arm. Members of both groups were requested to complete a structured questionnaire, through face-to-face interviews. Among JMB responders, 138 were the intervention clusters, and 94 from those receiving routine activities (control arm), and there were 604 responders among residents of intervention clusters. Among the JMB members, safety of the control methods (spraying and ADDs) was among the most important potential facilitators. Among barriers, the ones identified by over one-third of the participants were lack of information about the iDEM IVM methods, lack of communication and of involvement with the iDEM project personnel. Overall, the iDEM IVM methods were seen positively, and investment by the trial in community engagement may have contributed to this.</description>
	<pubDate>2026-07-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 199: Acceptability of Integrated Vector Management of Aedes in the iDEM Project: Findings from a Community-Based Survey in Urban Malaysia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/199">doi: 10.3390/tropicalmed11070199</a></p>
	<p>Authors:
		Neal Alexander
		Nurulhusna Ab Hamid
		Farah Diana Ariffin
		Muriel Rabilloud
		Tim W. R. Möhlmann
		Frédéric Schmitt
		Jason H. Richardson
		Mitra Saadatian-Elahi
		</p>
	<p>For dengue, there is little evidence regarding community-level acceptance, facilitators and barriers for integrated vector management (IVM). We carried out a survey to measure these aspects in the context of a large cluster-randomized controlled trial of IVM against dengue vectors in urban Malaysia, in which the component control methods were (i) outdoor residual spraying, (ii) autodissemination devices (ADDs) and (iii) community engagement. The survey population comprised (i) members of the Joint Management Body (JMB) of building developments in both arms, and (ii) residents in the intervention arm. Members of both groups were requested to complete a structured questionnaire, through face-to-face interviews. Among JMB responders, 138 were the intervention clusters, and 94 from those receiving routine activities (control arm), and there were 604 responders among residents of intervention clusters. Among the JMB members, safety of the control methods (spraying and ADDs) was among the most important potential facilitators. Among barriers, the ones identified by over one-third of the participants were lack of information about the iDEM IVM methods, lack of communication and of involvement with the iDEM project personnel. Overall, the iDEM IVM methods were seen positively, and investment by the trial in community engagement may have contributed to this.</p>
	]]></content:encoded>

	<dc:title>Acceptability of Integrated Vector Management of Aedes in the iDEM Project: Findings from a Community-Based Survey in Urban Malaysia</dc:title>
			<dc:creator>Neal Alexander</dc:creator>
			<dc:creator>Nurulhusna Ab Hamid</dc:creator>
			<dc:creator>Farah Diana Ariffin</dc:creator>
			<dc:creator>Muriel Rabilloud</dc:creator>
			<dc:creator>Tim W. R. Möhlmann</dc:creator>
			<dc:creator>Frédéric Schmitt</dc:creator>
			<dc:creator>Jason H. Richardson</dc:creator>
			<dc:creator>Mitra Saadatian-Elahi</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070199</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-15</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-15</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>199</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070199</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/199</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/198">

	<title>TropicalMed, Vol. 11, Pages 198: Trends in HIV Incidence, Prevalence, Antiretroviral Therapy Coverage and Mother-to-Child Transmission Among Pregnant and Breastfeeding Women in the Eastern Cape Province, South Africa, 2000&amp;ndash;2023</title>
	<link>https://www.mdpi.com/2414-6366/11/7/198</link>
	<description>Background: The Eastern Cape Province carries the second-highest antenatal HIV prevalence nationally (32.9%), yet province-level longitudinal data on HIV incidence among pregnant and breastfeeding women (PBW) remain limited. This study examined trends in HIV incidence, HIV prevalence, mother-to-child transmission (MTCT), and antiretroviral therapy (ART) coverage among PBW in the Eastern Cape from 2000 to 2023. Methods: A quantitative ecological design was employed using secondary analysis of modelled estimates from the Thembisa Provincial HIV Model, version 4.8. Annual HIV incidence in PBW, HIV prevalence in pregnant women (overall and by five-year maternal age group), MTCT rate, new MTCT cases, and ART coverage were extracted with 95% confidence intervals (CIs) for the Eastern Cape, 2000&amp;amp;ndash;2023. Descriptive analysis characterised temporal trends at seven reference years, and formal trend significance was assessed using the Mann&amp;amp;ndash;Kendall test and log-linear regression. Results: HIV incidence in PBW declined from 3.8% (95% CI: 3.7&amp;amp;ndash;3.9) in 2000 to 1.8% (95% CI: 1.3&amp;amp;ndash;2.4) in 2023, a relative reduction of approximately 53%. ART coverage rose from 0% to 71.6%, coinciding with an 88% reduction in MTCT rate from 31.3% to 3.6%. By 2023, the MTCT rate had crossed below the World Health Organization 5% elimination threshold. HIV prevalence among pregnant women remained high at 25.0% despite declining incidence. The age distribution of HIV burden shifted markedly toward older maternal cohorts: prevalence among women aged 40&amp;amp;ndash;49 years increased from 9.9% in 2000 to 46.5% in 2023, while prevalence in the 15&amp;amp;ndash;24 age group declined substantially. New MTCT cases fell from 9990 in 2000 to 1236 in 2023. Conclusions: Declining HIV incidence in PBW coincided with substantial ART scale-up in the Eastern Cape, while HIV prevalence among pregnant women remained persistently high, a divergence that reflects the accumulating, ART-sustained pool of women living with HIV who survive into older reproductive age rather than a reversal of programmatic progress; this divergence between declining incidence and persistent, ageing prevalence is the central epidemiological finding of this study. Targeted interventions, including age-responsive antenatal protocols and strengthened PMTCT retention, alongside more careful consideration of expanded pre-exposure prophylaxis (PrEP) access, are needed to achieve elimination of mother-to-child transmission.</description>
	<pubDate>2026-07-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 198: Trends in HIV Incidence, Prevalence, Antiretroviral Therapy Coverage and Mother-to-Child Transmission Among Pregnant and Breastfeeding Women in the Eastern Cape Province, South Africa, 2000&amp;ndash;2023</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/198">doi: 10.3390/tropicalmed11070198</a></p>
	<p>Authors:
		Tronic Sithole
		Ziphelele Peter
		</p>
	<p>Background: The Eastern Cape Province carries the second-highest antenatal HIV prevalence nationally (32.9%), yet province-level longitudinal data on HIV incidence among pregnant and breastfeeding women (PBW) remain limited. This study examined trends in HIV incidence, HIV prevalence, mother-to-child transmission (MTCT), and antiretroviral therapy (ART) coverage among PBW in the Eastern Cape from 2000 to 2023. Methods: A quantitative ecological design was employed using secondary analysis of modelled estimates from the Thembisa Provincial HIV Model, version 4.8. Annual HIV incidence in PBW, HIV prevalence in pregnant women (overall and by five-year maternal age group), MTCT rate, new MTCT cases, and ART coverage were extracted with 95% confidence intervals (CIs) for the Eastern Cape, 2000&amp;amp;ndash;2023. Descriptive analysis characterised temporal trends at seven reference years, and formal trend significance was assessed using the Mann&amp;amp;ndash;Kendall test and log-linear regression. Results: HIV incidence in PBW declined from 3.8% (95% CI: 3.7&amp;amp;ndash;3.9) in 2000 to 1.8% (95% CI: 1.3&amp;amp;ndash;2.4) in 2023, a relative reduction of approximately 53%. ART coverage rose from 0% to 71.6%, coinciding with an 88% reduction in MTCT rate from 31.3% to 3.6%. By 2023, the MTCT rate had crossed below the World Health Organization 5% elimination threshold. HIV prevalence among pregnant women remained high at 25.0% despite declining incidence. The age distribution of HIV burden shifted markedly toward older maternal cohorts: prevalence among women aged 40&amp;amp;ndash;49 years increased from 9.9% in 2000 to 46.5% in 2023, while prevalence in the 15&amp;amp;ndash;24 age group declined substantially. New MTCT cases fell from 9990 in 2000 to 1236 in 2023. Conclusions: Declining HIV incidence in PBW coincided with substantial ART scale-up in the Eastern Cape, while HIV prevalence among pregnant women remained persistently high, a divergence that reflects the accumulating, ART-sustained pool of women living with HIV who survive into older reproductive age rather than a reversal of programmatic progress; this divergence between declining incidence and persistent, ageing prevalence is the central epidemiological finding of this study. Targeted interventions, including age-responsive antenatal protocols and strengthened PMTCT retention, alongside more careful consideration of expanded pre-exposure prophylaxis (PrEP) access, are needed to achieve elimination of mother-to-child transmission.</p>
	]]></content:encoded>

	<dc:title>Trends in HIV Incidence, Prevalence, Antiretroviral Therapy Coverage and Mother-to-Child Transmission Among Pregnant and Breastfeeding Women in the Eastern Cape Province, South Africa, 2000&amp;amp;ndash;2023</dc:title>
			<dc:creator>Tronic Sithole</dc:creator>
			<dc:creator>Ziphelele Peter</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070198</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-15</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-15</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>198</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070198</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/198</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/197">

	<title>TropicalMed, Vol. 11, Pages 197: Community Drivers of Leishmania Infection, Transmission and Control in Baringo County, Kenya: Implications for Integrated One Health Intervention Strategies</title>
	<link>https://www.mdpi.com/2414-6366/11/7/197</link>
	<description>Leishmaniasis is an endemic zoonotic disease caused by the protozoan parasite Leishmania and transmitted by infected female phlebotomine sandflies. The World Health Organization (WHO) classifies it among the 20 neglected tropical diseases (NTDs), ranking eighth globally. The disease predominantly affects resource-limited populations in tropical regions. Kenya bears a significant global burden of leishmaniasis, with Baringo County identified as a major endemic area. A cross-sectional survey on knowledge, attitudes, and practices (KAP) was conducted from July 2025 to January 2026 among 135 residents of Baringo South Sub-County using a structured questionnaire. The study evaluated sociodemographic characteristics, disease awareness, perceptions, preventive practices, and treatment-seeking behaviors. Additionally, 12 healthcare professionals were interviewed regarding their diagnostic and treatment capacities. Associations between variables were analyzed using Chi-square tests and multivariate logistic regression. Overall awareness of leishmaniasis was high (94.8%), with KAP scores of 86.7%, 76%, and 77.7%, respectively. Despite this, critical knowledge gaps persisted regarding transmission dynamics, the role of dogs as reservoir hosts, and preventive measures. Significant associations were found for awareness of local cases, recognition of clinical signs, knowledge of vector activity, community control measures, and attitudes toward treatment preferences. Age and education level predicted KAP outcomes. Healthcare practitioners demonstrated technical capacity to diagnose and treat human Leishmania infections, whereas veterinarians lacked awareness of Leishmania infection in dogs, including its diagnosis and treatment. Integration of human, animal, and vector surveillance within a One Health framework is recommended to enhance disease monitoring and control in Baringo County.</description>
	<pubDate>2026-07-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 197: Community Drivers of Leishmania Infection, Transmission and Control in Baringo County, Kenya: Implications for Integrated One Health Intervention Strategies</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/197">doi: 10.3390/tropicalmed11070197</a></p>
	<p>Authors:
		Hellen Njeri Maingi
		Maingi Ndichu
		James Ng’ang’a Chege
		Davis Njuguna Karanja
		Derrick Noah Sentamu
		Bruno Enagnon Lokonon
		Damaris Matoke-Muhia
		Helena Ngowi
		Bassirou Bonfoh
		</p>
	<p>Leishmaniasis is an endemic zoonotic disease caused by the protozoan parasite Leishmania and transmitted by infected female phlebotomine sandflies. The World Health Organization (WHO) classifies it among the 20 neglected tropical diseases (NTDs), ranking eighth globally. The disease predominantly affects resource-limited populations in tropical regions. Kenya bears a significant global burden of leishmaniasis, with Baringo County identified as a major endemic area. A cross-sectional survey on knowledge, attitudes, and practices (KAP) was conducted from July 2025 to January 2026 among 135 residents of Baringo South Sub-County using a structured questionnaire. The study evaluated sociodemographic characteristics, disease awareness, perceptions, preventive practices, and treatment-seeking behaviors. Additionally, 12 healthcare professionals were interviewed regarding their diagnostic and treatment capacities. Associations between variables were analyzed using Chi-square tests and multivariate logistic regression. Overall awareness of leishmaniasis was high (94.8%), with KAP scores of 86.7%, 76%, and 77.7%, respectively. Despite this, critical knowledge gaps persisted regarding transmission dynamics, the role of dogs as reservoir hosts, and preventive measures. Significant associations were found for awareness of local cases, recognition of clinical signs, knowledge of vector activity, community control measures, and attitudes toward treatment preferences. Age and education level predicted KAP outcomes. Healthcare practitioners demonstrated technical capacity to diagnose and treat human Leishmania infections, whereas veterinarians lacked awareness of Leishmania infection in dogs, including its diagnosis and treatment. Integration of human, animal, and vector surveillance within a One Health framework is recommended to enhance disease monitoring and control in Baringo County.</p>
	]]></content:encoded>

	<dc:title>Community Drivers of Leishmania Infection, Transmission and Control in Baringo County, Kenya: Implications for Integrated One Health Intervention Strategies</dc:title>
			<dc:creator>Hellen Njeri Maingi</dc:creator>
			<dc:creator>Maingi Ndichu</dc:creator>
			<dc:creator>James Ng’ang’a Chege</dc:creator>
			<dc:creator>Davis Njuguna Karanja</dc:creator>
			<dc:creator>Derrick Noah Sentamu</dc:creator>
			<dc:creator>Bruno Enagnon Lokonon</dc:creator>
			<dc:creator>Damaris Matoke-Muhia</dc:creator>
			<dc:creator>Helena Ngowi</dc:creator>
			<dc:creator>Bassirou Bonfoh</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070197</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-14</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-14</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>197</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070197</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/197</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/196">

	<title>TropicalMed, Vol. 11, Pages 196: A Rare Cause of Folliculitis by Dermatophilus congolensis in a Tropical Martial Arts Fighter</title>
	<link>https://www.mdpi.com/2414-6366/11/7/196</link>
	<description>Background: Dermatophilus congolensis, a Gram-positive actinomycete, is a well-known animal pathogen but a rare cause of human skin infections. Human dermatophilosis is an infection associated with tropical environments and animal contact that remains frequently underdiagnosed. Case Presentation: We report a case of recurrent folliculitis in a 34-year-old male Muay Thai fighter returning from Thailand to Spain. The patient presented with pustular lesions on his lower limbs following frequent leg shaving and close physical contact during training. Microbiological culture from skin swabs yielded beta-hemolytic colonies, identified as D. congolensis by MALDI-TOF MS. Identification was confirmed through Whole-Genome Sequencing (WGS), which also revealed an absence of antimicrobial resistance genes. Despite the lack of established EUCAST breakpoints, the isolate showed low MICs for most tested antibiotics. The patient was treated with doxycycline, although clinical follow-up was not possible due to travel. Conclusions: This case highlights D. congolensis as an emerging differential diagnosis for persistent folliculitis in travelers and athletes. Our findings suggest a potential horizontal transmission route through contact sports and fomites (e.g., mats) in high-humidity settings.</description>
	<pubDate>2026-07-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 196: A Rare Cause of Folliculitis by Dermatophilus congolensis in a Tropical Martial Arts Fighter</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/196">doi: 10.3390/tropicalmed11070196</a></p>
	<p>Authors:
		Guillermo Martínez-Carrión
		Leire Fernández-Ciriza
		Iosu Razquin
		María Ángeles del Río-Poza
		María Eugenia Portillo
		</p>
	<p>Background: Dermatophilus congolensis, a Gram-positive actinomycete, is a well-known animal pathogen but a rare cause of human skin infections. Human dermatophilosis is an infection associated with tropical environments and animal contact that remains frequently underdiagnosed. Case Presentation: We report a case of recurrent folliculitis in a 34-year-old male Muay Thai fighter returning from Thailand to Spain. The patient presented with pustular lesions on his lower limbs following frequent leg shaving and close physical contact during training. Microbiological culture from skin swabs yielded beta-hemolytic colonies, identified as D. congolensis by MALDI-TOF MS. Identification was confirmed through Whole-Genome Sequencing (WGS), which also revealed an absence of antimicrobial resistance genes. Despite the lack of established EUCAST breakpoints, the isolate showed low MICs for most tested antibiotics. The patient was treated with doxycycline, although clinical follow-up was not possible due to travel. Conclusions: This case highlights D. congolensis as an emerging differential diagnosis for persistent folliculitis in travelers and athletes. Our findings suggest a potential horizontal transmission route through contact sports and fomites (e.g., mats) in high-humidity settings.</p>
	]]></content:encoded>

	<dc:title>A Rare Cause of Folliculitis by Dermatophilus congolensis in a Tropical Martial Arts Fighter</dc:title>
			<dc:creator>Guillermo Martínez-Carrión</dc:creator>
			<dc:creator>Leire Fernández-Ciriza</dc:creator>
			<dc:creator>Iosu Razquin</dc:creator>
			<dc:creator>María Ángeles del Río-Poza</dc:creator>
			<dc:creator>María Eugenia Portillo</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070196</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-14</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-14</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>196</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070196</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/196</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/195">

	<title>TropicalMed, Vol. 11, Pages 195: Intestinal Parasitic Infections and Respiratory Morbidity in Children with Sickle Cell Disease in French Guiana: A Multicenter Cross-Sectional Study</title>
	<link>https://www.mdpi.com/2414-6366/11/7/195</link>
	<description>Background: Intestinal parasitic infections are common in tropical settings and may influence immune regulation, allergic responses, and respiratory health. In children with sickle cell disease (SCD), respiratory morbidity is multifactorial, and the contribution of intestinal parasites remains uncertain. This study assessed whether documented intestinal parasitic infections, particularly helminth infections, were associated with asthma-like respiratory phenotypes and clinical morbidity in children with SCD in French Guiana. Methods: We conducted a multicenter cross-sectional analysis of children and adolescents younger than 18 years with confirmed SCD who were being followed by the pediatric SCD centers of Saint-Laurent-du-Maroni, Cayenne, and Kourou between January 2022 and December 2025. Clinical, respiratory, and parasitological data were extracted from routine-care medical records. Intestinal parasitic infection was defined as at least one documented stool parasitology result identifying Strongyloides stercoralis, hookworm, or Entamoeba histolytica, according to the variables consistently available in the database. Respiratory outcomes included physician-diagnosed asthma, bronchial obstruction, bronchodilator reversibility, and an asthma-like respiratory phenotype. Results: Among 233 included children, 105 (45.1%) had at least one documented intestinal parasitic infection and 82 (35.2%) had a helminth infection. Hookworm was the most common parasite (75/233, 32.2%), followed by Entamoeba histolytica (33/233, 14.2%) and Strongyloides stercoralis (24/233, 10.3%). An asthma-like respiratory phenotype was observed in 32/105 infected children (30.5%) versus 44/128 non-infected children (34.4%). Bronchial obstruction and bronchodilator reversibility were also similar between groups. After adjustment for age, sex, genotype, hydroxyurea treatment, rural residence, site of follow-up, and environmental tobacco smoke exposure, intestinal parasitic infection was not associated with asthma-like respiratory phenotype (adjusted OR: 0.94, 95% CI: 0.51&amp;amp;ndash;1.72; p = 0.844), recurrent hospitalization, or history of acute chest syndrome. Conclusions: In this routine-care multicenter pediatric SCD cohort from French Guiana, intestinal parasitic infections were common but were not associated with respiratory phenotype or selected morbidity outcomes. Because testing and respiratory assessment were not systematic, these findings should be interpreted as showing that routine parasitological status alone could not identify children with respiratory morbidity. Prospective studies with standardized repeated parasitological, immunological, environmental, and respiratory assessments are needed.</description>
	<pubDate>2026-07-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 195: Intestinal Parasitic Infections and Respiratory Morbidity in Children with Sickle Cell Disease in French Guiana: A Multicenter Cross-Sectional Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/195">doi: 10.3390/tropicalmed11070195</a></p>
	<p>Authors:
		Gabriel Bafunyembaka
		Christian Kinsiona
		Joody Mafema
		Emmanuel Irakoze
		Philbert Furero
		Christelle Samou
		Narcisse Elenga
		</p>
	<p>Background: Intestinal parasitic infections are common in tropical settings and may influence immune regulation, allergic responses, and respiratory health. In children with sickle cell disease (SCD), respiratory morbidity is multifactorial, and the contribution of intestinal parasites remains uncertain. This study assessed whether documented intestinal parasitic infections, particularly helminth infections, were associated with asthma-like respiratory phenotypes and clinical morbidity in children with SCD in French Guiana. Methods: We conducted a multicenter cross-sectional analysis of children and adolescents younger than 18 years with confirmed SCD who were being followed by the pediatric SCD centers of Saint-Laurent-du-Maroni, Cayenne, and Kourou between January 2022 and December 2025. Clinical, respiratory, and parasitological data were extracted from routine-care medical records. Intestinal parasitic infection was defined as at least one documented stool parasitology result identifying Strongyloides stercoralis, hookworm, or Entamoeba histolytica, according to the variables consistently available in the database. Respiratory outcomes included physician-diagnosed asthma, bronchial obstruction, bronchodilator reversibility, and an asthma-like respiratory phenotype. Results: Among 233 included children, 105 (45.1%) had at least one documented intestinal parasitic infection and 82 (35.2%) had a helminth infection. Hookworm was the most common parasite (75/233, 32.2%), followed by Entamoeba histolytica (33/233, 14.2%) and Strongyloides stercoralis (24/233, 10.3%). An asthma-like respiratory phenotype was observed in 32/105 infected children (30.5%) versus 44/128 non-infected children (34.4%). Bronchial obstruction and bronchodilator reversibility were also similar between groups. After adjustment for age, sex, genotype, hydroxyurea treatment, rural residence, site of follow-up, and environmental tobacco smoke exposure, intestinal parasitic infection was not associated with asthma-like respiratory phenotype (adjusted OR: 0.94, 95% CI: 0.51&amp;amp;ndash;1.72; p = 0.844), recurrent hospitalization, or history of acute chest syndrome. Conclusions: In this routine-care multicenter pediatric SCD cohort from French Guiana, intestinal parasitic infections were common but were not associated with respiratory phenotype or selected morbidity outcomes. Because testing and respiratory assessment were not systematic, these findings should be interpreted as showing that routine parasitological status alone could not identify children with respiratory morbidity. Prospective studies with standardized repeated parasitological, immunological, environmental, and respiratory assessments are needed.</p>
	]]></content:encoded>

	<dc:title>Intestinal Parasitic Infections and Respiratory Morbidity in Children with Sickle Cell Disease in French Guiana: A Multicenter Cross-Sectional Study</dc:title>
			<dc:creator>Gabriel Bafunyembaka</dc:creator>
			<dc:creator>Christian Kinsiona</dc:creator>
			<dc:creator>Joody Mafema</dc:creator>
			<dc:creator>Emmanuel Irakoze</dc:creator>
			<dc:creator>Philbert Furero</dc:creator>
			<dc:creator>Christelle Samou</dc:creator>
			<dc:creator>Narcisse Elenga</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070195</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-13</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-13</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>195</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070195</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/195</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/194">

	<title>TropicalMed, Vol. 11, Pages 194: Malaria Epidemiology and Plasmodium Species&amp;ndash;Specific Antimalarial Treatment Patterns Among RDT&amp;ndash;Confirmed Cases in Northwestern Pakistan</title>
	<link>https://www.mdpi.com/2414-6366/11/7/194</link>
	<description>Background: Malaria remains a major public health challenge in Pakistan, where persistent transmission, heterogeneous risk patterns, and evolving treatment practices continue to impede control and elimination efforts. Methods: A community-based cross-sectional study was conducted among 9211 symptomatic individuals in District Dera Ismail Khan, northwestern Pakistan, from January 2024 to December 2025. Malaria was diagnosed using rapid immunochromatographic assays for Plasmodium vivax (P. vivax) and Plasmodium falciparum (P. falciparum), and associated risk factors were assessed using multivariable logistic regression. Results: Overall malaria prevalence was 36.27% (3341/9211). P. vivax predominated, accounting for 93.8% (3133/3341) of infections, while P. falciparum represented 5.8% (195/3341) and mixed infections 0.4% (13/3341). Infection risk was significantly associated based on multivariate analysis with male sex, younger age, pregnancy (AOR = 4.69), and absence of mosquito net use (AOR = 6.17), whereas indoor residual spraying (AOR = 0.08) showed a strong protective effect. Malaria transmission showed two peaks: October&amp;amp;ndash;December (AOR = 3.78&amp;amp;ndash;4.97) and February&amp;amp;ndash;March (AOR = 2.25&amp;amp;ndash;2.31) and declined significantly based on unadjusted analysis from 39.5% in 2024 to 32.8% in 2025 (OR = 0.74; p &amp;amp;lt; 0.001). Blood groups B+ (AOR = 0.77), B&amp;amp;minus; (AOR = 0.78), and AB&amp;amp;minus; (AOR = 0.86) were significantly associated with reduced odds of malaria infection. A notable shift toward artemisinin-based combination therapy was observed, with artemether&amp;amp;ndash;lumefantrine largely replacing chloroquine for malaria treatment. Conclusions: The persistence of P. vivax-dominated transmission alongside ongoing P. falciparum circulation highlights the need for targeted vector control, enhanced surveillance, and evidence-based treatment strategies to accelerate malaria elimination in Pakistan.</description>
	<pubDate>2026-07-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 194: Malaria Epidemiology and Plasmodium Species&amp;ndash;Specific Antimalarial Treatment Patterns Among RDT&amp;ndash;Confirmed Cases in Northwestern Pakistan</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/194">doi: 10.3390/tropicalmed11070194</a></p>
	<p>Authors:
		Aqsa Mansoor
		Ghulam Narjis
		Imen Ben Abdelmalek
		Sabika Firasat
		Iffat Naz
		Kiran Afshan
		</p>
	<p>Background: Malaria remains a major public health challenge in Pakistan, where persistent transmission, heterogeneous risk patterns, and evolving treatment practices continue to impede control and elimination efforts. Methods: A community-based cross-sectional study was conducted among 9211 symptomatic individuals in District Dera Ismail Khan, northwestern Pakistan, from January 2024 to December 2025. Malaria was diagnosed using rapid immunochromatographic assays for Plasmodium vivax (P. vivax) and Plasmodium falciparum (P. falciparum), and associated risk factors were assessed using multivariable logistic regression. Results: Overall malaria prevalence was 36.27% (3341/9211). P. vivax predominated, accounting for 93.8% (3133/3341) of infections, while P. falciparum represented 5.8% (195/3341) and mixed infections 0.4% (13/3341). Infection risk was significantly associated based on multivariate analysis with male sex, younger age, pregnancy (AOR = 4.69), and absence of mosquito net use (AOR = 6.17), whereas indoor residual spraying (AOR = 0.08) showed a strong protective effect. Malaria transmission showed two peaks: October&amp;amp;ndash;December (AOR = 3.78&amp;amp;ndash;4.97) and February&amp;amp;ndash;March (AOR = 2.25&amp;amp;ndash;2.31) and declined significantly based on unadjusted analysis from 39.5% in 2024 to 32.8% in 2025 (OR = 0.74; p &amp;amp;lt; 0.001). Blood groups B+ (AOR = 0.77), B&amp;amp;minus; (AOR = 0.78), and AB&amp;amp;minus; (AOR = 0.86) were significantly associated with reduced odds of malaria infection. A notable shift toward artemisinin-based combination therapy was observed, with artemether&amp;amp;ndash;lumefantrine largely replacing chloroquine for malaria treatment. Conclusions: The persistence of P. vivax-dominated transmission alongside ongoing P. falciparum circulation highlights the need for targeted vector control, enhanced surveillance, and evidence-based treatment strategies to accelerate malaria elimination in Pakistan.</p>
	]]></content:encoded>

	<dc:title>Malaria Epidemiology and Plasmodium Species&amp;amp;ndash;Specific Antimalarial Treatment Patterns Among RDT&amp;amp;ndash;Confirmed Cases in Northwestern Pakistan</dc:title>
			<dc:creator>Aqsa Mansoor</dc:creator>
			<dc:creator>Ghulam Narjis</dc:creator>
			<dc:creator>Imen Ben Abdelmalek</dc:creator>
			<dc:creator>Sabika Firasat</dc:creator>
			<dc:creator>Iffat Naz</dc:creator>
			<dc:creator>Kiran Afshan</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070194</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-10</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-10</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>194</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070194</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/194</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/193">

	<title>TropicalMed, Vol. 11, Pages 193: Tuberculosis-Related Hospitalization According to Comorbidity Burden: A Retrospective Single-Center Cohort Study</title>
	<link>https://www.mdpi.com/2414-6366/11/7/193</link>
	<description>Tuberculosis (TB) remains a major infectious disease associated with substantial healthcare burdens. Although previous studies mainly focused on mortality and treatment outcomes, factors associated with TB-related hospitalization have not been sufficiently investigated. The aim of our study was to evaluate clinical factors associated with TB-related hospitalization in patients with TB. Patients diagnosed with TB at Kangwon National University Hospital between January 2024 and December 2025 were included in our study. The primary outcome was TB-related hospitalization during follow-up after TB diagnosis. Hospitalization-free probability was analyzed using Kaplan&amp;amp;ndash;Meier analysis, and Cox proportional hazards regression analysis was performed to identify factors associated with hospitalization risk. A total of 81 patients were included; 63 patients were in the outpatient group and 18 patients were in the hospitalization group. The median time to hospitalization was 36 days. The Charlson comorbidity index (CCI) was significantly higher in the hospitalization group (5.78 &amp;amp;plusmn; 2.88 vs. 4.16 &amp;amp;plusmn; 2.22, p = 0.038). Patients with CCI values &amp;amp;ge; 5 showed significantly lower hospitalization-free probability during the 180-day follow-up period (log-rank p = 0.013). In multivariable Cox hazards regression analysis, both serum creatinine (hazard ratio (HR), 1.599; 95% confidence interval (CI), 1.057&amp;amp;ndash;2.419; p = 0.026) and CCI (HR, 1.221; 95% CI, 1.018&amp;amp;ndash;1.466; p = 0.032) were significantly associated with TB-related hospitalization. A higher comorbidity burden may help identify patients at risk for TB-related hospitalization.</description>
	<pubDate>2026-07-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 193: Tuberculosis-Related Hospitalization According to Comorbidity Burden: A Retrospective Single-Center Cohort Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/193">doi: 10.3390/tropicalmed11070193</a></p>
	<p>Authors:
		Oh Beom Kwon
		Yeonjeong Heo
		Da Hye Moon
		Woo Jin Kim
		Seung-Joon Lee
		Seon-Sook Han
		</p>
	<p>Tuberculosis (TB) remains a major infectious disease associated with substantial healthcare burdens. Although previous studies mainly focused on mortality and treatment outcomes, factors associated with TB-related hospitalization have not been sufficiently investigated. The aim of our study was to evaluate clinical factors associated with TB-related hospitalization in patients with TB. Patients diagnosed with TB at Kangwon National University Hospital between January 2024 and December 2025 were included in our study. The primary outcome was TB-related hospitalization during follow-up after TB diagnosis. Hospitalization-free probability was analyzed using Kaplan&amp;amp;ndash;Meier analysis, and Cox proportional hazards regression analysis was performed to identify factors associated with hospitalization risk. A total of 81 patients were included; 63 patients were in the outpatient group and 18 patients were in the hospitalization group. The median time to hospitalization was 36 days. The Charlson comorbidity index (CCI) was significantly higher in the hospitalization group (5.78 &amp;amp;plusmn; 2.88 vs. 4.16 &amp;amp;plusmn; 2.22, p = 0.038). Patients with CCI values &amp;amp;ge; 5 showed significantly lower hospitalization-free probability during the 180-day follow-up period (log-rank p = 0.013). In multivariable Cox hazards regression analysis, both serum creatinine (hazard ratio (HR), 1.599; 95% confidence interval (CI), 1.057&amp;amp;ndash;2.419; p = 0.026) and CCI (HR, 1.221; 95% CI, 1.018&amp;amp;ndash;1.466; p = 0.032) were significantly associated with TB-related hospitalization. A higher comorbidity burden may help identify patients at risk for TB-related hospitalization.</p>
	]]></content:encoded>

	<dc:title>Tuberculosis-Related Hospitalization According to Comorbidity Burden: A Retrospective Single-Center Cohort Study</dc:title>
			<dc:creator>Oh Beom Kwon</dc:creator>
			<dc:creator>Yeonjeong Heo</dc:creator>
			<dc:creator>Da Hye Moon</dc:creator>
			<dc:creator>Woo Jin Kim</dc:creator>
			<dc:creator>Seung-Joon Lee</dc:creator>
			<dc:creator>Seon-Sook Han</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070193</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-10</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-10</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>193</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070193</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/193</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/192">

	<title>TropicalMed, Vol. 11, Pages 192: Transmission Interruption of Leprosy in the Philippines: An Update on the Current Program Priorities and Interventions</title>
	<link>https://www.mdpi.com/2414-6366/11/7/192</link>
	<description>The Philippines achieved World Health Organization (WHO) certification for the elimination of leprosy as a public health problem in 1998. Despite this milestone, new cases continue to be reported each year, highlighting the need for sustained surveillance and interventions to achieve zero transmission. This paper provides an update on the country&amp;amp;rsquo;s progress toward interruption of leprosy transmission using national surveillance data and programmatic reports from 2020&amp;amp;ndash;2024. Quantitative data were obtained from the Department of Health (DOH) Field Health Services Information System (FHSIS), while policy and programmatic information were drawn from national reports, WHO guidance, and implementation reviews. Descriptive analyses were conducted to examine trends in prevalence, case detection rates (CDRs), and age-sex distribution patterns to identify high-risk groups. Leprosy prevalence declined from 0.41 per 10,000 population in 2020 to 0.11 in 2024, remaining below the WHO elimination threshold. The CDR increased from 0.45 in 2022 to 1.17 per 100,000 in 2024, indicating recovery of active surveillance after COVID-19-related disruptions. Most newly detected cases occurred among adults aged 20&amp;amp;ndash;59 years (72%), although continued detection among children aged 0&amp;amp;ndash;14 years (6&amp;amp;ndash;7%) suggests ongoing transmission in selected endemic areas. Key program strengths include policy integration and WHO-supported surveillance initiatives, while major barriers include stigma, uneven local implementation, and limited access to rehabilitation. The Philippines has maintained low national prevalence while strengthening efforts toward transmission interruption. Continued investment in surveillance, contact tracing, stigma reduction, and integrated neglected tropical disease (NTD) services will be essential to achieving zero transmission, zero disability, and zero discrimination by 2030.</description>
	<pubDate>2026-07-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 192: Transmission Interruption of Leprosy in the Philippines: An Update on the Current Program Priorities and Interventions</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/192">doi: 10.3390/tropicalmed11070192</a></p>
	<p>Authors:
		Bayo Segun Fatunmbi
		Alexander Yabes Taruc
		Kazim Hizbullah Sanikullah
		Anna Marie Celina Garfin
		Jose Gerard Belimac
		Almira Cruz Gatchalian
		Ma. Regina De Jesus Valdez
		Carmel Angela Buado
		Kim Patrick Tejano
		Abelaine Venida-Tablizo
		Frederica Veronica Marquez-Protacio
		Belen L. Dofitas
		Arturo Cunanan
		Reginald Alain R. Santos
		Francesca Cando Gajete
		Concepcion P. Dumawat
		Eugene Caccam
		Eunyoung Ko
		Rui Paulo de Jesus
		</p>
	<p>The Philippines achieved World Health Organization (WHO) certification for the elimination of leprosy as a public health problem in 1998. Despite this milestone, new cases continue to be reported each year, highlighting the need for sustained surveillance and interventions to achieve zero transmission. This paper provides an update on the country&amp;amp;rsquo;s progress toward interruption of leprosy transmission using national surveillance data and programmatic reports from 2020&amp;amp;ndash;2024. Quantitative data were obtained from the Department of Health (DOH) Field Health Services Information System (FHSIS), while policy and programmatic information were drawn from national reports, WHO guidance, and implementation reviews. Descriptive analyses were conducted to examine trends in prevalence, case detection rates (CDRs), and age-sex distribution patterns to identify high-risk groups. Leprosy prevalence declined from 0.41 per 10,000 population in 2020 to 0.11 in 2024, remaining below the WHO elimination threshold. The CDR increased from 0.45 in 2022 to 1.17 per 100,000 in 2024, indicating recovery of active surveillance after COVID-19-related disruptions. Most newly detected cases occurred among adults aged 20&amp;amp;ndash;59 years (72%), although continued detection among children aged 0&amp;amp;ndash;14 years (6&amp;amp;ndash;7%) suggests ongoing transmission in selected endemic areas. Key program strengths include policy integration and WHO-supported surveillance initiatives, while major barriers include stigma, uneven local implementation, and limited access to rehabilitation. The Philippines has maintained low national prevalence while strengthening efforts toward transmission interruption. Continued investment in surveillance, contact tracing, stigma reduction, and integrated neglected tropical disease (NTD) services will be essential to achieving zero transmission, zero disability, and zero discrimination by 2030.</p>
	]]></content:encoded>

	<dc:title>Transmission Interruption of Leprosy in the Philippines: An Update on the Current Program Priorities and Interventions</dc:title>
			<dc:creator>Bayo Segun Fatunmbi</dc:creator>
			<dc:creator>Alexander Yabes Taruc</dc:creator>
			<dc:creator>Kazim Hizbullah Sanikullah</dc:creator>
			<dc:creator>Anna Marie Celina Garfin</dc:creator>
			<dc:creator>Jose Gerard Belimac</dc:creator>
			<dc:creator>Almira Cruz Gatchalian</dc:creator>
			<dc:creator>Ma. Regina De Jesus Valdez</dc:creator>
			<dc:creator>Carmel Angela Buado</dc:creator>
			<dc:creator>Kim Patrick Tejano</dc:creator>
			<dc:creator>Abelaine Venida-Tablizo</dc:creator>
			<dc:creator>Frederica Veronica Marquez-Protacio</dc:creator>
			<dc:creator>Belen L. Dofitas</dc:creator>
			<dc:creator>Arturo Cunanan</dc:creator>
			<dc:creator>Reginald Alain R. Santos</dc:creator>
			<dc:creator>Francesca Cando Gajete</dc:creator>
			<dc:creator>Concepcion P. Dumawat</dc:creator>
			<dc:creator>Eugene Caccam</dc:creator>
			<dc:creator>Eunyoung Ko</dc:creator>
			<dc:creator>Rui Paulo de Jesus</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070192</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>192</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070192</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/192</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/191">

	<title>TropicalMed, Vol. 11, Pages 191: Behavioural Determinants of Intestinal Nematode Infection Risk Among Children in a Post-Mass-Drug-Administration Setting in Sri Lanka: A Survey of Caregiver Knowledge, Attitudes, and Practices</title>
	<link>https://www.mdpi.com/2414-6366/11/7/191</link>
	<description>Human intestinal nematode infections (HINIs) remain a public health concern despite reduced prevalence following mass drug administration (MDA) in low- and middle-income countries. Children continue to bear a substantial burden of infection, and caregiver knowledge and practices may influence their risk of acquiring infection. Sustaining control during the transition of prevention programmes to surveillance-based strategies requires an understanding of behavioural determinants of transmission. Therefore, we assessed caregiver knowledge, attitudes, and practices (KAP) and their associations with sociodemographic characteristics and child infection status. A community-based cross-sectional study was conducted among 945 caregivers of primary school children in Anuradhapura, a low-prevalence setting where school-based MDA ceased in 2019, to assess caregiver KAP and child HINI status. An interviewer-administered questionnaire assessed KAP, sociodemographic, water, sanitation, hygiene (WASH), and behavioural factors. Participants were predominantly mothers (89.5%). Good knowledge was observed in 61.7%, positive attitudes in 95.6% and good practices in 99.2%. Knowledge gaps persisted regarding transmission and complications. Higher caregiver knowledge (OR = 0.52; 95% CI: 0.36&amp;amp;ndash;0.72) and regular deworming (OR = 0.58, 95% CI: 0.40&amp;amp;ndash;0.83) were associated with lower odds of infection, whereas attitudes and practices were not independently associated. Caregiver knowledge remains a key determinant of infection risk. Gaps in knowledge, misconceptions, and practices may sustain transmission even in low-prevalence settings. Strengthening health education, school-based hygiene promotion, and community engagement remains essential to reinforce preventive behaviours and support long-term control as countries transition from routine MDA to elimination-oriented strategies.</description>
	<pubDate>2026-07-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 191: Behavioural Determinants of Intestinal Nematode Infection Risk Among Children in a Post-Mass-Drug-Administration Setting in Sri Lanka: A Survey of Caregiver Knowledge, Attitudes, and Practices</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/191">doi: 10.3390/tropicalmed11070191</a></p>
	<p>Authors:
		Nalini Jayakody
		Catherine A. Gordon
		Anjana Silva
		Nuwan Wickramasinghe
		Susiji Wickramasinghe
		Natasha Collinson
		Asela Wijayasekara
		Chanaka Karunarathne
		Harshi Weerakoon
		Manjula Weerasinghe
		Nilanthi de Silva
		Kosala Weerakoon
		</p>
	<p>Human intestinal nematode infections (HINIs) remain a public health concern despite reduced prevalence following mass drug administration (MDA) in low- and middle-income countries. Children continue to bear a substantial burden of infection, and caregiver knowledge and practices may influence their risk of acquiring infection. Sustaining control during the transition of prevention programmes to surveillance-based strategies requires an understanding of behavioural determinants of transmission. Therefore, we assessed caregiver knowledge, attitudes, and practices (KAP) and their associations with sociodemographic characteristics and child infection status. A community-based cross-sectional study was conducted among 945 caregivers of primary school children in Anuradhapura, a low-prevalence setting where school-based MDA ceased in 2019, to assess caregiver KAP and child HINI status. An interviewer-administered questionnaire assessed KAP, sociodemographic, water, sanitation, hygiene (WASH), and behavioural factors. Participants were predominantly mothers (89.5%). Good knowledge was observed in 61.7%, positive attitudes in 95.6% and good practices in 99.2%. Knowledge gaps persisted regarding transmission and complications. Higher caregiver knowledge (OR = 0.52; 95% CI: 0.36&amp;amp;ndash;0.72) and regular deworming (OR = 0.58, 95% CI: 0.40&amp;amp;ndash;0.83) were associated with lower odds of infection, whereas attitudes and practices were not independently associated. Caregiver knowledge remains a key determinant of infection risk. Gaps in knowledge, misconceptions, and practices may sustain transmission even in low-prevalence settings. Strengthening health education, school-based hygiene promotion, and community engagement remains essential to reinforce preventive behaviours and support long-term control as countries transition from routine MDA to elimination-oriented strategies.</p>
	]]></content:encoded>

	<dc:title>Behavioural Determinants of Intestinal Nematode Infection Risk Among Children in a Post-Mass-Drug-Administration Setting in Sri Lanka: A Survey of Caregiver Knowledge, Attitudes, and Practices</dc:title>
			<dc:creator>Nalini Jayakody</dc:creator>
			<dc:creator>Catherine A. Gordon</dc:creator>
			<dc:creator>Anjana Silva</dc:creator>
			<dc:creator>Nuwan Wickramasinghe</dc:creator>
			<dc:creator>Susiji Wickramasinghe</dc:creator>
			<dc:creator>Natasha Collinson</dc:creator>
			<dc:creator>Asela Wijayasekara</dc:creator>
			<dc:creator>Chanaka Karunarathne</dc:creator>
			<dc:creator>Harshi Weerakoon</dc:creator>
			<dc:creator>Manjula Weerasinghe</dc:creator>
			<dc:creator>Nilanthi de Silva</dc:creator>
			<dc:creator>Kosala Weerakoon</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070191</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>191</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070191</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/191</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/190">

	<title>TropicalMed, Vol. 11, Pages 190: Submicroscopic Plasmodium falciparum Carriage and Molecular Markers of Antimalarial Drug Resistance Among Outpatients Attending Korle Bu Teaching Hospital, Ghana</title>
	<link>https://www.mdpi.com/2414-6366/11/7/190</link>
	<description>Background: Malaria remains a major public health challenge in sub-Saharan Africa, where asymptomatic infections continue to hinder elimination efforts. Although the clinical and epidemiological consequences of microscopic infections are well documented, the health implications of submicroscopic Plasmodium falciparum infections remain poorly understood, particularly in Ghana. This study assessed the burden of submicroscopic P. falciparum infections and their association with antimalarial drug resistance markers among outpatients attending Korle Bu Teaching Hospital. Methods: A cross-sectional study involving 345 participants was conducted. Malaria infection was assessed using mRDT, blood smear microscopy, and LAMP-PCR for parasite detection and species identification. Antimalarial drug resistance markers were analyzed by multiplex PCR and Oxford Nanopore sequencing. Statistical analysis was performed using STATA version 14, applying Pearson&amp;amp;rsquo;s chi-square test and logistic regression. Results: The overall prevalence of asymptomatic P. falciparum infection was 35.0% (117/334), with 18.9% microscopic and 16.1% submicroscopic infections. The wild-type pfcrt K76 allele, associated with chloroquine susceptibility, was highly prevalent (90.1%). Conclusions: Asymptomatic P. falciparum infections are common in this population, with a substantial proportion occurring at submicroscopic levels. The high prevalence of chloroquine-susceptible parasites and identified transmission hotspots underscore the need for sensitive diagnostics and targeted interventions to support malaria elimination efforts in Ghana.</description>
	<pubDate>2026-07-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 190: Submicroscopic Plasmodium falciparum Carriage and Molecular Markers of Antimalarial Drug Resistance Among Outpatients Attending Korle Bu Teaching Hospital, Ghana</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/190">doi: 10.3390/tropicalmed11070190</a></p>
	<p>Authors:
		Benjamin Tetteh Mensah
		Hannah Otu
		Dorinda Naa Okailey Armah
		Comfort Teiko Abuanor
		Lucas Amenga-Etego
		Samuel Antwi-Baffour
		</p>
	<p>Background: Malaria remains a major public health challenge in sub-Saharan Africa, where asymptomatic infections continue to hinder elimination efforts. Although the clinical and epidemiological consequences of microscopic infections are well documented, the health implications of submicroscopic Plasmodium falciparum infections remain poorly understood, particularly in Ghana. This study assessed the burden of submicroscopic P. falciparum infections and their association with antimalarial drug resistance markers among outpatients attending Korle Bu Teaching Hospital. Methods: A cross-sectional study involving 345 participants was conducted. Malaria infection was assessed using mRDT, blood smear microscopy, and LAMP-PCR for parasite detection and species identification. Antimalarial drug resistance markers were analyzed by multiplex PCR and Oxford Nanopore sequencing. Statistical analysis was performed using STATA version 14, applying Pearson&amp;amp;rsquo;s chi-square test and logistic regression. Results: The overall prevalence of asymptomatic P. falciparum infection was 35.0% (117/334), with 18.9% microscopic and 16.1% submicroscopic infections. The wild-type pfcrt K76 allele, associated with chloroquine susceptibility, was highly prevalent (90.1%). Conclusions: Asymptomatic P. falciparum infections are common in this population, with a substantial proportion occurring at submicroscopic levels. The high prevalence of chloroquine-susceptible parasites and identified transmission hotspots underscore the need for sensitive diagnostics and targeted interventions to support malaria elimination efforts in Ghana.</p>
	]]></content:encoded>

	<dc:title>Submicroscopic Plasmodium falciparum Carriage and Molecular Markers of Antimalarial Drug Resistance Among Outpatients Attending Korle Bu Teaching Hospital, Ghana</dc:title>
			<dc:creator>Benjamin Tetteh Mensah</dc:creator>
			<dc:creator>Hannah Otu</dc:creator>
			<dc:creator>Dorinda Naa Okailey Armah</dc:creator>
			<dc:creator>Comfort Teiko Abuanor</dc:creator>
			<dc:creator>Lucas Amenga-Etego</dc:creator>
			<dc:creator>Samuel Antwi-Baffour</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070190</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>190</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070190</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/190</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/189">

	<title>TropicalMed, Vol. 11, Pages 189: Climate-Driven Distribution and Ecological Niche Modeling of Three Anopheles Species in China Using the Biomod2 Ensemble Framework</title>
	<link>https://www.mdpi.com/2414-6366/11/7/189</link>
	<description>This study aimed to project the current and future suitable habitats of three primary malaria vectors in China&amp;amp;mdash;An. lesteri, An. minimus, and An. sinensis&amp;amp;mdash;using an ensemble modeling approach. We simulated their geographical distributions under current and future climates (SSP126, SSP245, SSP585) using the Biomod2 platform with 19 bioclimatic variables and elevation. The ensemble models achieved high predictive performance, as reflected by AUC and TSS values. Environmental drivers were species-specific: An. lesteri was primarily influenced by elevation, temperature seasonality (Bio4), and seasonal precipitation (Bio18, Bio19); An. minimus by the mean temperature of the coldest quarter (Bio11); and An. sinensis by annual precipitation (Bio12), mean temperature of the wettest quarter (Bio8), and elevation. Future projections revealed divergent responses: the habitat of An. lesteri is projected to contract and shift northeastward; An. sinensis is expected to expand northward, potentially extending climatically suitable areas into new regions; and although the overall range of An. minimus remains stable, its internal suitability shifts toward higher classes under warming. These findings demonstrate that climate change will critically reshape the distribution of major malaria vectors across China, underscoring the need to integrate climate-informed projections into adaptive surveillance and vector control strategies in the post-elimination era.</description>
	<pubDate>2026-07-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 189: Climate-Driven Distribution and Ecological Niche Modeling of Three Anopheles Species in China Using the Biomod2 Ensemble Framework</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/189">doi: 10.3390/tropicalmed11070189</a></p>
	<p>Authors:
		Dan Jiang
		Kun Wang
		Shenbo Chen
		Yang Hong
		Senping Yang
		Xiaoyuan Su
		Yongdong Hao
		Fei Luo
		Junhu Chen
		</p>
	<p>This study aimed to project the current and future suitable habitats of three primary malaria vectors in China&amp;amp;mdash;An. lesteri, An. minimus, and An. sinensis&amp;amp;mdash;using an ensemble modeling approach. We simulated their geographical distributions under current and future climates (SSP126, SSP245, SSP585) using the Biomod2 platform with 19 bioclimatic variables and elevation. The ensemble models achieved high predictive performance, as reflected by AUC and TSS values. Environmental drivers were species-specific: An. lesteri was primarily influenced by elevation, temperature seasonality (Bio4), and seasonal precipitation (Bio18, Bio19); An. minimus by the mean temperature of the coldest quarter (Bio11); and An. sinensis by annual precipitation (Bio12), mean temperature of the wettest quarter (Bio8), and elevation. Future projections revealed divergent responses: the habitat of An. lesteri is projected to contract and shift northeastward; An. sinensis is expected to expand northward, potentially extending climatically suitable areas into new regions; and although the overall range of An. minimus remains stable, its internal suitability shifts toward higher classes under warming. These findings demonstrate that climate change will critically reshape the distribution of major malaria vectors across China, underscoring the need to integrate climate-informed projections into adaptive surveillance and vector control strategies in the post-elimination era.</p>
	]]></content:encoded>

	<dc:title>Climate-Driven Distribution and Ecological Niche Modeling of Three Anopheles Species in China Using the Biomod2 Ensemble Framework</dc:title>
			<dc:creator>Dan Jiang</dc:creator>
			<dc:creator>Kun Wang</dc:creator>
			<dc:creator>Shenbo Chen</dc:creator>
			<dc:creator>Yang Hong</dc:creator>
			<dc:creator>Senping Yang</dc:creator>
			<dc:creator>Xiaoyuan Su</dc:creator>
			<dc:creator>Yongdong Hao</dc:creator>
			<dc:creator>Fei Luo</dc:creator>
			<dc:creator>Junhu Chen</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070189</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-09</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-09</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>189</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070189</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/189</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/188">

	<title>TropicalMed, Vol. 11, Pages 188: Distribution of Mother-to-Child Transmitted (MTCT) Infections and Socioeconomic Vulnerability Within the Gran Chaco Region</title>
	<link>https://www.mdpi.com/2414-6366/11/7/188</link>
	<description>Mother-to-child transmission (MTCT) of infectious diseases remains a public health challenge in socially vulnerable regions with limited healthcare access. This study assessed the epidemiological situation, spatial distribution, and socioeconomic context of MTCT infections&amp;amp;mdash;Chagas disease (ChD), syphilis, HIV, and hepatitis B (HB)&amp;amp;mdash;in the Gran Chaco region (Argentina&amp;amp;ndash;Paraguay), 2018&amp;amp;ndash;2024. Epidemiological data from 2877 patients enrolled in an MTCT Plus programme were analysed, alongside socioeconomic variables and spatio-temporal cluster analysis using SaTScan software. Maternal seroprevalence of ChD was 4.1%, the highest among the infections evaluated. Syphilis prevalence was 0.8%, while no HIV or HBV infections were detected among screened pregnant women. Two statistically significant spatiotemporal clusters of maternal Trypanosoma cruzi seropositivity were identified: a household-level cluster in 2018 and a regional cluster during 2019&amp;amp;ndash;2021. The highest prevalence of maternal ChD seropositivity was observed in census tracts with greater socioeconomic vulnerability, although this spatial overlap was assessed descriptively. These findings highlight the effectiveness of integrated maternal&amp;amp;ndash;child health services in ensuring coverage, timely diagnosis, and treatment in vulnerable populations. The identified spatial patterns provide evidence to support targeted surveillance and coordinated binational public health strategies in border regions affected by persistent social inequalities.</description>
	<pubDate>2026-07-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 188: Distribution of Mother-to-Child Transmitted (MTCT) Infections and Socioeconomic Vulnerability Within the Gran Chaco Region</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/188">doi: 10.3390/tropicalmed11070188</a></p>
	<p>Authors:
		Carla Rodríguez González
		Susana Ávila
		Karina Cardone
		Mariana Fernández
		Favio Crudo
		Verónica Andreo
		M. Victoria Periago
		</p>
	<p>Mother-to-child transmission (MTCT) of infectious diseases remains a public health challenge in socially vulnerable regions with limited healthcare access. This study assessed the epidemiological situation, spatial distribution, and socioeconomic context of MTCT infections&amp;amp;mdash;Chagas disease (ChD), syphilis, HIV, and hepatitis B (HB)&amp;amp;mdash;in the Gran Chaco region (Argentina&amp;amp;ndash;Paraguay), 2018&amp;amp;ndash;2024. Epidemiological data from 2877 patients enrolled in an MTCT Plus programme were analysed, alongside socioeconomic variables and spatio-temporal cluster analysis using SaTScan software. Maternal seroprevalence of ChD was 4.1%, the highest among the infections evaluated. Syphilis prevalence was 0.8%, while no HIV or HBV infections were detected among screened pregnant women. Two statistically significant spatiotemporal clusters of maternal Trypanosoma cruzi seropositivity were identified: a household-level cluster in 2018 and a regional cluster during 2019&amp;amp;ndash;2021. The highest prevalence of maternal ChD seropositivity was observed in census tracts with greater socioeconomic vulnerability, although this spatial overlap was assessed descriptively. These findings highlight the effectiveness of integrated maternal&amp;amp;ndash;child health services in ensuring coverage, timely diagnosis, and treatment in vulnerable populations. The identified spatial patterns provide evidence to support targeted surveillance and coordinated binational public health strategies in border regions affected by persistent social inequalities.</p>
	]]></content:encoded>

	<dc:title>Distribution of Mother-to-Child Transmitted (MTCT) Infections and Socioeconomic Vulnerability Within the Gran Chaco Region</dc:title>
			<dc:creator>Carla Rodríguez González</dc:creator>
			<dc:creator>Susana Ávila</dc:creator>
			<dc:creator>Karina Cardone</dc:creator>
			<dc:creator>Mariana Fernández</dc:creator>
			<dc:creator>Favio Crudo</dc:creator>
			<dc:creator>Verónica Andreo</dc:creator>
			<dc:creator>M. Victoria Periago</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070188</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-08</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-08</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>188</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070188</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/188</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/187">

	<title>TropicalMed, Vol. 11, Pages 187: An Unintended Hazard of Environmental Stewardship: Marine Envenomation Following Invasive Lionfish Culling in Curacao</title>
	<link>https://www.mdpi.com/2414-6366/11/7/187</link>
	<description>Marine envenomations are common non-infectious hazards for travelers. Lionfish, venomous fish native to Indo-Pacific waters, have become an invasive species in the Atlantic Ocean and threat to native marine ecosystems. Various control measures have been implemented in response to rapidly expanding lionfish populations, including licensed culling by recreational divers. We herein review lionfish envenomation through framing with a case that occurred during a diving trip to Curacao for the purpose of lionfish spearfishing. Following initial management in Curacao with hot water immersion, wound care, and antibiotic prophylaxis, the patient continued to have persistent swelling, bruising, and pain to the puncture site and was referred to our outpatient clinic for further evaluation. In addition to reviewing clinical syndromes and approach to management for common marine envenomations that may be encountered in the post-travel setting, we situate this case within the broader ecological context of expanding invasive species ranges with climate change and rising sea temperatures. Pre-travel providers should counsel patients at high risk for marine envenomations on preventative measures, along with how and when to seek care following exposure. Post-travel providers should be familiar with the immediate and long-term sequelae of non-infectious envenomations and intoxications, including marine exposures. Larger national and multinational collaborations are required to mitigate the effects of climate change and international marine movement on invasive species, especially those that incur risk to marine and human health alike.</description>
	<pubDate>2026-07-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 187: An Unintended Hazard of Environmental Stewardship: Marine Envenomation Following Invasive Lionfish Culling in Curacao</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/187">doi: 10.3390/tropicalmed11070187</a></p>
	<p>Authors:
		Gregory D. Hawley
		Chu Sandy Wang
		Andrea K. Boggild
		</p>
	<p>Marine envenomations are common non-infectious hazards for travelers. Lionfish, venomous fish native to Indo-Pacific waters, have become an invasive species in the Atlantic Ocean and threat to native marine ecosystems. Various control measures have been implemented in response to rapidly expanding lionfish populations, including licensed culling by recreational divers. We herein review lionfish envenomation through framing with a case that occurred during a diving trip to Curacao for the purpose of lionfish spearfishing. Following initial management in Curacao with hot water immersion, wound care, and antibiotic prophylaxis, the patient continued to have persistent swelling, bruising, and pain to the puncture site and was referred to our outpatient clinic for further evaluation. In addition to reviewing clinical syndromes and approach to management for common marine envenomations that may be encountered in the post-travel setting, we situate this case within the broader ecological context of expanding invasive species ranges with climate change and rising sea temperatures. Pre-travel providers should counsel patients at high risk for marine envenomations on preventative measures, along with how and when to seek care following exposure. Post-travel providers should be familiar with the immediate and long-term sequelae of non-infectious envenomations and intoxications, including marine exposures. Larger national and multinational collaborations are required to mitigate the effects of climate change and international marine movement on invasive species, especially those that incur risk to marine and human health alike.</p>
	]]></content:encoded>

	<dc:title>An Unintended Hazard of Environmental Stewardship: Marine Envenomation Following Invasive Lionfish Culling in Curacao</dc:title>
			<dc:creator>Gregory D. Hawley</dc:creator>
			<dc:creator>Chu Sandy Wang</dc:creator>
			<dc:creator>Andrea K. Boggild</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070187</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-07</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-07</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Case Report</prism:section>
	<prism:startingPage>187</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070187</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/187</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/186">

	<title>TropicalMed, Vol. 11, Pages 186: Artificial Intelligence Tools in Pre-Travel Health Consultations: A Scoping Review of Clinical Evidence, Implementation Gaps, and Emerging Opportunities</title>
	<link>https://www.mdpi.com/2414-6366/11/7/186</link>
	<description>Background: Pre-travel health consultations require individualised risk assessment across itinerary, destination, traveller characteristics, vaccine and medication history, comorbidities, pregnancy and immune status, activities, and access to care. Artificial intelligence (AI), particularly large language models (LLMs), may support pre-consultation education, structured history collection, guideline retrieval, multilingual communication and post-consultation reinforcement, but unsafe use may introduce hallucinated, outdated or insufficiently personalised recommendations. Objectives: This scoping review maps the current evidence on AI tools relevant to pre-travel health consultations, characterises implementation gaps, identifies patient-safety risks and proposes a supervised implementation model for travel medicine clinics. Original contribution: Unlike previous reviews of clinical AI, patient-education LLMs or chatbots in chronic illness, this is the first scoping review focused specifically on AI in pre-travel consultations. It uniquely combines a five-tier evidence hierarchy that separates direct travel-medicine AI evidence from indirect clinical-AI safety and equity evidence, and provides a travel-medicine-specific clinical safety risk taxonomy and a supervised implementation framework anchored to authoritative travel-medicine guidance and current AI regulatory regimes. Methods: A scoping review was conducted following PRISMA-ScR reporting, using a Population&amp;amp;ndash;Concept&amp;amp;ndash;Context eligibility framework and a targeted retrieval in May 2026 covering January 2017 to May 2026. Sources were screened and charted by a single reviewer using a structured eligibility checklist. Quality and applicability were appraised conceptually using MMAT, AMSTAR 2 and JBI text-and-opinion criteria, with GRADE-informed certainty. Results: Of 70 records identified, 11 were included: four direct pre-travel AI sources, one adjacent travel-related decision-support study, four guideline and context sources and two clinical LLM safety sources. The only patient-level implementation involved 26 travellers using a GPT-4 Travel Clinic Assistant in Singapore, where physicians and travellers reported acceptability and workflow benefit but objective effectiveness outcomes were not measured. Broader clinical LLM evidence indicates heterogeneous evaluation methods, vulnerability to hallucinated guidelines, and accuracy that varies widely across model versions and specialties. Conclusions: Current evidence supports supervised AI augmentation of pre-travel consultations but does not support autonomous AI-led vaccine selection, malaria prophylaxis, contraindication screening or individualised travel-risk clearance. Near-term deployment should be restricted to clinician-supervised education, structured intake, source-grounded guideline retrieval, after-visit reinforcement and escalation-triggered workflow support. Priority research includes travel-medicine-specific hallucination audits; equity testing in visiting-friends-and-relatives, migrant, older-adult, First Nations Australian, and Pacific Islander travellers; and prospective trials reported under CONSORT-AI, SPIRIT-AI and TRIPOD + AI.</description>
	<pubDate>2026-07-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 186: Artificial Intelligence Tools in Pre-Travel Health Consultations: A Scoping Review of Clinical Evidence, Implementation Gaps, and Emerging Opportunities</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/186">doi: 10.3390/tropicalmed11070186</a></p>
	<p>Authors:
		Haider Saddam Qasim
		Maree Donna Simpson
		</p>
	<p>Background: Pre-travel health consultations require individualised risk assessment across itinerary, destination, traveller characteristics, vaccine and medication history, comorbidities, pregnancy and immune status, activities, and access to care. Artificial intelligence (AI), particularly large language models (LLMs), may support pre-consultation education, structured history collection, guideline retrieval, multilingual communication and post-consultation reinforcement, but unsafe use may introduce hallucinated, outdated or insufficiently personalised recommendations. Objectives: This scoping review maps the current evidence on AI tools relevant to pre-travel health consultations, characterises implementation gaps, identifies patient-safety risks and proposes a supervised implementation model for travel medicine clinics. Original contribution: Unlike previous reviews of clinical AI, patient-education LLMs or chatbots in chronic illness, this is the first scoping review focused specifically on AI in pre-travel consultations. It uniquely combines a five-tier evidence hierarchy that separates direct travel-medicine AI evidence from indirect clinical-AI safety and equity evidence, and provides a travel-medicine-specific clinical safety risk taxonomy and a supervised implementation framework anchored to authoritative travel-medicine guidance and current AI regulatory regimes. Methods: A scoping review was conducted following PRISMA-ScR reporting, using a Population&amp;amp;ndash;Concept&amp;amp;ndash;Context eligibility framework and a targeted retrieval in May 2026 covering January 2017 to May 2026. Sources were screened and charted by a single reviewer using a structured eligibility checklist. Quality and applicability were appraised conceptually using MMAT, AMSTAR 2 and JBI text-and-opinion criteria, with GRADE-informed certainty. Results: Of 70 records identified, 11 were included: four direct pre-travel AI sources, one adjacent travel-related decision-support study, four guideline and context sources and two clinical LLM safety sources. The only patient-level implementation involved 26 travellers using a GPT-4 Travel Clinic Assistant in Singapore, where physicians and travellers reported acceptability and workflow benefit but objective effectiveness outcomes were not measured. Broader clinical LLM evidence indicates heterogeneous evaluation methods, vulnerability to hallucinated guidelines, and accuracy that varies widely across model versions and specialties. Conclusions: Current evidence supports supervised AI augmentation of pre-travel consultations but does not support autonomous AI-led vaccine selection, malaria prophylaxis, contraindication screening or individualised travel-risk clearance. Near-term deployment should be restricted to clinician-supervised education, structured intake, source-grounded guideline retrieval, after-visit reinforcement and escalation-triggered workflow support. Priority research includes travel-medicine-specific hallucination audits; equity testing in visiting-friends-and-relatives, migrant, older-adult, First Nations Australian, and Pacific Islander travellers; and prospective trials reported under CONSORT-AI, SPIRIT-AI and TRIPOD + AI.</p>
	]]></content:encoded>

	<dc:title>Artificial Intelligence Tools in Pre-Travel Health Consultations: A Scoping Review of Clinical Evidence, Implementation Gaps, and Emerging Opportunities</dc:title>
			<dc:creator>Haider Saddam Qasim</dc:creator>
			<dc:creator>Maree Donna Simpson</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070186</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-06</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-06</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>186</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070186</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/186</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/185">

	<title>TropicalMed, Vol. 11, Pages 185: Age-Stratified Heterogeneity of Brucellosis Awareness and Knowledge Among Hospital-Attending Adults in an Endemic Turkish Province: A Single-Center Cross-Sectional KAP Study</title>
	<link>https://www.mdpi.com/2414-6366/11/7/185</link>
	<description>Background: Human brucellosis is a widespread zoonotic febrile illness in livestock-rearing endemic regions, including T&amp;amp;uuml;rkiye (pooled human seroprevalence approximately 4.5%). Age-stratified item-level knowledge profiles paired with information-source patterns are rarely reported in adult populations. We aimed to describe age-stratified brucellosis knowledge and information-source ecosystems in a hospital-attending adult sample from an endemic Turkish province. Methods: A hospital-based cross-sectional survey enrolled 397 adults in Bal&amp;amp;#305;kesir, T&amp;amp;uuml;rkiye. A 17-question instrument assessed demographics, prior awareness, a 26-item composite knowledge score among aware respondents, and information sources. Item-level recognition was compared across four age strata, with multivariable logistic regression identifying independent predictors. Results: Of 397 adults (mean age 36.1 years; 62.7% male), 233 (58.7%) reported prior awareness, increasing with age (51.8% in 18&amp;amp;ndash;29 vs. 74.5% in &amp;amp;ge;60 years; p &amp;amp;lt; 0.001). Among aware respondents, composite knowledge declined with age (mean 8.52 vs. 5.94; p &amp;amp;lt; 0.001). Raw dairy transmission and treatment availability were uniformly recognized (&amp;amp;gt;80% across all strata). Recognition of clinical symptoms (fever 68.9% vs. 34.3%; p = 0.005) and veterinary signs (decreased milk yield 36.9% vs. 8.6%; p = 0.001) was substantially lower in older respondents. Internet citation declined with age (41.7% to 17.1%), while older respondents relied more on interpersonal networks. Conclusions: Brucellosis knowledge was not uniformly distributed across the adult age spectrum. Dominant transmission and treatment messages were near-universally recognized, while clinical-symptom and veterinary-sign recognition showed substantial age-related deficits, accompanied by generational divergence in information-source ecosystems. These findings suggest that age-tailored, channel-specific reinforcement of less-recognized clinical and veterinary knowledge, delivered through trusted healthcare-worker channels, may strengthen brucellosis education in endemic Turkish settings. Community-based replication is required before broader policy translation.</description>
	<pubDate>2026-07-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 185: Age-Stratified Heterogeneity of Brucellosis Awareness and Knowledge Among Hospital-Attending Adults in an Endemic Turkish Province: A Single-Center Cross-Sectional KAP Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/185">doi: 10.3390/tropicalmed11070185</a></p>
	<p>Authors:
		Enes Dalmanoğlu
		İrem Sakarya
		Ali Osman Yıldız
		Muhammed Taha Özügüzel
		Çiğdem Işık
		Ahmet Enes Kaya
		Yasin Uslu
		Vedat Elgün
		Muhammed Enes Geylani
		</p>
	<p>Background: Human brucellosis is a widespread zoonotic febrile illness in livestock-rearing endemic regions, including T&amp;amp;uuml;rkiye (pooled human seroprevalence approximately 4.5%). Age-stratified item-level knowledge profiles paired with information-source patterns are rarely reported in adult populations. We aimed to describe age-stratified brucellosis knowledge and information-source ecosystems in a hospital-attending adult sample from an endemic Turkish province. Methods: A hospital-based cross-sectional survey enrolled 397 adults in Bal&amp;amp;#305;kesir, T&amp;amp;uuml;rkiye. A 17-question instrument assessed demographics, prior awareness, a 26-item composite knowledge score among aware respondents, and information sources. Item-level recognition was compared across four age strata, with multivariable logistic regression identifying independent predictors. Results: Of 397 adults (mean age 36.1 years; 62.7% male), 233 (58.7%) reported prior awareness, increasing with age (51.8% in 18&amp;amp;ndash;29 vs. 74.5% in &amp;amp;ge;60 years; p &amp;amp;lt; 0.001). Among aware respondents, composite knowledge declined with age (mean 8.52 vs. 5.94; p &amp;amp;lt; 0.001). Raw dairy transmission and treatment availability were uniformly recognized (&amp;amp;gt;80% across all strata). Recognition of clinical symptoms (fever 68.9% vs. 34.3%; p = 0.005) and veterinary signs (decreased milk yield 36.9% vs. 8.6%; p = 0.001) was substantially lower in older respondents. Internet citation declined with age (41.7% to 17.1%), while older respondents relied more on interpersonal networks. Conclusions: Brucellosis knowledge was not uniformly distributed across the adult age spectrum. Dominant transmission and treatment messages were near-universally recognized, while clinical-symptom and veterinary-sign recognition showed substantial age-related deficits, accompanied by generational divergence in information-source ecosystems. These findings suggest that age-tailored, channel-specific reinforcement of less-recognized clinical and veterinary knowledge, delivered through trusted healthcare-worker channels, may strengthen brucellosis education in endemic Turkish settings. Community-based replication is required before broader policy translation.</p>
	]]></content:encoded>

	<dc:title>Age-Stratified Heterogeneity of Brucellosis Awareness and Knowledge Among Hospital-Attending Adults in an Endemic Turkish Province: A Single-Center Cross-Sectional KAP Study</dc:title>
			<dc:creator>Enes Dalmanoğlu</dc:creator>
			<dc:creator>İrem Sakarya</dc:creator>
			<dc:creator>Ali Osman Yıldız</dc:creator>
			<dc:creator>Muhammed Taha Özügüzel</dc:creator>
			<dc:creator>Çiğdem Işık</dc:creator>
			<dc:creator>Ahmet Enes Kaya</dc:creator>
			<dc:creator>Yasin Uslu</dc:creator>
			<dc:creator>Vedat Elgün</dc:creator>
			<dc:creator>Muhammed Enes Geylani</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070185</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-06</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-06</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>185</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070185</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/185</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/184">

	<title>TropicalMed, Vol. 11, Pages 184: Ethanolic Leaf Extract of Annona muricata Pauses Plasmodium knowlesi Schizogony and Reduces Binding of Infected Red Blood Cells to Endothelial Cells</title>
	<link>https://www.mdpi.com/2414-6366/11/7/184</link>
	<description>Plasmodium knowlesi infections can progress rapidly to life-threatening complications, such as acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI), which are driven by the ability of the zoonotic parasite to rapidly replicate towards high parasitemia and the cytoadherence properties of the infected erythrocytes (IRBCs). This study evaluated the anti-parasitic and vasoprotective potential of Annona muricata (soursop) leaf ethanol extract against P. knowlesi. In vitro assays using the P. knowlesi A1-H.1 reference strain revealed significant blood stage schizogony inhibition (IC50: 9.65 &amp;amp;micro;g/mL), specifically targeting the trophozoites. The anti-parasitic activity was concentrated in the &amp;amp;lt;30 kDa subfraction of the extract. Washout assays confirmed that the effect was parasitostatic rather than parasiticidal, where the malaria parasites underwent developmental arrest but remained morphologically normal and resumed growth post-removal. Furthermore, priming human endothelial cell lines with the extract significantly reduced IRBC&amp;amp;ndash;endothelial binding. These results demonstrate that A. muricata extract exerts a dual-action effect by arresting P. knowlesi asexual replication and inhibiting IRBC&amp;amp;ndash;endothelial cytoadherence. While clinical translation would require exhaustive standardization and chemotypic profiling due to the natural variability of plant compositions, these findings provide a foundational academic framework for the potential of A. muricata leaf extract in mitigating severe knowlesi malaria complications.</description>
	<pubDate>2026-07-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 184: Ethanolic Leaf Extract of Annona muricata Pauses Plasmodium knowlesi Schizogony and Reduces Binding of Infected Red Blood Cells to Endothelial Cells</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/184">doi: 10.3390/tropicalmed11070184</a></p>
	<p>Authors:
		Yi-Jun Lim
		Gordon Xue-Zhen Chong
		Joo-Yie Chin
		Muhammed-Nur-Iman Mohammed-Syafiei
		Muhammad-Nasreen Suhaimi
		Siti-Nursyazziana Nordin
		Shin-Yee Fung
		Hazel Anne Tabo
		Polrat Wilairatana
		Tadesse Hailu
		Veeranoot Nissapatorn
		Wenn-Chyau Lee
		</p>
	<p>Plasmodium knowlesi infections can progress rapidly to life-threatening complications, such as acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI), which are driven by the ability of the zoonotic parasite to rapidly replicate towards high parasitemia and the cytoadherence properties of the infected erythrocytes (IRBCs). This study evaluated the anti-parasitic and vasoprotective potential of Annona muricata (soursop) leaf ethanol extract against P. knowlesi. In vitro assays using the P. knowlesi A1-H.1 reference strain revealed significant blood stage schizogony inhibition (IC50: 9.65 &amp;amp;micro;g/mL), specifically targeting the trophozoites. The anti-parasitic activity was concentrated in the &amp;amp;lt;30 kDa subfraction of the extract. Washout assays confirmed that the effect was parasitostatic rather than parasiticidal, where the malaria parasites underwent developmental arrest but remained morphologically normal and resumed growth post-removal. Furthermore, priming human endothelial cell lines with the extract significantly reduced IRBC&amp;amp;ndash;endothelial binding. These results demonstrate that A. muricata extract exerts a dual-action effect by arresting P. knowlesi asexual replication and inhibiting IRBC&amp;amp;ndash;endothelial cytoadherence. While clinical translation would require exhaustive standardization and chemotypic profiling due to the natural variability of plant compositions, these findings provide a foundational academic framework for the potential of A. muricata leaf extract in mitigating severe knowlesi malaria complications.</p>
	]]></content:encoded>

	<dc:title>Ethanolic Leaf Extract of Annona muricata Pauses Plasmodium knowlesi Schizogony and Reduces Binding of Infected Red Blood Cells to Endothelial Cells</dc:title>
			<dc:creator>Yi-Jun Lim</dc:creator>
			<dc:creator>Gordon Xue-Zhen Chong</dc:creator>
			<dc:creator>Joo-Yie Chin</dc:creator>
			<dc:creator>Muhammed-Nur-Iman Mohammed-Syafiei</dc:creator>
			<dc:creator>Muhammad-Nasreen Suhaimi</dc:creator>
			<dc:creator>Siti-Nursyazziana Nordin</dc:creator>
			<dc:creator>Shin-Yee Fung</dc:creator>
			<dc:creator>Hazel Anne Tabo</dc:creator>
			<dc:creator>Polrat Wilairatana</dc:creator>
			<dc:creator>Tadesse Hailu</dc:creator>
			<dc:creator>Veeranoot Nissapatorn</dc:creator>
			<dc:creator>Wenn-Chyau Lee</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070184</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-06</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-06</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>184</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070184</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/184</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/183">

	<title>TropicalMed, Vol. 11, Pages 183: A Preliminary Analysis of Sex-Based Differences in Immune Status, ART Adherence, and Opportunistic Infections Among HIV-Positive Patients in Rural Eastern Cape, South Africa</title>
	<link>https://www.mdpi.com/2414-6366/11/7/183</link>
	<description>Background: Opportunistic infections remain a significant cause of morbidity among people living with HIV (PLHIV) in sub-Saharan Africa despite expanded access to antiretroviral therapy (ART). This study evaluated the association between immune status, viral load suppression, ART adherence, and the risk of opportunistic infections among HIV-positive patients receiving ART in the rural Eastern Cape, South Africa. Methods: A retrospective cross-sectional study was conducted using clinical records of HIV-positive patients attending an HIV clinic in Mthatha between January 2021 and December 2024. Demographic characteristics, CD4 counts, viral load results, ART regimens, adherence status, and documented opportunistic infections were extracted. Viral load suppression was defined according to WHO guidelines as &amp;amp;lt;1000 copies/mL. CD4 counts were categorized as &amp;amp;lt;200, 200&amp;amp;ndash;499, and &amp;amp;ge;500 cells/mm3. Multivariable logistic regression analysis was performed to identify independent predictors of opportunistic infections. Results: A total of 155 patients (105 females, 50 males) were included. Females demonstrated significantly higher mean CD4 counts than males (p = 0.037) and better ART adherence (p &amp;amp;lt; 0.001). Tuberculosis, hepatitis B virus, and herpes simplex virus infections were more prevalent among males, whereas candidiasis was significantly more common among females (p = 0.034). In multivariable analysis, CD4 count &amp;amp;lt; 200 cells/mm3, unsuppressed viral load, and poor ART adherence were independently associated with increased odds of opportunistic infections. Conclusions: Immune suppression and suboptimal ART adherence significantly increase the risk of opportunistic infections among HIV-positive patients in rural South Africa. Strengthening adherence interventions and early immune monitoring may reduce infection burden in high-prevalence settings.</description>
	<pubDate>2026-07-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 183: A Preliminary Analysis of Sex-Based Differences in Immune Status, ART Adherence, and Opportunistic Infections Among HIV-Positive Patients in Rural Eastern Cape, South Africa</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/183">doi: 10.3390/tropicalmed11070183</a></p>
	<p>Authors:
		Ikhona Ntshobane
		Dominic Targema Abaver
		</p>
	<p>Background: Opportunistic infections remain a significant cause of morbidity among people living with HIV (PLHIV) in sub-Saharan Africa despite expanded access to antiretroviral therapy (ART). This study evaluated the association between immune status, viral load suppression, ART adherence, and the risk of opportunistic infections among HIV-positive patients receiving ART in the rural Eastern Cape, South Africa. Methods: A retrospective cross-sectional study was conducted using clinical records of HIV-positive patients attending an HIV clinic in Mthatha between January 2021 and December 2024. Demographic characteristics, CD4 counts, viral load results, ART regimens, adherence status, and documented opportunistic infections were extracted. Viral load suppression was defined according to WHO guidelines as &amp;amp;lt;1000 copies/mL. CD4 counts were categorized as &amp;amp;lt;200, 200&amp;amp;ndash;499, and &amp;amp;ge;500 cells/mm3. Multivariable logistic regression analysis was performed to identify independent predictors of opportunistic infections. Results: A total of 155 patients (105 females, 50 males) were included. Females demonstrated significantly higher mean CD4 counts than males (p = 0.037) and better ART adherence (p &amp;amp;lt; 0.001). Tuberculosis, hepatitis B virus, and herpes simplex virus infections were more prevalent among males, whereas candidiasis was significantly more common among females (p = 0.034). In multivariable analysis, CD4 count &amp;amp;lt; 200 cells/mm3, unsuppressed viral load, and poor ART adherence were independently associated with increased odds of opportunistic infections. Conclusions: Immune suppression and suboptimal ART adherence significantly increase the risk of opportunistic infections among HIV-positive patients in rural South Africa. Strengthening adherence interventions and early immune monitoring may reduce infection burden in high-prevalence settings.</p>
	]]></content:encoded>

	<dc:title>A Preliminary Analysis of Sex-Based Differences in Immune Status, ART Adherence, and Opportunistic Infections Among HIV-Positive Patients in Rural Eastern Cape, South Africa</dc:title>
			<dc:creator>Ikhona Ntshobane</dc:creator>
			<dc:creator>Dominic Targema Abaver</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070183</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-07-04</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-07-04</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>183</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070183</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/183</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/182">

	<title>TropicalMed, Vol. 11, Pages 182: Climate Change and Autochthonous Vector-Borne Disease Transmission in Europe: Dengue as a Sentinel Signal for Surveillance and Preparedness</title>
	<link>https://www.mdpi.com/2414-6366/11/7/182</link>
	<description>Climate change is reshaping the epidemiology of vector-borne diseases in Europe by altering the ecological conditions that determine vector survival, seasonal activity and pathogen transmission. Rising temperatures, milder winters, prolonged warm seasons and changing precipitation patterns are increasing the suitability of parts of Europe for competent mosquito, tick and sandfly vectors. These changes, combined with human mobility and land-use change, increase the probability that imported pathogens encounter permissive conditions for local transmission. This Opinion article examines autochthonous vector-borne disease transmission in Europe, using dengue as a sentinel example of a wider climate-sensitive transition. We discuss how imported viraemic cases, established competent vectors, vector&amp;amp;ndash;host contact and delayed clinical recognition can converge to enable local outbreaks. Beyond dengue, we consider West Nile virus, chikungunya, tick-borne encephalitis, leishmaniasis and Crimean&amp;amp;ndash;Congo haemorrhagic fever as examples of a broader and increasingly heterogeneous European risk landscape. We argue that the public-health impact of this transition is shaped not only by vector expansion, but also by gaps in surveillance integration, diagnostic readiness, workforce preparedness and One Health coordination. Strengthening climate-informed surveillance, rapid laboratory capacity, frontline clinical awareness and cross-sectoral response systems will be essential to prevent repeated introductions from becoming sustained public-health challenges.</description>
	<pubDate>2026-06-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 182: Climate Change and Autochthonous Vector-Borne Disease Transmission in Europe: Dengue as a Sentinel Signal for Surveillance and Preparedness</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/182">doi: 10.3390/tropicalmed11070182</a></p>
	<p>Authors:
		Maciej Grzybek
		Anna Bogacka
		</p>
	<p>Climate change is reshaping the epidemiology of vector-borne diseases in Europe by altering the ecological conditions that determine vector survival, seasonal activity and pathogen transmission. Rising temperatures, milder winters, prolonged warm seasons and changing precipitation patterns are increasing the suitability of parts of Europe for competent mosquito, tick and sandfly vectors. These changes, combined with human mobility and land-use change, increase the probability that imported pathogens encounter permissive conditions for local transmission. This Opinion article examines autochthonous vector-borne disease transmission in Europe, using dengue as a sentinel example of a wider climate-sensitive transition. We discuss how imported viraemic cases, established competent vectors, vector&amp;amp;ndash;host contact and delayed clinical recognition can converge to enable local outbreaks. Beyond dengue, we consider West Nile virus, chikungunya, tick-borne encephalitis, leishmaniasis and Crimean&amp;amp;ndash;Congo haemorrhagic fever as examples of a broader and increasingly heterogeneous European risk landscape. We argue that the public-health impact of this transition is shaped not only by vector expansion, but also by gaps in surveillance integration, diagnostic readiness, workforce preparedness and One Health coordination. Strengthening climate-informed surveillance, rapid laboratory capacity, frontline clinical awareness and cross-sectoral response systems will be essential to prevent repeated introductions from becoming sustained public-health challenges.</p>
	]]></content:encoded>

	<dc:title>Climate Change and Autochthonous Vector-Borne Disease Transmission in Europe: Dengue as a Sentinel Signal for Surveillance and Preparedness</dc:title>
			<dc:creator>Maciej Grzybek</dc:creator>
			<dc:creator>Anna Bogacka</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070182</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-29</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-29</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Opinion</prism:section>
	<prism:startingPage>182</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070182</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/182</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/181">

	<title>TropicalMed, Vol. 11, Pages 181: Leveraging Public Health Informatics Through the Data&amp;ndash;Information&amp;ndash;Knowledge&amp;ndash;Wisdom (DIKW) Framework in Community-Based Surveillance of Bangladesh</title>
	<link>https://www.mdpi.com/2414-6366/11/7/181</link>
	<description>Early detection of infectious disease outbreaks is critical in densely populated, resource-limited settings. This study aimed to describe the community-based surveillance (CBS) system and its application of the Data&amp;amp;ndash;Information&amp;amp;ndash;Knowledge&amp;amp;ndash;Wisdom (DIKW) framework in Bangladesh. CBS was implemented in 12 urban wards across Dhaka South, Rajshahi, and Sylhet, where trained community volunteers conducted routine household visits to identify five priority syndromes. Data were collected through a mobile application integrated with an automated pipeline for cleaning, geocoding, cluster detection, and alert generation. Between January and June 2025, 38,489 households were visited, enrolling 128,626 individuals. The system generated 10,191 alerts and 577 clusters, predominantly for suspected dengue (58.7%), followed by acute watery diarrhea (24.1%) and influenza-like illness (10.7%). Rajshahi contributed the majority of alerts and clusters. Spatiotemporal analysis identified ward-level outbreak signals, including localized dengue peaks across all three cities. Over 98% of records were synchronized within 24 h, and more than 99% of data entry errors were automatically corrected, ensuring timely and high-quality analytics. These findings demonstrate that digital CBS can effectively transform community-level data into actionable public health intelligence, supporting early outbreak detection and response. This translation enabled timely public health actions, including targeted outbreak investigations and localized vector control measures in identified hotspots. Integration with national surveillance platforms may further strengthen health system responsiveness and epidemic preparedness.</description>
	<pubDate>2026-06-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 181: Leveraging Public Health Informatics Through the Data&amp;ndash;Information&amp;ndash;Knowledge&amp;ndash;Wisdom (DIKW) Framework in Community-Based Surveillance of Bangladesh</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/181">doi: 10.3390/tropicalmed11070181</a></p>
	<p>Authors:
		Immamul Muntasir
		Md. Omar Qayum
		Arifa Hasnat Ali
		Fahim Mohammad Sadique Srijon
		Mohammad Rashedul Hassan
		Mahbubur Rahman
		Tahmina Shirin
		</p>
	<p>Early detection of infectious disease outbreaks is critical in densely populated, resource-limited settings. This study aimed to describe the community-based surveillance (CBS) system and its application of the Data&amp;amp;ndash;Information&amp;amp;ndash;Knowledge&amp;amp;ndash;Wisdom (DIKW) framework in Bangladesh. CBS was implemented in 12 urban wards across Dhaka South, Rajshahi, and Sylhet, where trained community volunteers conducted routine household visits to identify five priority syndromes. Data were collected through a mobile application integrated with an automated pipeline for cleaning, geocoding, cluster detection, and alert generation. Between January and June 2025, 38,489 households were visited, enrolling 128,626 individuals. The system generated 10,191 alerts and 577 clusters, predominantly for suspected dengue (58.7%), followed by acute watery diarrhea (24.1%) and influenza-like illness (10.7%). Rajshahi contributed the majority of alerts and clusters. Spatiotemporal analysis identified ward-level outbreak signals, including localized dengue peaks across all three cities. Over 98% of records were synchronized within 24 h, and more than 99% of data entry errors were automatically corrected, ensuring timely and high-quality analytics. These findings demonstrate that digital CBS can effectively transform community-level data into actionable public health intelligence, supporting early outbreak detection and response. This translation enabled timely public health actions, including targeted outbreak investigations and localized vector control measures in identified hotspots. Integration with national surveillance platforms may further strengthen health system responsiveness and epidemic preparedness.</p>
	]]></content:encoded>

	<dc:title>Leveraging Public Health Informatics Through the Data&amp;amp;ndash;Information&amp;amp;ndash;Knowledge&amp;amp;ndash;Wisdom (DIKW) Framework in Community-Based Surveillance of Bangladesh</dc:title>
			<dc:creator>Immamul Muntasir</dc:creator>
			<dc:creator>Md. Omar Qayum</dc:creator>
			<dc:creator>Arifa Hasnat Ali</dc:creator>
			<dc:creator>Fahim Mohammad Sadique Srijon</dc:creator>
			<dc:creator>Mohammad Rashedul Hassan</dc:creator>
			<dc:creator>Mahbubur Rahman</dc:creator>
			<dc:creator>Tahmina Shirin</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070181</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-29</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-29</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>181</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070181</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/181</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/180">

	<title>TropicalMed, Vol. 11, Pages 180: Cystic Echinococcosis in Agro-Pastoral Regions: A 10-Year Retrospective Study (2015&amp;ndash;2024) and the Case for a One Health Approach</title>
	<link>https://www.mdpi.com/2414-6366/11/7/180</link>
	<description>Cystic echinococcosis (CE), a neglected zoonotic disease caused by Echinococcus granulosus sensu lato, poses a persistent public health burden in agro-pastoral regions worldwide. This study provides a large-scale epidemiological assessment of CE, highlighting sustained zoonotic transmission driven by agro-pastoral practices and human&amp;amp;ndash;animal interactions, and supporting the urgent implementation of One Health strategies. This ten-year retrospective study (2015&amp;amp;ndash;2024) analyzed 326 surgically confirmed cases from five hospitals in Djelfa. The cumulative surgical incidence was 2.04 cases per 100,000 person-years, classifying the region as hypoendemic. Females predominated (61.96%), and individuals aged 31&amp;amp;ndash;60 years represented 47.24% of cases. Rural residence (73.62%) and dog contact (94.17%) were major risk factors, with hepatic localization dominating (88.96%). Correlation analysis showed moderate associations between rural habitat and dog contact (V = 0.46, p &amp;amp;lt; 0.001) and between sex and habitat (V = 0.34, p &amp;amp;lt; 0.001), as well as weaker but significant associations for age and cyst location (V = 0.28, p &amp;amp;lt; 0.001) and dog contact and cyst location (V = 0.20, p &amp;amp;lt; 0.05). No postoperative mortality was recorded. These findings confirm active transmission linked to agro-pastoral practices and emphasize the need for coordinated One Health control strategies.</description>
	<pubDate>2026-06-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 180: Cystic Echinococcosis in Agro-Pastoral Regions: A 10-Year Retrospective Study (2015&amp;ndash;2024) and the Case for a One Health Approach</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/180">doi: 10.3390/tropicalmed11070180</a></p>
	<p>Authors:
		Messaoud Bouragba
		Samir Abdellaoui
		Sarah Saci
		Nasir A. Ibrahim
		Mohammed Saad Aleissa
		Nosiba S. Basher
		Nesrine Goumich
		Sundes Rabia Khelifa
		Meriem Aissou
		Abir Belakehal
		Hadjer Djaafer
		AbdElkarim Laatamna
		</p>
	<p>Cystic echinococcosis (CE), a neglected zoonotic disease caused by Echinococcus granulosus sensu lato, poses a persistent public health burden in agro-pastoral regions worldwide. This study provides a large-scale epidemiological assessment of CE, highlighting sustained zoonotic transmission driven by agro-pastoral practices and human&amp;amp;ndash;animal interactions, and supporting the urgent implementation of One Health strategies. This ten-year retrospective study (2015&amp;amp;ndash;2024) analyzed 326 surgically confirmed cases from five hospitals in Djelfa. The cumulative surgical incidence was 2.04 cases per 100,000 person-years, classifying the region as hypoendemic. Females predominated (61.96%), and individuals aged 31&amp;amp;ndash;60 years represented 47.24% of cases. Rural residence (73.62%) and dog contact (94.17%) were major risk factors, with hepatic localization dominating (88.96%). Correlation analysis showed moderate associations between rural habitat and dog contact (V = 0.46, p &amp;amp;lt; 0.001) and between sex and habitat (V = 0.34, p &amp;amp;lt; 0.001), as well as weaker but significant associations for age and cyst location (V = 0.28, p &amp;amp;lt; 0.001) and dog contact and cyst location (V = 0.20, p &amp;amp;lt; 0.05). No postoperative mortality was recorded. These findings confirm active transmission linked to agro-pastoral practices and emphasize the need for coordinated One Health control strategies.</p>
	]]></content:encoded>

	<dc:title>Cystic Echinococcosis in Agro-Pastoral Regions: A 10-Year Retrospective Study (2015&amp;amp;ndash;2024) and the Case for a One Health Approach</dc:title>
			<dc:creator>Messaoud Bouragba</dc:creator>
			<dc:creator>Samir Abdellaoui</dc:creator>
			<dc:creator>Sarah Saci</dc:creator>
			<dc:creator>Nasir A. Ibrahim</dc:creator>
			<dc:creator>Mohammed Saad Aleissa</dc:creator>
			<dc:creator>Nosiba S. Basher</dc:creator>
			<dc:creator>Nesrine Goumich</dc:creator>
			<dc:creator>Sundes Rabia Khelifa</dc:creator>
			<dc:creator>Meriem Aissou</dc:creator>
			<dc:creator>Abir Belakehal</dc:creator>
			<dc:creator>Hadjer Djaafer</dc:creator>
			<dc:creator>AbdElkarim Laatamna</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070180</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-28</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-28</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>180</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070180</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/180</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/179">

	<title>TropicalMed, Vol. 11, Pages 179: Prevalence and Species Diversity of Spotted Fever Group Rickettsiae in Ixodid Ticks Collected in Northwest Russia</title>
	<link>https://www.mdpi.com/2414-6366/11/7/179</link>
	<description>Rickettsia spp. are ubiquitous in nature and capable of causing diseases of varying severity. The most extensive group comprises the spotted fever group (SFG) Rickettsiae, the members of which are predominantly transmitted by ticks. The expansion of tick habitats observed in recent decades poses an increasing threat of dissemination of tick-borne infections into regions previously considered non-endemic. The aim of this study was to determine the prevalence of SFG Rickettsiae in ixodid ticks collected in Northwest Russia and to characterize the species diversity of these pathogens within the study area. Questing adult ixodid ticks (n = 4566) were collected from eight regions of Northwest Russia (Arkhangelsk, Kaliningrad, Leningrad, Novgorod, Pskov and Vologda Regions, as well as the Republic of Karelia and St. Petersburg) in 2023 to 2025 (from April to September). The species composition included Ixodes ricinus (n = 1683), Ixodes persulcatus (n = 2404), and Dermacentor reticulatus (n = 479). Genomic DNA was extracted from individual ticks and screened for SFG Rickettsiae using real-time PCR, followed by conventional PCR targeting the gltA, ompA, ompB, and sca4 (gene D) genes. Nucleotide sequences obtained for a subset of positive samples for the various genes were analyzed. The overall prevalence of SFG Rickettsiae was 12.6% (95% CI: 11.7&amp;amp;ndash;13.6). Circulation of the following species was detected: Rickettsia helvetica, Rickettsia conorii subsp. raoultii, Candidatus Rickettsia tarasevichiae, Rickettsia monacensis, and Rickettsia felis. The findings indicate considerable species diversity of SFG Rickettsiae in natural foci of Northwest Russia. Rickettsia monacensis was detected in ixodid ticks within the study area for the first time, and R. felis was identified in Russia for the first time.</description>
	<pubDate>2026-06-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 179: Prevalence and Species Diversity of Spotted Fever Group Rickettsiae in Ixodid Ticks Collected in Northwest Russia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/179">doi: 10.3390/tropicalmed11070179</a></p>
	<p>Authors:
		Islam Karmokov
		Olga Freylikhman
		Regina Baimova
		Daria Grechishkina
		Gelena Lunina
		Ivan Lyzenko
		Ekaterina Riabiko
		Tatiana Arbuzova
		Anastasiia Bachevskaia
		Edward Ramsay
		Erik Khalilov
		Karina Kukleva
		Lyubov Bespyatova
		Sergey Bugmyrin
		Maxim Petrov
		Olga Neverova
		Ksenia Titarchuk
		Vera Agasoi
		Nikolai Kalinin
		Olga Vorobyeva
		Olga Mikheenko
		Tatiana Iakimenko
		Inna Druzhinina
		Olga Matina
		Daria Monastyrskaya-Nuzhina
		Anna Smirnova
		Nikolay Tokarevich
		</p>
	<p>Rickettsia spp. are ubiquitous in nature and capable of causing diseases of varying severity. The most extensive group comprises the spotted fever group (SFG) Rickettsiae, the members of which are predominantly transmitted by ticks. The expansion of tick habitats observed in recent decades poses an increasing threat of dissemination of tick-borne infections into regions previously considered non-endemic. The aim of this study was to determine the prevalence of SFG Rickettsiae in ixodid ticks collected in Northwest Russia and to characterize the species diversity of these pathogens within the study area. Questing adult ixodid ticks (n = 4566) were collected from eight regions of Northwest Russia (Arkhangelsk, Kaliningrad, Leningrad, Novgorod, Pskov and Vologda Regions, as well as the Republic of Karelia and St. Petersburg) in 2023 to 2025 (from April to September). The species composition included Ixodes ricinus (n = 1683), Ixodes persulcatus (n = 2404), and Dermacentor reticulatus (n = 479). Genomic DNA was extracted from individual ticks and screened for SFG Rickettsiae using real-time PCR, followed by conventional PCR targeting the gltA, ompA, ompB, and sca4 (gene D) genes. Nucleotide sequences obtained for a subset of positive samples for the various genes were analyzed. The overall prevalence of SFG Rickettsiae was 12.6% (95% CI: 11.7&amp;amp;ndash;13.6). Circulation of the following species was detected: Rickettsia helvetica, Rickettsia conorii subsp. raoultii, Candidatus Rickettsia tarasevichiae, Rickettsia monacensis, and Rickettsia felis. The findings indicate considerable species diversity of SFG Rickettsiae in natural foci of Northwest Russia. Rickettsia monacensis was detected in ixodid ticks within the study area for the first time, and R. felis was identified in Russia for the first time.</p>
	]]></content:encoded>

	<dc:title>Prevalence and Species Diversity of Spotted Fever Group Rickettsiae in Ixodid Ticks Collected in Northwest Russia</dc:title>
			<dc:creator>Islam Karmokov</dc:creator>
			<dc:creator>Olga Freylikhman</dc:creator>
			<dc:creator>Regina Baimova</dc:creator>
			<dc:creator>Daria Grechishkina</dc:creator>
			<dc:creator>Gelena Lunina</dc:creator>
			<dc:creator>Ivan Lyzenko</dc:creator>
			<dc:creator>Ekaterina Riabiko</dc:creator>
			<dc:creator>Tatiana Arbuzova</dc:creator>
			<dc:creator>Anastasiia Bachevskaia</dc:creator>
			<dc:creator>Edward Ramsay</dc:creator>
			<dc:creator>Erik Khalilov</dc:creator>
			<dc:creator>Karina Kukleva</dc:creator>
			<dc:creator>Lyubov Bespyatova</dc:creator>
			<dc:creator>Sergey Bugmyrin</dc:creator>
			<dc:creator>Maxim Petrov</dc:creator>
			<dc:creator>Olga Neverova</dc:creator>
			<dc:creator>Ksenia Titarchuk</dc:creator>
			<dc:creator>Vera Agasoi</dc:creator>
			<dc:creator>Nikolai Kalinin</dc:creator>
			<dc:creator>Olga Vorobyeva</dc:creator>
			<dc:creator>Olga Mikheenko</dc:creator>
			<dc:creator>Tatiana Iakimenko</dc:creator>
			<dc:creator>Inna Druzhinina</dc:creator>
			<dc:creator>Olga Matina</dc:creator>
			<dc:creator>Daria Monastyrskaya-Nuzhina</dc:creator>
			<dc:creator>Anna Smirnova</dc:creator>
			<dc:creator>Nikolay Tokarevich</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070179</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-27</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-27</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>179</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070179</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/179</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/177">

	<title>TropicalMed, Vol. 11, Pages 177: A Retrospective Assessment of HIV Prevalence in the Central Black Sea Region of T&amp;uuml;rkiye</title>
	<link>https://www.mdpi.com/2414-6366/11/7/177</link>
	<description>Background: HIV has been a major global health issue since the 1980s. The proportions of diagnosed and undiagnosed infections are important indicators of HIV control. This study investigated the prevalence and characteristics of HIV based on blood samples from patients presenting for diagnosis and treatment at a tertiary healthcare hospital in the Central Black Sea Region over a four-year retrospective period. Methods: We retrospectively evaluated 271,367 samples submitted for anti-HIV serology testing for pre-operative screening or clinical suspicion between 2020 and 2023. HIV-1/2 antibodies and p24 antigen were screened using chemiluminescence microparticle immunoassay (CMIA), and reactive samples were confirmed by real-time RT-PCR. HIV RNA results and immunological parameters were also analyzed. Results: Among 271,367 samples, 694 were HIV-positive, yielding a prevalence of 0.25%. Of 2207 individuals tested for HIV RNA, 699 (31.7%) were positive. HIV RNA positivity was higher in men than women (35.5% vs. 18.6%). Absolute CD4+ T-cell counts were similar between genders, while the CD4/CD8 ratio was significantly higher in women. Both CD4+ T-cell counts and CD4/CD8 ratios increased significantly after three months of treatment. Conclusions: This study demonstrates a low but increasing HIV seroprevalence in the region, with a clear predominance among males and young adults. The findings also reflect effective viral suppression among treated patients and significant immunological recovery after therapy, providing important regional data to guide HIV monitoring and public health interventions.</description>
	<pubDate>2026-06-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 177: A Retrospective Assessment of HIV Prevalence in the Central Black Sea Region of T&amp;uuml;rkiye</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/177">doi: 10.3390/tropicalmed11070177</a></p>
	<p>Authors:
		Mehmet Hakan Taskin
		Sule Ozturk
		Esra Tas
		Reyhan Caliskan
		Ergin Kariptas
		Ecem Dilara Aygun
		Seda Gozel
		Zafer Yazici
		Ahmed Eisa Elhag
		</p>
	<p>Background: HIV has been a major global health issue since the 1980s. The proportions of diagnosed and undiagnosed infections are important indicators of HIV control. This study investigated the prevalence and characteristics of HIV based on blood samples from patients presenting for diagnosis and treatment at a tertiary healthcare hospital in the Central Black Sea Region over a four-year retrospective period. Methods: We retrospectively evaluated 271,367 samples submitted for anti-HIV serology testing for pre-operative screening or clinical suspicion between 2020 and 2023. HIV-1/2 antibodies and p24 antigen were screened using chemiluminescence microparticle immunoassay (CMIA), and reactive samples were confirmed by real-time RT-PCR. HIV RNA results and immunological parameters were also analyzed. Results: Among 271,367 samples, 694 were HIV-positive, yielding a prevalence of 0.25%. Of 2207 individuals tested for HIV RNA, 699 (31.7%) were positive. HIV RNA positivity was higher in men than women (35.5% vs. 18.6%). Absolute CD4+ T-cell counts were similar between genders, while the CD4/CD8 ratio was significantly higher in women. Both CD4+ T-cell counts and CD4/CD8 ratios increased significantly after three months of treatment. Conclusions: This study demonstrates a low but increasing HIV seroprevalence in the region, with a clear predominance among males and young adults. The findings also reflect effective viral suppression among treated patients and significant immunological recovery after therapy, providing important regional data to guide HIV monitoring and public health interventions.</p>
	]]></content:encoded>

	<dc:title>A Retrospective Assessment of HIV Prevalence in the Central Black Sea Region of T&amp;amp;uuml;rkiye</dc:title>
			<dc:creator>Mehmet Hakan Taskin</dc:creator>
			<dc:creator>Sule Ozturk</dc:creator>
			<dc:creator>Esra Tas</dc:creator>
			<dc:creator>Reyhan Caliskan</dc:creator>
			<dc:creator>Ergin Kariptas</dc:creator>
			<dc:creator>Ecem Dilara Aygun</dc:creator>
			<dc:creator>Seda Gozel</dc:creator>
			<dc:creator>Zafer Yazici</dc:creator>
			<dc:creator>Ahmed Eisa Elhag</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070177</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-27</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-27</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>177</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070177</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/177</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/178">

	<title>TropicalMed, Vol. 11, Pages 178: Neutralizing Antibody Response Dynamics in COVID-19: Insights from Healthy Vaccinees, Breakthrough Infections, and Critically Ill Patients</title>
	<link>https://www.mdpi.com/2414-6366/11/7/178</link>
	<description>Neutralizing antibodies (NABs) play a critical role in assessing the immune response elicited by vaccines, providing insight into their protective efficacy. Despite their importance, there is a notable gap in research directly comparing NAB levels among individuals vaccinated with different vaccines, across diverse ethnicities, and between genders. The study aimed to compare NAB levels across variables such as vaccination status, vaccine type, age, gender, and ethnicity. The NAB levels among different study groups were measured using the Finecare RBD Antibody Test and the cPass kit (ELISA). The data was analyzed statistically using SPSS version 27. A total of 172 study subjects were analyzed. The mean age of participants was 45.03 &amp;amp;plusmn; 16.72 years, with 50.9% male and 77.3% of Malay ethnicity. Median NAB levels, assessed by both assays, were highest in females, vaccinated healthy participants, and those who received the Pfizer vaccine. Age-group comparisons revealed variations in median NAB levels across studied groups. Participants aged 10&amp;amp;ndash;25 years in the vaccinated healthy (VH) group exhibited the highest median antibody levels; on the other hand, the 26&amp;amp;ndash;45 year age group showed the highest median levels in the breakthrough infection (BI) and certain non-vaccinated categories. Ethnic group comparisons highlighted that Malays consistently had the highest median NAB levels. Significant differences in antibody levels were found across vaccination status, ethnicity, and vaccine type (p &amp;amp;lt; 0.001). This study underscores the influence of vaccination status, demographic factors, and vaccine type on NAB levels. The Finecare RBD Antibody Test and cPass kit demonstrated comparable trends, highlighting their utility in evaluating vaccine-induced immunity. The findings of this study highlight the need for tailored immunization strategies to optimize protective immunity.</description>
	<pubDate>2026-06-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 178: Neutralizing Antibody Response Dynamics in COVID-19: Insights from Healthy Vaccinees, Breakthrough Infections, and Critically Ill Patients</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/178">doi: 10.3390/tropicalmed11070178</a></p>
	<p>Authors:
		Naveed Ahmed
		Wardah Yusof
		Nurfadhlina Musa
		Kueh Yee Cheng
		Nurzulaikha Abdullah
		Rosline Hassan
		Muhammad Nashrul Farhan Samsudin
		Alwi Muhd Besari Hashim
		Manickam Ravichandran
		Chua Wei Chuan
		Chan Yean Yean
		</p>
	<p>Neutralizing antibodies (NABs) play a critical role in assessing the immune response elicited by vaccines, providing insight into their protective efficacy. Despite their importance, there is a notable gap in research directly comparing NAB levels among individuals vaccinated with different vaccines, across diverse ethnicities, and between genders. The study aimed to compare NAB levels across variables such as vaccination status, vaccine type, age, gender, and ethnicity. The NAB levels among different study groups were measured using the Finecare RBD Antibody Test and the cPass kit (ELISA). The data was analyzed statistically using SPSS version 27. A total of 172 study subjects were analyzed. The mean age of participants was 45.03 &amp;amp;plusmn; 16.72 years, with 50.9% male and 77.3% of Malay ethnicity. Median NAB levels, assessed by both assays, were highest in females, vaccinated healthy participants, and those who received the Pfizer vaccine. Age-group comparisons revealed variations in median NAB levels across studied groups. Participants aged 10&amp;amp;ndash;25 years in the vaccinated healthy (VH) group exhibited the highest median antibody levels; on the other hand, the 26&amp;amp;ndash;45 year age group showed the highest median levels in the breakthrough infection (BI) and certain non-vaccinated categories. Ethnic group comparisons highlighted that Malays consistently had the highest median NAB levels. Significant differences in antibody levels were found across vaccination status, ethnicity, and vaccine type (p &amp;amp;lt; 0.001). This study underscores the influence of vaccination status, demographic factors, and vaccine type on NAB levels. The Finecare RBD Antibody Test and cPass kit demonstrated comparable trends, highlighting their utility in evaluating vaccine-induced immunity. The findings of this study highlight the need for tailored immunization strategies to optimize protective immunity.</p>
	]]></content:encoded>

	<dc:title>Neutralizing Antibody Response Dynamics in COVID-19: Insights from Healthy Vaccinees, Breakthrough Infections, and Critically Ill Patients</dc:title>
			<dc:creator>Naveed Ahmed</dc:creator>
			<dc:creator>Wardah Yusof</dc:creator>
			<dc:creator>Nurfadhlina Musa</dc:creator>
			<dc:creator>Kueh Yee Cheng</dc:creator>
			<dc:creator>Nurzulaikha Abdullah</dc:creator>
			<dc:creator>Rosline Hassan</dc:creator>
			<dc:creator>Muhammad Nashrul Farhan Samsudin</dc:creator>
			<dc:creator>Alwi Muhd Besari Hashim</dc:creator>
			<dc:creator>Manickam Ravichandran</dc:creator>
			<dc:creator>Chua Wei Chuan</dc:creator>
			<dc:creator>Chan Yean Yean</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070178</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-27</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-27</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>178</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070178</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/178</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/176">

	<title>TropicalMed, Vol. 11, Pages 176: Cutaneous Leishmaniasis in Tigray, North Ethiopia: Community Awareness, Perceptions, Treatment-Seeking, and Prevention Practices in Disease Endemic Areas</title>
	<link>https://www.mdpi.com/2414-6366/11/7/176</link>
	<description>Cutaneous leishmaniasis (CL) is highly prevalent in northern Ethiopia but data on community knowledge, attitudes, and health-seeking behaviours remain limited. A cross-sectional survey was conducted between November and December 2022 in CL-endemic areas of Tigray using mixed sampling and a structured questionnaire administered to 512 households. Knowledge of CL transmission was poor: only 1% correctly identified sand flies as the vector, while 25% believed the disease was genetically acquired. Approximately 67% of participants perceived CL as stigmatizing, and 63.3% reported a preference for traditional or local treatments over biomedical care. Knowledge levels were higher among rural residents and in households with prior CL experience. Gender and education were significantly associated with treatment-seeking and prevention practices, and participants from households with previous CL episodes reported better practices overall. Despite this, most participants demonstrated limited knowledge, unfavourable attitudes and suboptimal treatment-seeking and prevention behaviours. These findings highlight a disconnect between high disease burden, perceived seriousness and stigma, and limited understanding of transmission and prevention. Targeted, community-based health education interventions are needed to improve awareness of transmission, reduce stigma, and enhance access to effective treatment in CL-endemic settings.</description>
	<pubDate>2026-06-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 176: Cutaneous Leishmaniasis in Tigray, North Ethiopia: Community Awareness, Perceptions, Treatment-Seeking, and Prevention Practices in Disease Endemic Areas</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/176">doi: 10.3390/tropicalmed11070176</a></p>
	<p>Authors:
		Shewaye Belay Tessema
		Afework Mulugeta Bezabih
		Helen P. Price
		</p>
	<p>Cutaneous leishmaniasis (CL) is highly prevalent in northern Ethiopia but data on community knowledge, attitudes, and health-seeking behaviours remain limited. A cross-sectional survey was conducted between November and December 2022 in CL-endemic areas of Tigray using mixed sampling and a structured questionnaire administered to 512 households. Knowledge of CL transmission was poor: only 1% correctly identified sand flies as the vector, while 25% believed the disease was genetically acquired. Approximately 67% of participants perceived CL as stigmatizing, and 63.3% reported a preference for traditional or local treatments over biomedical care. Knowledge levels were higher among rural residents and in households with prior CL experience. Gender and education were significantly associated with treatment-seeking and prevention practices, and participants from households with previous CL episodes reported better practices overall. Despite this, most participants demonstrated limited knowledge, unfavourable attitudes and suboptimal treatment-seeking and prevention behaviours. These findings highlight a disconnect between high disease burden, perceived seriousness and stigma, and limited understanding of transmission and prevention. Targeted, community-based health education interventions are needed to improve awareness of transmission, reduce stigma, and enhance access to effective treatment in CL-endemic settings.</p>
	]]></content:encoded>

	<dc:title>Cutaneous Leishmaniasis in Tigray, North Ethiopia: Community Awareness, Perceptions, Treatment-Seeking, and Prevention Practices in Disease Endemic Areas</dc:title>
			<dc:creator>Shewaye Belay Tessema</dc:creator>
			<dc:creator>Afework Mulugeta Bezabih</dc:creator>
			<dc:creator>Helen P. Price</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070176</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-27</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-27</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>176</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070176</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/176</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/175">

	<title>TropicalMed, Vol. 11, Pages 175: Magnitude and Factors Associated with HIV Viral Suppression Among Adult People Living with HIV-HBV Co-Infection in Northwest Ethiopia</title>
	<link>https://www.mdpi.com/2414-6366/11/7/175</link>
	<description>Background:&amp;amp;nbsp;HIV-HBV co-infection remains a major public health challenge, particularly in sub-Saharan Africa. HBV co-infection worsens clinical outcomes among people living with HIV by accelerating liver disease and complicating treatment. Although antiretroviral therapy can effectively suppress both viruses, achieving optimal HIV viral suppression remains critical for reducing morbidity and transmission. While several factors influencing viral suppression among PLHIV are well documented, evidence on HIV viral suppression among HIV-HBV co-infected individuals is limited, especially in resource-limited settings like Ethiopia. Furthermore, data on the magnitude of viral suppression and its associated factors in this population are scarce. Therefore, this study aimed to assess the magnitude of HIV viral suppression and identify its associated factors among adult HIV-HBV co-infected patients in Northwest Ethiopia. Objective: This study aimed to assess the magnitude and factors associated with HIV viral suppression among adult people living with HIV-HBV Co-infection in Northwest Ethiopia. Methods: An institution-based cross-sectional study was conducted in Northwest Ethiopia among adults with HIV-HBV co-infection on antiretroviral therapy. A simple random sample of 402 participants was selected. Data were collected using a pretested structured interviewer-administered questionnaire and medical record review, covering sociodemographic, clinical, behavioral, treatment, follow-up, and adherence factors. HIV viral suppression was defined as a plasma viral load &amp;amp;lt; 1000 copies/mL. Data were coded in EpiData 4.6 and analyzed using STATA 18. Descriptive statistics estimated suppression rates. Bivariable and multivariable logistic regression identified factors associated with suppression; variables with p &amp;amp;lt; 0.25 in bivariable analysis were included in the multivariable model. Statistical significance was set at p &amp;amp;lt; 0.05 with adjusted odds ratios and 95% confidence intervals reported. Model fit was assessed using the Hosmer&amp;amp;ndash;Lemeshow test, and multicollinearity was checked using variance inflation factors. Results: There were 423 participants in all. Among the 423 HIV-HBV co-infected adults on antiretroviral therapy included in this study, 138 (34, CI, 30&amp;amp;ndash;39%) achieved HIV viral suppression, while 264 (66%) had an unsuppressed viral load at the time of assessment. Viral suppression was found to be independently correlated with the ART TDF-3TC-LPV/r regimen, first-line medication adherence, bedridden functional level, missed clinic appointments, and length of therapy. While TDF-3TC-LPV/r usage (AOR 2.34; 95% CI: 1.40&amp;amp;ndash;3.90) and longer treatment duration (AOR 2.09; 95% CI: 1.30&amp;amp;ndash;3.34) were advantageous, good adherence significantly improved the likelihood of suppression (AOR 5.54; 95% CI: 3.27&amp;amp;ndash;9.38). Missed appointments and a bedridden state decreased the likelihood of suppression. Conclusions: HIV viral suppression was achieved in only 34% of participants. Adherence, ART regimen, treatment duration, functional status, and retention in care were significant predictors. Strengthening adherence support, patient retention, optimized ART regimens, routine viral load monitoring, and targeted care for high-risk patients could improve treatment outcomes and help Ethiopia achieve UNAIDS viral suppression targets.</description>
	<pubDate>2026-06-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 175: Magnitude and Factors Associated with HIV Viral Suppression Among Adult People Living with HIV-HBV Co-Infection in Northwest Ethiopia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/175">doi: 10.3390/tropicalmed11070175</a></p>
	<p>Authors:
		Mequanente Dagnaw
		Destaw Fetene Teshome
		Tilahun Bizuayehu Demass
		Abebaw Gebyehu Worku
		</p>
	<p>Background:&amp;amp;nbsp;HIV-HBV co-infection remains a major public health challenge, particularly in sub-Saharan Africa. HBV co-infection worsens clinical outcomes among people living with HIV by accelerating liver disease and complicating treatment. Although antiretroviral therapy can effectively suppress both viruses, achieving optimal HIV viral suppression remains critical for reducing morbidity and transmission. While several factors influencing viral suppression among PLHIV are well documented, evidence on HIV viral suppression among HIV-HBV co-infected individuals is limited, especially in resource-limited settings like Ethiopia. Furthermore, data on the magnitude of viral suppression and its associated factors in this population are scarce. Therefore, this study aimed to assess the magnitude of HIV viral suppression and identify its associated factors among adult HIV-HBV co-infected patients in Northwest Ethiopia. Objective: This study aimed to assess the magnitude and factors associated with HIV viral suppression among adult people living with HIV-HBV Co-infection in Northwest Ethiopia. Methods: An institution-based cross-sectional study was conducted in Northwest Ethiopia among adults with HIV-HBV co-infection on antiretroviral therapy. A simple random sample of 402 participants was selected. Data were collected using a pretested structured interviewer-administered questionnaire and medical record review, covering sociodemographic, clinical, behavioral, treatment, follow-up, and adherence factors. HIV viral suppression was defined as a plasma viral load &amp;amp;lt; 1000 copies/mL. Data were coded in EpiData 4.6 and analyzed using STATA 18. Descriptive statistics estimated suppression rates. Bivariable and multivariable logistic regression identified factors associated with suppression; variables with p &amp;amp;lt; 0.25 in bivariable analysis were included in the multivariable model. Statistical significance was set at p &amp;amp;lt; 0.05 with adjusted odds ratios and 95% confidence intervals reported. Model fit was assessed using the Hosmer&amp;amp;ndash;Lemeshow test, and multicollinearity was checked using variance inflation factors. Results: There were 423 participants in all. Among the 423 HIV-HBV co-infected adults on antiretroviral therapy included in this study, 138 (34, CI, 30&amp;amp;ndash;39%) achieved HIV viral suppression, while 264 (66%) had an unsuppressed viral load at the time of assessment. Viral suppression was found to be independently correlated with the ART TDF-3TC-LPV/r regimen, first-line medication adherence, bedridden functional level, missed clinic appointments, and length of therapy. While TDF-3TC-LPV/r usage (AOR 2.34; 95% CI: 1.40&amp;amp;ndash;3.90) and longer treatment duration (AOR 2.09; 95% CI: 1.30&amp;amp;ndash;3.34) were advantageous, good adherence significantly improved the likelihood of suppression (AOR 5.54; 95% CI: 3.27&amp;amp;ndash;9.38). Missed appointments and a bedridden state decreased the likelihood of suppression. Conclusions: HIV viral suppression was achieved in only 34% of participants. Adherence, ART regimen, treatment duration, functional status, and retention in care were significant predictors. Strengthening adherence support, patient retention, optimized ART regimens, routine viral load monitoring, and targeted care for high-risk patients could improve treatment outcomes and help Ethiopia achieve UNAIDS viral suppression targets.</p>
	]]></content:encoded>

	<dc:title>Magnitude and Factors Associated with HIV Viral Suppression Among Adult People Living with HIV-HBV Co-Infection in Northwest Ethiopia</dc:title>
			<dc:creator>Mequanente Dagnaw</dc:creator>
			<dc:creator>Destaw Fetene Teshome</dc:creator>
			<dc:creator>Tilahun Bizuayehu Demass</dc:creator>
			<dc:creator>Abebaw Gebyehu Worku</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070175</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-26</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-26</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>175</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070175</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/175</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/174">

	<title>TropicalMed, Vol. 11, Pages 174: The Impact of &amp;ldquo;The Magic Glasses Opisthorchiasis&amp;rdquo; on Schoolchildren&amp;rsquo;s Knowledge, Attitudes and Practices Surrounding Opisthorchis viverrini in the Lower Mekong Basin, a Cluster-Randomised Controlled Trial</title>
	<link>https://www.mdpi.com/2414-6366/11/7/174</link>
	<description>Opisthorchis viverrini (OV) is a liver fluke endemic to the Lower Mekong Basin. Infections often begin in childhood and are causally linked to cholangiocarcinoma, an often-fatal bile duct cancer. Anthelmintic treatment is the primary control strategy, but infection can recur. Therefore, additional strategies are needed. This study assessed the impact of &amp;amp;ldquo;The Magic Glasses Opisthorchiasis&amp;amp;rdquo; (MGO), a cartoon-based intervention, on schoolchildren&amp;amp;rsquo;s OV-related knowledge, attitudes and practices (KAP). A cluster (school)-randomised controlled trial was conducted in Cambodia, Laos and Thailand. Clusters were randomised into either school health education only or with MGO. OV KAP was measured using a standardised questionnaire. FGDs and interviews were also conducted in intervention schools with schoolchildren, parents, and teachers. Cambodia intervention knowledge and attitude scores improved by 19.2 (p &amp;amp;lt; 0.001) and 25.3 (p &amp;amp;lt; 0.001) percentage points, respectively, relative to the control. Laos intervention knowledge and attitude scores improved by 19.0 (p &amp;amp;lt; 0.001) and 14.2 (p &amp;amp;lt; 0.001) percentage points. However, Thailand&amp;amp;rsquo;s intervention knowledge and attitude scores declined by 23.3 (p &amp;amp;lt; 0.001) and 15.8 percentage points (p &amp;amp;lt; 0.001). There were no improvements in behaviour scores in any country, but parents and schoolchildren in Cambodia and Laos reported improved fish preparation practices, suggesting positive spillover effects from MGO. The findings support MGO as an effective tool for school-based health education.</description>
	<pubDate>2026-06-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 174: The Impact of &amp;ldquo;The Magic Glasses Opisthorchiasis&amp;rdquo; on Schoolchildren&amp;rsquo;s Knowledge, Attitudes and Practices Surrounding Opisthorchis viverrini in the Lower Mekong Basin, a Cluster-Randomised Controlled Trial</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/174">doi: 10.3390/tropicalmed11070174</a></p>
	<p>Authors:
		Suji Y. O’Connor
		Mary Lorraine Mationg
		Matthew J. Kelly
		Gail M. Williams
		Archie C. A. Clements
		Banchob Sripa
		Somphou Sayasone
		Virak Khieu
		Kinley Wangdi
		Donald E. Stewart
		Sirikachorn Tangkawattana
		Apiporn T. Suwannatrai
		Vanthanom Savathdy
		Visal Khieu
		Peter Odermatt
		Catherine A. Gordon
		Sangduan Wannachart
		Donald P. McManus
		Darren J. Gray
		</p>
	<p>Opisthorchis viverrini (OV) is a liver fluke endemic to the Lower Mekong Basin. Infections often begin in childhood and are causally linked to cholangiocarcinoma, an often-fatal bile duct cancer. Anthelmintic treatment is the primary control strategy, but infection can recur. Therefore, additional strategies are needed. This study assessed the impact of &amp;amp;ldquo;The Magic Glasses Opisthorchiasis&amp;amp;rdquo; (MGO), a cartoon-based intervention, on schoolchildren&amp;amp;rsquo;s OV-related knowledge, attitudes and practices (KAP). A cluster (school)-randomised controlled trial was conducted in Cambodia, Laos and Thailand. Clusters were randomised into either school health education only or with MGO. OV KAP was measured using a standardised questionnaire. FGDs and interviews were also conducted in intervention schools with schoolchildren, parents, and teachers. Cambodia intervention knowledge and attitude scores improved by 19.2 (p &amp;amp;lt; 0.001) and 25.3 (p &amp;amp;lt; 0.001) percentage points, respectively, relative to the control. Laos intervention knowledge and attitude scores improved by 19.0 (p &amp;amp;lt; 0.001) and 14.2 (p &amp;amp;lt; 0.001) percentage points. However, Thailand&amp;amp;rsquo;s intervention knowledge and attitude scores declined by 23.3 (p &amp;amp;lt; 0.001) and 15.8 percentage points (p &amp;amp;lt; 0.001). There were no improvements in behaviour scores in any country, but parents and schoolchildren in Cambodia and Laos reported improved fish preparation practices, suggesting positive spillover effects from MGO. The findings support MGO as an effective tool for school-based health education.</p>
	]]></content:encoded>

	<dc:title>The Impact of &amp;amp;ldquo;The Magic Glasses Opisthorchiasis&amp;amp;rdquo; on Schoolchildren&amp;amp;rsquo;s Knowledge, Attitudes and Practices Surrounding Opisthorchis viverrini in the Lower Mekong Basin, a Cluster-Randomised Controlled Trial</dc:title>
			<dc:creator>Suji Y. O’Connor</dc:creator>
			<dc:creator>Mary Lorraine Mationg</dc:creator>
			<dc:creator>Matthew J. Kelly</dc:creator>
			<dc:creator>Gail M. Williams</dc:creator>
			<dc:creator>Archie C. A. Clements</dc:creator>
			<dc:creator>Banchob Sripa</dc:creator>
			<dc:creator>Somphou Sayasone</dc:creator>
			<dc:creator>Virak Khieu</dc:creator>
			<dc:creator>Kinley Wangdi</dc:creator>
			<dc:creator>Donald E. Stewart</dc:creator>
			<dc:creator>Sirikachorn Tangkawattana</dc:creator>
			<dc:creator>Apiporn T. Suwannatrai</dc:creator>
			<dc:creator>Vanthanom Savathdy</dc:creator>
			<dc:creator>Visal Khieu</dc:creator>
			<dc:creator>Peter Odermatt</dc:creator>
			<dc:creator>Catherine A. Gordon</dc:creator>
			<dc:creator>Sangduan Wannachart</dc:creator>
			<dc:creator>Donald P. McManus</dc:creator>
			<dc:creator>Darren J. Gray</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070174</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>174</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070174</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/174</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/173">

	<title>TropicalMed, Vol. 11, Pages 173: Seasonal Dynamics of Mosquito and Tick Vectors and Molecular Detection of Rift Valley Fever and Crimean&amp;ndash;Congo Hemorrhagic Fever Viruses in Transboundary and Non-Transboundary Areas of Senegal</title>
	<link>https://www.mdpi.com/2414-6366/11/7/173</link>
	<description>Rift Valley fever virus (RVFV) and Crimean&amp;amp;ndash;Congo hemorrhagic fever virus (CCHFV) are endemic zoonotic pathogens in Senegal, transmitted by mosquitoes and ticks, respectively. Understanding the seasonal and spatial dynamics of their vectors is essential to improve targeted surveillance. This study investigated the abundance, diversity, and viral infection status of vector populations in a transboundary region (Matam) and a non-transboundary region (Thi&amp;amp;egrave;s) over two seasons from September 2022 to March 2024. We collected mosquitoes using CO2-baited CDC light traps and sampled ticks directly from domestic small ruminants. A total of 6558 mosquitoes across 23 species and 1904 ticks representing seven species were morphologically identified. Mosquito abundance peaked significantly during the rainy season. Conversely, tick diversity increased during the dry season, with Hyalomma rufipes emerging as the predominant species. Crucially, RVFV was detected exclusively in Aedes vexans mosquito pools from the transboundary Matam region, emphasizing the epidemiological risk associated with cross-border livestock mobility. Viral RNA of CCHFV was detected in multiple tick species across both regions and seasons, confirming a sustained, multi-vector enzootic cycle. These findings demonstrate persistent RVFV and CCHFV circulation in Senegal and highlight the critical need for integrated, season-specific vector surveillance frameworks.</description>
	<pubDate>2026-06-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 173: Seasonal Dynamics of Mosquito and Tick Vectors and Molecular Detection of Rift Valley Fever and Crimean&amp;ndash;Congo Hemorrhagic Fever Viruses in Transboundary and Non-Transboundary Areas of Senegal</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/173">doi: 10.3390/tropicalmed11070173</a></p>
	<p>Authors:
		Thialao Sarr
		Mame Thierno Bakhoum
		Aminata Ba
		Gorgui Diouf
		Moussa Fall
		Mamadou Lamine Djiba
		Abdou Samath Thiall
		Modou Moustapha Lo
		Jessica Radzio Basu
		Assane Gueye Fall
		</p>
	<p>Rift Valley fever virus (RVFV) and Crimean&amp;amp;ndash;Congo hemorrhagic fever virus (CCHFV) are endemic zoonotic pathogens in Senegal, transmitted by mosquitoes and ticks, respectively. Understanding the seasonal and spatial dynamics of their vectors is essential to improve targeted surveillance. This study investigated the abundance, diversity, and viral infection status of vector populations in a transboundary region (Matam) and a non-transboundary region (Thi&amp;amp;egrave;s) over two seasons from September 2022 to March 2024. We collected mosquitoes using CO2-baited CDC light traps and sampled ticks directly from domestic small ruminants. A total of 6558 mosquitoes across 23 species and 1904 ticks representing seven species were morphologically identified. Mosquito abundance peaked significantly during the rainy season. Conversely, tick diversity increased during the dry season, with Hyalomma rufipes emerging as the predominant species. Crucially, RVFV was detected exclusively in Aedes vexans mosquito pools from the transboundary Matam region, emphasizing the epidemiological risk associated with cross-border livestock mobility. Viral RNA of CCHFV was detected in multiple tick species across both regions and seasons, confirming a sustained, multi-vector enzootic cycle. These findings demonstrate persistent RVFV and CCHFV circulation in Senegal and highlight the critical need for integrated, season-specific vector surveillance frameworks.</p>
	]]></content:encoded>

	<dc:title>Seasonal Dynamics of Mosquito and Tick Vectors and Molecular Detection of Rift Valley Fever and Crimean&amp;amp;ndash;Congo Hemorrhagic Fever Viruses in Transboundary and Non-Transboundary Areas of Senegal</dc:title>
			<dc:creator>Thialao Sarr</dc:creator>
			<dc:creator>Mame Thierno Bakhoum</dc:creator>
			<dc:creator>Aminata Ba</dc:creator>
			<dc:creator>Gorgui Diouf</dc:creator>
			<dc:creator>Moussa Fall</dc:creator>
			<dc:creator>Mamadou Lamine Djiba</dc:creator>
			<dc:creator>Abdou Samath Thiall</dc:creator>
			<dc:creator>Modou Moustapha Lo</dc:creator>
			<dc:creator>Jessica Radzio Basu</dc:creator>
			<dc:creator>Assane Gueye Fall</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070173</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>173</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070173</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/173</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/172">

	<title>TropicalMed, Vol. 11, Pages 172: Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan</title>
	<link>https://www.mdpi.com/2414-6366/11/7/172</link>
	<description>Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in the eastern city of Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: A total of 159 patients with liver hydatid cysts were included in the study. Among them, 91 (57.2%) were female, 80 (50.3%) were aged 20&amp;amp;ndash;39 years, and 128 (80.5%) resided in rural areas. Most patients presented with a single cyst (144/159, 90.6%), while multiple cysts were observed in 15 (9.4%). The majority of cysts measured 5&amp;amp;ndash;9.9 cm in diameter (43.4%), followed by 1&amp;amp;ndash;4.9 cm (42.1%) and &amp;amp;ge;10 cm (14.5%). According to the WHO-IWGE classification, CE1 (25.8%) and CE4 (24.5%) were the most common stages, followed by CE2 (17.6%), CE3a (13.8%), CE3b (11.3%), and CE5 (7.0%). Common exposure-related factors included dog ownership, poor hygiene practices, and consumption of raw vegetables. Ultrasound accurately identified cyst stages and demonstrated a significant association between WHO-IWGE staging and treatment modality (&amp;amp;chi;2 = 63.56, p &amp;amp;lt; 0.001). Almost perfect agreement was observed between ultrasound and CT for cyst classification (Cohen&amp;amp;rsquo;s &amp;amp;kappa; &amp;amp;gt; 0.90), although CT provided additional anatomical information in selected complex cases. Conclusions: Ultrasound is an accessible, accurate, and reliable imaging modality for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.</description>
	<pubDate>2026-06-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 172: Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/172">doi: 10.3390/tropicalmed11070172</a></p>
	<p>Authors:
		Samiullah Sajjad
		Parnpen Viriyavejakul
		Dorn Watthanakulpanich
		Sant Muangnoicharoen
		Paron Dekumyoy
		Wirongrong Chierakul
		Chayasin Mansaguan
		Prakaykaew Charunwatthana
		</p>
	<p>Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in the eastern city of Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: A total of 159 patients with liver hydatid cysts were included in the study. Among them, 91 (57.2%) were female, 80 (50.3%) were aged 20&amp;amp;ndash;39 years, and 128 (80.5%) resided in rural areas. Most patients presented with a single cyst (144/159, 90.6%), while multiple cysts were observed in 15 (9.4%). The majority of cysts measured 5&amp;amp;ndash;9.9 cm in diameter (43.4%), followed by 1&amp;amp;ndash;4.9 cm (42.1%) and &amp;amp;ge;10 cm (14.5%). According to the WHO-IWGE classification, CE1 (25.8%) and CE4 (24.5%) were the most common stages, followed by CE2 (17.6%), CE3a (13.8%), CE3b (11.3%), and CE5 (7.0%). Common exposure-related factors included dog ownership, poor hygiene practices, and consumption of raw vegetables. Ultrasound accurately identified cyst stages and demonstrated a significant association between WHO-IWGE staging and treatment modality (&amp;amp;chi;2 = 63.56, p &amp;amp;lt; 0.001). Almost perfect agreement was observed between ultrasound and CT for cyst classification (Cohen&amp;amp;rsquo;s &amp;amp;kappa; &amp;amp;gt; 0.90), although CT provided additional anatomical information in selected complex cases. Conclusions: Ultrasound is an accessible, accurate, and reliable imaging modality for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.</p>
	]]></content:encoded>

	<dc:title>Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan</dc:title>
			<dc:creator>Samiullah Sajjad</dc:creator>
			<dc:creator>Parnpen Viriyavejakul</dc:creator>
			<dc:creator>Dorn Watthanakulpanich</dc:creator>
			<dc:creator>Sant Muangnoicharoen</dc:creator>
			<dc:creator>Paron Dekumyoy</dc:creator>
			<dc:creator>Wirongrong Chierakul</dc:creator>
			<dc:creator>Chayasin Mansaguan</dc:creator>
			<dc:creator>Prakaykaew Charunwatthana</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070172</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>172</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070172</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/172</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/7/171">

	<title>TropicalMed, Vol. 11, Pages 171: Trends and Projected Burden of HIV/AIDS in Kazakhstan, 2010&amp;ndash;2030: A Comparative Analysis Using GBD 2023 Estimates</title>
	<link>https://www.mdpi.com/2414-6366/11/7/171</link>
	<description>Background: HIV/AIDS remains a major global public health challenge, with persistent regional disparities in burden and progress toward the UNAIDS 95&amp;amp;ndash;95&amp;amp;ndash;95 targets. This study assessed temporal trends in the HIV/AIDS burden in Kazakhstan, compared them with Central Asia and global patterns, and projected trends through 2030. Methods: We conducted a population-level analysis using Global Burden of Disease 2023 data, examining age-standardized rates (per 100,000) of incidence, prevalence, mortality, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) from 2010 to 2023. Trends were quantified using percent change and average annual percentage change, with projections based on log-linear models. Results: Between 2010 and 2023, prevalence in Kazakhstan increased by 332.1% and incidence by 111.0%, contrasting with the decline in global incidence (&amp;amp;minus;24.7%). Mortality decreased (&amp;amp;minus;32.7%), along with DALYs (&amp;amp;minus;28.8%) and YLLs (&amp;amp;minus;37.1%), while YLDs increased by 135.5%, indicating a shift toward a chronic disease burden. In 2023, Kazakhstan had a lower overall burden than global estimates but showed steeper increases in incidence and prevalence. Age-specific analyses indicated the largest increases among adults aged 30&amp;amp;ndash;69 years. Under current trend assumptions, projections suggest continued growth in prevalence and incidence, with modest mortality declines through 2030, though these trajectories do not account for future changes in prevention coverage, treatment access, or policy. Conclusions: Kazakhstan is undergoing a transition toward a chronic HIV epidemic, underscoring the need to strengthen prevention, expand PrEP and testing coverage, and address structural barriers to achieve epidemic control.</description>
	<pubDate>2026-06-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 171: Trends and Projected Burden of HIV/AIDS in Kazakhstan, 2010&amp;ndash;2030: A Comparative Analysis Using GBD 2023 Estimates</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/7/171">doi: 10.3390/tropicalmed11070171</a></p>
	<p>Authors:
		Indira Karibayeva
		Gulzar Shah
		Nikolay Lunchenkov
		Roza Kuanyshbekova
		Kuanysh Shonbay
		Botagoz Turdaliyeva
		</p>
	<p>Background: HIV/AIDS remains a major global public health challenge, with persistent regional disparities in burden and progress toward the UNAIDS 95&amp;amp;ndash;95&amp;amp;ndash;95 targets. This study assessed temporal trends in the HIV/AIDS burden in Kazakhstan, compared them with Central Asia and global patterns, and projected trends through 2030. Methods: We conducted a population-level analysis using Global Burden of Disease 2023 data, examining age-standardized rates (per 100,000) of incidence, prevalence, mortality, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) from 2010 to 2023. Trends were quantified using percent change and average annual percentage change, with projections based on log-linear models. Results: Between 2010 and 2023, prevalence in Kazakhstan increased by 332.1% and incidence by 111.0%, contrasting with the decline in global incidence (&amp;amp;minus;24.7%). Mortality decreased (&amp;amp;minus;32.7%), along with DALYs (&amp;amp;minus;28.8%) and YLLs (&amp;amp;minus;37.1%), while YLDs increased by 135.5%, indicating a shift toward a chronic disease burden. In 2023, Kazakhstan had a lower overall burden than global estimates but showed steeper increases in incidence and prevalence. Age-specific analyses indicated the largest increases among adults aged 30&amp;amp;ndash;69 years. Under current trend assumptions, projections suggest continued growth in prevalence and incidence, with modest mortality declines through 2030, though these trajectories do not account for future changes in prevention coverage, treatment access, or policy. Conclusions: Kazakhstan is undergoing a transition toward a chronic HIV epidemic, underscoring the need to strengthen prevention, expand PrEP and testing coverage, and address structural barriers to achieve epidemic control.</p>
	]]></content:encoded>

	<dc:title>Trends and Projected Burden of HIV/AIDS in Kazakhstan, 2010&amp;amp;ndash;2030: A Comparative Analysis Using GBD 2023 Estimates</dc:title>
			<dc:creator>Indira Karibayeva</dc:creator>
			<dc:creator>Gulzar Shah</dc:creator>
			<dc:creator>Nikolay Lunchenkov</dc:creator>
			<dc:creator>Roza Kuanyshbekova</dc:creator>
			<dc:creator>Kuanysh Shonbay</dc:creator>
			<dc:creator>Botagoz Turdaliyeva</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11070171</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-24</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-24</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>171</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11070171</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/7/171</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/170">

	<title>TropicalMed, Vol. 11, Pages 170: Molecular Identification of Schistosoma Species Associated with Atypical Urinary Eggs in Abuja (Nigeria): Evidence of Potential Zoonotic Transmission</title>
	<link>https://www.mdpi.com/2414-6366/11/6/170</link>
	<description>Schistosomiasis remains a major public health concern in Nigeria. We molecularly characterized Schistosoma eggs obtained from human urine to identify species and assess the presence of hybrid schistosomes in Abuja, Nigeria. Urine samples were collected from 1887 participants aged five years and above. Samples were examined for Schistosoma eggs using light microscopy. A total of 507 (26.9%) were positive for any form of Schistosoma while 91 (4.8%) had atypical Schistosoma eggs. DNA extracted from pooled ova was analyzed using metagenomic sequencing, read mapping, phylogenetic analysis, and BLASTn confirmation. Molecular analyses identified genetic signatures associated with both S. haematobium and S. bovis within pooled human urine samples, indicating the co-circulation of multiple schistosome species in the study area. Phylogenetic analyses based on trans-ITS and mitochondrial COX1 markers supported the presence of distinct nuclear and mitochondrial schistosome lineages. However, because sequencing was performed on pooled egg samples, the findings cannot distinguish between true recombinants and mixed infections involving co-circulating parental species. These findings highlight the potential complexity of schistosome transmission dynamics in endemic communities and underscore the need for enhanced molecular surveillance, especially single-parasite genomic approaches, and integrated One Health investigations to better understand schistosome transmission and its implications for control and elimination efforts in Nigeria.</description>
	<pubDate>2026-06-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 170: Molecular Identification of Schistosoma Species Associated with Atypical Urinary Eggs in Abuja (Nigeria): Evidence of Potential Zoonotic Transmission</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/170">doi: 10.3390/tropicalmed11060170</a></p>
	<p>Authors:
		Solomon Monday Jacob
		Sophie Y. Akinbo
		Oluwaremilekun G. Ajakaye
		Uwem F. Ekpo
		Zainab Omoruyi
		Temitope Agbana
		Louise Makau-Barasa
		Moses O. Aderogba
		Jan-Carel Diehl
		David Bell
		Adedotun A. Bayegun
		Michael A. Okungbowa
		Juliana A-Enegela
		Frederick O. Akinbo
		</p>
	<p>Schistosomiasis remains a major public health concern in Nigeria. We molecularly characterized Schistosoma eggs obtained from human urine to identify species and assess the presence of hybrid schistosomes in Abuja, Nigeria. Urine samples were collected from 1887 participants aged five years and above. Samples were examined for Schistosoma eggs using light microscopy. A total of 507 (26.9%) were positive for any form of Schistosoma while 91 (4.8%) had atypical Schistosoma eggs. DNA extracted from pooled ova was analyzed using metagenomic sequencing, read mapping, phylogenetic analysis, and BLASTn confirmation. Molecular analyses identified genetic signatures associated with both S. haematobium and S. bovis within pooled human urine samples, indicating the co-circulation of multiple schistosome species in the study area. Phylogenetic analyses based on trans-ITS and mitochondrial COX1 markers supported the presence of distinct nuclear and mitochondrial schistosome lineages. However, because sequencing was performed on pooled egg samples, the findings cannot distinguish between true recombinants and mixed infections involving co-circulating parental species. These findings highlight the potential complexity of schistosome transmission dynamics in endemic communities and underscore the need for enhanced molecular surveillance, especially single-parasite genomic approaches, and integrated One Health investigations to better understand schistosome transmission and its implications for control and elimination efforts in Nigeria.</p>
	]]></content:encoded>

	<dc:title>Molecular Identification of Schistosoma Species Associated with Atypical Urinary Eggs in Abuja (Nigeria): Evidence of Potential Zoonotic Transmission</dc:title>
			<dc:creator>Solomon Monday Jacob</dc:creator>
			<dc:creator>Sophie Y. Akinbo</dc:creator>
			<dc:creator>Oluwaremilekun G. Ajakaye</dc:creator>
			<dc:creator>Uwem F. Ekpo</dc:creator>
			<dc:creator>Zainab Omoruyi</dc:creator>
			<dc:creator>Temitope Agbana</dc:creator>
			<dc:creator>Louise Makau-Barasa</dc:creator>
			<dc:creator>Moses O. Aderogba</dc:creator>
			<dc:creator>Jan-Carel Diehl</dc:creator>
			<dc:creator>David Bell</dc:creator>
			<dc:creator>Adedotun A. Bayegun</dc:creator>
			<dc:creator>Michael A. Okungbowa</dc:creator>
			<dc:creator>Juliana A-Enegela</dc:creator>
			<dc:creator>Frederick O. Akinbo</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060170</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-22</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-22</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>170</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060170</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/170</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/169">

	<title>TropicalMed, Vol. 11, Pages 169: Imported Tungiasis in Greece: Secondary Household Transmission and Transient Mixed Liver Enzyme Elevation</title>
	<link>https://www.mdpi.com/2414-6366/11/6/169</link>
	<description>Tungiasis is a cutaneous ectoparasitosis caused by the penetration of gravid female Tunga penetrans fleas into the epidermis. Although endemic in tropical and subtropical regions, it remains rare in Europe, where most cases are travel-associated and secondary household transmission is seldom documented. This study describes imported tungiasis in Greece and investigates possible secondary household transmission in a non-endemic setting. Seven Greek men residing in Attica developed tungiasis following occupational exposure in Tanzania, together with one secondary case in a non-travelling household contact who had never travelled outside Greece. Diagnosis was based on clinical and dermoscopic findings and confirmed by amplification and sequencing of the mitochondrial cytochrome oxidase I (COI) gene. Household investigations were also performed. Eight male patients presented with painful plantar and/or subungual nodular lesions. Sequence analysis of COI demonstrated 657/662 bp (99%) identity with the Tunga penetrans reference sequence, and identical sequences were identified in all samples. A representative sequence was deposited in GenBank (accession no. PZ336383). All patients exhibited mild-to-moderate elevations of hepatocellular and cholestatic liver enzymes, which resolved within two weeks following treatment. One probable secondary household case was identified, and no infestation was detected among additional cohabitants or companion animals. This report documents imported tungiasis with probable secondary household transmission in Greece and highlights the importance of clinical awareness and environmental assessment in non-endemic settings.</description>
	<pubDate>2026-06-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 169: Imported Tungiasis in Greece: Secondary Household Transmission and Transient Mixed Liver Enzyme Elevation</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/169">doi: 10.3390/tropicalmed11060169</a></p>
	<p>Authors:
		Thomas Fotas
		Ioannis A. Giantsis
		Menelaos Lefkaditis
		Ioannis S. Pappas
		Mathis A. B. Christodoulopoulos
		Efterpi Zafiriou
		Electra Nicolaidou
		Alexander C. Katoulis
		Georgios Christodoulopoulos
		</p>
	<p>Tungiasis is a cutaneous ectoparasitosis caused by the penetration of gravid female Tunga penetrans fleas into the epidermis. Although endemic in tropical and subtropical regions, it remains rare in Europe, where most cases are travel-associated and secondary household transmission is seldom documented. This study describes imported tungiasis in Greece and investigates possible secondary household transmission in a non-endemic setting. Seven Greek men residing in Attica developed tungiasis following occupational exposure in Tanzania, together with one secondary case in a non-travelling household contact who had never travelled outside Greece. Diagnosis was based on clinical and dermoscopic findings and confirmed by amplification and sequencing of the mitochondrial cytochrome oxidase I (COI) gene. Household investigations were also performed. Eight male patients presented with painful plantar and/or subungual nodular lesions. Sequence analysis of COI demonstrated 657/662 bp (99%) identity with the Tunga penetrans reference sequence, and identical sequences were identified in all samples. A representative sequence was deposited in GenBank (accession no. PZ336383). All patients exhibited mild-to-moderate elevations of hepatocellular and cholestatic liver enzymes, which resolved within two weeks following treatment. One probable secondary household case was identified, and no infestation was detected among additional cohabitants or companion animals. This report documents imported tungiasis with probable secondary household transmission in Greece and highlights the importance of clinical awareness and environmental assessment in non-endemic settings.</p>
	]]></content:encoded>

	<dc:title>Imported Tungiasis in Greece: Secondary Household Transmission and Transient Mixed Liver Enzyme Elevation</dc:title>
			<dc:creator>Thomas Fotas</dc:creator>
			<dc:creator>Ioannis A. Giantsis</dc:creator>
			<dc:creator>Menelaos Lefkaditis</dc:creator>
			<dc:creator>Ioannis S. Pappas</dc:creator>
			<dc:creator>Mathis A. B. Christodoulopoulos</dc:creator>
			<dc:creator>Efterpi Zafiriou</dc:creator>
			<dc:creator>Electra Nicolaidou</dc:creator>
			<dc:creator>Alexander C. Katoulis</dc:creator>
			<dc:creator>Georgios Christodoulopoulos</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060169</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-21</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-21</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>169</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060169</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/169</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/168">

	<title>TropicalMed, Vol. 11, Pages 168: Implementation of Open PCR System for the Detection of TB/DR-TB and NTM in Sputum Samples from Suspected Pulmonary Tuberculosis Patients in Medan, Indonesia</title>
	<link>https://www.mdpi.com/2414-6366/11/6/168</link>
	<description>(1) Background: Indonesia faces the dual challenge of a high tuberculosis (TB) burden and increasing drug resistance. Conventional molecular diagnostics frequently fail to detect isoniazid resistance and nontuberculous mycobacteria (NTM). This study evaluates a domestic multiplex Open PCR system in Medan, Indonesia. (2) Methods: From July to November 2025, 1569 sputum specimens from suspected TB patients were analysed using the Indigen MTB/NTM/DR-TB Real-time PCR Kit Gen 2. (3) Results: Mycobacterial DNA was detected in 421 specimens (26.8%). Among these, 396 (94.1%) were drug-susceptible TB, while 16 (3.8%) showed resistance, predominantly INH mono-resistance (n = 14; 0.89% of total). Additionally, 9 cases (2.1%) involved NTM or TB-NTM co-infections. Tertiary hospitals showed significantly higher positivity rates (33.5%) than primary care (18.9%; p &amp;amp;lt; 0.001). TB status was significantly associated with male (p = 0.0052) and older age (p = 0.006), whereas resistance profiles and NTM distribution were consistent across all demographic groups (p &amp;amp;gt; 0.80). (4) Conclusions: This study describes the implementation and diagnostic yield of a domestic multiplex Open PCR system in Medan, Indonesia. By bridging diagnostic gaps across a decentralized referral network, this facilitates rapid and targeted therapy. Integrating multiplex domestic innovations into national diagnostic algorithms is essential for achieving Indonesia&amp;amp;rsquo;s TB elimination targets.</description>
	<pubDate>2026-06-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 168: Implementation of Open PCR System for the Detection of TB/DR-TB and NTM in Sputum Samples from Suspected Pulmonary Tuberculosis Patients in Medan, Indonesia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/168">doi: 10.3390/tropicalmed11060168</a></p>
	<p>Authors:
		R Lia Kusumawati
		Mirzan Hasibuan
		Nisrina Tari
		Gema Nazri Yanni
		Laura Isa Ginting
		Cynthia Gozali
		Tryna Tania
		</p>
	<p>(1) Background: Indonesia faces the dual challenge of a high tuberculosis (TB) burden and increasing drug resistance. Conventional molecular diagnostics frequently fail to detect isoniazid resistance and nontuberculous mycobacteria (NTM). This study evaluates a domestic multiplex Open PCR system in Medan, Indonesia. (2) Methods: From July to November 2025, 1569 sputum specimens from suspected TB patients were analysed using the Indigen MTB/NTM/DR-TB Real-time PCR Kit Gen 2. (3) Results: Mycobacterial DNA was detected in 421 specimens (26.8%). Among these, 396 (94.1%) were drug-susceptible TB, while 16 (3.8%) showed resistance, predominantly INH mono-resistance (n = 14; 0.89% of total). Additionally, 9 cases (2.1%) involved NTM or TB-NTM co-infections. Tertiary hospitals showed significantly higher positivity rates (33.5%) than primary care (18.9%; p &amp;amp;lt; 0.001). TB status was significantly associated with male (p = 0.0052) and older age (p = 0.006), whereas resistance profiles and NTM distribution were consistent across all demographic groups (p &amp;amp;gt; 0.80). (4) Conclusions: This study describes the implementation and diagnostic yield of a domestic multiplex Open PCR system in Medan, Indonesia. By bridging diagnostic gaps across a decentralized referral network, this facilitates rapid and targeted therapy. Integrating multiplex domestic innovations into national diagnostic algorithms is essential for achieving Indonesia&amp;amp;rsquo;s TB elimination targets.</p>
	]]></content:encoded>

	<dc:title>Implementation of Open PCR System for the Detection of TB/DR-TB and NTM in Sputum Samples from Suspected Pulmonary Tuberculosis Patients in Medan, Indonesia</dc:title>
			<dc:creator>R Lia Kusumawati</dc:creator>
			<dc:creator>Mirzan Hasibuan</dc:creator>
			<dc:creator>Nisrina Tari</dc:creator>
			<dc:creator>Gema Nazri Yanni</dc:creator>
			<dc:creator>Laura Isa Ginting</dc:creator>
			<dc:creator>Cynthia Gozali</dc:creator>
			<dc:creator>Tryna Tania</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060168</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>168</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060168</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/168</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/167">

	<title>TropicalMed, Vol. 11, Pages 167: Anti-Dengue IgG Seroprevalence and Exposure-Related Risk in Italian Military Personnel Deployed on Overseas Missions: A Cross-Sectional Study</title>
	<link>https://www.mdpi.com/2414-6366/11/6/167</link>
	<description>Dengue virus infection remains a significant public health challenge in endemic regions, with growing evidence of autochthonous transmission in Europe. Assessing serological exposure in high-risk populations such as military personnel deployed to endemic areas is essential to quantify exposure risk and support operational decision-making, particularly regarding pre-deployment counselling and risks associated with secondary infection. We conducted a cross-sectional study involving 1355 members of the Italian Armed Forces, measuring anti-dengue IgG antibodies by ELISA and collecting data on deployment history and exposure risk. Overall, IgG seropositivity was 8.12%, with significantly higher prevalence among individuals reporting travel or deployment to endemic regions (24.71%) compared with non-exposed personnel (4.27%). Seropositivity increased with age and correlated with a CDC-derived cumulative dengue risk score (Spearman&amp;amp;rsquo;s &amp;amp;rho; = 0.299, p &amp;amp;lt; 0.0001). A multivariable logistic regression model including age and exposure risk achieved an AUC of 0.75, while machine-learning models provided complementary predictive assessment, with random forest reaching an AUC of 0.79. These findings indicate substantial anti-dengue IgG seropositivity compatible with previous dengue exposure among Italian military personnel, particularly those deployed to endemic settings. The study highlights the need for targeted surveillance and risk-based preventive strategies, and supports the use of exposure-based models to improve epidemiological assessment and inform vaccination strategies in mobile populations.</description>
	<pubDate>2026-06-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 167: Anti-Dengue IgG Seroprevalence and Exposure-Related Risk in Italian Military Personnel Deployed on Overseas Missions: A Cross-Sectional Study</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/167">doi: 10.3390/tropicalmed11060167</a></p>
	<p>Authors:
		Andrea Ciammaruconi
		Anna Rocchetti
		Filippo Molinari
		Elisa Recchia
		Nathalie Totaro
		Chiara Pascolini
		Silvia Chimienti
		Giovanni Faggioni
		Riccardo De Santis
		Filippo Moramarco
		Alberto Autore
		Florigio Lista
		</p>
	<p>Dengue virus infection remains a significant public health challenge in endemic regions, with growing evidence of autochthonous transmission in Europe. Assessing serological exposure in high-risk populations such as military personnel deployed to endemic areas is essential to quantify exposure risk and support operational decision-making, particularly regarding pre-deployment counselling and risks associated with secondary infection. We conducted a cross-sectional study involving 1355 members of the Italian Armed Forces, measuring anti-dengue IgG antibodies by ELISA and collecting data on deployment history and exposure risk. Overall, IgG seropositivity was 8.12%, with significantly higher prevalence among individuals reporting travel or deployment to endemic regions (24.71%) compared with non-exposed personnel (4.27%). Seropositivity increased with age and correlated with a CDC-derived cumulative dengue risk score (Spearman&amp;amp;rsquo;s &amp;amp;rho; = 0.299, p &amp;amp;lt; 0.0001). A multivariable logistic regression model including age and exposure risk achieved an AUC of 0.75, while machine-learning models provided complementary predictive assessment, with random forest reaching an AUC of 0.79. These findings indicate substantial anti-dengue IgG seropositivity compatible with previous dengue exposure among Italian military personnel, particularly those deployed to endemic settings. The study highlights the need for targeted surveillance and risk-based preventive strategies, and supports the use of exposure-based models to improve epidemiological assessment and inform vaccination strategies in mobile populations.</p>
	]]></content:encoded>

	<dc:title>Anti-Dengue IgG Seroprevalence and Exposure-Related Risk in Italian Military Personnel Deployed on Overseas Missions: A Cross-Sectional Study</dc:title>
			<dc:creator>Andrea Ciammaruconi</dc:creator>
			<dc:creator>Anna Rocchetti</dc:creator>
			<dc:creator>Filippo Molinari</dc:creator>
			<dc:creator>Elisa Recchia</dc:creator>
			<dc:creator>Nathalie Totaro</dc:creator>
			<dc:creator>Chiara Pascolini</dc:creator>
			<dc:creator>Silvia Chimienti</dc:creator>
			<dc:creator>Giovanni Faggioni</dc:creator>
			<dc:creator>Riccardo De Santis</dc:creator>
			<dc:creator>Filippo Moramarco</dc:creator>
			<dc:creator>Alberto Autore</dc:creator>
			<dc:creator>Florigio Lista</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060167</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>167</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060167</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/167</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/166">

	<title>TropicalMed, Vol. 11, Pages 166: Borrelia miyamotoi in Saint Petersburg and Leningrad Oblast, Russia: A Multi-Level Assessment of Ticks, Rodents, and Human Exposure</title>
	<link>https://www.mdpi.com/2414-6366/11/6/166</link>
	<description>Background:&amp;amp;nbsp;Borrelia miyamotoi is an emerging tick-borne pathogen causing relapsing fever in humans. Although Saint Petersburg and the surrounding Leningrad Oblast harbor a high abundance of ixodid ticks (I. ricinus, I. persulcatus), no integrated assessment has yet simultaneously addressed pathogen circulation in vectors, reservoir hosts, and human populations in this specific northwestern region of Russia. Methods: During 2022&amp;amp;ndash;2024, we collected 1518 questing adult ticks and trapped 516 small mammals in Saint Petersburg and Leningrad Oblast. B. miyamotoi DNA was detected by real-time PCR. Sera from 3743 randomly selected volunteers (1553 from Saint Petersburg, 2190 from Leningrad Oblast) were tested for anti-B. miyamotoi IgG/IgM using a protein microarray (antigens: GlpQ, Vmps, flagellin). Infection rates and seroprevalence with 95% Wilson confidence intervals were compared using chi-square tests. Results: The overall tick infection rate was 3.78% (57/1506). I. ricinus had a significantly higher prevalence (4.94%; 95% CI: 3.67&amp;amp;ndash;6.60%) than I. persulcatus (2.29%; 95% CI: 1.39&amp;amp;ndash;3.74%; p = 0.011). Ticks from Leningrad Oblast also showed markedly elevated infection rates (4.98%; 95% CI: 3.75&amp;amp;ndash;6.58%) compared to those from Saint Petersburg (1.89%; 95% CI: 1.06&amp;amp;ndash;3.35%; p = 0.004). Small mammals exhibited substantially higher infection rates in Leningrad Oblast (39.44%; 95% CI: 31.78&amp;amp;ndash;47.65%) than in Saint Petersburg (13.90%; 95% CI: 10.76&amp;amp;ndash;17.78%; p &amp;amp;lt; 0.001). Bank voles (Myodes glareolus) and yellow-necked mice (Apodemus flavicollis) were the main reservoirs; synanthropic rodents trapped within the city were found to be infected for the first time. No significant organotropism was detected, but positive correlations between infection in the heart, liver, and kidney suggested hematogenous dissemination. The overall human seroprevalence of B. miyamotoi was 1.71% (95% CI: 1.34&amp;amp;ndash;2.18%) and was significantly higher in Leningrad Oblast (2.19%; 95% CI: 1.66&amp;amp;ndash;2.89%) than in Saint Petersburg (1.03%; 95% CI: 0.64&amp;amp;ndash;1.67%; p = 0.010). In contrast, the seroprevalence of B. burgdorferi s. l. did not differ between the two regions (approximately 5.1%). Conclusions: This first comprehensive, multi-level investigation in Saint Petersburg and Leningrad Oblast reveals a stable epidemiological gradient: natural foci in Leningrad Oblast sustain higher B. miyamotoi circulation in ticks and rodents, which translates into a two-fold higher exposure of the rural population. The findings highlight the need to include B. miyamotoi in regional tick-borne infection surveillance programs and to adopt differentiated risk assessment strategies for urban and rural settings.</description>
	<pubDate>2026-06-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 166: Borrelia miyamotoi in Saint Petersburg and Leningrad Oblast, Russia: A Multi-Level Assessment of Ticks, Rodents, and Human Exposure</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/166">doi: 10.3390/tropicalmed11060166</a></p>
	<p>Authors:
		Ivan Lyzenko
		Olga Stukolova
		Nikolay Tokarevich
		Marina Sokolova
		Regina Baimova
		Islam Karmokov
		Ekaterina Riabiko
		Daria Grechishkina
		Gelena Lunina
		Vladimir Dedkov
		</p>
	<p>Background:&amp;amp;nbsp;Borrelia miyamotoi is an emerging tick-borne pathogen causing relapsing fever in humans. Although Saint Petersburg and the surrounding Leningrad Oblast harbor a high abundance of ixodid ticks (I. ricinus, I. persulcatus), no integrated assessment has yet simultaneously addressed pathogen circulation in vectors, reservoir hosts, and human populations in this specific northwestern region of Russia. Methods: During 2022&amp;amp;ndash;2024, we collected 1518 questing adult ticks and trapped 516 small mammals in Saint Petersburg and Leningrad Oblast. B. miyamotoi DNA was detected by real-time PCR. Sera from 3743 randomly selected volunteers (1553 from Saint Petersburg, 2190 from Leningrad Oblast) were tested for anti-B. miyamotoi IgG/IgM using a protein microarray (antigens: GlpQ, Vmps, flagellin). Infection rates and seroprevalence with 95% Wilson confidence intervals were compared using chi-square tests. Results: The overall tick infection rate was 3.78% (57/1506). I. ricinus had a significantly higher prevalence (4.94%; 95% CI: 3.67&amp;amp;ndash;6.60%) than I. persulcatus (2.29%; 95% CI: 1.39&amp;amp;ndash;3.74%; p = 0.011). Ticks from Leningrad Oblast also showed markedly elevated infection rates (4.98%; 95% CI: 3.75&amp;amp;ndash;6.58%) compared to those from Saint Petersburg (1.89%; 95% CI: 1.06&amp;amp;ndash;3.35%; p = 0.004). Small mammals exhibited substantially higher infection rates in Leningrad Oblast (39.44%; 95% CI: 31.78&amp;amp;ndash;47.65%) than in Saint Petersburg (13.90%; 95% CI: 10.76&amp;amp;ndash;17.78%; p &amp;amp;lt; 0.001). Bank voles (Myodes glareolus) and yellow-necked mice (Apodemus flavicollis) were the main reservoirs; synanthropic rodents trapped within the city were found to be infected for the first time. No significant organotropism was detected, but positive correlations between infection in the heart, liver, and kidney suggested hematogenous dissemination. The overall human seroprevalence of B. miyamotoi was 1.71% (95% CI: 1.34&amp;amp;ndash;2.18%) and was significantly higher in Leningrad Oblast (2.19%; 95% CI: 1.66&amp;amp;ndash;2.89%) than in Saint Petersburg (1.03%; 95% CI: 0.64&amp;amp;ndash;1.67%; p = 0.010). In contrast, the seroprevalence of B. burgdorferi s. l. did not differ between the two regions (approximately 5.1%). Conclusions: This first comprehensive, multi-level investigation in Saint Petersburg and Leningrad Oblast reveals a stable epidemiological gradient: natural foci in Leningrad Oblast sustain higher B. miyamotoi circulation in ticks and rodents, which translates into a two-fold higher exposure of the rural population. The findings highlight the need to include B. miyamotoi in regional tick-borne infection surveillance programs and to adopt differentiated risk assessment strategies for urban and rural settings.</p>
	]]></content:encoded>

	<dc:title>Borrelia miyamotoi in Saint Petersburg and Leningrad Oblast, Russia: A Multi-Level Assessment of Ticks, Rodents, and Human Exposure</dc:title>
			<dc:creator>Ivan Lyzenko</dc:creator>
			<dc:creator>Olga Stukolova</dc:creator>
			<dc:creator>Nikolay Tokarevich</dc:creator>
			<dc:creator>Marina Sokolova</dc:creator>
			<dc:creator>Regina Baimova</dc:creator>
			<dc:creator>Islam Karmokov</dc:creator>
			<dc:creator>Ekaterina Riabiko</dc:creator>
			<dc:creator>Daria Grechishkina</dc:creator>
			<dc:creator>Gelena Lunina</dc:creator>
			<dc:creator>Vladimir Dedkov</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060166</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>166</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060166</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/166</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/165">

	<title>TropicalMed, Vol. 11, Pages 165: Determinants of Rabies Post-Exposure Prophylaxis Compliance in Bangladesh: Informing Policy for Elimination by 2030</title>
	<link>https://www.mdpi.com/2414-6366/11/6/165</link>
	<description>Rabies remains a preventable yet fatal zoonotic disease and a major public health concern in Bangladesh, which aims to eliminate dog-mediated human rabies by 2030. Despite free availability of post-exposure prophylaxis (PEP), adherence to the WHO-recommended PEP regimen remains low. This study assessed PEP compliance and identified determinants of regimen completion among animal-exposed patients. We conducted a hospital-based observational study using secondary data from 457 patients who initiated PEP at the National Rabies Prevention and Control Centre (NRPCC) in Dhaka, from February 2023 to July 2023. Sociodemographic, clinical, and exposure-related factors were analyzed to identify predictors of compliance. Only 17.1% of patients completed the full PEP regimen, including rabies immunoglobulin (RIG) administration for WHO Category III exposures where indicated. Higher adherence was observed among females, individuals aged &amp;amp;ge;15 years, lower-income groups, and those residing within 10 km of the treatment center. Exposure-related factors including dog bites, multiple exposures, unprovoked incidents, and appropriate exposure care were also associated with improved compliance. Despite free access, PEP completion remains critically low. Targeted strategies, including decentralized PEP delivery, improved public awareness, and strengthened follow-up systems, are essential to improve adherence and support progress toward rabies elimination by 2030.</description>
	<pubDate>2026-06-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 165: Determinants of Rabies Post-Exposure Prophylaxis Compliance in Bangladesh: Informing Policy for Elimination by 2030</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/165">doi: 10.3390/tropicalmed11060165</a></p>
	<p>Authors:
		Sumon Ghosh
		Mohammad Nayeem Hasan
		Sukanta Chowdhury
		Narayan C. Paul
		Waqas Ahmad
		Jiangang Chen
		Thankam S. Sunil
		</p>
	<p>Rabies remains a preventable yet fatal zoonotic disease and a major public health concern in Bangladesh, which aims to eliminate dog-mediated human rabies by 2030. Despite free availability of post-exposure prophylaxis (PEP), adherence to the WHO-recommended PEP regimen remains low. This study assessed PEP compliance and identified determinants of regimen completion among animal-exposed patients. We conducted a hospital-based observational study using secondary data from 457 patients who initiated PEP at the National Rabies Prevention and Control Centre (NRPCC) in Dhaka, from February 2023 to July 2023. Sociodemographic, clinical, and exposure-related factors were analyzed to identify predictors of compliance. Only 17.1% of patients completed the full PEP regimen, including rabies immunoglobulin (RIG) administration for WHO Category III exposures where indicated. Higher adherence was observed among females, individuals aged &amp;amp;ge;15 years, lower-income groups, and those residing within 10 km of the treatment center. Exposure-related factors including dog bites, multiple exposures, unprovoked incidents, and appropriate exposure care were also associated with improved compliance. Despite free access, PEP completion remains critically low. Targeted strategies, including decentralized PEP delivery, improved public awareness, and strengthened follow-up systems, are essential to improve adherence and support progress toward rabies elimination by 2030.</p>
	]]></content:encoded>

	<dc:title>Determinants of Rabies Post-Exposure Prophylaxis Compliance in Bangladesh: Informing Policy for Elimination by 2030</dc:title>
			<dc:creator>Sumon Ghosh</dc:creator>
			<dc:creator>Mohammad Nayeem Hasan</dc:creator>
			<dc:creator>Sukanta Chowdhury</dc:creator>
			<dc:creator>Narayan C. Paul</dc:creator>
			<dc:creator>Waqas Ahmad</dc:creator>
			<dc:creator>Jiangang Chen</dc:creator>
			<dc:creator>Thankam S. Sunil</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060165</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>165</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060165</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/165</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/164">

	<title>TropicalMed, Vol. 11, Pages 164: Rickettsia parkeri as a Probable Agent of Mild Spotted-Fever Group Rickettsiosis Identified by Seroreactivity in Villeta, Colombia</title>
	<link>https://www.mdpi.com/2414-6366/11/6/164</link>
	<description>Spotted fever group (SFG) rickettsioses are emerging zoonotic diseases of increasing relevance in Latin America, yet the specific species involved in human infections remain poorly defined in many endemic regions. This study aimed to determine the most probable antigen among SFG-seroreactive febrile patients from Villeta, Colombia. A panel of 25 convalescent-phase serum samples previously identified as positive for SFG Rickettsia spp. antibodies was analyzed by indirect immunofluorescence assay using antigens of Rickettsia rickettsii, R. amblyommatis and R. parkeri. Antibody titers were compared to identify differential seroreactivity patterns. Overall, 44% (11/25) of the samples showed differential antibody titers against one of the tested antigens. Among these, nine (36%) exhibited higher titers to R. parkeri and two (8%) to R. amblyommatis, while none showed exclusive reactivity to R. rickettsii. The remaining 56% (14/25) presented similar titers across antigens, consistent with indeterminate or cross-reactive SFG responses. Antibody titers ranged from 1:128 to 1:4096, with R. parkeri showing the strongest reactivity. These findings suggest R. parkeri or a highly related Rickettsia species as the predominant probable antigen in Villeta, highlighting its potential role in mild rickettsial infections and emphasizing the need for eco-epidemiological studies to identify local vectors and reservoirs.</description>
	<pubDate>2026-06-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 164: Rickettsia parkeri as a Probable Agent of Mild Spotted-Fever Group Rickettsiosis Identified by Seroreactivity in Villeta, Colombia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/164">doi: 10.3390/tropicalmed11060164</a></p>
	<p>Authors:
		Carlos Ramiro Silva-Ramos
		Peter C. Melby
		Patricia V. Aguilar
		Miguel M. Cabada
		Juan David Rodas
		Marylin Hidalgo
		Álvaro A. Faccini-Martínez
		</p>
	<p>Spotted fever group (SFG) rickettsioses are emerging zoonotic diseases of increasing relevance in Latin America, yet the specific species involved in human infections remain poorly defined in many endemic regions. This study aimed to determine the most probable antigen among SFG-seroreactive febrile patients from Villeta, Colombia. A panel of 25 convalescent-phase serum samples previously identified as positive for SFG Rickettsia spp. antibodies was analyzed by indirect immunofluorescence assay using antigens of Rickettsia rickettsii, R. amblyommatis and R. parkeri. Antibody titers were compared to identify differential seroreactivity patterns. Overall, 44% (11/25) of the samples showed differential antibody titers against one of the tested antigens. Among these, nine (36%) exhibited higher titers to R. parkeri and two (8%) to R. amblyommatis, while none showed exclusive reactivity to R. rickettsii. The remaining 56% (14/25) presented similar titers across antigens, consistent with indeterminate or cross-reactive SFG responses. Antibody titers ranged from 1:128 to 1:4096, with R. parkeri showing the strongest reactivity. These findings suggest R. parkeri or a highly related Rickettsia species as the predominant probable antigen in Villeta, highlighting its potential role in mild rickettsial infections and emphasizing the need for eco-epidemiological studies to identify local vectors and reservoirs.</p>
	]]></content:encoded>

	<dc:title>Rickettsia parkeri as a Probable Agent of Mild Spotted-Fever Group Rickettsiosis Identified by Seroreactivity in Villeta, Colombia</dc:title>
			<dc:creator>Carlos Ramiro Silva-Ramos</dc:creator>
			<dc:creator>Peter C. Melby</dc:creator>
			<dc:creator>Patricia V. Aguilar</dc:creator>
			<dc:creator>Miguel M. Cabada</dc:creator>
			<dc:creator>Juan David Rodas</dc:creator>
			<dc:creator>Marylin Hidalgo</dc:creator>
			<dc:creator>Álvaro A. Faccini-Martínez</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060164</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-18</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-18</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>164</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060164</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/164</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/163">

	<title>TropicalMed, Vol. 11, Pages 163: Serological, Molecular, and Epidemiological Investigation of Toxoplasma gondii Infection in Blood Donors from the Brazilian Semiarid Region</title>
	<link>https://www.mdpi.com/2414-6366/11/6/163</link>
	<description>This study aimed to determine the prevalence and risk factors associated with Toxoplasma gondii infection in blood donors from the Brazilian Semiarid region, and to explore its implications for transfusion safety. Samples were collected from 646 donors at blood donation centers in the states of Cear&amp;amp;aacute; and Para&amp;amp;iacute;ba. Serological diagnosis was performed using BIOLISA TOXOPLASMOSE ELISA kits for anti-T. gondii IgM and IgG antibodies, and molecular diagnosis was conducted by conventional PCR targeting a 529-bp noncoding repetitive fragment. Epidemiological questionnaires on variables associated with infection were administered, and statistical analysis was performed in univariate and multivariate stages, using multiple logistic regression. Among the 646 donors, 43.4% (281/646) were positive for anti-T. gondii IgG antibodies, 0.3% (2/646) for IgM antibodies, and none tested positive by PCR. In the univariate analysis, age, family income, educational level, salad washing practices, water source, raw milk consumption, and duration as a donor were significantly associated, whereas in the multivariate analysis only &amp;amp;ldquo;age&amp;amp;rdquo; and &amp;amp;ldquo;salad washing practices&amp;amp;rdquo; remained significant. A substantial IgG seroprevalence was observed among blood donors in the Brazilian Semiarid. The low IgM frequency, concurrent IgG positivity, and negative PCR results are consistent with a low transfusion risk in the region. However, these findings should be interpreted cautiously, as negative PCR results do not completely rule out the presence of circulating parasites. Age was identified as a risk factor, whereas proper salad washing showed a protective effect.</description>
	<pubDate>2026-06-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 163: Serological, Molecular, and Epidemiological Investigation of Toxoplasma gondii Infection in Blood Donors from the Brazilian Semiarid Region</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/163">doi: 10.3390/tropicalmed11060163</a></p>
	<p>Authors:
		Basílio Felizardo Lima Neto
		Ana Caroline Dantas Amorim
		Maria Jessianny Diniz Alves
		Ana Maria Santos Lima
		Janielton Albuquerque Lima
		Celine Sousa Menezes Sá
		Emilly Henrique Silva
		João Luís Garcia
		Vinicius Longo Ribeiro Vilela
		Thais Ferreira Feitosa
		</p>
	<p>This study aimed to determine the prevalence and risk factors associated with Toxoplasma gondii infection in blood donors from the Brazilian Semiarid region, and to explore its implications for transfusion safety. Samples were collected from 646 donors at blood donation centers in the states of Cear&amp;amp;aacute; and Para&amp;amp;iacute;ba. Serological diagnosis was performed using BIOLISA TOXOPLASMOSE ELISA kits for anti-T. gondii IgM and IgG antibodies, and molecular diagnosis was conducted by conventional PCR targeting a 529-bp noncoding repetitive fragment. Epidemiological questionnaires on variables associated with infection were administered, and statistical analysis was performed in univariate and multivariate stages, using multiple logistic regression. Among the 646 donors, 43.4% (281/646) were positive for anti-T. gondii IgG antibodies, 0.3% (2/646) for IgM antibodies, and none tested positive by PCR. In the univariate analysis, age, family income, educational level, salad washing practices, water source, raw milk consumption, and duration as a donor were significantly associated, whereas in the multivariate analysis only &amp;amp;ldquo;age&amp;amp;rdquo; and &amp;amp;ldquo;salad washing practices&amp;amp;rdquo; remained significant. A substantial IgG seroprevalence was observed among blood donors in the Brazilian Semiarid. The low IgM frequency, concurrent IgG positivity, and negative PCR results are consistent with a low transfusion risk in the region. However, these findings should be interpreted cautiously, as negative PCR results do not completely rule out the presence of circulating parasites. Age was identified as a risk factor, whereas proper salad washing showed a protective effect.</p>
	]]></content:encoded>

	<dc:title>Serological, Molecular, and Epidemiological Investigation of Toxoplasma gondii Infection in Blood Donors from the Brazilian Semiarid Region</dc:title>
			<dc:creator>Basílio Felizardo Lima Neto</dc:creator>
			<dc:creator>Ana Caroline Dantas Amorim</dc:creator>
			<dc:creator>Maria Jessianny Diniz Alves</dc:creator>
			<dc:creator>Ana Maria Santos Lima</dc:creator>
			<dc:creator>Janielton Albuquerque Lima</dc:creator>
			<dc:creator>Celine Sousa Menezes Sá</dc:creator>
			<dc:creator>Emilly Henrique Silva</dc:creator>
			<dc:creator>João Luís Garcia</dc:creator>
			<dc:creator>Vinicius Longo Ribeiro Vilela</dc:creator>
			<dc:creator>Thais Ferreira Feitosa</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060163</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-17</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-17</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>163</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060163</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/163</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/162">

	<title>TropicalMed, Vol. 11, Pages 162: Detection of Dengue Virus and Serological Evidence of Chikungunya and Zika Virus Exposure in Patients with Acute Febrile Syndrome in C&amp;oacute;rdoba, Colombia</title>
	<link>https://www.mdpi.com/2414-6366/11/6/162</link>
	<description>Background/Objectives: Arboviral diseases transmitted by Aedes mosquitoes, including Dengue (DENV), Zika (ZIKV), and Chikungunya (CHIKV), represent a major public health challenge in tropical regions. Their clinical similarity complicates differential diagnosis, particularly in settings of viral co-circulation, and may lead to underdiagnosis. The objective was to detect acute dengue infection and assess serological evidence of Chikungunya and Zika virus exposure among patients with acute febrile syndrome and clinical suspicion of dengue in the department of C&amp;amp;oacute;rdoba, Colombia. Methods: A prospective descriptive study was conducted between 2023 and 2024 in healthcare institutions in Monter&amp;amp;iacute;a and Sahag&amp;amp;uacute;n. Serum samples were analyzed by ELISA to detect DENV NS1 antigen, anti-CHIKV IgM, and anti-ZIKV IgG antibodies. Sociodemographic, clinical, and laboratory variables were described, and the association between prior ZIKV infection and dengue severity was assessed. Results: Ninety patients were included. Isolated laboratory marker detection was observed for DENV NS1 antigen in 36.7% (33/90), anti-ZIKV IgG in 30.0% (27/90), and anti-CHIKV IgM in 2.2% (2/90); combined arboviral markers were identified in 22.2% (20/90), and 8.9% (8/90) had no detectable markers. Among NS1-confirmed dengue cases (n = 47), 61.7% (29/47) were classified as dengue with warning signs. Anti-ZIKV IgG detection was not associated with dengue clinical classification (p = 0.989), although platelet counts were lower in IgG-positive cases (p = 0.037). Conclusions: The findings support laboratory-supported diagnosis and integrated acute febrile illness surveillance in C&amp;amp;oacute;rdoba, including locally adapted vector control, in a setting of arbovirus co-circulation with overlapping laboratory markers.</description>
	<pubDate>2026-06-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 162: Detection of Dengue Virus and Serological Evidence of Chikungunya and Zika Virus Exposure in Patients with Acute Febrile Syndrome in C&amp;oacute;rdoba, Colombia</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/162">doi: 10.3390/tropicalmed11060162</a></p>
	<p>Authors:
		Paula A. Avilés-Vergara
		Dina Ricardo-Caldera
		Carlos Alberto Bolívar Pineda
		Eliud Daniel Pérez Vergara
		Ana Carolina Negrette Oquendo
		Luis Carlos Ruiz Garces
		Sara Cecilia Soto-De León
		Catalina Tovar-Acero
		</p>
	<p>Background/Objectives: Arboviral diseases transmitted by Aedes mosquitoes, including Dengue (DENV), Zika (ZIKV), and Chikungunya (CHIKV), represent a major public health challenge in tropical regions. Their clinical similarity complicates differential diagnosis, particularly in settings of viral co-circulation, and may lead to underdiagnosis. The objective was to detect acute dengue infection and assess serological evidence of Chikungunya and Zika virus exposure among patients with acute febrile syndrome and clinical suspicion of dengue in the department of C&amp;amp;oacute;rdoba, Colombia. Methods: A prospective descriptive study was conducted between 2023 and 2024 in healthcare institutions in Monter&amp;amp;iacute;a and Sahag&amp;amp;uacute;n. Serum samples were analyzed by ELISA to detect DENV NS1 antigen, anti-CHIKV IgM, and anti-ZIKV IgG antibodies. Sociodemographic, clinical, and laboratory variables were described, and the association between prior ZIKV infection and dengue severity was assessed. Results: Ninety patients were included. Isolated laboratory marker detection was observed for DENV NS1 antigen in 36.7% (33/90), anti-ZIKV IgG in 30.0% (27/90), and anti-CHIKV IgM in 2.2% (2/90); combined arboviral markers were identified in 22.2% (20/90), and 8.9% (8/90) had no detectable markers. Among NS1-confirmed dengue cases (n = 47), 61.7% (29/47) were classified as dengue with warning signs. Anti-ZIKV IgG detection was not associated with dengue clinical classification (p = 0.989), although platelet counts were lower in IgG-positive cases (p = 0.037). Conclusions: The findings support laboratory-supported diagnosis and integrated acute febrile illness surveillance in C&amp;amp;oacute;rdoba, including locally adapted vector control, in a setting of arbovirus co-circulation with overlapping laboratory markers.</p>
	]]></content:encoded>

	<dc:title>Detection of Dengue Virus and Serological Evidence of Chikungunya and Zika Virus Exposure in Patients with Acute Febrile Syndrome in C&amp;amp;oacute;rdoba, Colombia</dc:title>
			<dc:creator>Paula A. Avilés-Vergara</dc:creator>
			<dc:creator>Dina Ricardo-Caldera</dc:creator>
			<dc:creator>Carlos Alberto Bolívar Pineda</dc:creator>
			<dc:creator>Eliud Daniel Pérez Vergara</dc:creator>
			<dc:creator>Ana Carolina Negrette Oquendo</dc:creator>
			<dc:creator>Luis Carlos Ruiz Garces</dc:creator>
			<dc:creator>Sara Cecilia Soto-De León</dc:creator>
			<dc:creator>Catalina Tovar-Acero</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060162</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-17</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-17</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>162</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060162</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/162</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/161">

	<title>TropicalMed, Vol. 11, Pages 161: Crimean&amp;ndash;Congo Hemorrhagic Fever Virus in Africa: Epidemiological Trends, Transmission Ecology, Hotspot Heterogeneity, and Preparedness Challenges&amp;mdash;A Narrative Review</title>
	<link>https://www.mdpi.com/2414-6366/11/6/161</link>
	<description>Background: Crimean&amp;amp;ndash;Congo hemorrhagic fever virus (CCHFV) is an important tick-borne zoonosis and an emerging public health threat across Africa. Although evidence of viral circulation is mounting, information remains fragmented, limiting a comprehensive understanding of transmission ecology, regional hotspot heterogeneity, and preparedness needs across the continent. Methods: This narrative review critically synthesized published literature on CCHFV in Africa, identified through PubMed, Scopus, and Google Scholar and supplemented by citation tracking and authoritative public health reports. Evidence from epidemiological, ecological, molecular, surveillance, and One Health studies was integrated to examine transmission dynamics, geographic hotspot distribution, viral diversity, risk factors, diagnostic and surveillance challenges, and preparedness strategies. Results: Available evidence shows marked geographic heterogeneity in CCHFV transmission across Africa, with hotspot regions shaped by ecological suitability, Hyalomma tick distribution, livestock&amp;amp;ndash;human interactions, and health system capacity. Livestock consistently show higher exposure than humans, underscoring their role as key indicators of viral circulation. Diagnostic limitations, passive surveillance, ecological variability, and serological cross-reactivity contribute to substantial under recognition of disease burden, while molecular studies reveal considerable viral diversity and ongoing evolution across African regions. Conclusions: CCHFV remains underdiagnosed and underreported in many African settings because of limited surveillance and diagnostic capacity. Strengthening integrated One Health surveillance, expanding laboratory and genomic capacity, utilizing livestock as sentinel populations, and improving cross-sectoral collaboration are critical for enhancing early detection, outbreak preparedness, and effective public health response across the continent.</description>
	<pubDate>2026-06-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 161: Crimean&amp;ndash;Congo Hemorrhagic Fever Virus in Africa: Epidemiological Trends, Transmission Ecology, Hotspot Heterogeneity, and Preparedness Challenges&amp;mdash;A Narrative Review</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/161">doi: 10.3390/tropicalmed11060161</a></p>
	<p>Authors:
		Elichilia Robert Shao
		Jeremia J. Pyuza
		Tito Kibona
		Laura Shirima
		Eliaichi A. Mlay
		Alice Andongolile
		Ray Kayaga
		Semvua Kilonzo
		Blandina T. Mmbaga
		Jaffu Chilongola
		</p>
	<p>Background: Crimean&amp;amp;ndash;Congo hemorrhagic fever virus (CCHFV) is an important tick-borne zoonosis and an emerging public health threat across Africa. Although evidence of viral circulation is mounting, information remains fragmented, limiting a comprehensive understanding of transmission ecology, regional hotspot heterogeneity, and preparedness needs across the continent. Methods: This narrative review critically synthesized published literature on CCHFV in Africa, identified through PubMed, Scopus, and Google Scholar and supplemented by citation tracking and authoritative public health reports. Evidence from epidemiological, ecological, molecular, surveillance, and One Health studies was integrated to examine transmission dynamics, geographic hotspot distribution, viral diversity, risk factors, diagnostic and surveillance challenges, and preparedness strategies. Results: Available evidence shows marked geographic heterogeneity in CCHFV transmission across Africa, with hotspot regions shaped by ecological suitability, Hyalomma tick distribution, livestock&amp;amp;ndash;human interactions, and health system capacity. Livestock consistently show higher exposure than humans, underscoring their role as key indicators of viral circulation. Diagnostic limitations, passive surveillance, ecological variability, and serological cross-reactivity contribute to substantial under recognition of disease burden, while molecular studies reveal considerable viral diversity and ongoing evolution across African regions. Conclusions: CCHFV remains underdiagnosed and underreported in many African settings because of limited surveillance and diagnostic capacity. Strengthening integrated One Health surveillance, expanding laboratory and genomic capacity, utilizing livestock as sentinel populations, and improving cross-sectoral collaboration are critical for enhancing early detection, outbreak preparedness, and effective public health response across the continent.</p>
	]]></content:encoded>

	<dc:title>Crimean&amp;amp;ndash;Congo Hemorrhagic Fever Virus in Africa: Epidemiological Trends, Transmission Ecology, Hotspot Heterogeneity, and Preparedness Challenges&amp;amp;mdash;A Narrative Review</dc:title>
			<dc:creator>Elichilia Robert Shao</dc:creator>
			<dc:creator>Jeremia J. Pyuza</dc:creator>
			<dc:creator>Tito Kibona</dc:creator>
			<dc:creator>Laura Shirima</dc:creator>
			<dc:creator>Eliaichi A. Mlay</dc:creator>
			<dc:creator>Alice Andongolile</dc:creator>
			<dc:creator>Ray Kayaga</dc:creator>
			<dc:creator>Semvua Kilonzo</dc:creator>
			<dc:creator>Blandina T. Mmbaga</dc:creator>
			<dc:creator>Jaffu Chilongola</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060161</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-16</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-16</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>161</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060161</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/161</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2414-6366/11/6/160">

	<title>TropicalMed, Vol. 11, Pages 160: The Impact of HIV Viral Suppression and Immune Status on Rifampicin-Resistant Tuberculosis Outcomes: A Systematic Review and Meta-Analysis Protocol</title>
	<link>https://www.mdpi.com/2414-6366/11/6/160</link>
	<description>Background/Objectives: Rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection remain major contributors to morbidity and mortality, particularly in high-burden settings. HIV-related clinical factors, including viral suppression, CD4-defined immune status, HIV drug resistance, virological failure, and ART failure, may influence RR-TB treatment response; however, existing evidence remains fragmented. This systematic review and meta-analysis protocol aims to synthesize evidence on the impact of HIV viral suppression, immune status, and HIV drug resistance/ART resistance status on RR-TB treatment outcomes. Methods: This protocol was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guidelines. Published peer-reviewed studies and relevant grey literature from January 2005 to December 2025 will be searched in PubMed/MEDLINE, Cochrane Library, Embase, Web of Science, ScienceDirect, EBSCOhost, PsycINFO, Google Scholar, and other relevant sources. No language restriction will be applied at the search stage. Where feasible, non-English records will be translated for title/abstract and full-text screening. Two reviewers will independently screen studies, extract data, and assess study quality, with disagreements resolved by a third reviewer. Study-level risk of bias will be assessed using design-appropriate tools, and the certainty of evidence for each outcome will be evaluated using GRADE. Results: Evidence will be synthesized narratively and, where studies are sufficiently homogeneous, quantitatively through meta-analysis. Outcomes of interest will include treatment success, treatment failure, mortality, treatment completion, microbiological cure, and adverse events. Subgroup analyses will be considered by viral suppression status, CD4-defined immune status, HIV drug resistance/ART resistance status, geographic region, and treatment regimen where data permit. Conclusions: This review will provide evidence on how HIV viral suppression, immune status, and HIV drug resistance/ART resistance influence RR-TB treatment outcomes. The findings may inform integrated TB/HIV care, clinical monitoring, and treatment strategies for individuals co-infected with HIV and RR-TB.</description>
	<pubDate>2026-06-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>TropicalMed, Vol. 11, Pages 160: The Impact of HIV Viral Suppression and Immune Status on Rifampicin-Resistant Tuberculosis Outcomes: A Systematic Review and Meta-Analysis Protocol</b></p>
	<p>Tropical Medicine and Infectious Disease <a href="https://www.mdpi.com/2414-6366/11/6/160">doi: 10.3390/tropicalmed11060160</a></p>
	<p>Authors:
		Tukisho Mphahlele
		Thendo Gertie Makhado
		Lufuno Makhado
		</p>
	<p>Background/Objectives: Rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection remain major contributors to morbidity and mortality, particularly in high-burden settings. HIV-related clinical factors, including viral suppression, CD4-defined immune status, HIV drug resistance, virological failure, and ART failure, may influence RR-TB treatment response; however, existing evidence remains fragmented. This systematic review and meta-analysis protocol aims to synthesize evidence on the impact of HIV viral suppression, immune status, and HIV drug resistance/ART resistance status on RR-TB treatment outcomes. Methods: This protocol was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guidelines. Published peer-reviewed studies and relevant grey literature from January 2005 to December 2025 will be searched in PubMed/MEDLINE, Cochrane Library, Embase, Web of Science, ScienceDirect, EBSCOhost, PsycINFO, Google Scholar, and other relevant sources. No language restriction will be applied at the search stage. Where feasible, non-English records will be translated for title/abstract and full-text screening. Two reviewers will independently screen studies, extract data, and assess study quality, with disagreements resolved by a third reviewer. Study-level risk of bias will be assessed using design-appropriate tools, and the certainty of evidence for each outcome will be evaluated using GRADE. Results: Evidence will be synthesized narratively and, where studies are sufficiently homogeneous, quantitatively through meta-analysis. Outcomes of interest will include treatment success, treatment failure, mortality, treatment completion, microbiological cure, and adverse events. Subgroup analyses will be considered by viral suppression status, CD4-defined immune status, HIV drug resistance/ART resistance status, geographic region, and treatment regimen where data permit. Conclusions: This review will provide evidence on how HIV viral suppression, immune status, and HIV drug resistance/ART resistance influence RR-TB treatment outcomes. The findings may inform integrated TB/HIV care, clinical monitoring, and treatment strategies for individuals co-infected with HIV and RR-TB.</p>
	]]></content:encoded>

	<dc:title>The Impact of HIV Viral Suppression and Immune Status on Rifampicin-Resistant Tuberculosis Outcomes: A Systematic Review and Meta-Analysis Protocol</dc:title>
			<dc:creator>Tukisho Mphahlele</dc:creator>
			<dc:creator>Thendo Gertie Makhado</dc:creator>
			<dc:creator>Lufuno Makhado</dc:creator>
		<dc:identifier>doi: 10.3390/tropicalmed11060160</dc:identifier>
	<dc:source>Tropical Medicine and Infectious Disease</dc:source>
	<dc:date>2026-06-15</dc:date>

	<prism:publicationName>Tropical Medicine and Infectious Disease</prism:publicationName>
	<prism:publicationDate>2026-06-15</prism:publicationDate>
	<prism:volume>11</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Systematic Review</prism:section>
	<prism:startingPage>160</prism:startingPage>
		<prism:doi>10.3390/tropicalmed11060160</prism:doi>
	<prism:url>https://www.mdpi.com/2414-6366/11/6/160</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
    
<cc:License rdf:about="https://creativecommons.org/licenses/by/4.0/">
	<cc:permits rdf:resource="https://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
